data_2dgz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dgz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.705 0.288 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -41.86 -59.17 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -99.97 -37.37 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -42.49 -57.59 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.94 -57.3 6.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 54.6 m -46.99 -43.4 19.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.169 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.9 -38.65 86.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.71 -53.21 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 59.1 t -62.49 -40.13 87.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 20.9 tp -65.83 -59.33 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.1 t80 -37.55 -51.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.98 -42.64 60.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 31.8 mttm -61.96 -45.18 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 43.2 mt -59.53 -52.99 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 77.6 t -48.02 -47.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.55 -46.52 83.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.84 -53.0 62.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -47.59 -45.09 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1165 ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' 1168 ' ' ALA . 21.6 tt0 -59.08 -70.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -45.96 -26.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.92 -32.39 21.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1168 ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' 1165 ' ' GLN . . . -57.97 -50.22 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.55 -44.92 96.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.12 -52.18 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.451 ' CE ' HD12 ' A' 1178 ' ' LEU . 10.4 mtm -77.74 -6.02 52.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.96 39.41 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 31.7 m -127.82 142.69 45.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 138.64 21.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.93 -23.26 4.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -91.23 -35.61 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.7 mm -59.0 -48.91 85.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.451 HD12 ' CE ' ' A' 1171 ' ' MET . 13.3 tp -49.34 -62.26 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.72 124.19 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.0 t -78.58 154.13 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -45.86 -38.8 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -51.58 -45.08 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.93 -51.38 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.53 -48.83 65.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 90.6 t -52.73 -53.26 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.52 -50.39 70.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 82.2 mtp -56.54 -36.35 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -73.68 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -90.0 -54.73 3.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 17.5 mtt -75.06 -27.68 60.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.429 ' N ' ' CD ' ' A' 1192 ' ' PRO . 21.8 mtm180 54.89 54.85 10.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.1 Cg_endo -69.78 125.19 11.84 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 0.0 112.314 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.5 p -97.29 -24.51 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 77.6 p -107.61 138.52 43.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.533 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.4 p -52.94 -28.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.45 ' N ' HG12 ' A' 1195 ' ' VAL . 71.3 mm-40 -58.43 -50.08 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.2 -36.52 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 97.6 t -57.58 -47.16 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 18.0 mttp -50.94 -36.78 40.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -65.55 -23.9 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 32.5 mm -52.48 150.99 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.69 137.85 37.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 98.69 -37.99 3.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.8 p -74.04 132.43 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 47.8 t -95.92 145.23 25.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -40.85 131.35 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 88.87 -58.45 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' 1209 ' ' ALA . 9.1 ttmm -37.63 -50.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.98 -48.74 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 2.0 ptt? -46.91 -28.11 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 70.9 mt -86.53 29.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.559 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -66.37 -51.66 41.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.711 . . . . 0.0 111.079 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.01 -22.54 3.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.61 -67.27 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -60.65 -30.09 69.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' 1216 ' ' TRP . 8.8 mm-40 -54.17 -34.63 60.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.3 t -74.0 -32.96 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.7 -40.95 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.136 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1220 ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' 1224 ' ' GLN . 25.2 ttpt -59.84 -38.53 82.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1221 ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' A' 1225 ' ' THR . 10.9 t60 -77.99 -47.08 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 39.3 t80 -51.54 -41.46 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' 1227 ' ' SER . 21.5 p -84.11 -35.34 23.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.487 ' CG ' ' O ' ' A' 1220 ' ' LYS . 8.9 mm100 -64.22 -31.79 73.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' 1221 ' ' HIS . 3.5 t -88.99 -15.67 33.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -119.78 15.03 12.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' 1223 ' ' CYS . 4.3 t 41.61 40.89 1.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 89.7 t -87.5 144.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -64.78 148.54 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.7 p -146.79 -175.5 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.53 49.93 4.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.719 0.295 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' 1147 ' ' ALA . 66.8 mt-30 -34.5 -47.05 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -97.68 -51.02 4.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -44.03 -59.15 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -47.63 -58.8 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 89.4 m -43.76 -45.3 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -65.35 -38.54 90.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.6 -46.72 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -42.37 87.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.463 HD21 ' NE ' ' A' 1191 ' ' ARG . 22.2 tp -67.35 -57.82 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 54.5 t80 -38.12 -50.83 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.2 -45.19 92.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 35.8 mttm -57.4 -45.21 84.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.29 -51.82 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 100.0 t -52.4 -41.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.01 -55.16 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -46.86 -34.07 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -66.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' 1167 ' ' HIS . 12.5 pttp -53.48 -27.11 23.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.595 ' CE1' ' SD ' ' A' 1171 ' ' MET . 2.3 t60 -83.43 -35.19 25.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -53.84 -48.9 69.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.26 -37.21 83.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.6 tttt -51.42 -41.37 60.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.595 ' SD ' ' CE1' ' A' 1167 ' ' HIS . 3.2 mpp? -96.7 2.78 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 61.73 31.32 18.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 34.8 m -112.02 138.27 21.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.693 . . . . 0.0 111.166 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 136.02 23.38 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -16.77 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.17 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.87 -39.83 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.527 ' CD1' ' CE ' ' A' 1171 ' ' MET . 15.8 tp -59.3 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.34 139.8 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 38.1 p -93.27 162.24 14.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -56.79 -36.16 69.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.62 -51.94 67.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.71 -48.35 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.04 -50.95 65.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 79.8 t -56.74 -52.03 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.472 ' HB2' ' CG2' ' A' 1201 ' ' ILE . 51.8 m-20 -55.1 -46.68 75.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.99 -40.74 81.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1188 ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' 1191 ' ' ARG . . . -64.75 -31.56 72.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -80.04 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' 1201 ' ' ILE . 17.8 mtt -62.17 -38.39 88.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' 1188 ' ' ALA . 17.1 mmt85 65.28 52.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 131.96 22.38 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -120.54 24.56 10.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1194 ' ' THR . . . . . 0.404 ' O ' ' CG2' ' A' 1198 ' ' VAL . 19.1 p -138.36 134.72 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.12 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.56 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 7.1 p -52.98 -26.96 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -75.35 -67.93 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -44.11 -39.59 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' 1209 ' ' ALA . 74.6 t -48.57 -43.58 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1199 ' ' LYS . . . . . 0.425 ' HA ' ' CG1' ' A' 1204 ' ' VAL . 6.0 mtmp? -56.67 -30.43 63.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -67.16 -29.16 68.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' 1202 ' ' ASP . 13.7 mm -59.32 102.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' 1201 ' ' ILE . 9.3 t70 -31.46 145.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.43 -41.83 2.08 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1204 ' ' VAL . . . . . 0.444 ' CG2' ' HD2' ' A' 1208 ' ' LYS . 2.8 p -93.52 140.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1205 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1206 ' ' GLU . 12.9 t -100.2 138.96 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1206 ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' 1205 ' ' SER . 36.3 tt0 -34.26 129.61 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 100.17 -64.94 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.444 ' HD2' ' CG2' ' A' 1204 ' ' VAL . 16.6 ttmm -38.7 -48.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' 1198 ' ' VAL . . . -34.8 -42.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.75 -65.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.7 ptt? -53.3 -24.59 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.08 34.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.553 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.51 -49.81 39.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.689 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.536 ' HG2' ' CD2' ' A' 1167 ' ' HIS . 65.0 Cg_exo -48.0 -20.14 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.69 -63.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.9 OUTLIER -65.37 -23.15 66.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.405 ' N ' ' CD1' ' A' 1216 ' ' TRP . 33.2 mt-10 -61.59 -36.23 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.1 t -67.28 -42.91 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.52 -40.29 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -60.63 -43.13 97.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.36 -44.54 58.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.5 t80 -56.81 -46.13 81.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' 1227 ' ' SER . 28.4 p -70.09 -36.21 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -57.76 -34.65 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.469 HG21 ' ND2' ' A' 1226 ' ' ASN . 5.3 t -93.13 -37.3 12.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.469 ' ND2' HG21 ' A' 1225 ' ' THR . 34.4 m-80 -93.39 15.81 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' 1223 ' ' CYS . 17.6 m 35.49 46.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' 1229 ' ' GLN . 59.0 t -87.57 139.27 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.469 ' N ' HG13 ' A' 1228 ' ' VAL . 1.2 tp-100 -63.57 148.02 49.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1230 ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' 1231 ' ' ASP . 37.6 p -138.35 -175.39 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1231 ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' 1230 ' ' THR . 4.8 p-10 48.13 49.24 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.723 0.297 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -38.43 -49.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -93.32 -50.2 5.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1150 ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' 1150 ' ' GLN . 3.0 tp60 -47.11 -60.06 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -42.7 -60.81 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 86.7 m -43.96 -46.02 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -62.26 -38.76 90.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.19 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 96.7 t -68.93 -43.73 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.414 HD12 ' CD2' ' A' 1222 ' ' PHE . 17.6 tp -63.72 -55.32 24.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 62.8 t80 -40.62 -49.51 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.17 92.78 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1159 ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' 1162 ' ' GLU . 37.9 mttm -55.3 -33.46 63.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1160 ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' 1161 ' ' VAL . 25.0 mt -74.13 -59.99 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1161 ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' 1160 ' ' LEU . 97.3 t -37.17 -62.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.06 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1162 ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' 1159 ' ' LYS . 5.2 pt-20 -38.89 -54.71 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.51 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -54.47 -48.63 71.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -58.56 -65.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' 1167 ' ' HIS . 1.2 ptpm? -47.56 -44.9 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.433 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.7 OUTLIER -58.24 -42.84 87.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.16 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -60.44 -47.3 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 57.4 tttp -42.68 -51.06 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.59 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 59.1 mtm -87.69 -5.62 58.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.59 32.62 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -114.63 141.31 26.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.596 0.712 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 136.68 23.29 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.97 -17.23 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.41 -40.79 9.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.2 mm -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.59 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.8 tp -53.78 -68.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.42 120.39 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.0 t -72.61 156.38 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -47.01 -43.75 19.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -48.61 -52.68 21.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.32 -40.88 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.76 -61.51 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.6 t -41.46 -50.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.64 -51.52 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 93.8 mtp -55.95 -36.94 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.12 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -78.42 -63.37 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 25.8 mtt -63.87 -39.33 93.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.7 mtt-85 66.31 54.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.594 0.712 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.78 129.35 17.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 58.2 p -104.89 -26.08 12.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 72.1 p -108.24 149.61 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.417 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.9 p -58.46 -26.89 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' 1195 ' ' VAL . 31.2 mt-10 -57.85 -45.85 85.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -73.62 -44.1 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 69.7 t -44.26 -45.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.2 mttm -57.38 -35.72 70.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -68.94 -26.12 64.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' 1202 ' ' ASP . 27.2 mm -55.42 98.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' 1201 ' ' ILE . 10.4 t0 -34.58 143.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.33 -46.55 1.43 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.52 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.4 p -76.13 142.31 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 42.5 t -99.83 154.01 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 145.0 10.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.03 -55.72 5.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.5 ttmp? -44.62 -49.47 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -34.63 -49.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -38.16 -65.84 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.0 ptt? -52.67 -25.85 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' 1209 ' ' ALA . 52.7 mt -87.28 32.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.565 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -70.51 -53.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 111.078 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.5 Cg_exo -47.97 -17.74 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.71 -64.76 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -62.55 -24.17 67.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' 1216 ' ' TRP . 51.5 mt-10 -58.78 -39.4 80.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 93.3 t -69.21 -41.85 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.82 -48.45 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.167 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -54.66 -44.56 73.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 14.1 t60 -62.83 -56.4 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.414 ' CD2' HD12 ' A' 1156 ' ' LEU . 66.2 t80 -44.07 -67.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' 1227 ' ' SER . 61.6 m -50.83 -55.29 17.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' 1223 ' ' CYS . 30.2 mt-30 -35.32 -69.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -37.23 79.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' 1227 ' ' SER . 2.1 m-80 -85.27 16.6 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.1 t 33.98 50.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 85.3 t -103.26 141.84 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.61 155.53 40.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.2 p -143.02 -177.08 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 10.9 t0 54.91 51.24 13.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.718 0.294 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' 1147 ' ' ALA . 94.0 mm-40 -37.62 -53.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -94.23 -48.14 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.84 -58.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -43.79 -60.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 85.1 m -44.41 -48.58 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.78 -33.24 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 90.2 mt -67.02 -61.89 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 46.9 t -52.39 -43.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 19.3 tp -64.86 -57.34 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -38.76 -42.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.7 -45.72 95.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 26.8 mttm -61.72 -44.09 97.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.97 -52.49 65.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 85.0 t -48.24 -44.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.08 -45.51 83.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.2 98.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -58.19 -41.69 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1165 ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' 1166 ' ' LYS . 10.5 tm0? -64.37 -60.5 3.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.462 ' N ' ' OE1' ' A' 1165 ' ' GLN . 5.6 ptmm? -54.92 -35.98 64.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -46.94 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.31 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.28 -45.9 92.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 30.8 tttt -46.38 -55.64 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.901 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.46 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 29.3 mtm -79.61 -7.83 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.8 t70 68.43 30.87 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 34.8 m -113.61 139.66 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.692 0.758 . . . . 0.0 111.128 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.96 136.7 23.02 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.395 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 -16.76 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.69 9.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.4 mm -56.68 -42.99 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.46 ' CD1' ' HE1' ' A' 1171 ' ' MET . 14.8 tp -57.35 -70.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.63 131.34 13.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.6 t -80.9 175.47 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.23 -46.73 87.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -53.21 17.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.18 -52.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.44 -49.92 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.5 t -49.92 -52.83 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -50.03 -55.27 15.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 71.1 mtp -47.47 -44.75 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.88 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -78.17 -62.16 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.77 -37.58 79.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' 1192 ' ' PRO . 27.2 mtp180 63.74 51.96 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.73 139.43 40.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 18.9 p -124.23 25.72 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.179 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 27.2 p -140.26 125.65 18.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.445 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.3 p -44.59 -33.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.7 -62.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -48.68 -43.16 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 87.1 t -50.53 -39.99 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -62.04 -23.54 66.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.469 HG21 ' N ' ' A' 1202 ' ' ASP . 27.4 mm -61.53 142.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.469 ' N ' HG21 ' A' 1201 ' ' ILE . 32.6 t0 -67.46 139.65 57.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.03 -52.22 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 6.1 p -65.59 137.05 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.1 t -100.06 145.42 27.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -38.86 135.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 86.5 -57.37 4.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.6 OUTLIER -40.53 -54.09 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.79 -48.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.73 -62.65 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.3 ptt? -50.06 -22.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.69 35.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.571 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -66.54 -52.99 32.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 0.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.03 -67.38 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -59.2 -23.77 62.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.432 ' N ' ' CD1' ' A' 1216 ' ' TRP . 12.3 mm-40 -57.63 -45.28 85.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.65 -42.92 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.78 -26.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -68.26 -35.95 78.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -82.04 -49.3 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.42 ' HB3' ' NH2' ' A' 1191 ' ' ARG . 30.0 t80 -40.31 -42.49 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.6 p -77.54 -37.22 51.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -61.35 -43.84 98.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.446 HG21 ' ND2' ' A' 1226 ' ' ASN . 7.1 t -75.43 -37.97 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' 1227 ' ' SER . 33.8 m-80 -93.44 16.08 14.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' 1226 ' ' ASN . 22.6 t 34.9 51.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.409 HG22 ' CB ' ' A' 1226 ' ' ASN . 45.7 t -105.92 157.55 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -81.11 152.49 27.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 67.9 p -145.78 -179.66 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.47 45.83 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.778 0.323 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 67.3 mt-30 -34.49 -51.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -96.17 -51.02 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -38.47 -63.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -42.35 -62.86 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.3 m -40.14 -50.24 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.24 -39.39 82.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.64 -57.71 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.5 t -57.59 -43.21 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.512 HD13 ' CG ' ' A' 1222 ' ' PHE . 23.6 tp -63.84 -62.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' 1156 ' ' LEU . 65.9 t80 -35.84 -45.44 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.54 90.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 23.1 mttm -56.91 -44.18 82.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.92 -43.79 97.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.4 t -56.54 -46.13 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -53.75 -39.1 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.8 -49.19 63.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -53.68 -44.31 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.72 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' 1167 ' ' HIS . 0.5 OUTLIER -53.5 -41.96 66.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.453 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.8 OUTLIER -62.38 -45.05 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.61 -59.12 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -55.82 -45.53 78.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -43.78 -54.69 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.523 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 38.8 mtm -84.77 -1.92 56.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.68 29.52 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.7 m -111.62 141.24 24.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.98 138.54 21.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.236 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.96 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.302 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.14 -47.88 6.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.5 mm -48.01 -39.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.523 ' CD1' ' CE ' ' A' 1171 ' ' MET . 11.2 tp -58.78 -67.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -149.35 147.6 28.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.088 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 57.8 p -89.43 169.75 11.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.45 -33.84 76.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -62.45 -50.17 72.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 90.5 mt -55.75 -46.49 79.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.95 -53.29 59.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 70.8 t -48.41 -47.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' 1201 ' ' ILE . 67.7 m-20 -59.24 -45.56 90.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 89.4 mtp -58.1 -40.79 82.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.23 75.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -77.26 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.434 ' CE ' HD13 ' A' 1201 ' ' ILE . 13.8 mtt -65.0 -41.2 95.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' A' 1192 ' ' PRO . 33.8 mtt-85 68.18 54.39 0.63 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.8 134.5 28.04 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.661 2.241 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.1 p -102.11 -33.17 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 60.8 p -101.82 149.92 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.471 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 12.5 p -57.23 -33.6 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' 1195 ' ' VAL . 46.5 mt-10 -53.05 -47.43 68.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -66.5 -46.37 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 99.1 t -50.74 -54.5 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.191 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -46.5 -36.29 6.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.19 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.434 HD13 ' CE ' ' A' 1190 ' ' MET . 37.9 mm -43.21 148.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.56 139.69 43.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 97.46 -49.14 1.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.514 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 6.3 p -66.13 131.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 7.7 t -95.77 173.74 7.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.31 143.39 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.83 -54.02 4.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' 1209 ' ' ALA . 28.5 ttmt -41.67 -53.78 3.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.2 -50.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.74 -66.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.13 -25.14 1.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' 1209 ' ' ALA . 69.8 mt -89.44 32.26 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.542 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -69.12 -53.3 14.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 111.105 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.0 Cg_exo -47.9 -18.16 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.392 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.04 -69.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.1 p90 -57.36 -26.32 60.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.5 mt-10 -56.5 -37.28 70.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.2 t -71.13 -41.82 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.83 -53.45 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.102 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -45.12 -45.1 11.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -72.62 -46.58 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.512 ' CG ' HD13 ' A' 1156 ' ' LEU . 49.9 t80 -50.17 -59.59 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' 1227 ' ' SER . 25.7 p -54.89 -47.91 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -42.0 -69.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -62.01 -40.54 96.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' 1227 ' ' SER . 72.1 m-80 -80.41 13.54 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' 1223 ' ' CYS . 79.0 p 33.7 51.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 84.7 t -102.76 143.33 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.78 160.42 30.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 59.1 p -148.02 -179.23 6.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 39.8 t0 65.67 40.06 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.778 0.323 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 27.1 mt-30 -36.64 -50.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -94.37 -51.91 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -45.27 -56.06 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.56 -58.4 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 96.8 m -44.82 -41.78 7.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1153 ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 37.3 mt-30 -67.24 -37.22 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.96 -57.24 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 75.2 t -57.28 -45.1 84.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' 1157 ' ' TYR . 22.8 tp -62.16 -62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 54.4 t80 -36.58 -56.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -48.97 -43.79 31.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.472 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1159 ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' 1222 ' ' PHE . 5.8 mtmp? -66.08 -40.25 90.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.927 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.2 t -56.3 -42.05 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -54.29 -53.78 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.26 96.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' 1179 ' ' ALA . 7.1 tmm_? -57.82 -26.41 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.802 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.24 -72.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' 1167 ' ' HIS . 2.3 pttm -40.7 -29.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.431 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.3 t60 -78.13 -45.53 23.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.1 15.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -58.49 -40.24 82.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -48.63 -56.87 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.526 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 69.5 mtm -80.35 4.64 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 49.7 m-20 58.51 36.29 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.1 m -114.95 141.59 27.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.677 0.751 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 133.58 23.06 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.383 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -47.95 -18.47 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.39 -40.44 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 25.1 mm -58.23 -47.73 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.526 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.4 tp -53.14 -63.86 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1179 ' ' ALA . . . . . 0.41 ' HB2' ' CG ' ' A' 1164 ' ' ARG . . . -153.13 120.3 5.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 6.4 t -75.9 146.04 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -41.76 -44.57 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -46.06 -53.01 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.43 -56.49 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 66.1 mt -51.26 -52.26 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 89.6 t -44.68 -49.29 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.32 -44.48 91.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.7 mtp -55.72 -41.52 73.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.21 -30.82 69.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1189 ' ' LYS . . . . . 0.416 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 6.3 mtpm? -77.25 -58.35 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 24.7 mtt -68.71 -40.86 79.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.422 ' N ' ' CD ' ' A' 1192 ' ' PRO . 35.1 mtt-85 68.74 55.08 0.58 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.81 137.31 35.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 0.0 112.334 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 50.7 p -105.59 -29.3 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.098 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 66.0 p -107.92 148.92 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.558 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.8 p -58.97 -39.7 78.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.466 ' N ' HG12 ' A' 1195 ' ' VAL . 7.4 mm-40 -47.33 -29.54 2.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -90.94 -39.16 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.442 HG23 ' CE3' ' A' 1216 ' ' TRP . 74.4 t -55.79 -49.02 77.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -56.31 -30.53 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.34 -24.22 62.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 35.3 mm -52.43 146.76 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -68.96 138.24 54.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.11 -51.95 1.02 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.7 p -70.86 144.26 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 5.8 t -100.04 157.85 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -51.4 140.38 17.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 81.51 -55.49 4.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' 1209 ' ' ALA . 25.3 ttpt -39.61 -56.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.75 -43.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.36 -62.44 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 7.6 ptt? -55.88 -23.42 31.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 96.1 mt -89.85 34.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.568 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -68.79 -48.64 29.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.0 -17.15 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.4 mp -82.22 -66.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.568 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.0 OUTLIER -61.48 -25.44 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.466 ' N ' ' CD1' ' A' 1216 ' ' TRP . 20.3 mt-10 -57.68 -36.5 72.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 99.0 t -68.8 -39.02 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.05 -53.04 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -46.21 -42.58 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -76.74 -45.39 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.417 ' HB2' ' NZ ' ' A' 1159 ' ' LYS . 17.0 t80 -52.99 -39.84 63.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -79.9 -29.0 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.69 -38.24 90.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 4.5 t -87.07 -16.58 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' 1227 ' ' SER . 18.3 m-80 -119.65 18.48 12.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' 1223 ' ' CYS . 14.8 m 34.23 46.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' 1223 ' ' CYS . 85.4 t -84.83 152.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.12 140.58 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 21.5 p -129.1 176.57 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 43.52 47.23 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.728 0.299 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' 1147 ' ' ALA . 87.2 mt-30 -37.63 -51.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.76 -48.96 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -44.36 -51.74 8.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -52.29 -57.94 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1152 ' ' THR . . . . . 0.421 HG21 ' NH1' ' A' 1191 ' ' ARG . 78.0 m -44.17 -43.49 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -65.73 -37.16 85.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.93 -43.16 96.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.8 t -70.82 -41.04 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.33 -55.81 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -37.44 -43.62 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.98 -47.53 88.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 46.3 mttm -56.61 -41.76 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.88 -42.8 97.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 94.0 t -59.64 -42.15 87.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.35 -39.22 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.53 72.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.565 ' NH2' ' CD2' ' A' 1215 ' ' LEU . 43.3 ttm-85 -79.76 -43.12 23.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.34 -34.96 62.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.2 pttp -84.31 -38.34 20.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' 1170 ' ' LYS . 0.6 OUTLIER -63.97 -56.76 12.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1168 ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' 1167 ' ' HIS . . . -37.27 -53.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.68 -37.8 85.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1170 ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' 1167 ' ' HIS . 18.4 ttmt -55.95 -51.75 66.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1171 ' ' MET . . . . . . . . . . . . . 15.7 mtm -80.07 -1.4 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 68.19 30.09 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.2 m -119.66 134.53 23.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.99 141.86 16.41 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.97 -16.64 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.75 -47.01 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 12.7 mm -51.43 -42.76 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.419 HD23 ' NH1' ' A' 1164 ' ' ARG . 14.4 tp -56.83 -57.34 12.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1179 ' ' ALA . . . . . 0.478 ' HB2' ' CZ ' ' A' 1164 ' ' ARG . . . -160.38 156.07 25.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 26.1 p -94.48 161.12 14.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.113 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -54.85 -28.64 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 26.7 tptt -62.62 -51.78 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 -40.06 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1184 ' ' LEU . . . . . 0.405 ' CD2' ' HE ' ' A' 1164 ' ' ARG . 63.2 mt -60.76 -54.46 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 79.9 t -49.31 -36.69 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.421 ' CB ' ' CG2' ' A' 1201 ' ' ILE . 1.2 m-20 -60.65 -62.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 95.0 mtp -55.51 -20.55 13.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -75.12 -21.68 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 21.4 mttm -102.82 -51.97 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.45 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.1 OUTLIER -74.45 -20.91 59.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.539 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 13.0 ptt180 33.65 55.05 1.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.78 149.48 66.81 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.391 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 61.6 p -127.35 24.11 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 120.97 14.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.546 HG23 ' CH2' ' A' 1216 ' ' TRP . 11.3 p -40.31 -39.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.69 -66.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -48.25 -41.96 29.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 94.9 t -50.17 -47.95 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.2 mttp -50.07 -30.92 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -70.98 -29.59 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' 1202 ' ' ASP . 26.0 mm -53.53 101.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' 1201 ' ' ILE . 12.3 t70 -35.3 145.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 96.01 -41.05 2.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.3 p -78.22 138.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 111.068 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 4.0 m -99.98 140.79 33.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -40.22 138.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.88 -58.82 5.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' 1209 ' ' ALA . 38.7 tttt -40.38 -55.71 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.93 -39.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.3 -65.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.1 ptt? -49.31 -25.51 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 17.1 mt -88.94 26.76 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.569 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.68 -52.36 26.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.565 0.698 . . . . 0.0 111.05 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.6 Cg_exo -48.01 -16.94 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.678 2.252 . . . . 0.0 112.321 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1215 ' ' LEU . . . . . 0.565 ' CD2' ' NH2' ' A' 1164 ' ' ARG . 7.3 mp -82.24 -71.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -52.83 -15.8 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.26 -38.86 88.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -66.4 -50.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.1 mt -46.49 -40.95 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -55.06 -40.39 70.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -76.84 -42.94 38.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -53.95 -61.38 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' 1227 ' ' SER . 22.8 p -53.87 -45.67 71.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.874 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -43.4 -68.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -63.87 -39.45 94.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.454 ' O ' ' C ' ' A' 1227 ' ' SER . 2.6 m-80 -81.22 13.13 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' 1223 ' ' CYS . 72.2 m 33.84 50.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.539 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 84.2 t -97.5 149.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.461 ' N ' HG13 ' A' 1228 ' ' VAL . 2.5 mp0 -67.93 154.77 40.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 20.5 p -145.56 158.77 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 43.4 t0 64.77 42.56 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 54.8 mt-30 -34.75 -52.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.57 -53.47 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -42.76 -59.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -42.75 -57.14 2.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 90.9 m -46.71 -50.5 17.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.14 -40.86 95.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.73 -58.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 73.6 t -54.75 -39.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.481 HD12 ' CG ' ' A' 1222 ' ' PHE . 12.8 tp -66.32 -57.75 6.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 75.1 t80 -38.34 -46.69 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.12 -46.23 91.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1159 ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' 1162 ' ' GLU . 21.1 mttm -59.45 -33.22 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 25.2 mt -75.06 -52.67 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 95.7 t -40.16 -62.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1162 ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' 1159 ' ' LYS . 4.6 pt-20 -40.47 -56.39 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.68 94.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -59.15 -28.57 66.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1165 ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' 1168 ' ' ALA . 31.8 tt0 -82.0 -71.6 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 8.9 pttp -43.39 -29.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.9 t60 -78.02 -37.51 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1168 ' ' ALA . . . . . 0.465 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.66 -61.71 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -55.7 -35.28 65.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 9.9 tttp -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' 1178 ' ' LEU . 27.3 mtm -76.41 6.27 5.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.36 29.15 18.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.3 m -114.57 139.75 24.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.94 140.23 18.78 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -48.05 -16.68 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.63 -52.34 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 32.9 mm -47.67 -46.7 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.465 HD22 ' CA ' ' A' 1168 ' ' ALA . 16.9 tp -49.46 -65.97 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -148.28 118.46 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1180 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.5 t -72.91 139.1 46.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1181 ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' 1180 ' ' THR . 31.9 m120 -35.77 -46.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.9 tptm -43.34 -58.16 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.39 -59.16 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 33.6 mt -47.38 -44.73 24.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 55.4 t -56.5 -55.03 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.428 ' HA ' ' CE ' ' A' 1189 ' ' LYS . 1.1 m-20 -58.89 -42.03 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.2 mtp -58.37 -35.69 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.1 74.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1189 ' ' LYS . . . . . 0.428 ' CE ' ' HA ' ' A' 1186 ' ' ASP . 49.5 mtmt -76.75 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 13.9 mtt -67.07 -39.27 86.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.1 mtt85 64.31 53.4 1.33 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.639 0.733 . . . . 0.0 110.935 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.71 126.9 13.89 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 34.0 p -96.27 -32.08 12.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 73.3 p -101.24 147.58 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.564 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -57.52 -36.53 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.158 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' 1195 ' ' VAL . 48.4 mt-10 -48.38 -52.02 23.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -68.19 -45.96 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.429 HG22 ' CE3' ' A' 1216 ' ' TRP . 99.5 t -48.4 -52.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -49.53 -33.88 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -68.39 -27.97 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 30.7 mm -51.21 139.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 30.4 t0 -65.66 141.05 58.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.85 -48.45 1.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.0 p -65.7 137.44 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 3.0 m -100.0 142.78 31.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -39.06 130.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.96 -63.64 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' 1207 ' ' GLY . 18.1 ttmt -34.36 -48.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -35.34 -49.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.94 -63.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.2 ptt? -53.0 -22.63 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' 1209 ' ' ALA . 84.1 mt -90.7 32.68 0.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.561 ' HB3' ' CZ2' ' A' 1216 ' ' TRP . . . -70.3 -52.32 12.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 111.132 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.9 Cg_exo -47.99 -17.36 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.44 -67.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.564 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.1 p90 -58.74 -26.98 64.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' 1216 ' ' TRP . 10.1 mt-10 -54.89 -35.81 64.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 74.7 t -71.14 -35.77 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.6 -46.93 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -47.36 -39.21 14.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1221 ' ' HIS . . . . . 0.533 ' CD2' ' HG2' ' A' 1224 ' ' GLN . 3.4 t-160 -80.64 -52.78 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.481 ' CG ' HD12 ' A' 1156 ' ' LEU . 47.2 t80 -38.95 -33.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' 1227 ' ' SER . 21.8 p -92.98 -28.64 16.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.533 ' HG2' ' CD2' ' A' 1221 ' ' HIS . 3.5 pt20 -66.52 -46.6 75.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' 1224 ' ' GLN . 9.0 t -76.7 -11.98 59.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' 1227 ' ' SER . 23.0 m-80 -123.11 15.24 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' 1223 ' ' CYS . 58.7 p 36.2 49.29 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' 1229 ' ' GLN . 89.1 t -93.03 142.17 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.462 ' N ' HG12 ' A' 1228 ' ' VAL . 19.1 pt20 -69.56 148.0 50.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 72.6 p -137.48 -177.81 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 7.0 m-20 62.65 43.41 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1232 ' ' LEU . . . . . 0.408 HD13 ' NH1' ' A' 1191 ' ' ARG . 11.9 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.726 0.298 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -46.04 -52.45 11.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -99.7 -42.38 6.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -41.89 -57.03 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -46.76 -56.19 6.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.0 m -50.21 -49.59 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.34 -33.93 71.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.58 -56.7 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.4 t -59.37 -43.1 89.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' 1157 ' ' TYR . 23.1 tp -59.87 -60.41 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' 1156 ' ' LEU . 58.9 t80 -35.96 -47.97 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.06 -46.16 61.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 51.2 mttt -58.22 -42.37 86.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1160 ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' 1219 ' ' ILE . 39.6 mt -62.74 -42.27 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.2 t -61.07 -44.11 97.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.94 -46.96 85.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.3 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.44 -41.62 76.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.46 -61.49 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' 1167 ' ' HIS . 17.2 ptpt -52.27 -46.18 65.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.45 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.9 OUTLIER -61.23 -46.43 90.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.84 -51.79 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -61.9 -44.49 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 61.6 tttt -46.34 -56.99 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.469 ' HE2' ' CD1' ' A' 1178 ' ' LEU . 29.0 mtm -79.68 0.91 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.94 42.62 19.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.6 m -125.14 141.78 39.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.61 0.719 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 135.98 23.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.228 . . . . 0.0 112.349 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.92 -17.45 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.23 -41.2 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.8 mm -54.37 -40.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.469 ' CD1' ' HE2' ' A' 1171 ' ' MET . 10.9 tp -60.13 -62.36 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.29 150.21 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 71.4 p -87.34 167.61 13.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.39 -38.53 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -50.32 73.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 69.9 mt -51.06 -46.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 61.3 mt -56.25 -50.59 70.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.8 t -49.45 -53.61 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -54.89 -51.04 67.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.9 mtp -53.69 -40.04 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.44 72.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 31.7 mttm -79.2 -63.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 19.4 mtt -61.29 -40.91 95.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.426 ' N ' ' CD ' ' A' 1192 ' ' PRO . 39.2 mtm-85 66.08 55.04 0.99 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.708 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 141.84 46.34 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 57.0 p -110.34 -33.34 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.163 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 25.3 p -100.59 144.18 29.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.543 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.8 p -56.53 -23.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.458 ' N ' HG12 ' A' 1195 ' ' VAL . 52.3 mt-10 -64.49 -46.12 84.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -68.75 -37.75 79.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 81.7 t -52.87 -45.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 25.3 mttp -52.18 -36.52 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -65.56 -24.37 67.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.6 148.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.14 134.76 41.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.16 -44.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.506 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.9 p -59.13 131.84 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.093 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1205 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1206 ' ' GLU . 48.9 m -99.97 137.89 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1206 ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' 1205 ' ' SER . 6.4 tp10 -36.41 127.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 92.51 -60.03 2.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' 1207 ' ' GLY . 0.9 OUTLIER -37.64 -49.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.77 -47.72 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.58 -63.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -50.82 -25.05 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' 1209 ' ' ALA . 70.2 mt -88.25 30.9 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.558 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -66.11 -55.74 19.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 111.096 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' 1213 ' ' ALA . 65.0 Cg_exo -47.96 -18.15 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.338 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.22 -67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.558 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -59.19 -26.09 64.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' 1216 ' ' TRP . 14.1 mt-10 -60.08 -37.48 80.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.9 t -70.93 -43.6 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1219 ' ' ILE . . . . . 0.417 ' CD1' HD23 ' A' 1160 ' ' LEU . 86.4 mt -56.31 -42.55 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.58 -45.8 63.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1221 ' ' HIS . . . . . 0.476 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.0 t-160 -74.91 -56.65 4.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' 1221 ' ' HIS . 73.3 t80 -34.09 -36.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' 1227 ' ' SER . 78.6 m -90.91 -37.44 13.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' 1225 ' ' THR . 0.2 OUTLIER -55.45 -49.34 72.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.524 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.7 t -68.36 -37.76 80.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -86.71 -0.76 56.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' 1223 ' ' CYS . 38.8 t 56.08 36.48 27.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 94.1 t -92.04 153.56 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -71.9 146.51 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 24.8 p -137.52 -179.01 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 2.2 p30 44.6 48.82 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1232 ' ' LEU . . . . . 0.418 HD11 ' NH2' ' A' 1191 ' ' ARG . 14.9 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.737 0.304 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.3 pt20 -33.07 -50.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -97.47 -51.53 4.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -43.12 -53.93 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.02 -60.35 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.0 m -42.46 -46.7 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.132 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.68 -39.33 91.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 80.9 mt -64.32 -52.13 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1155 ' ' VAL . . . . . 0.404 HG12 ' NZ ' ' A' 1159 ' ' LYS . 92.8 t -61.6 -39.14 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.127 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' 1222 ' ' PHE . 32.3 tp -69.02 -55.95 9.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.4 t80 -36.62 -46.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -56.79 -50.15 65.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1159 ' ' LYS . . . . . 0.473 ' NZ ' ' CD1' ' A' 1222 ' ' PHE . 40.2 mttp -52.82 -44.08 66.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 29.0 mt -61.75 -52.23 65.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 61.7 t -54.04 -42.76 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.69 -47.99 78.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.12 72.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -50.25 -39.75 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -64.83 -68.01 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' 1167 ' ' HIS . 15.8 pttp -48.8 -41.44 32.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.461 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.1 t60 -66.35 -45.86 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.79 -62.75 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -50.73 -38.24 46.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -51.21 -56.7 11.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.464 ' HE2' ' CD1' ' A' 1178 ' ' LEU . 44.8 mtm -82.13 7.15 14.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.8 t70 57.73 36.1 26.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 26.9 m -118.08 138.43 25.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.96 136.61 23.08 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -48.05 -16.85 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.718 2.279 . . . . 0.0 112.288 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.01 -42.87 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.12 -46.78 77.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.464 ' CD1' ' HE2' ' A' 1171 ' ' MET . 11.4 tp -52.73 -66.04 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -143.61 127.23 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.7 t -83.95 165.46 18.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 2.6 p30 -53.06 -45.0 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -49.49 -48.13 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -56.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 77.5 mt -47.59 -54.34 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 78.4 t -47.18 -47.69 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.151 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.69 -55.08 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 37.2 mtp -51.65 -16.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -87.15 -51.13 6.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.455 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.0 OUTLIER -83.28 -18.13 40.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' 1190 ' ' MET . 15.5 ptt180 33.37 54.95 1.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.79 151.57 68.91 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.69 2.26 . . . . 0.0 112.309 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.6 p -130.83 27.62 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 29.2 p -140.05 125.08 18.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 11.5 p -42.14 -42.2 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.75 -60.89 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.28 -40.49 61.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 92.8 t -50.36 -38.98 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 21.8 mttm -59.61 -25.73 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -72.18 -26.49 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' 1202 ' ' ASP . 40.4 mm -51.63 142.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.461 ' N ' HG23 ' A' 1201 ' ' ILE . 24.4 t0 -73.89 135.13 43.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.05 -50.71 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1204 ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' 1212 ' ' LEU . 3.3 p -67.61 132.23 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 0.0 111.156 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 23.8 p -99.74 157.19 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -49.58 149.57 2.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.73 -54.08 4.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' 1209 ' ' ALA . 2.7 ttmp? -53.09 -49.03 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.04 -46.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -44.79 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -48.64 -23.82 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' 1204 ' ' VAL . 90.5 mt -91.02 34.85 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.55 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -70.54 -49.09 16.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.8 Cg_exo -47.99 -19.22 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.89 -64.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.58 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.7 OUTLIER -64.83 -25.11 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.424 ' N ' ' CD1' ' A' 1216 ' ' TRP . 11.4 mt-10 -56.71 -43.52 80.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 71.9 t -67.06 -48.61 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1219 ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' 1191 ' ' ARG . 68.8 mt -47.05 -37.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -36.72 75.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.82 -43.2 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.473 ' CD1' ' NZ ' ' A' 1159 ' ' LYS . 30.0 t80 -55.68 -40.08 71.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.7 p -83.48 -31.71 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -63.46 -40.68 97.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 5.6 t -80.66 -23.61 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.45 ' O ' ' C ' ' A' 1227 ' ' SER . 10.9 m-80 -108.88 22.05 16.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1226 ' ' ASN . 6.8 t 34.38 42.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 95.1 t -89.6 144.18 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.407 ' C ' HG23 ' A' 1230 ' ' THR . 5.3 tp60 -70.64 162.49 28.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1230 ' ' THR . . . . . 0.407 HG23 ' C ' ' A' 1229 ' ' GLN . 76.7 p -151.66 -178.56 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.5 50.26 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' 1147 ' ' ALA . 14.6 mt-30 -35.81 -47.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.01 -48.97 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -50.53 -61.1 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -40.01 -58.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.4 m -48.94 -47.17 43.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.159 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -65.5 -32.64 74.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.36 -54.62 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 60.9 t -60.96 -40.43 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' 1222 ' ' PHE . 22.5 tp -65.36 -58.41 5.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.58 -57.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -47.42 -46.42 22.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttm -59.27 -42.45 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.4 -46.86 86.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 70.2 t -54.23 -40.81 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.27 -50.95 71.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.68 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.74 -38.16 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1165 ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' 1166 ' ' LYS . 12.6 tm0? -69.04 -70.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.416 ' N ' ' OE1' ' A' 1165 ' ' GLN . 0.2 OUTLIER -44.37 -39.32 4.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.5 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 1.6 t60 -70.42 -43.73 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.68 -62.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -52.94 -34.6 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -50.52 -53.45 30.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.594 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 66.2 mtm -83.15 -6.34 59.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.84 28.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 30.9 m -112.95 141.27 25.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.03 139.02 21.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.98 -17.77 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.23 -43.75 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 9.4 mm -51.16 -46.1 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.594 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.4 tp -54.85 -69.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -139.5 135.06 33.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1180 ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' 1181 ' ' ASN . 8.4 t -91.76 139.03 31.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1181 ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' 1180 ' ' THR . 11.1 m-20 -34.65 -42.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -46.4 -51.23 15.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.1 -48.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 81.2 mt -51.72 -56.03 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 84.7 t -45.54 -51.6 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.93 -44.51 94.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 48.8 mmm -54.73 -42.5 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.18 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.26 -64.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.432 ' CE ' HD13 ' A' 1201 ' ' ILE . 12.2 mtt -68.9 -42.18 77.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' 1192 ' ' PRO . 34.2 mtt85 70.61 52.7 0.39 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.76 136.27 32.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 17.9 p -123.7 23.16 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.18 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 12.0 p -139.77 138.14 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.173 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.567 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 6.8 p -54.91 -27.2 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.25 -54.05 14.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1197 ' ' ASN . . . . . 0.406 ' ND2' ' OD1' ' A' 1231 ' ' ASP . 34.9 m-20 -59.11 -49.36 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.457 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.3 t -46.43 -37.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -63.68 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.33 -26.96 66.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.453 ' O ' ' CG1' ' A' 1204 ' ' VAL . 24.7 mm -56.23 145.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.73 145.57 53.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.59 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.466 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1204 ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' 1201 ' ' ILE . 4.4 p -62.27 132.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 31.9 m -100.21 136.7 39.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.08 114.16 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 121.83 -70.6 0.4 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.0 OUTLIER -32.98 -44.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.73 0.3 . . . . 0.0 110.876 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -30.43 -46.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.063 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.77 -62.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.103 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 15.4 ptt? -63.16 -23.3 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' 1209 ' ' ALA . 81.0 mt -85.77 31.47 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.569 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -76.88 -51.24 2.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.541 0.686 . . . . 0.0 111.122 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.5 ' HG2' ' CD2' ' A' 1167 ' ' HIS . 64.9 Cg_exo -48.02 -21.79 3.03 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.64 -67.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.569 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.2 p90 -61.05 -24.63 66.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' 1216 ' ' TRP . 6.4 mt-10 -60.31 -36.95 79.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 53.7 t -73.45 -43.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.1 -34.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -59.2 -48.12 82.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 13.4 t60 -73.75 -41.25 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.528 ' CD2' HD11 ' A' 1156 ' ' LEU . 36.3 t80 -53.25 -41.76 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.1 p -82.33 -34.51 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -64.98 -37.17 86.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 10.2 t -83.35 -18.8 37.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.467 ' CB ' HG22 ' A' 1228 ' ' VAL . 12.7 m-80 -116.93 21.2 13.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' 1226 ' ' ASN . 74.4 m 34.32 42.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' 1226 ' ' ASN . 57.6 t -91.02 147.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -73.81 147.55 43.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 38.7 p -143.4 173.8 11.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1231 ' ' ASP . . . . . 0.406 ' OD1' ' ND2' ' A' 1197 ' ' ASN . 4.2 m-20 60.81 51.6 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1232 ' ' LEU . . . . . 0.418 HD13 ' NH1' ' A' 1191 ' ' ARG . 11.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 49.5 mt-30 -35.55 -52.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.27 -51.42 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -43.05 -59.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -43.68 -61.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.6 m -43.37 -42.57 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -72.04 -36.21 69.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 82.4 mt -64.56 -49.91 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 48.0 t -66.09 -40.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' 1222 ' ' PHE . 22.8 tp -64.01 -57.15 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 65.6 t80 -40.51 -49.23 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.72 61.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1159 ' ' LYS . . . . . 0.538 ' HE3' ' CD1' ' A' 1222 ' ' PHE . 33.8 mttm -59.19 -41.27 88.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.96 -52.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.7 t -49.39 -34.05 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.05 -51.42 58.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.2 -59.1 3.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.507 ' O ' ' NE ' ' A' 1164 ' ' ARG . 0.0 OUTLIER -46.94 -44.14 19.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1165 ' ' GLN . . . . . 0.419 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 44.3 tt0 -63.35 -72.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' 1167 ' ' HIS . 9.3 ptpt -43.09 -28.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.417 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -60.66 -53.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1168 ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' 1167 ' ' HIS . . . -37.14 -53.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -58.14 -46.8 85.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 29.6 tttt -47.99 -51.12 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.6 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 55.8 mtm -92.52 15.29 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 35.7 t70 43.04 40.79 2.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.9 m -117.34 141.42 28.64 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.626 0.727 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.9 132.92 22.56 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.356 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1175 ' ' PRO . . . . . 0.412 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 65.2 Cg_exo -48.0 -17.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.682 2.255 . . . . 0.0 112.325 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.81 -45.37 7.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.4 mm -51.2 -43.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.6 ' CD1' ' CE ' ' A' 1171 ' ' MET . 8.4 tp -64.69 -69.79 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.66 147.38 27.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 70.2 p -94.06 173.79 7.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -61.66 -52.44 64.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.59 -51.29 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 95.0 mt -47.51 -53.98 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 70.8 t -45.19 -45.84 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -55.23 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 62.2 mmm -47.0 -41.23 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.0 95.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -71.26 -60.6 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 38.1 mtt -63.9 -49.31 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.498 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 24.6 mtm180 69.39 54.78 0.52 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.568 0.699 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.5 Cg_endo -69.75 133.78 26.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.338 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1193 ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' A' 1220 ' ' LYS . 33.1 p -104.16 -22.18 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.3 p -108.1 144.42 35.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 10.5 p -50.52 -35.63 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' 1200 ' ' ARG . 14.8 mt-10 -55.82 -68.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1197 ' ' ASN . . . . . 0.41 ' C ' ' HD3' ' A' 1200 ' ' ARG . 84.9 m-20 -41.7 -36.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 88.6 t -63.05 -49.07 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.21 -29.58 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1200 ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' 1196 ' ' GLU . 2.1 mpt_? -67.57 -31.69 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 23.8 mm -48.91 135.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.39 141.55 57.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.48 -44.27 1.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.4 p -76.88 137.6 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.153 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 74.3 m -96.14 172.11 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.58 129.94 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 94.02 -59.66 2.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.448 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1208 ' ' LYS . . . . . . . . . . . . . 30.1 tttt -37.95 -47.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.894 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -38.13 -44.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.25 -59.82 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.5 ptt? -53.11 -24.8 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 33.89 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.531 ' N ' ' CD ' ' A' 1214 ' ' PRO . . . -68.83 -49.27 27.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.725 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.6 Cg_exo -47.99 -19.14 1.41 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.64 -68.35 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.8 OUTLIER -61.6 -19.19 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.06 -35.11 80.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.3 t -73.16 -45.48 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.28 -56.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1220 ' ' LYS . . . . . 0.405 ' CD ' ' HB ' ' A' 1193 ' ' THR . 16.1 ttpp -43.05 -49.07 6.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.55 -53.52 33.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.538 ' CD1' ' HE3' ' A' 1159 ' ' LYS . 22.1 t80 -47.51 -52.26 17.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' 1227 ' ' SER . 26.4 p -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -61.82 -36.33 80.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.456 HG23 ' ND2' ' A' 1226 ' ' ASN . 6.2 t -85.84 -27.58 25.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.456 ' ND2' HG23 ' A' 1225 ' ' THR . 24.1 m-80 -99.39 6.33 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.4 t 50.5 34.6 9.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.498 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 45.3 t -87.01 143.73 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.433 ' N ' HG12 ' A' 1228 ' ' VAL . 4.8 tt0 -68.7 148.36 50.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 22.0 p -149.17 175.5 11.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.69 51.94 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.731 0.301 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' 1147 ' ' ALA . 16.1 mt-30 -34.39 -56.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.36 -48.28 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -40.85 -60.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -46.04 -60.72 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.2 m -42.16 -46.12 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -66.06 -43.8 86.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.1 -55.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.2 t -60.85 -43.2 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' 1222 ' ' PHE . 28.5 tp -60.66 -60.86 3.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' 1156 ' ' LEU . 64.5 t80 -35.29 -47.42 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -59.55 -51.97 55.88 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -50.12 -42.24 50.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.64 -51.58 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 95.5 t -45.66 -57.2 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.96 -57.5 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.38 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.57 -45.24 85.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.38 -54.01 50.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' 1167 ' ' HIS . 8.8 pttm -64.11 -38.62 91.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.469 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -61.71 -51.03 70.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.03 -53.49 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.98 -45.58 92.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1170 ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' 1170 ' ' LYS . 6.6 tmtm? -48.49 -51.18 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.551 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 50.0 mtm -91.53 15.36 12.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 36.9 t70 42.74 37.0 0.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1173 ' ' VAL . . . . . 0.47 ' CG2' HD13 ' A' 1178 ' ' LEU . 34.9 m -116.0 136.81 23.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.603 0.716 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.97 134.63 23.66 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.02 -16.41 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.372 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.84 -45.06 8.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.057 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.96 -45.05 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.551 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.9 tp -52.0 -69.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.06 114.85 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.6 t -64.89 176.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.67 -47.44 85.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -44.67 -55.28 5.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 91.9 mt -51.52 -62.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 71.3 mt -45.49 -56.89 4.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 62.9 t -41.06 -57.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' 1189 ' ' LYS . 4.2 m-20 -56.68 -57.28 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 70.0 mtp -43.94 -23.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1188 ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' 1186 ' ' ASP . . . -93.12 -32.24 14.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1189 ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' 1186 ' ' ASP . 0.2 OUTLIER -74.14 -48.86 26.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.464 ' HE1' ' CD1' ' A' 1201 ' ' ILE . 0.0 OUTLIER -85.4 -38.76 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 50.2 mtt85 68.74 54.98 0.58 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.2 Cg_endo -69.73 128.06 15.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 67.6 p -101.94 -24.22 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 70.2 p -102.66 135.74 43.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.538 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.5 p -53.3 -42.34 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.416 ' HA ' ' CE ' ' A' 1199 ' ' LYS . 27.0 mp0 -48.5 -35.35 12.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -84.43 -35.02 23.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.428 HG23 ' CE3' ' A' 1216 ' ' TRP . 91.8 t -62.22 -48.51 88.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1199 ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' 1196 ' ' GLU . 13.2 ptpt -54.46 -17.15 2.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -82.92 -30.68 28.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.464 ' CD1' ' HE1' ' A' 1190 ' ' MET . 47.9 mm -43.73 144.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.67 135.33 54.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.3 -45.99 1.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.5 p -81.38 137.04 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.145 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.0 t -100.07 156.05 17.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -47.69 151.32 0.87 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 77.93 -62.91 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' 1209 ' ' ALA . 10.5 ttmm -40.6 -50.46 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.765 0.316 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.74 -46.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.09 -64.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -48.46 -31.73 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' 1209 ' ' ALA . 41.5 mt -84.43 30.36 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.536 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.53 -55.17 15.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.566 0.698 . . . . 0.0 111.05 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' 1213 ' ' ALA . 65.8 Cg_exo -47.99 -17.59 0.87 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.697 2.265 . . . . 0.0 112.34 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1215 ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' 1215 ' ' LEU . 8.6 mp -79.95 -65.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.2 p90 -60.88 -26.99 67.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.507 ' N ' ' CD1' ' A' 1216 ' ' TRP . 22.8 mt-10 -55.08 -40.17 70.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -65.79 -42.14 91.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.71 -49.66 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -51.02 -43.15 60.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.7 t60 -69.62 -47.75 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.567 ' CD2' HD11 ' A' 1156 ' ' LEU . 31.6 t80 -53.43 -61.23 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' 1227 ' ' SER . 17.9 p -53.15 -44.14 67.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -45.8 -63.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.5 m -67.69 -40.52 84.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.462 ' O ' ' C ' ' A' 1227 ' ' SER . 70.0 m-80 -81.76 13.59 3.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' 1223 ' ' CYS . 6.5 t 32.55 49.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' 1229 ' ' GLN . 71.2 t -99.07 138.37 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' 1228 ' ' VAL . 13.2 tp60 -64.81 162.68 15.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 53.3 p -146.69 178.16 8.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 38.7 t0 61.19 42.62 11.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.913 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.754 0.311 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 3.3 pt20 -33.38 -49.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -96.62 -52.49 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -43.55 -56.59 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -52.73 -60.6 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 74.0 m -41.4 -46.62 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -61.92 -45.14 95.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.62 -63.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 93.7 t -48.63 -54.16 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' 1222 ' ' PHE . 9.7 tp -54.04 -63.14 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -38.06 -55.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -50.42 -42.99 43.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.5 -43.96 79.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 38.9 mt -60.14 -43.4 95.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 98.2 t -57.73 -38.1 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -55.18 -50.52 69.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -68.25 -48.92 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' 1178 ' ' LEU . 4.7 tmm_? -47.4 -35.13 7.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.6 -69.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' 1169 ' ' ASN . 14.8 ptpt -44.96 -34.44 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.452 ' HB3' ' CD2' ' A' 1178 ' ' LEU . 1.3 t-80 -60.65 -37.29 81.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.7 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1169 ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' 1170 ' ' LYS . 6.4 p30 -61.08 -49.2 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1170 ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' 1169 ' ' ASN . 0.1 OUTLIER -48.12 -53.07 17.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 34.6 mtm -78.18 -7.61 57.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.907 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 12.5 t0 68.92 26.65 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.8 m -112.66 140.67 24.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.0 139.99 19.46 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1175 ' ' PRO . . . . . 0.447 ' O ' ' NH1' ' A' 1164 ' ' ARG . 65.9 Cg_exo -48.0 -16.74 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.71 2.273 . . . . 0.0 112.317 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.16 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.8 mm -46.54 -39.45 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.518 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.9 tp -61.04 -72.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -160.17 123.42 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 15.3 t -67.37 162.94 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -52.81 -46.39 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -42.84 -57.81 2.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.9 mt -45.48 -64.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1184 ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' 1164 ' ' ARG . 95.6 mt -44.69 -52.14 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.3 t -47.15 -54.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.22 -46.6 75.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 36.1 mmm -50.86 -37.58 44.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.92 68.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 9.1 mptt -75.69 -60.91 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.6 mtt -70.37 -38.29 74.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' 1192 ' ' PRO . 32.0 mtt-85 66.66 52.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.8 137.67 35.9 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.25 . . . . 0.0 112.373 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 64.2 p -127.69 21.69 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 1.2 p -137.53 127.19 25.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.424 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . 14.1 p -43.28 -26.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -72.54 -64.59 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -47.65 -43.25 26.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.517 HG23 ' CE3' ' A' 1216 ' ' TRP . 90.2 t -52.43 -42.03 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -58.4 -26.29 63.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -73.83 -33.28 64.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' 1202 ' ' ASP . 43.5 mm -47.5 140.16 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.418 ' N ' HG23 ' A' 1201 ' ' ILE . 26.5 t0 -68.77 142.51 54.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.91 -41.38 2.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.539 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 8.4 p -78.62 137.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1205 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1206 ' ' GLU . 65.1 m -99.5 144.06 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1206 ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' 1205 ' ' SER . 22.7 tt0 -35.44 130.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.88 -59.8 3.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.7 ttmp? -38.41 -52.11 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.84 -52.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.5 -66.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.2 ptt? -47.44 -28.64 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 65.8 mt -85.4 30.73 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.565 ' HB2' ' CZ2' ' A' 1216 ' ' TRP . . . -63.47 -50.0 75.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.5 Cg_exo -47.91 -18.94 1.27 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.329 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.64 -70.77 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' 1213 ' ' ALA . 1.1 p90 -56.55 -24.47 47.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.451 ' N ' ' CD1' ' A' 1216 ' ' TRP . 30.1 mt-10 -59.5 -35.34 73.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 63.6 t -68.24 -34.76 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.71 -42.92 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.35 -46.52 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -72.61 -41.69 65.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.488 ' CG ' HD11 ' A' 1156 ' ' LEU . 22.0 t80 -54.25 -42.83 70.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 23.7 p -81.36 -34.59 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -62.53 -33.68 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 3.1 t -89.72 -15.35 32.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' 1227 ' ' SER . 7.6 m-80 -118.65 20.15 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1226 ' ' ASN . 55.1 m 35.55 46.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' 1229 ' ' GLN . 41.0 t -93.72 140.43 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.15 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.442 ' N ' HG11 ' A' 1228 ' ' VAL . 16.7 pt20 -68.79 153.44 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 47.3 p -146.87 -179.89 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 61.93 45.62 7.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.944 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.781 0.325 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 76.5 mt-30 -35.95 -52.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1149 ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' 1150 ' ' GLN . 44.1 tt0 -99.89 -47.07 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1150 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' 1149 ' ' GLU . 20.3 tt0 -36.81 -50.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -54.54 -56.22 21.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 53.3 m -44.45 -46.74 9.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1153 ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 2.1 mm-40 -68.25 -35.1 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.38 -53.39 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 44.7 t -63.57 -39.7 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.61 -53.8 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.6 t80 -40.27 -44.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -55.0 -44.93 83.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1159 ' ' LYS . . . . . 0.476 ' HE2' ' CD1' ' A' 1222 ' ' PHE . 44.1 mttp -61.84 -46.16 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.6 mt -57.23 -40.73 78.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 96.3 t -62.59 -44.07 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -64.75 -45.89 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.86 95.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.453 ' CG ' HD23 ' A' 1178 ' ' LEU . 27.7 ttp180 -59.06 -46.13 89.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -56.58 -61.05 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 26.4 pttt -52.54 -26.89 14.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -47.85 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.14 -50.99 3.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -65.83 -46.18 79.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 66.1 tttt -45.55 -53.69 8.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 44.6 mtm -84.26 -1.95 56.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.88 30.57 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -113.19 138.74 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.99 136.74 23.21 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.679 2.252 . . . . 0.0 112.37 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.94 -16.79 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.45 -46.39 7.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.3 mm -53.28 -44.81 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.571 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.8 tp -54.08 -68.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -154.89 129.68 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 3.6 t -75.54 166.1 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.32 -44.44 84.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -48.82 -42.77 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.87 -45.16 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.72 -49.47 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 98.6 t -49.87 -50.95 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.22 -46.8 88.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 38.2 mtp -53.01 -43.39 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.52 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1189 ' ' LYS . . . . . 0.433 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 26.2 mttm -73.53 -63.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 21.5 mtt -59.1 -38.6 79.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 31.7 mtp180 62.24 55.02 2.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.584 0.707 . . . . 0.0 110.898 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.458 ' CB ' ' HB2' ' A' 1197 ' ' ASN . 53.7 Cg_endo -69.8 135.08 29.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.375 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1193 ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' 1216 ' ' TRP . 30.3 p -103.66 -36.91 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 2.8 p -99.99 164.27 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 14.8 p -62.15 -42.59 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -49.01 -50.83 34.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1197 ' ' ASN . . . . . 0.458 ' HB2' ' CB ' ' A' 1192 ' ' PRO . 0.6 OUTLIER -59.34 -42.7 92.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' A' 1209 ' ' ALA . 58.7 t -59.14 -49.21 84.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 64.1 mttt -49.89 -35.87 25.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -71.43 -24.89 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' 1202 ' ' ASP . 23.9 mm -55.45 100.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' 1201 ' ' ILE . 6.7 t70 -34.8 143.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.2 -50.86 1.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1204 ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' 1201 ' ' ILE . 14.9 p -69.84 137.54 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1205 ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' 1206 ' ' GLU . 1.2 t -96.82 140.38 31.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1206 ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' 1205 ' ' SER . 22.4 tt0 -34.21 140.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.8 -54.01 4.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' 1209 ' ' ALA . 43.1 tttm -39.51 -57.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.12 -39.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.51 -66.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.99 -22.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.84 33.84 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.57 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -66.2 -53.32 33.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.723 . . . . 0.0 111.109 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.9 Cg_exo -48.03 -17.65 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.1 -65.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.57 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.2 p90 -61.02 -21.53 63.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.3 -44.37 95.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 97.6 t -67.21 -38.37 80.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.59 -39.42 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1220 ' ' LYS . . . . . 0.401 ' O ' ' SG ' ' A' 1223 ' ' CYS . 23.2 ttpt -64.53 -27.63 69.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1221 ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' 1224 ' ' GLN . 1.8 t-80 -81.9 -60.64 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.476 ' CD1' ' HE2' ' A' 1159 ' ' LYS . 59.3 t80 -38.36 -37.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -81.99 -33.79 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -66.33 -47.39 73.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' 1224 ' ' GLN . 9.0 t -71.32 -30.82 66.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' 1227 ' ' SER . 36.6 m-80 -105.6 14.01 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' 1223 ' ' CYS . 82.4 p 33.9 48.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' 1226 ' ' ASN . 60.1 t -98.99 147.63 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -65.22 146.62 54.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1230 ' ' THR . . . . . 0.428 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.9 p -145.38 -175.39 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1231 ' ' ASP . . . . . 0.428 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 47.18 50.14 14.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.925 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.721 0.296 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -40.8 -51.92 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -91.33 -49.27 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -41.55 -58.0 2.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -48.71 -61.65 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.3 m -42.65 -46.8 5.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1153 ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 18.4 mt-30 -64.82 -37.16 86.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.84 -57.52 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.0 t -56.08 -38.68 54.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' 1222 ' ' PHE . 33.7 tp -72.08 -61.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 70.2 t80 -36.79 -40.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.2 94.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -57.13 -44.64 83.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.69 -52.27 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 88.5 t -45.76 -45.18 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.64 -46.72 88.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.65 80.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -52.12 -46.45 65.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -57.73 -66.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' 1167 ' ' HIS . 10.3 pttp -47.58 -38.29 14.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.453 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.6 OUTLIER -65.9 -51.93 54.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.96 -58.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -57.29 -41.09 79.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.88 -55.23 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.458 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 39.6 mtm -80.83 -2.83 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.25 29.31 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.7 m -113.39 138.83 22.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.94 138.31 21.36 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 -16.93 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.603 2.202 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.0 -45.61 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.7 mm -51.82 -42.05 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.458 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.9 tp -57.54 -67.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.28 129.43 11.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1180 ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.3 t -83.69 150.62 25.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1181 ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' 1180 ' ' THR . 5.6 m120 -35.38 -48.7 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -45.1 -56.62 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 81.4 mt -52.28 -52.6 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 71.8 mt -46.36 -57.03 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 21.6 t -46.55 -50.31 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.454 ' CB ' HG21 ' A' 1201 ' ' ILE . 1.9 m-20 -56.22 -41.6 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 56.4 mtp -68.88 -22.6 64.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -90.27 -29.01 18.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1189 ' ' LYS . . . . . 0.421 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 9.2 ptmm? -85.39 -44.41 12.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' 1189 ' ' LYS . 15.8 mtm -88.07 -14.79 38.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.428 ' HG2' ' CD2' ' A' 1156 ' ' LEU . 47.9 mtm-85 39.62 54.87 5.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.77 138.79 38.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.9 p -131.45 22.33 4.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 13.3 p -138.24 126.27 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 9.6 p -49.08 -27.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -73.78 -30.5 62.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -89.84 -49.88 6.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.537 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.6 t -45.89 -44.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -58.04 -30.06 65.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -74.5 -14.03 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' 1202 ' ' ASP . 23.0 mm -59.58 138.69 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.477 ' N ' HG23 ' A' 1201 ' ' ILE . 16.4 t70 -60.23 136.99 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1204 ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' 1205 ' ' SER . 7.4 p -77.2 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.164 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1205 ' ' SER . . . . . 0.419 ' N ' HG21 ' A' 1204 ' ' VAL . 38.1 m -100.17 170.9 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -61.49 143.85 55.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.32 -57.68 4.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.409 ' HD3' ' CG2' ' A' 1204 ' ' VAL . 46.5 tttt -39.54 -45.31 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -39.77 -45.19 1.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.08 -65.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -50.15 -25.91 4.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 53.8 mt -88.99 32.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.514 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.33 -51.37 34.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 111.125 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.2 Cg_exo -48.03 -17.18 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1215 ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' 1215 ' ' LEU . 7.8 mp -82.35 -64.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.9 OUTLIER -64.47 -20.7 66.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.27 -37.15 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 76.7 t -68.53 -51.89 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.15 -48.33 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -48.17 -48.51 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.34 -46.61 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' 1222 ' ' PHE . 3.3 t80 -54.01 -38.14 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' 1227 ' ' SER . 28.1 p -85.97 -31.16 22.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -69.0 -35.4 76.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 7.6 t -84.78 -20.36 31.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -108.88 -3.69 17.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' 1223 ' ' CYS . 3.5 t 61.06 33.22 19.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' 1229 ' ' GLN . 62.9 t -80.81 140.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.173 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.469 ' N ' HG11 ' A' 1228 ' ' VAL . 5.9 tp60 -71.43 151.3 44.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 75.9 p -144.88 173.71 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 68.72 47.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.71 0.29 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.7 pt20 -32.82 -51.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.06 -48.95 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -47.87 -67.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -40.82 -60.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.8 m -43.03 -52.03 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -61.77 -36.61 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.58 -58.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 88.4 t -60.15 -40.15 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.506 ' HB2' ' CE2' ' A' 1222 ' ' PHE . 38.6 tp -62.95 -56.88 13.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' 1156 ' ' LEU . 45.2 t80 -37.23 -42.24 0.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.93 -49.27 73.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.432 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 25.3 mttm -53.38 -40.89 65.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.81 -49.36 68.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 83.1 t -47.55 -41.37 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -62.66 -42.8 99.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.74 96.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -62.74 -43.28 99.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.66 -51.27 70.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1166 ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' 1167 ' ' HIS . 19.0 ptpt -64.89 -44.1 90.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.456 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.1 t-80 -60.54 -47.98 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.13 -53.12 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -61.37 -46.82 88.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1170 ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' 1170 ' ' LYS . 14.4 tmtt? -43.07 -54.74 4.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.472 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 29.2 mtm -82.86 -4.79 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 18.4 t0 67.27 32.02 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.0 m -115.26 137.79 23.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.606 0.717 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.93 138.88 20.69 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.96 -16.51 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 0.0 112.394 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.78 -47.38 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.93 -41.33 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.472 ' CD1' ' HE1' ' A' 1171 ' ' MET . 11.8 tp -57.55 -63.96 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -153.46 143.97 22.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 59.1 p -93.17 169.57 10.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -55.32 -37.65 67.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.86 -48.06 82.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.85 -39.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 77.3 mt -72.71 -48.13 41.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 93.2 t -52.24 -40.23 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -44.25 72.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 52.5 mtp -59.5 -37.19 77.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -72.4 -27.75 62.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 44.3 mttt -79.33 -63.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 15.2 mtt -64.92 -39.04 92.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' 1192 ' ' PRO . 29.1 mtm180 66.55 53.71 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.9 Cg_endo -69.77 141.23 44.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.708 2.272 . . . . 0.0 112.344 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -127.58 18.29 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 31.3 p -137.85 130.8 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.511 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 14.7 p -51.29 -24.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' 1195 ' ' VAL . 8.5 mm-40 -71.9 -64.16 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -51.53 -42.92 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 88.7 t -47.78 -45.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.9 mttp -52.06 -34.13 42.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -64.34 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.33 153.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 31.7 t0 -80.69 133.46 35.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.0 -46.03 1.43 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 12.8 p -66.64 134.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 8.6 m -98.91 152.18 20.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -43.47 137.45 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.88 -62.91 4.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.441 ' HG3' ' CE ' ' A' 1211 ' ' MET . 40.1 tttt -34.97 -48.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.44 -48.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.09 -65.62 0.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1211 ' ' MET . . . . . 0.441 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 5.6 ptt? -46.16 -28.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' 1209 ' ' ALA . 51.2 mt -87.17 32.95 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.57 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -70.42 -54.86 8.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.567 0.699 . . . . 0.0 111.089 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' 1167 ' ' HIS . 65.2 Cg_exo -47.95 -17.57 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.91 -64.04 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.57 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.2 p90 -62.42 -21.86 65.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.403 ' N ' ' CD1' ' A' 1216 ' ' TRP . 55.1 mt-10 -60.43 -37.87 82.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.0 t -69.36 -57.9 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.085 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -38.71 -46.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -46.96 -55.23 8.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.04 -46.56 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' 1156 ' ' LEU . 64.1 t80 -46.65 -47.53 20.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 97.4 m -81.93 -46.87 13.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -46.86 -46.44 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.42 HG23 ' ND2' ' A' 1226 ' ' ASN . 15.4 t -70.96 -37.37 72.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.455 ' CB ' HG21 ' A' 1228 ' ' VAL . 15.6 m-80 -90.05 23.8 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 4.7 t 39.37 39.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1228 ' ' VAL . . . . . 0.455 HG21 ' CB ' ' A' 1226 ' ' ASN . 61.1 t -99.35 143.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1229 ' ' GLN . . . . . 0.44 ' N ' HG13 ' A' 1228 ' ' VAL . 17.7 tt0 -71.0 153.1 42.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 25.4 p -145.9 152.39 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.85 54.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.928 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -41.67 -49.4 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.52 -52.38 4.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1150 ' ' GLN . . . . . 0.461 ' NE2' ' HA ' ' A' 1150 ' ' GLN . 2.1 tp60 -42.22 -52.77 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.22 -60.09 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 70.7 m -41.0 -54.54 2.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -54.06 -40.81 67.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.13 -53.41 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.1 t -61.52 -42.04 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.511 HD13 ' CG ' ' A' 1222 ' ' PHE . 17.6 tp -62.22 -59.13 5.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' 1156 ' ' LEU . 55.8 t80 -35.74 -51.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.47 56.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 17.1 mttm -58.75 -38.82 79.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.07 -42.22 73.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 68.3 t -47.57 -51.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -56.84 -46.2 81.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.92 -44.96 95.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.409 ' HD3' ' CB ' ' A' 1179 ' ' ALA . 4.0 tpm_? -60.79 -29.37 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -80.7 -70.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -40.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1167 ' ' HIS . . . . . 0.493 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 0.5 OUTLIER -65.26 -54.57 27.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -37.26 -59.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.42 -35.88 76.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1170 ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' 1167 ' ' HIS . 43.0 tttp -52.61 -54.31 34.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.471 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 36.7 mtm -81.57 -1.77 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.18 37.37 8.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 25.6 m -119.62 142.39 32.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.98 135.64 23.6 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.97 -16.81 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.35 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.93 -45.49 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 35.9 mm -55.41 -38.79 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.471 ' CD1' ' HE1' ' A' 1171 ' ' MET . 14.0 tp -59.63 -64.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1179 ' ' ALA . . . . . 0.409 ' CB ' ' HD3' ' A' 1164 ' ' ARG . . . -168.66 127.41 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 11.0 t -67.82 170.28 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -63.78 -45.8 88.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -42.92 -57.34 2.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.6 mt -47.69 -48.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.87 -58.54 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 93.1 t -40.87 -53.49 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.7 -56.7 15.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 42.7 mtp -47.79 -43.5 27.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.0 79.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -71.36 -63.82 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 20.2 mtt -63.69 -39.64 94.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.9 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.3 mtm-85 65.61 54.67 1.07 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.578 0.704 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 143.73 51.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.33 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 6.2 p -124.87 15.5 8.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 16.9 p -140.03 134.91 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' 1196 ' ' GLU . 11.1 p -57.85 -29.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.456 ' N ' HG13 ' A' 1195 ' ' VAL . 3.0 pt-20 -67.47 -31.68 71.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -87.37 -37.78 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 90.4 t -53.37 -36.48 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.169 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -62.89 -27.36 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -68.21 -33.24 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' 1202 ' ' ASP . 46.9 mm -42.63 160.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' A' 1201 ' ' ILE . 16.8 t70 -87.36 134.51 33.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.06 -38.71 3.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 138.82 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 63.8 p -99.82 154.71 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.48 139.18 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 80.7 -56.68 4.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' 1209 ' ' ALA . 14.6 ttmm -36.98 -45.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.22 -45.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.46 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 9.7 ptt? -52.94 -17.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' 1209 ' ' ALA . 17.0 mt -90.88 31.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.553 ' HB3' ' CZ2' ' A' 1216 ' ' TRP . . . -76.8 -49.87 2.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 0.0 111.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' 1213 ' ' ALA . 66.2 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1215 ' ' LEU . . . . . 0.403 HD13 ' NH2' ' A' 1164 ' ' ARG . 6.8 mp -84.04 -70.94 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.564 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.0 OUTLIER -56.2 -19.18 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.02 -35.79 81.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 81.7 t -75.89 -51.79 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.0 -50.57 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -42.08 -45.22 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1221 ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.4 t-160 -75.59 -56.27 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1222 ' ' PHE . . . . . 0.511 ' CG ' HD13 ' A' 1156 ' ' LEU . 10.0 t80 -41.88 -32.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 83.1 m -90.96 -25.21 19.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' 1221 ' ' HIS . 2.9 pt20 -72.04 -46.95 55.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.493 HG22 ' ND2' ' A' 1226 ' ' ASN . 7.4 t -74.11 -24.66 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.493 ' ND2' HG22 ' A' 1225 ' ' THR . 36.3 m-80 -102.1 -0.79 32.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 32.1 t 55.37 36.65 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 74.9 t -83.09 153.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.11 145.95 51.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 23.6 p -143.58 165.62 27.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.13 46.65 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.746 0.308 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 80.8 mt-30 -34.77 -56.91 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1149 ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' 1153 ' ' GLN . 27.9 tt0 -96.09 -44.56 7.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1150 ' ' GLN . . . . . 0.426 ' CD ' HD11 ' A' 1154 ' ' ILE . 4.3 tm0? -44.19 -54.2 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -70.79 -58.82 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 47.5 m -38.05 -53.51 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1153 ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' 1149 ' ' GLU . 61.6 mt-30 -60.07 -45.64 92.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1154 ' ' ILE . . . . . 0.426 HD11 ' CD ' ' A' 1150 ' ' GLN . 63.2 mt -57.99 -51.46 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 94.4 t -61.66 -42.06 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' 1157 ' ' TYR . 17.0 tp -63.73 -59.82 4.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.416 ' C ' ' O ' ' A' 1156 ' ' LEU . 61.4 t80 -36.58 -44.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.49 90.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -57.01 -40.44 76.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.59 -46.05 84.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 85.7 t -54.11 -41.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.05 -47.41 83.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1164 ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' 1164 ' ' ARG . 14.0 ttp-105 -62.86 -32.42 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -74.83 -55.22 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.12 -46.81 48.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.82 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.75 -45.74 91.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.2 tttp -48.72 -51.6 27.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.603 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 50.6 mtm -88.01 11.0 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 10.6 m-20 49.83 31.34 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.3 m -112.62 136.87 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 138.79 21.28 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 -17.42 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.91 -43.6 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.53 -45.45 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.603 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.3 tp -51.36 -67.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -152.77 134.12 14.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.1 t -78.86 159.24 27.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.04 -42.93 60.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -47.54 -44.55 26.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.55 -62.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 94.1 mt -40.01 -54.09 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 96.1 t -47.15 -57.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.415 ' CB ' HG22 ' A' 1201 ' ' ILE . 4.2 m-20 -53.73 -57.41 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1187 ' ' MET . . . . . 0.403 ' CE ' HD11 ' A' 1219 ' ' ILE . 65.7 mtp -43.98 -38.19 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.56 73.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -74.02 -58.31 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -69.79 -32.82 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.9 mtp180 55.7 53.36 8.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 135.02 29.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 45.3 p -102.05 -31.85 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.4 p -102.62 149.37 24.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.567 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -59.34 -39.15 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' 1195 ' ' VAL . 27.4 mm-40 -51.93 -25.12 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.45 -39.31 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.462 HG21 ' CE3' ' A' 1216 ' ' TRP . 76.8 t -58.13 -47.58 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -54.64 -29.4 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -71.27 -19.93 62.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' 1202 ' ' ASP . 38.0 mm -55.58 149.38 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1202 ' ' ASP . . . . . 0.429 ' N ' HG21 ' A' 1201 ' ' ILE . 26.5 t0 -69.62 135.93 50.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.56 -48.82 1.23 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 10.3 p -73.59 135.99 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 18.2 m -99.47 150.58 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -41.62 141.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.19 -65.6 4.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' 1209 ' ' ALA . 32.3 ttpt -34.72 -54.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.96 -47.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.69 -64.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 6.6 ptt? -48.99 -30.36 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1212 ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' 1209 ' ' ALA . 43.5 mt -84.86 30.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.567 ' HB2' ' CZ2' ' A' 1216 ' ' TRP . . . -64.6 -52.52 51.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 111.11 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' 1213 ' ' ALA . 63.8 Cg_exo -47.95 -17.91 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.38 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -80.91 -65.32 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.567 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.0 OUTLIER -61.8 -23.15 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' 1216 ' ' TRP . 21.5 mm-40 -58.66 -38.94 79.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.7 t -70.02 -30.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1219 ' ' ILE . . . . . 0.403 HD11 ' CE ' ' A' 1187 ' ' MET . 68.1 mt -66.12 -44.7 91.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -54.77 -30.06 55.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1221 ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.3 t-160 -82.92 -56.93 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.0 t80 -39.94 -34.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1223 ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' 1227 ' ' SER . 22.2 p -86.89 -30.44 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1224 ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -70.53 -46.76 63.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1225 ' ' THR . . . . . 0.481 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.6 t -71.84 -13.49 61.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1226 ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' 1227 ' ' SER . 31.0 m-80 -127.08 14.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1227 ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' 1223 ' ' CYS . 7.6 t 34.75 48.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 76.4 t -94.65 147.79 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -66.7 144.19 56.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1230 ' ' THR . . . . . 0.453 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.0 p -141.1 -175.29 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1231 ' ' ASP . . . . . 0.453 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 48.36 53.39 12.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.721 0.296 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -37.63 -55.15 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.34 -47.37 8.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -42.04 -62.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -42.81 -59.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 84.9 m -44.18 -49.96 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.1 -37.76 88.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 62.8 mt -63.3 -57.2 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 45.3 t -58.47 -40.69 79.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1156 ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' 1157 ' ' TYR . 40.1 tp -66.18 -60.98 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1157 ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' 1156 ' ' LEU . 56.8 t80 -37.81 -48.19 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.89 -45.65 61.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttp -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.18 -47.76 83.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 99.9 t -54.24 -44.65 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -63.74 -46.39 85.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.18 76.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -53.35 -41.59 65.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.9 -69.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -36.93 5.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 2.4 t60 -74.64 -43.84 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -45.32 -55.71 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.03 -36.68 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -53.89 53.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1171 ' ' MET . . . . . 0.467 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 15.9 mtm -75.61 -6.44 50.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.14 33.63 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 27.0 m -121.54 138.97 29.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.133 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 136.62 22.97 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -20.59 2.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.52 -38.79 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 19.5 mm -58.91 -46.82 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1178 ' ' LEU . . . . . 0.467 ' CD1' ' HE1' ' A' 1171 ' ' MET . 13.1 tp -51.31 -61.75 2.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.4 148.83 28.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 76.6 p -94.91 165.95 12.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -60.05 -37.23 79.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -61.56 -48.87 79.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.25 -40.74 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.55 -54.12 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 94.4 t -55.2 -38.76 48.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1186 ' ' ASP . . . . . 0.43 ' O ' ' SD ' ' A' 1190 ' ' MET . 1.1 m-20 -59.08 -60.98 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 49.2 mtp -53.55 -28.15 30.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.99 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 22.2 mttt -97.42 -60.47 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1190 ' ' MET . . . . . 0.43 ' SD ' ' O ' ' A' 1186 ' ' ASP . 1.1 mpt? -64.61 -39.76 94.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1191 ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' 1192 ' ' PRO . 49.1 mtm-85 64.17 55.01 1.55 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1192 ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.78 119.61 6.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 52.4 p -92.2 -21.52 20.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 59.2 p -109.04 144.14 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1195 ' ' VAL . . . . . 0.513 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.3 p -56.06 -30.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.126 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1196 ' ' GLU . . . . . 0.442 ' N ' HG12 ' A' 1195 ' ' VAL . 25.1 mp0 -58.95 -41.32 87.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -75.19 -37.09 61.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1198 ' ' VAL . . . . . 0.494 HG23 ' CE3' ' A' 1216 ' ' TRP . 58.6 t -59.11 -49.21 84.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -50.91 -28.77 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -70.38 -32.15 69.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1201 ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' 1186 ' ' ASP . 21.6 mm -49.57 146.11 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.07 142.17 49.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.22 -46.46 1.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.6 p -67.51 132.6 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 58.8 m -96.88 145.66 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -40.72 126.8 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 93.52 -59.7 2.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1208 ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.1 ttmp? -38.69 -48.69 1.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1209 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.67 -46.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -43.92 -66.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.8 ptt? -47.12 -26.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.09 32.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1213 ' ' ALA . . . . . 0.567 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.41 -53.75 21.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 111.102 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1214 ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.9 -17.26 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.715 2.276 . . . . 0.0 112.321 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.39 -60.53 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1216 ' ' TRP . . . . . 0.567 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -67.29 -28.28 67.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1217 ' ' GLU . . . . . 0.531 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.8 mt-10 -56.41 -33.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.4 t -70.17 -41.21 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.82 -53.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -45.77 -43.67 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -76.03 -43.95 41.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -54.18 -38.98 66.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -81.06 -26.47 36.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 9.3 t -87.06 -34.93 19.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -91.43 8.19 37.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 43.1 t 42.04 43.51 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 70.6 t -89.03 148.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -76.09 151.86 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 71.0 p -145.05 174.64 10.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 20.1 t0 66.22 41.79 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 77.5 p -136.29 169.42 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.822 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 3.1 m -137.92 109.74 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -72.23 -177.15 29.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 42.9 p -152.03 175.7 12.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.856 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 29.4 t -110.89 160.4 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -107.72 -177.64 22.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.439 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 67.0 p -76.11 179.46 5.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.867 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 90.4 p -143.92 127.14 16.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 149.94 54.61 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 154.71 67.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.31 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 24.3 m -51.21 157.38 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.465 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 54.3 mt -86.32 135.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 28.3 p -59.15 127.83 34.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . -38.38 -34.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -41.86 -59.17 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1149 ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 7.3 pt-20 -99.97 -37.37 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -42.49 -57.59 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.94 -57.3 6.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 54.6 m -46.99 -43.4 19.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.169 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.9 -38.65 86.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.71 -53.21 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 59.1 t -62.49 -40.13 87.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 20.9 tp -65.83 -59.33 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.1 t80 -37.55 -51.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.98 -42.64 60.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 31.8 mttm -61.96 -45.18 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 43.2 mt -59.53 -52.99 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 77.6 t -48.02 -47.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.55 -46.52 83.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.84 -53.0 62.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -47.59 -45.09 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1165 ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' 1168 ' ' ALA . 21.6 tt0 -59.08 -70.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -45.96 -26.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.92 -32.39 21.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1168 ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' 1165 ' ' GLN . . . -57.97 -50.22 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.55 -44.92 96.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.12 -52.18 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.451 ' CE ' HD12 ' A' 1178 ' ' LEU . 10.4 mtm -77.74 -6.02 52.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.96 39.41 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 31.7 m -127.82 142.69 45.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 138.64 21.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.93 -23.26 4.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -91.23 -35.61 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.7 mm -59.0 -48.91 85.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.451 HD12 ' CE ' ' A' 1171 ' ' MET . 13.3 tp -49.34 -62.26 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.72 124.19 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.0 t -78.58 154.13 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -45.86 -38.8 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -51.58 -45.08 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.93 -51.38 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 77.2 mt -52.53 -48.83 65.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 90.6 t -52.73 -53.26 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.52 -50.39 70.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 82.2 mtp -56.54 -36.35 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -73.68 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -90.0 -54.73 3.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.544 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 17.5 mtt -75.06 -27.68 60.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.429 ' N ' ' CD ' ' A' 1192 ' ' PRO . 21.8 mtm180 54.89 54.85 10.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.1 Cg_endo -69.78 125.19 11.84 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 0.0 112.314 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.5 p -97.29 -24.51 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 77.6 p -107.61 138.52 43.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.533 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.4 p -52.94 -28.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.45 ' N ' HG12 ' A' 1195 ' ' VAL . 71.3 mm-40 -58.43 -50.08 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.2 -36.52 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 97.6 t -57.58 -47.16 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 18.0 mttp -50.94 -36.78 40.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -65.55 -23.9 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 32.5 mm -52.48 150.99 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.69 137.85 37.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 98.69 -37.99 3.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.8 p -74.04 132.43 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 47.8 t -95.92 145.23 25.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -40.85 131.35 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 88.87 -58.45 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' 1209 ' ' ALA . 9.1 ttmm -37.63 -50.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.98 -48.74 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 2.0 ptt? -46.91 -28.11 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 70.9 mt -86.53 29.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.559 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -66.37 -51.66 41.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.711 . . . . 0.0 111.079 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.01 -22.54 3.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.61 -67.27 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -60.65 -30.09 69.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' 1216 ' ' TRP . 8.8 mm-40 -54.17 -34.63 60.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.3 t -74.0 -32.96 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.7 -40.95 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.136 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1220 ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' 1224 ' ' GLN . 25.2 ttpt -59.84 -38.53 82.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1221 ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' A' 1225 ' ' THR . 10.9 t60 -77.99 -47.08 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 39.3 t80 -51.54 -41.46 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' 1227 ' ' SER . 21.5 p -84.11 -35.34 23.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.487 ' CG ' ' O ' ' A' 1220 ' ' LYS . 8.9 mm100 -64.22 -31.79 73.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' 1221 ' ' HIS . 3.5 t -88.99 -15.67 33.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -119.78 15.03 12.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' 1223 ' ' CYS . 4.3 t 41.61 40.89 1.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 89.7 t -87.5 144.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -64.78 148.54 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.7 p -146.79 -175.5 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.53 49.93 4.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.9 mt -81.37 42.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' 1190 ' ' MET . 21.9 m-85 -82.61 175.9 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 41.6 p -93.97 -51.63 4.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 39.4 t -96.36 91.12 5.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 14.7 t -97.72 176.43 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.098 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.61 143.88 34.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 0.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -175.34 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -128.14 84.68 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 73.2 p -89.12 -0.4 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 65.63 81.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 177.11 5.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.747 2.298 . . . . 0.0 112.369 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 112.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 3.1 m -142.6 171.63 13.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.456 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 35.2 p -74.51 104.59 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 32.2 t -133.58 164.17 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 176.73 42.81 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 82.5 p -86.86 109.05 19.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 0.0 110.823 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 94.4 p -86.32 172.66 10.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -140.69 -163.62 9.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.473 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 80.0 p -115.96 157.38 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 84.0 p -54.09 127.97 28.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -138.93 150.71 66.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.713 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -173.29 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.256 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.2 m -71.68 165.7 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' 1146 ' ' SER . 66.5 mt -86.48 139.04 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.464 ' N ' HG22 ' A' 1145 ' ' ILE . 22.7 t -45.92 119.41 2.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.73 -48.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' 1147 ' ' ALA . 66.8 mt-30 -34.5 -47.05 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -97.68 -51.02 4.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -44.03 -59.15 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -47.63 -58.8 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 89.4 m -43.76 -45.3 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -65.35 -38.54 90.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.6 -46.72 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -42.37 87.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.463 HD21 ' NE ' ' A' 1191 ' ' ARG . 22.2 tp -67.35 -57.82 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 54.5 t80 -38.12 -50.83 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.2 -45.19 92.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 35.8 mttm -57.4 -45.21 84.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.29 -51.82 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 100.0 t -52.4 -41.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.01 -55.16 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -46.86 -34.07 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -66.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' 1167 ' ' HIS . 12.5 pttp -53.48 -27.11 23.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.595 ' CE1' ' SD ' ' A' 1171 ' ' MET . 2.3 t60 -83.43 -35.19 25.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -53.84 -48.9 69.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.26 -37.21 83.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.6 tttt -51.42 -41.37 60.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.595 ' SD ' ' CE1' ' A' 1167 ' ' HIS . 3.2 mpp? -96.7 2.78 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 61.73 31.32 18.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 34.8 m -112.02 138.27 21.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.693 . . . . 0.0 111.166 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 136.02 23.38 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -16.77 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.17 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.87 -39.83 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.527 ' CD1' ' CE ' ' A' 1171 ' ' MET . 15.8 tp -59.3 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.34 139.8 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 38.1 p -93.27 162.24 14.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -56.79 -36.16 69.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.62 -51.94 67.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.71 -48.35 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 76.1 mt -54.04 -50.95 65.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 79.8 t -56.74 -52.03 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.472 ' HB2' ' CG2' ' A' 1201 ' ' ILE . 51.8 m-20 -55.1 -46.68 75.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.99 -40.74 81.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1188 ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' 1191 ' ' ARG . . . -64.75 -31.56 72.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -80.04 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' 1201 ' ' ILE . 17.8 mtt -62.17 -38.39 88.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' 1188 ' ' ALA . 17.1 mmt85 65.28 52.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 131.96 22.38 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -120.54 24.56 10.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1194 ' ' THR . . . . . 0.404 ' O ' ' CG2' ' A' 1198 ' ' VAL . 19.1 p -138.36 134.72 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.12 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.56 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 7.1 p -52.98 -26.96 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -75.35 -67.93 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -44.11 -39.59 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' 1209 ' ' ALA . 74.6 t -48.57 -43.58 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1199 ' ' LYS . . . . . 0.425 ' HA ' ' CG1' ' A' 1204 ' ' VAL . 6.0 mtmp? -56.67 -30.43 63.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -67.16 -29.16 68.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' 1202 ' ' ASP . 13.7 mm -59.32 102.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' 1201 ' ' ILE . 9.3 t70 -31.46 145.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.43 -41.83 2.08 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1204 ' ' VAL . . . . . 0.444 ' CG2' ' HD2' ' A' 1208 ' ' LYS . 2.8 p -93.52 140.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1205 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1206 ' ' GLU . 12.9 t -100.2 138.96 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1206 ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' 1205 ' ' SER . 36.3 tt0 -34.26 129.61 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 100.17 -64.94 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.444 ' HD2' ' CG2' ' A' 1204 ' ' VAL . 16.6 ttmm -38.7 -48.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' 1198 ' ' VAL . . . -34.8 -42.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.75 -65.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.7 ptt? -53.3 -24.59 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.08 34.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.553 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.51 -49.81 39.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.689 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.536 ' HG2' ' CD2' ' A' 1167 ' ' HIS . 65.0 Cg_exo -48.0 -20.14 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.69 -63.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.9 OUTLIER -65.37 -23.15 66.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.405 ' N ' ' CD1' ' A' 1216 ' ' TRP . 33.2 mt-10 -61.59 -36.23 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.1 t -67.28 -42.91 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.52 -40.29 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -60.63 -43.13 97.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.36 -44.54 58.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.5 t80 -56.81 -46.13 81.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' 1227 ' ' SER . 28.4 p -70.09 -36.21 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -57.76 -34.65 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.469 HG21 ' ND2' ' A' 1226 ' ' ASN . 5.3 t -93.13 -37.3 12.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.469 ' ND2' HG21 ' A' 1225 ' ' THR . 34.4 m-80 -93.39 15.81 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' 1223 ' ' CYS . 17.6 m 35.49 46.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' 1229 ' ' GLN . 59.0 t -87.57 139.27 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.469 ' N ' HG13 ' A' 1228 ' ' VAL . 1.2 tp-100 -63.57 148.02 49.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1230 ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' 1231 ' ' ASP . 37.6 p -138.35 -175.39 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1231 ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' 1230 ' ' THR . 4.8 p-10 48.13 49.24 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 47.51 1.0 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -102.0 177.17 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 3.1 m -44.87 -43.54 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 12.0 t 69.03 39.67 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 11.6 t -78.6 149.45 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.161 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.15 150.69 10.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.3 12.01 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -59.21 96.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 74.7 p -49.42 132.19 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -159.15 83.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.26 6.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.645 2.23 . . . . 0.0 112.383 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 1.4 t -96.01 126.12 41.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 31.4 m -101.49 -56.35 2.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.526 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 16.9 m -159.48 131.85 6.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.381 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 13.9 m -98.95 163.44 12.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -122.4 -141.7 6.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 58.7 m -130.93 144.75 51.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 110.827 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 8.2 t -167.59 171.68 10.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -107.17 50.47 0.79 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.523 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1140 ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' 1141 ' ' SER . 49.6 m -159.7 107.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1141 ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' 1140 ' ' SER . 56.4 p -37.98 124.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -87.74 154.42 53.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 166.74 26.59 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 69.5 t -40.65 145.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.18 137.78 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.167 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 1.9 t -50.29 131.42 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . -42.89 -45.94 5.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -38.43 -49.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -93.32 -50.2 5.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1150 ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' 1150 ' ' GLN . 3.0 tp60 -47.11 -60.06 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -42.7 -60.81 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 86.7 m -43.96 -46.02 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -62.26 -38.76 90.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.19 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 96.7 t -68.93 -43.73 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.414 HD12 ' CD2' ' A' 1222 ' ' PHE . 17.6 tp -63.72 -55.32 24.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 62.8 t80 -40.62 -49.51 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.17 92.78 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1159 ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' 1162 ' ' GLU . 37.9 mttm -55.3 -33.46 63.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1160 ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' 1161 ' ' VAL . 25.0 mt -74.13 -59.99 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1161 ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' 1160 ' ' LEU . 97.3 t -37.17 -62.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.06 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1162 ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' 1159 ' ' LYS . 5.2 pt-20 -38.89 -54.71 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.51 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -54.47 -48.63 71.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -58.56 -65.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' 1167 ' ' HIS . 1.2 ptpm? -47.56 -44.9 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.433 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.7 OUTLIER -58.24 -42.84 87.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.16 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -60.44 -47.3 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 57.4 tttp -42.68 -51.06 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.59 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 59.1 mtm -87.69 -5.62 58.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.59 32.62 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -114.63 141.31 26.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.596 0.712 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 136.68 23.29 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.97 -17.23 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.41 -40.79 9.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.2 mm -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.59 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.8 tp -53.78 -68.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.42 120.39 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.0 t -72.61 156.38 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -47.01 -43.75 19.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -48.61 -52.68 21.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.32 -40.88 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.76 -61.51 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.6 t -41.46 -50.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.64 -51.52 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 93.8 mtp -55.95 -36.94 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.12 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -78.42 -63.37 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.479 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 25.8 mtt -63.87 -39.33 93.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.7 mtt-85 66.31 54.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.594 0.712 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.78 129.35 17.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 58.2 p -104.89 -26.08 12.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 72.1 p -108.24 149.61 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.417 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.9 p -58.46 -26.89 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' 1195 ' ' VAL . 31.2 mt-10 -57.85 -45.85 85.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 37.0 m-80 -73.62 -44.1 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 69.7 t -44.26 -45.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.2 mttm -57.38 -35.72 70.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -68.94 -26.12 64.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' 1202 ' ' ASP . 27.2 mm -55.42 98.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' 1201 ' ' ILE . 10.4 t0 -34.58 143.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.33 -46.55 1.43 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.52 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.4 p -76.13 142.31 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 42.5 t -99.83 154.01 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 145.0 10.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.03 -55.72 5.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.5 ttmp? -44.62 -49.47 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -34.63 -49.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -38.16 -65.84 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.0 ptt? -52.67 -25.85 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' 1209 ' ' ALA . 52.7 mt -87.28 32.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.565 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -70.51 -53.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 111.078 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.5 Cg_exo -47.97 -17.74 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.71 -64.76 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -62.55 -24.17 67.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' 1216 ' ' TRP . 51.5 mt-10 -58.78 -39.4 80.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 93.3 t -69.21 -41.85 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.82 -48.45 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.167 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -54.66 -44.56 73.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 14.1 t60 -62.83 -56.4 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.414 ' CD2' HD12 ' A' 1156 ' ' LEU . 66.2 t80 -44.07 -67.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' 1227 ' ' SER . 61.6 m -50.83 -55.29 17.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' 1223 ' ' CYS . 30.2 mt-30 -35.32 -69.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -37.23 79.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' 1227 ' ' SER . 2.1 m-80 -85.27 16.6 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.1 t 33.98 50.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 85.3 t -103.26 141.84 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.61 155.53 40.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.2 p -143.02 -177.08 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 10.9 t0 54.91 51.24 13.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.49 43.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' 1197 ' ' ASN . 2.6 m-85 -92.58 -48.45 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 2.9 m -92.94 89.18 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 68.8 p -50.42 -47.93 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 69.8 p -106.76 142.62 36.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -151.94 149.66 24.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -31.12 21.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.716 2.277 . . . . 0.0 112.29 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1239 ' ' GLN . . . . . 0.43 ' C ' ' CD ' ' A' 1239 ' ' GLN . 2.8 pp0? -174.87 158.42 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 1.8 m -95.29 101.52 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -136.96 -93.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.5 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 171.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.326 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 7.8 t 61.24 44.39 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 82.7 p -144.72 142.08 29.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.448 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 76.2 p -100.25 169.28 9.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.846 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 35.8 t -98.81 -58.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 119.58 -178.21 16.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 31.8 t -156.68 143.66 18.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.885 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 9.1 t -66.13 117.23 8.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 53.74 99.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.434 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 87.3 p -158.77 177.48 11.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 53.1 p -93.89 81.81 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -55.07 150.19 21.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.572 0.701 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 125.75 12.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 33.8 m -49.41 168.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.12 139.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' 1147 ' ' ALA . 15.4 t -58.02 127.58 32.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' 1146 ' ' SER . . . -34.07 -43.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' 1147 ' ' ALA . 94.0 mm-40 -37.62 -53.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -94.23 -48.14 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.84 -58.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -43.79 -60.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 85.1 m -44.41 -48.58 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.78 -33.24 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 90.2 mt -67.02 -61.89 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 46.9 t -52.39 -43.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 19.3 tp -64.86 -57.34 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 77.9 t80 -38.76 -42.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.7 -45.72 95.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 26.8 mttm -61.72 -44.09 97.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.97 -52.49 65.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 85.0 t -48.24 -44.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.08 -45.51 83.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.2 98.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -58.19 -41.69 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1165 ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' 1166 ' ' LYS . 10.5 tm0? -64.37 -60.5 3.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.462 ' N ' ' OE1' ' A' 1165 ' ' GLN . 5.6 ptmm? -54.92 -35.98 64.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -46.94 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.31 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.28 -45.9 92.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 30.8 tttt -46.38 -55.64 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.901 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.46 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 29.3 mtm -79.61 -7.83 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.8 t70 68.43 30.87 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 34.8 m -113.61 139.66 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.692 0.758 . . . . 0.0 111.128 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.96 136.7 23.02 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.395 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 -16.76 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.69 9.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.4 mm -56.68 -42.99 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.46 ' CD1' ' HE1' ' A' 1171 ' ' MET . 14.8 tp -57.35 -70.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.63 131.34 13.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.6 t -80.9 175.47 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.23 -46.73 87.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -53.21 17.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.18 -52.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.44 -49.92 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.5 t -49.92 -52.83 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -50.03 -55.27 15.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 71.1 mtp -47.47 -44.75 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.88 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -78.17 -62.16 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.77 -37.58 79.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' 1192 ' ' PRO . 27.2 mtp180 63.74 51.96 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.73 139.43 40.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 18.9 p -124.23 25.72 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.179 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 27.2 p -140.26 125.65 18.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.445 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.3 p -44.59 -33.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.7 -62.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -48.68 -43.16 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 87.1 t -50.53 -39.99 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -62.04 -23.54 66.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.469 HG21 ' N ' ' A' 1202 ' ' ASP . 27.4 mm -61.53 142.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.469 ' N ' HG21 ' A' 1201 ' ' ILE . 32.6 t0 -67.46 139.65 57.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.03 -52.22 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 6.1 p -65.59 137.05 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.1 t -100.06 145.42 27.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -38.86 135.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 86.5 -57.37 4.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.6 OUTLIER -40.53 -54.09 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.79 -48.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.73 -62.65 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.3 ptt? -50.06 -22.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.69 35.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.571 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -66.54 -52.99 32.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 0.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.03 -67.38 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -59.2 -23.77 62.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.432 ' N ' ' CD1' ' A' 1216 ' ' TRP . 12.3 mm-40 -57.63 -45.28 85.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.65 -42.92 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.78 -26.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -68.26 -35.95 78.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -82.04 -49.3 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.42 ' HB3' ' NH2' ' A' 1191 ' ' ARG . 30.0 t80 -40.31 -42.49 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.6 p -77.54 -37.22 51.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -61.35 -43.84 98.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.446 HG21 ' ND2' ' A' 1226 ' ' ASN . 7.1 t -75.43 -37.97 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' 1227 ' ' SER . 33.8 m-80 -93.44 16.08 14.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' 1226 ' ' ASN . 22.6 t 34.9 51.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.409 HG22 ' CB ' ' A' 1226 ' ' ASN . 45.7 t -105.92 157.55 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -81.11 152.49 27.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 67.9 p -145.78 -179.66 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.47 45.83 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.28 50.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -90.13 -59.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 1.3 t -75.62 115.93 15.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 33.0 p -48.7 -31.32 6.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.832 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 58.6 p -52.07 117.3 2.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1237 ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' 1238 ' ' PRO . 0.8 OUTLIER -61.32 -58.55 18.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.613 0.72 . . . . 0.0 110.941 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1238 ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' 1237 ' ' LYS . 53.8 Cg_endo -69.74 134.73 28.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.65 2.233 . . . . 0.0 112.349 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -80.98 86.98 6.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 39.9 t -94.63 147.31 23.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 64.63 85.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 104.2 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 17.4 m -132.44 90.58 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 1.9 m -163.42 133.92 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.506 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 92.1 p -118.42 -44.08 2.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 53.2 m 38.01 42.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -44.38 156.24 0.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.492 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 2.7 m -130.51 157.59 42.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.371 . . . . 0.0 110.851 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 46.8 t -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.868 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 135.79 -122.85 2.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 17.2 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.823 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1141 ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' 1142 ' ' GLN . 52.3 p -168.43 115.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.852 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1142 ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' 1141 ' ' SER . 6.2 mm100 -32.5 96.0 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1143 ' ' PRO . . . . . 0.44 ' N ' ' O ' ' A' 1141 ' ' SER . 54.0 Cg_endo -69.77 163.62 37.59 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 93.6 t -76.6 150.99 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.11 143.96 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.163 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 4.9 m -51.59 130.31 27.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -41.87 -48.17 4.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 67.3 mt-30 -34.49 -51.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -96.17 -51.02 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -38.47 -63.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -42.35 -62.86 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.3 m -40.14 -50.24 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.24 -39.39 82.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.64 -57.71 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.5 t -57.59 -43.21 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.512 HD13 ' CG ' ' A' 1222 ' ' PHE . 23.6 tp -63.84 -62.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' 1156 ' ' LEU . 65.9 t80 -35.84 -45.44 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.54 90.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 23.1 mttm -56.91 -44.18 82.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.92 -43.79 97.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.4 t -56.54 -46.13 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -53.75 -39.1 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.8 -49.19 63.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -53.68 -44.31 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.72 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' 1167 ' ' HIS . 0.5 OUTLIER -53.5 -41.96 66.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.453 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.8 OUTLIER -62.38 -45.05 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.61 -59.12 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -55.82 -45.53 78.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -43.78 -54.69 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.523 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 38.8 mtm -84.77 -1.92 56.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.68 29.52 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.7 m -111.62 141.24 24.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.98 138.54 21.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.236 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.96 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.302 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.14 -47.88 6.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.5 mm -48.01 -39.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.523 ' CD1' ' CE ' ' A' 1171 ' ' MET . 11.2 tp -58.78 -67.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -149.35 147.6 28.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.088 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 57.8 p -89.43 169.75 11.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.45 -33.84 76.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -62.45 -50.17 72.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 90.5 mt -55.75 -46.49 79.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.95 -53.29 59.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 70.8 t -48.41 -47.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' 1201 ' ' ILE . 67.7 m-20 -59.24 -45.56 90.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 89.4 mtp -58.1 -40.79 82.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.23 75.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -77.26 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 13.8 mtt -65.0 -41.2 95.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' A' 1192 ' ' PRO . 33.8 mtt-85 68.18 54.39 0.63 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.8 134.5 28.04 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.661 2.241 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.1 p -102.11 -33.17 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 60.8 p -101.82 149.92 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.471 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 12.5 p -57.23 -33.6 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' 1195 ' ' VAL . 46.5 mt-10 -53.05 -47.43 68.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 85.9 m-20 -66.5 -46.37 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 99.1 t -50.74 -54.5 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.191 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -46.5 -36.29 6.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.19 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.434 HD13 ' CE ' ' A' 1190 ' ' MET . 37.9 mm -43.21 148.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.56 139.69 43.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 97.46 -49.14 1.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.514 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 6.3 p -66.13 131.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 7.7 t -95.77 173.74 7.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.31 143.39 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.83 -54.02 4.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' 1209 ' ' ALA . 28.5 ttmt -41.67 -53.78 3.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.2 -50.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.74 -66.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.13 -25.14 1.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' 1209 ' ' ALA . 69.8 mt -89.44 32.26 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.542 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -69.12 -53.3 14.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 111.105 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.0 Cg_exo -47.9 -18.16 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.392 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.04 -69.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.1 p90 -57.36 -26.32 60.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.5 mt-10 -56.5 -37.28 70.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.2 t -71.13 -41.82 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.83 -53.45 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.102 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -45.12 -45.1 11.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -72.62 -46.58 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.512 ' CG ' HD13 ' A' 1156 ' ' LEU . 49.9 t80 -50.17 -59.59 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' 1227 ' ' SER . 25.7 p -54.89 -47.91 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -42.0 -69.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -62.01 -40.54 96.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' 1227 ' ' SER . 72.1 m-80 -80.41 13.54 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' 1223 ' ' CYS . 79.0 p 33.7 51.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 84.7 t -102.76 143.33 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.78 160.42 30.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 59.1 p -148.02 -179.23 6.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 39.8 t0 65.67 40.06 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.38 44.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' 1190 ' ' MET . 6.6 m-85 -96.05 178.74 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 17.2 m -106.52 80.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.831 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 6.4 m -118.23 176.3 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1236 ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' 1237 ' ' LYS . 1.4 t -125.14 106.95 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1237 ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' 1238 ' ' PRO . 0.0 OUTLIER 35.38 54.7 2.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.929 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1238 ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' 1237 ' ' LYS . 54.0 Cg_endo -69.74 117.45 5.09 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -96.63 86.87 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 4.7 m -75.41 138.52 41.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -123.73 146.27 16.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1242 ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' 1243 ' ' SER . 53.1 Cg_endo -69.81 2.65 3.37 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1243 ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' 1242 ' ' PRO . 94.2 p -35.22 130.06 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 2.7 m -67.87 136.96 54.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.458 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 46.6 m -55.39 170.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.889 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 11.0 t -132.61 147.3 52.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -64.31 -148.14 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 97.5 p -76.94 120.68 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.366 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 39.7 m -102.62 163.64 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -65.92 -159.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 25.6 p -55.52 -53.49 55.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.859 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 44.0 m 52.81 42.51 31.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1142 ' ' GLN . . . . . 0.462 ' NE2' ' HD2' ' A' 1143 ' ' PRO . 56.5 tp60 -72.39 118.95 72.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.942 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1143 ' ' PRO . . . . . 0.462 ' HD2' ' NE2' ' A' 1142 ' ' GLN . 53.8 Cg_endo -69.74 -176.15 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.679 2.253 . . . . 0.0 112.374 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 35.3 m -81.96 168.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.445 HG21 ' CA ' ' A' 1150 ' ' GLN . 76.4 mt -84.82 128.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' 1147 ' ' ALA . 75.6 p -62.6 132.41 52.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -36.79 -49.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 27.1 mt-30 -36.64 -50.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -94.37 -51.91 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1150 ' ' GLN . . . . . 0.445 ' CA ' HG21 ' A' 1145 ' ' ILE . 19.9 tt0 -45.27 -56.06 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.56 -58.4 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 96.8 m -44.82 -41.78 7.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1153 ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 37.3 mt-30 -67.24 -37.22 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.96 -57.24 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 75.2 t -57.28 -45.1 84.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' 1157 ' ' TYR . 22.8 tp -62.16 -62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 54.4 t80 -36.58 -56.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -48.97 -43.79 31.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.472 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1159 ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' 1222 ' ' PHE . 5.8 mtmp? -66.08 -40.25 90.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.927 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.2 t -56.3 -42.05 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -54.29 -53.78 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.26 96.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' 1179 ' ' ALA . 7.1 tmm_? -57.82 -26.41 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.802 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.24 -72.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' 1167 ' ' HIS . 2.3 pttm -40.7 -29.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.431 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.3 t60 -78.13 -45.53 23.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.1 15.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -58.49 -40.24 82.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -48.63 -56.87 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.526 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 69.5 mtm -80.35 4.64 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 49.7 m-20 58.51 36.29 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.1 m -114.95 141.59 27.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.677 0.751 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 133.58 23.06 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.383 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -47.95 -18.47 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.39 -40.44 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 25.1 mm -58.23 -47.73 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.526 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.4 tp -53.14 -63.86 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1179 ' ' ALA . . . . . 0.41 ' HB2' ' CG ' ' A' 1164 ' ' ARG . . . -153.13 120.3 5.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 6.4 t -75.9 146.04 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -41.76 -44.57 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -46.06 -53.01 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.43 -56.49 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 66.1 mt -51.26 -52.26 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 89.6 t -44.68 -49.29 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.32 -44.48 91.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.7 mtp -55.72 -41.52 73.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.21 -30.82 69.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1189 ' ' LYS . . . . . 0.416 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 6.3 mtpm? -77.25 -58.35 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.578 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 24.7 mtt -68.71 -40.86 79.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.422 ' N ' ' CD ' ' A' 1192 ' ' PRO . 35.1 mtt-85 68.74 55.08 0.58 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.81 137.31 35.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 0.0 112.334 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 50.7 p -105.59 -29.3 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.098 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 66.0 p -107.92 148.92 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.558 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.8 p -58.97 -39.7 78.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.466 ' N ' HG12 ' A' 1195 ' ' VAL . 7.4 mm-40 -47.33 -29.54 2.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.513 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 57.6 m-20 -90.94 -39.16 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.442 HG23 ' CE3' ' A' 1216 ' ' TRP . 74.4 t -55.79 -49.02 77.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -56.31 -30.53 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.34 -24.22 62.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 35.3 mm -52.43 146.76 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -68.96 138.24 54.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.11 -51.95 1.02 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.7 p -70.86 144.26 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 5.8 t -100.04 157.85 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -51.4 140.38 17.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 81.51 -55.49 4.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' 1209 ' ' ALA . 25.3 ttpt -39.61 -56.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.75 -43.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.36 -62.44 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 7.6 ptt? -55.88 -23.42 31.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 96.1 mt -89.85 34.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.568 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -68.79 -48.64 29.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.0 -17.15 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.4 mp -82.22 -66.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.568 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.0 OUTLIER -61.48 -25.44 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.466 ' N ' ' CD1' ' A' 1216 ' ' TRP . 20.3 mt-10 -57.68 -36.5 72.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 99.0 t -68.8 -39.02 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.05 -53.04 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -46.21 -42.58 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -76.74 -45.39 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.417 ' HB2' ' NZ ' ' A' 1159 ' ' LYS . 17.0 t80 -52.99 -39.84 63.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -79.9 -29.0 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.69 -38.24 90.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 4.5 t -87.07 -16.58 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' 1227 ' ' SER . 18.3 m-80 -119.65 18.48 12.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' 1223 ' ' CYS . 14.8 m 34.23 46.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' 1223 ' ' CYS . 85.4 t -84.83 152.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.12 140.58 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 21.5 p -129.1 176.57 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 43.52 47.23 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.83 40.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.578 ' CE2' ' SD ' ' A' 1190 ' ' MET . 14.1 m-85 -75.0 -55.83 5.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 69.2 p -104.19 103.28 13.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 56.5 m -42.42 -45.04 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.869 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 15.2 t -74.34 149.73 40.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.8 142.46 31.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.559 0.695 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 141.75 45.94 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -73.63 107.81 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 3.1 t -72.38 124.34 24.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -121.63 -160.78 11.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 106.51 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.335 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 44.0 p -174.18 171.91 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 88.9 p -110.75 -43.5 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.521 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 58.9 p -129.1 42.5 3.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 2.6 m -93.62 160.41 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -125.21 -135.09 4.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 6.3 t -119.5 80.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.885 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 60.3 p -168.32 154.83 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 150.36 -118.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 48.1 m 58.02 42.57 22.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 1.4 t -127.77 70.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.3 160.63 30.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.511 0.672 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 175.5 8.01 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.676 2.251 . . . . 0.0 112.368 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 99.8 t -42.77 149.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 51.1 mt -91.76 143.36 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 8.3 t -58.58 131.05 49.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -41.06 -44.14 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' 1147 ' ' ALA . 87.2 mt-30 -37.63 -51.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.76 -48.96 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -44.36 -51.74 8.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -52.29 -57.94 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1152 ' ' THR . . . . . 0.421 HG21 ' NH1' ' A' 1191 ' ' ARG . 78.0 m -44.17 -43.49 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -65.73 -37.16 85.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.93 -43.16 96.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.8 t -70.82 -41.04 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.33 -55.81 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 43.2 t80 -37.44 -43.62 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.98 -47.53 88.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 46.3 mttm -56.61 -41.76 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.88 -42.8 97.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 94.0 t -59.64 -42.15 87.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.35 -39.22 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.53 72.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.565 ' NH2' ' CD2' ' A' 1215 ' ' LEU . 43.3 ttm-85 -79.76 -43.12 23.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.34 -34.96 62.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.2 pttp -84.31 -38.34 20.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' 1170 ' ' LYS . 0.6 OUTLIER -63.97 -56.76 12.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1168 ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' 1167 ' ' HIS . . . -37.27 -53.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.68 -37.8 85.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1170 ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' 1167 ' ' HIS . 18.4 ttmt -55.95 -51.75 66.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1171 ' ' MET . . . . . . . . . . . . . 15.7 mtm -80.07 -1.4 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 68.19 30.09 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.2 m -119.66 134.53 23.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.99 141.86 16.41 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.97 -16.64 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.75 -47.01 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 12.7 mm -51.43 -42.76 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.419 HD23 ' NH1' ' A' 1164 ' ' ARG . 14.4 tp -56.83 -57.34 12.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1179 ' ' ALA . . . . . 0.478 ' HB2' ' CZ ' ' A' 1164 ' ' ARG . . . -160.38 156.07 25.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 26.1 p -94.48 161.12 14.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.113 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -54.85 -28.64 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 26.7 tptt -62.62 -51.78 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 -40.06 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1184 ' ' LEU . . . . . 0.405 ' CD2' ' HE ' ' A' 1164 ' ' ARG . 63.2 mt -60.76 -54.46 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 79.9 t -49.31 -36.69 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.421 ' CB ' ' CG2' ' A' 1201 ' ' ILE . 1.2 m-20 -60.65 -62.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 95.0 mtp -55.51 -20.55 13.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -75.12 -21.68 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 21.4 mttm -102.82 -51.97 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.45 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.1 OUTLIER -74.45 -20.91 59.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.539 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 13.0 ptt180 33.65 55.05 1.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.78 149.48 66.81 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.391 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 61.6 p -127.35 24.11 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 120.97 14.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.546 HG23 ' CH2' ' A' 1216 ' ' TRP . 11.3 p -40.31 -39.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -56.69 -66.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -48.25 -41.96 29.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 94.9 t -50.17 -47.95 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.2 mttp -50.07 -30.92 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -70.98 -29.59 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' 1202 ' ' ASP . 26.0 mm -53.53 101.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' 1201 ' ' ILE . 12.3 t70 -35.3 145.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 96.01 -41.05 2.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.3 p -78.22 138.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 111.068 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 4.0 m -99.98 140.79 33.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -40.22 138.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.88 -58.82 5.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' 1209 ' ' ALA . 38.7 tttt -40.38 -55.71 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.93 -39.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.3 -65.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.1 ptt? -49.31 -25.51 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 17.1 mt -88.94 26.76 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.569 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.68 -52.36 26.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.565 0.698 . . . . 0.0 111.05 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.6 Cg_exo -48.01 -16.94 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.678 2.252 . . . . 0.0 112.321 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1215 ' ' LEU . . . . . 0.565 ' CD2' ' NH2' ' A' 1164 ' ' ARG . 7.3 mp -82.24 -71.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -52.83 -15.8 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.26 -38.86 88.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -66.4 -50.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.1 mt -46.49 -40.95 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -55.06 -40.39 70.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -76.84 -42.94 38.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -53.95 -61.38 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' 1227 ' ' SER . 22.8 p -53.87 -45.67 71.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.874 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -43.4 -68.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -63.87 -39.45 94.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.454 ' O ' ' C ' ' A' 1227 ' ' SER . 2.6 m-80 -81.22 13.13 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' 1223 ' ' CYS . 72.2 m 33.84 50.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.539 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 84.2 t -97.5 149.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.461 ' N ' HG13 ' A' 1228 ' ' VAL . 2.5 mp0 -67.93 154.77 40.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 20.5 p -145.56 158.77 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 43.4 t0 64.77 42.56 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.97 41.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -93.72 136.54 33.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 30.2 t -108.6 95.49 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 47.4 p -143.64 167.2 22.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 28.3 m -103.97 95.77 6.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1237 ' ' LYS . . . . . 0.451 ' CG ' ' HD2' ' A' 1238 ' ' PRO . 22.2 tttp -145.53 142.54 18.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1238 ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' 1237 ' ' LYS . 53.5 Cg_endo -69.77 133.12 24.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.652 2.235 . . . . 0.0 112.358 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1239 ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' 1240 ' ' SER . 51.1 tt0 -44.36 -45.09 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1240 ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' 1239 ' ' GLN . 99.5 p -37.23 134.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -140.92 -178.99 17.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -176.29 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 39.9 p -56.56 -52.47 64.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.821 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 11.5 m -54.34 117.84 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 12.2 m -123.29 135.06 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 45.5 p -162.03 143.04 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -137.82 112.29 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 83.0 p -69.2 93.79 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 101.71 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1139 ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' 1140 ' ' SER . . . 134.07 -129.79 5.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1140 ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' 1139 ' ' GLY . 47.6 p 36.47 47.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 58.3 p -78.67 159.86 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.72 146.32 40.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 179.57 3.6 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 84.1 t -41.6 147.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.166 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 47.2 mt -92.65 137.68 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 73.1 m -53.07 132.79 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -45.18 -48.55 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 54.8 mt-30 -34.75 -52.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.57 -53.47 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -42.76 -59.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -42.75 -57.14 2.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 90.9 m -46.71 -50.5 17.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.14 -40.86 95.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.73 -58.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 73.6 t -54.75 -39.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.481 HD12 ' CG ' ' A' 1222 ' ' PHE . 12.8 tp -66.32 -57.75 6.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 75.1 t80 -38.34 -46.69 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.12 -46.23 91.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1159 ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' 1162 ' ' GLU . 21.1 mttm -59.45 -33.22 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 25.2 mt -75.06 -52.67 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 95.7 t -40.16 -62.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1162 ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' 1159 ' ' LYS . 4.6 pt-20 -40.47 -56.39 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.68 94.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -59.15 -28.57 66.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1165 ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' 1168 ' ' ALA . 31.8 tt0 -82.0 -71.6 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 8.9 pttp -43.39 -29.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.9 t60 -78.02 -37.51 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1168 ' ' ALA . . . . . 0.465 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.66 -61.71 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -55.7 -35.28 65.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 9.9 tttp -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' 1178 ' ' LEU . 27.3 mtm -76.41 6.27 5.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.36 29.15 18.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.3 m -114.57 139.75 24.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.94 140.23 18.78 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -48.05 -16.68 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.63 -52.34 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 32.9 mm -47.67 -46.7 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.465 HD22 ' CA ' ' A' 1168 ' ' ALA . 16.9 tp -49.46 -65.97 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -148.28 118.46 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1180 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.5 t -72.91 139.1 46.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1181 ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' 1180 ' ' THR . 31.9 m120 -35.77 -46.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.9 tptm -43.34 -58.16 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.39 -59.16 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 33.6 mt -47.38 -44.73 24.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 55.4 t -56.5 -55.03 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.428 ' HA ' ' CE ' ' A' 1189 ' ' LYS . 1.1 m-20 -58.89 -42.03 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.2 mtp -58.37 -35.69 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.1 74.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1189 ' ' LYS . . . . . 0.428 ' CE ' ' HA ' ' A' 1186 ' ' ASP . 49.5 mtmt -76.75 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 13.9 mtt -67.07 -39.27 86.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.1 mtt85 64.31 53.4 1.33 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.639 0.733 . . . . 0.0 110.935 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.71 126.9 13.89 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 34.0 p -96.27 -32.08 12.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 73.3 p -101.24 147.58 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.564 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -57.52 -36.53 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.158 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' 1195 ' ' VAL . 48.4 mt-10 -48.38 -52.02 23.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 66.4 m-20 -68.19 -45.96 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.429 HG22 ' CE3' ' A' 1216 ' ' TRP . 99.5 t -48.4 -52.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -49.53 -33.88 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -68.39 -27.97 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 30.7 mm -51.21 139.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 30.4 t0 -65.66 141.05 58.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.85 -48.45 1.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.0 p -65.7 137.44 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 3.0 m -100.0 142.78 31.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -39.06 130.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.96 -63.64 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' 1207 ' ' GLY . 18.1 ttmt -34.36 -48.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -35.34 -49.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.94 -63.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.2 ptt? -53.0 -22.63 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' 1209 ' ' ALA . 84.1 mt -90.7 32.68 0.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.561 ' HB3' ' CZ2' ' A' 1216 ' ' TRP . . . -70.3 -52.32 12.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 111.132 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.9 Cg_exo -47.99 -17.36 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.44 -67.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.564 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.1 p90 -58.74 -26.98 64.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' 1216 ' ' TRP . 10.1 mt-10 -54.89 -35.81 64.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 74.7 t -71.14 -35.77 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.6 -46.93 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -47.36 -39.21 14.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1221 ' ' HIS . . . . . 0.533 ' CD2' ' HG2' ' A' 1224 ' ' GLN . 3.4 t-160 -80.64 -52.78 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.481 ' CG ' HD12 ' A' 1156 ' ' LEU . 47.2 t80 -38.95 -33.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' 1227 ' ' SER . 21.8 p -92.98 -28.64 16.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.533 ' HG2' ' CD2' ' A' 1221 ' ' HIS . 3.5 pt20 -66.52 -46.6 75.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' 1224 ' ' GLN . 9.0 t -76.7 -11.98 59.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' 1227 ' ' SER . 23.0 m-80 -123.11 15.24 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' 1223 ' ' CYS . 58.7 p 36.2 49.29 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' 1229 ' ' GLN . 89.1 t -93.03 142.17 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.462 ' N ' HG12 ' A' 1228 ' ' VAL . 19.1 pt20 -69.56 148.0 50.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 72.6 p -137.48 -177.81 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 7.0 m-20 62.65 43.41 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1232 ' ' LEU . . . . . 0.408 HD13 ' NH1' ' A' 1191 ' ' ARG . 11.9 mt -84.14 41.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' 1190 ' ' MET . 9.6 m-85 -80.53 158.29 25.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 53.9 p -89.53 41.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 3.4 t -154.42 158.25 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 40.4 p -118.76 107.05 13.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -135.97 133.21 19.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.53 0.681 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -178.8 2.52 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 2.23 . . . . 0.0 112.327 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -114.43 134.25 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 4.2 m -156.67 126.62 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -121.64 83.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.62 30.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.273 . . . . 0.0 112.334 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 12.9 t -78.71 92.23 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 89.7 p -66.57 174.4 2.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.821 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 51.9 p -142.05 129.0 20.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.882 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 1.4 t -154.5 130.32 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.829 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -155.51 -144.25 3.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 70.3 m -80.46 44.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 50.6 m -122.87 171.04 9.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1139 ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' 1140 ' ' SER . . . -163.73 148.27 14.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1140 ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' 1139 ' ' GLY . 2.1 m -35.8 132.54 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.879 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 29.0 t -81.73 -59.49 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1142 ' ' GLN . . . . . 0.462 ' CG ' ' HD2' ' A' 1143 ' ' PRO . 40.2 tt0 -169.6 140.19 1.78 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1143 ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' 1142 ' ' GLN . 54.1 Cg_endo -69.71 162.0 43.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.29 . . . . 0.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1144 ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' 1143 ' ' PRO . 12.1 p -36.19 143.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.476 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 17.2 mt -81.64 154.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' 1148 ' ' GLN . 25.7 m -98.95 129.95 45.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' 1146 ' ' SER . . . -33.54 -35.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' 1146 ' ' SER . 28.0 mt-30 -46.04 -52.45 11.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1149 ' ' GLU . . . . . 0.476 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 7.8 pt-20 -99.7 -42.38 6.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -41.89 -57.03 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -46.76 -56.19 6.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.0 m -50.21 -49.59 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.34 -33.93 71.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.58 -56.7 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.4 t -59.37 -43.1 89.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' 1157 ' ' TYR . 23.1 tp -59.87 -60.41 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' 1156 ' ' LEU . 58.9 t80 -35.96 -47.97 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.06 -46.16 61.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 51.2 mttt -58.22 -42.37 86.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1160 ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' 1219 ' ' ILE . 39.6 mt -62.74 -42.27 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.2 t -61.07 -44.11 97.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.94 -46.96 85.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.3 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.44 -41.62 76.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.46 -61.49 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' 1167 ' ' HIS . 17.2 ptpt -52.27 -46.18 65.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.45 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.9 OUTLIER -61.23 -46.43 90.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.84 -51.79 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -61.9 -44.49 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 61.6 tttt -46.34 -56.99 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.469 ' HE2' ' CD1' ' A' 1178 ' ' LEU . 29.0 mtm -79.68 0.91 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.94 42.62 19.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.6 m -125.14 141.78 39.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.61 0.719 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 135.98 23.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.228 . . . . 0.0 112.349 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.92 -17.45 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.23 -41.2 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.8 mm -54.37 -40.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.469 ' CD1' ' HE2' ' A' 1171 ' ' MET . 10.9 tp -60.13 -62.36 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.29 150.21 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 71.4 p -87.34 167.61 13.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.39 -38.53 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -50.32 73.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 69.9 mt -51.06 -46.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 61.3 mt -56.25 -50.59 70.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.8 t -49.45 -53.61 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -54.89 -51.04 67.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.9 mtp -53.69 -40.04 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.44 72.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 31.7 mttm -79.2 -63.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 19.4 mtt -61.29 -40.91 95.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.426 ' N ' ' CD ' ' A' 1192 ' ' PRO . 39.2 mtm-85 66.08 55.04 0.99 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.708 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 141.84 46.34 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 57.0 p -110.34 -33.34 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.163 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 25.3 p -100.59 144.18 29.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.543 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.8 p -56.53 -23.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.458 ' N ' HG12 ' A' 1195 ' ' VAL . 52.3 mt-10 -64.49 -46.12 84.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -68.75 -37.75 79.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 81.7 t -52.87 -45.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 25.3 mttp -52.18 -36.52 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -65.56 -24.37 67.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.6 148.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.14 134.76 41.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.16 -44.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.506 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.9 p -59.13 131.84 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.093 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1205 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1206 ' ' GLU . 48.9 m -99.97 137.89 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1206 ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' 1205 ' ' SER . 6.4 tp10 -36.41 127.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 92.51 -60.03 2.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' 1207 ' ' GLY . 0.9 OUTLIER -37.64 -49.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.77 -47.72 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.58 -63.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -50.82 -25.05 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' 1209 ' ' ALA . 70.2 mt -88.25 30.9 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.558 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -66.11 -55.74 19.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 111.096 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' 1213 ' ' ALA . 65.0 Cg_exo -47.96 -18.15 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.338 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.22 -67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.558 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -59.19 -26.09 64.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' 1216 ' ' TRP . 14.1 mt-10 -60.08 -37.48 80.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.9 t -70.93 -43.6 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1219 ' ' ILE . . . . . 0.417 ' CD1' HD23 ' A' 1160 ' ' LEU . 86.4 mt -56.31 -42.55 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.58 -45.8 63.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1221 ' ' HIS . . . . . 0.476 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.0 t-160 -74.91 -56.65 4.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' 1221 ' ' HIS . 73.3 t80 -34.09 -36.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' 1227 ' ' SER . 78.6 m -90.91 -37.44 13.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' 1225 ' ' THR . 0.2 OUTLIER -55.45 -49.34 72.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.524 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.7 t -68.36 -37.76 80.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -86.71 -0.76 56.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' 1223 ' ' CYS . 38.8 t 56.08 36.48 27.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 94.1 t -92.04 153.56 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -71.9 146.51 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 24.8 p -137.52 -179.01 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 2.2 p30 44.6 48.82 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1232 ' ' LEU . . . . . 0.418 HD11 ' NH2' ' A' 1191 ' ' ARG . 14.9 mt -77.18 48.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' 1190 ' ' MET . 16.4 m-85 -94.95 173.87 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 89.1 p -94.77 44.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 91.0 p -111.88 147.49 35.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 39.4 p -116.72 39.44 3.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.18 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -109.85 92.08 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1238 ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' 1239 ' ' GLN . 54.6 Cg_endo -69.72 -2.38 10.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1239 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' 1238 ' ' PRO . 10.6 tt0 -35.77 125.55 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 1.3 t -149.23 156.94 42.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 176.62 -163.86 33.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 173.66 10.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 31.5 p -124.72 170.46 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 51.1 p -104.43 169.98 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.494 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 21.5 m -97.31 144.75 26.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 13.9 t -120.67 -57.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 130.0 166.53 11.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.475 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 19.7 m -121.55 -52.91 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 38.7 m -112.16 90.1 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -129.69 -85.39 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 37.1 p -67.44 -59.9 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.381 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 79.6 p -116.56 108.25 15.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -110.58 88.1 7.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 143.83 51.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.71 2.274 . . . . 0.0 112.349 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 13.6 p -47.28 153.77 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' 1146 ' ' SER . 67.5 mt -87.85 137.93 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' 1147 ' ' ALA . 20.8 m -65.34 126.84 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -35.89 -52.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.3 pt20 -33.07 -50.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -97.47 -51.53 4.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -43.12 -53.93 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.02 -60.35 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.0 m -42.46 -46.7 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.132 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.68 -39.33 91.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 80.9 mt -64.32 -52.13 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1155 ' ' VAL . . . . . 0.404 HG12 ' NZ ' ' A' 1159 ' ' LYS . 92.8 t -61.6 -39.14 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.127 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' 1222 ' ' PHE . 32.3 tp -69.02 -55.95 9.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.4 t80 -36.62 -46.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -56.79 -50.15 65.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1159 ' ' LYS . . . . . 0.473 ' NZ ' ' CD1' ' A' 1222 ' ' PHE . 40.2 mttp -52.82 -44.08 66.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 29.0 mt -61.75 -52.23 65.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 61.7 t -54.04 -42.76 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.69 -47.99 78.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.12 72.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -50.25 -39.75 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -64.83 -68.01 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' 1167 ' ' HIS . 15.8 pttp -48.8 -41.44 32.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.461 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.1 t60 -66.35 -45.86 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.79 -62.75 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -50.73 -38.24 46.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -51.21 -56.7 11.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.464 ' HE2' ' CD1' ' A' 1178 ' ' LEU . 44.8 mtm -82.13 7.15 14.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.8 t70 57.73 36.1 26.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 26.9 m -118.08 138.43 25.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.96 136.61 23.08 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -48.05 -16.85 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.718 2.279 . . . . 0.0 112.288 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.01 -42.87 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.12 -46.78 77.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.464 ' CD1' ' HE2' ' A' 1171 ' ' MET . 11.4 tp -52.73 -66.04 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -143.61 127.23 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.7 t -83.95 165.46 18.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 2.6 p30 -53.06 -45.0 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -49.49 -48.13 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -56.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 77.5 mt -47.59 -54.34 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 78.4 t -47.18 -47.69 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.151 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.69 -55.08 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 37.2 mtp -51.65 -16.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -87.15 -51.13 6.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.455 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.0 OUTLIER -83.28 -18.13 40.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' 1190 ' ' MET . 15.5 ptt180 33.37 54.95 1.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.79 151.57 68.91 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.69 2.26 . . . . 0.0 112.309 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.6 p -130.83 27.62 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 29.2 p -140.05 125.08 18.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 11.5 p -42.14 -42.2 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.75 -60.89 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.28 -40.49 61.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 92.8 t -50.36 -38.98 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 21.8 mttm -59.61 -25.73 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1200 ' ' ARG . . . . . 0.541 ' HB2' ' CE2' ' A' 1233 ' ' PHE . 41.5 mtp85 -72.18 -26.49 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' 1202 ' ' ASP . 40.4 mm -51.63 142.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.461 ' N ' HG23 ' A' 1201 ' ' ILE . 24.4 t0 -73.89 135.13 43.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.05 -50.71 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1204 ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' 1212 ' ' LEU . 3.3 p -67.61 132.23 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 0.0 111.156 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 23.8 p -99.74 157.19 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -49.58 149.57 2.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.73 -54.08 4.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' 1209 ' ' ALA . 2.7 ttmp? -53.09 -49.03 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.04 -46.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -44.79 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -48.64 -23.82 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' 1204 ' ' VAL . 90.5 mt -91.02 34.85 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.55 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -70.54 -49.09 16.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.8 Cg_exo -47.99 -19.22 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.89 -64.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.58 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.7 OUTLIER -64.83 -25.11 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.424 ' N ' ' CD1' ' A' 1216 ' ' TRP . 11.4 mt-10 -56.71 -43.52 80.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 71.9 t -67.06 -48.61 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1219 ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' 1191 ' ' ARG . 68.8 mt -47.05 -37.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -36.72 75.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.82 -43.2 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.473 ' CD1' ' NZ ' ' A' 1159 ' ' LYS . 30.0 t80 -55.68 -40.08 71.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.7 p -83.48 -31.71 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -63.46 -40.68 97.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 5.6 t -80.66 -23.61 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.45 ' O ' ' C ' ' A' 1227 ' ' SER . 10.9 m-80 -108.88 22.05 16.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1226 ' ' ASN . 6.8 t 34.38 42.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 95.1 t -89.6 144.18 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.407 ' C ' HG23 ' A' 1230 ' ' THR . 5.3 tp60 -70.64 162.49 28.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1230 ' ' THR . . . . . 0.407 HG23 ' C ' ' A' 1229 ' ' GLN . 76.7 p -151.66 -178.56 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.5 50.26 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.13 40.88 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' 1233 ' ' PHE . 0.1 OUTLIER -174.97 109.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 58.7 m -155.03 147.49 24.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 31.0 t -94.68 83.48 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 46.6 m -92.45 136.06 33.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.87 150.52 50.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 126.3 13.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -140.69 148.14 40.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 50.6 m -68.2 118.57 11.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 79.47 70.97 1.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 1.24 4.63 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 5.2 t -100.31 162.64 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 33.6 p -56.26 -57.59 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 87.8 p -106.87 153.41 22.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 11.2 m -160.49 123.05 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -168.19 -58.11 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 31.1 p -108.04 42.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 0.0 110.863 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 47.0 t -113.78 98.85 7.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -92.68 93.83 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.421 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 1.5 t -167.35 145.03 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.342 . . . . 0.0 110.879 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 2.3 t -50.59 126.4 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -114.83 143.84 30.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.609 0.719 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -174.54 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 61.2 t -46.75 140.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.83 129.04 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 44.9 m -50.03 136.19 19.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -44.16 -45.72 8.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' 1147 ' ' ALA . 14.6 mt-30 -35.81 -47.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.01 -48.97 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -50.53 -61.1 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -40.01 -58.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.4 m -48.94 -47.17 43.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.159 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -65.5 -32.64 74.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.36 -54.62 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 60.9 t -60.96 -40.43 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' 1222 ' ' PHE . 22.5 tp -65.36 -58.41 5.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.58 -57.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -47.42 -46.42 22.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttm -59.27 -42.45 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.4 -46.86 86.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 70.2 t -54.23 -40.81 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.27 -50.95 71.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.68 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.74 -38.16 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1165 ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' 1166 ' ' LYS . 12.6 tm0? -69.04 -70.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.416 ' N ' ' OE1' ' A' 1165 ' ' GLN . 0.2 OUTLIER -44.37 -39.32 4.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.5 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 1.6 t60 -70.42 -43.73 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.68 -62.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -52.94 -34.6 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -50.52 -53.45 30.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.594 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 66.2 mtm -83.15 -6.34 59.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.84 28.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 30.9 m -112.95 141.27 25.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.03 139.02 21.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.98 -17.77 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.23 -43.75 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 9.4 mm -51.16 -46.1 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.594 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.4 tp -54.85 -69.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -139.5 135.06 33.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1180 ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' 1181 ' ' ASN . 8.4 t -91.76 139.03 31.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1181 ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' 1180 ' ' THR . 11.1 m-20 -34.65 -42.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -46.4 -51.23 15.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.1 -48.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 81.2 mt -51.72 -56.03 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 84.7 t -45.54 -51.6 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.93 -44.51 94.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 48.8 mmm -54.73 -42.5 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.18 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.26 -64.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' 1233 ' ' PHE . 12.2 mtt -68.9 -42.18 77.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' 1192 ' ' PRO . 34.2 mtt85 70.61 52.7 0.39 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.76 136.27 32.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 17.9 p -123.7 23.16 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.18 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 12.0 p -139.77 138.14 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.173 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.567 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 6.8 p -54.91 -27.2 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.25 -54.05 14.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.496 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 34.9 m-20 -59.11 -49.36 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.457 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.3 t -46.43 -37.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -63.68 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1200 ' ' ARG . . . . . 0.446 ' HB2' ' CE2' ' A' 1233 ' ' PHE . 91.8 mtt180 -67.33 -26.96 66.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.453 ' O ' ' CG1' ' A' 1204 ' ' VAL . 24.7 mm -56.23 145.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.73 145.57 53.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.59 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.466 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1204 ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' 1201 ' ' ILE . 4.4 p -62.27 132.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 31.9 m -100.21 136.7 39.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.08 114.16 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 121.83 -70.6 0.4 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.0 OUTLIER -32.98 -44.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.73 0.3 . . . . 0.0 110.876 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -30.43 -46.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.063 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.77 -62.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.103 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 15.4 ptt? -63.16 -23.3 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' 1209 ' ' ALA . 81.0 mt -85.77 31.47 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.569 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -76.88 -51.24 2.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.541 0.686 . . . . 0.0 111.122 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.5 ' HG2' ' CD2' ' A' 1167 ' ' HIS . 64.9 Cg_exo -48.02 -21.79 3.03 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.64 -67.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.569 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.2 p90 -61.05 -24.63 66.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' 1216 ' ' TRP . 6.4 mt-10 -60.31 -36.95 79.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 53.7 t -73.45 -43.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.1 -34.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -59.2 -48.12 82.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 13.4 t60 -73.75 -41.25 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.528 ' CD2' HD11 ' A' 1156 ' ' LEU . 36.3 t80 -53.25 -41.76 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.1 p -82.33 -34.51 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -64.98 -37.17 86.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 10.2 t -83.35 -18.8 37.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.467 ' CB ' HG22 ' A' 1228 ' ' VAL . 12.7 m-80 -116.93 21.2 13.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' 1226 ' ' ASN . 74.4 m 34.32 42.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' 1226 ' ' ASN . 57.6 t -91.02 147.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -73.81 147.55 43.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 38.7 p -143.4 173.8 11.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1231 ' ' ASP . . . . . 0.406 ' OD1' ' ND2' ' A' 1197 ' ' ASN . 4.2 m-20 60.81 51.6 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1232 ' ' LEU . . . . . 0.418 HD13 ' NH1' ' A' 1191 ' ' ARG . 11.3 mt -83.32 37.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' 1233 ' ' PHE . 0.1 OUTLIER -174.99 119.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1234 ' ' SER . . . . . 0.411 ' HA ' ' NH1' ' A' 1200 ' ' ARG . 3.9 t -160.51 110.34 1.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 88.9 p -100.83 121.85 42.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 24.6 m -158.21 120.52 3.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -76.21 138.86 68.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.529 0.681 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 86.57 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.632 2.221 . . . . 0.0 112.354 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -106.46 131.73 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 54.1 m -66.74 -49.04 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -76.41 139.16 23.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -25.72 28.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 9.2 t 52.73 40.4 30.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 10.6 t -95.75 -54.12 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 97.1 p -89.26 135.38 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 110.827 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 5.5 t -95.41 101.68 13.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -172.72 -179.64 43.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 22.5 m -96.51 98.97 10.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 0.0 110.87 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 47.6 p -122.0 137.7 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -143.59 94.4 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 15.9 m -130.94 140.0 50.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.886 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 60.9 m -100.72 136.25 40.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -112.59 150.8 43.24 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.46 25.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 89.6 t -42.54 136.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 48.2 mt -76.66 136.63 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 24.2 p -59.02 135.66 57.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -38.85 -48.12 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 49.5 mt-30 -35.55 -52.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.27 -51.42 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -43.05 -59.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -43.68 -61.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.6 m -43.37 -42.57 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -72.04 -36.21 69.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 82.4 mt -64.56 -49.91 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 48.0 t -66.09 -40.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' 1222 ' ' PHE . 22.8 tp -64.01 -57.15 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 65.6 t80 -40.51 -49.23 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.72 61.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1159 ' ' LYS . . . . . 0.538 ' HE3' ' CD1' ' A' 1222 ' ' PHE . 33.8 mttm -59.19 -41.27 88.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.96 -52.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.7 t -49.39 -34.05 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.05 -51.42 58.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.2 -59.1 3.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.507 ' O ' ' NE ' ' A' 1164 ' ' ARG . 0.0 OUTLIER -46.94 -44.14 19.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1165 ' ' GLN . . . . . 0.419 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 44.3 tt0 -63.35 -72.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' 1167 ' ' HIS . 9.3 ptpt -43.09 -28.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.417 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -60.66 -53.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1168 ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' 1167 ' ' HIS . . . -37.14 -53.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -58.14 -46.8 85.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 29.6 tttt -47.99 -51.12 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.6 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 55.8 mtm -92.52 15.29 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 35.7 t70 43.04 40.79 2.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.9 m -117.34 141.42 28.64 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.626 0.727 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.9 132.92 22.56 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.356 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1175 ' ' PRO . . . . . 0.412 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 65.2 Cg_exo -48.0 -17.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.682 2.255 . . . . 0.0 112.325 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.81 -45.37 7.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.4 mm -51.2 -43.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.6 ' CD1' ' CE ' ' A' 1171 ' ' MET . 8.4 tp -64.69 -69.79 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.66 147.38 27.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 70.2 p -94.06 173.79 7.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -61.66 -52.44 64.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.59 -51.29 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 95.0 mt -47.51 -53.98 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 70.8 t -45.19 -45.84 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -55.23 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 62.2 mmm -47.0 -41.23 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.0 95.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -71.26 -60.6 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.566 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 38.1 mtt -63.9 -49.31 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.498 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 24.6 mtm180 69.39 54.78 0.52 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.568 0.699 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.539 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 53.5 Cg_endo -69.75 133.78 26.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.338 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1193 ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' A' 1220 ' ' LYS . 33.1 p -104.16 -22.18 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.3 p -108.1 144.42 35.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 10.5 p -50.52 -35.63 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' 1200 ' ' ARG . 14.8 mt-10 -55.82 -68.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' 1233 ' ' PHE . 84.9 m-20 -41.7 -36.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 88.6 t -63.05 -49.07 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.21 -29.58 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1200 ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' 1196 ' ' GLU . 2.1 mpt_? -67.57 -31.69 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 23.8 mm -48.91 135.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.39 141.55 57.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.48 -44.27 1.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.4 p -76.88 137.6 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.153 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 74.3 m -96.14 172.11 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.58 129.94 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 94.02 -59.66 2.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.448 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1208 ' ' LYS . . . . . . . . . . . . . 30.1 tttt -37.95 -47.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.894 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -38.13 -44.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.25 -59.82 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.5 ptt? -53.11 -24.8 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 33.89 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.531 ' N ' ' CD ' ' A' 1214 ' ' PRO . . . -68.83 -49.27 27.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.725 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.6 Cg_exo -47.99 -19.14 1.41 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.64 -68.35 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.8 OUTLIER -61.6 -19.19 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.06 -35.11 80.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.3 t -73.16 -45.48 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.28 -56.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1220 ' ' LYS . . . . . 0.405 ' CD ' ' HB ' ' A' 1193 ' ' THR . 16.1 ttpp -43.05 -49.07 6.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.55 -53.52 33.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.538 ' CD1' ' HE3' ' A' 1159 ' ' LYS . 22.1 t80 -47.51 -52.26 17.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' 1227 ' ' SER . 26.4 p -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -61.82 -36.33 80.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.456 HG23 ' ND2' ' A' 1226 ' ' ASN . 6.2 t -85.84 -27.58 25.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.456 ' ND2' HG23 ' A' 1225 ' ' THR . 24.1 m-80 -99.39 6.33 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.4 t 50.5 34.6 9.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.498 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 45.3 t -87.01 143.73 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.433 ' N ' HG12 ' A' 1228 ' ' VAL . 4.8 tt0 -68.7 148.36 50.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 22.0 p -149.17 175.5 11.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.69 51.94 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.74 38.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' 1197 ' ' ASN . 3.3 m-85 -98.0 -35.61 10.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 36.5 m -110.38 115.39 29.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 39.7 t -110.96 -44.37 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 93.9 m -53.56 -52.13 60.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -75.47 122.63 87.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.573 0.701 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -51.6 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.359 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -92.06 80.67 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 51.1 p -39.64 -57.3 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -169.19 127.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.53 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -0.41 6.86 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.656 2.237 . . . . 0.0 112.353 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 1.9 m -161.9 117.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 94.7 p -44.58 148.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 27.2 p -142.81 139.36 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 15.7 m -106.03 103.73 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 129.04 133.24 3.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 6.0 t -126.85 -57.64 1.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.844 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 3.6 t -98.24 136.27 38.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -166.51 -53.2 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 2.4 t 50.55 42.31 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 2.8 m -162.06 129.62 3.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.828 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -165.82 137.6 3.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.591 0.71 . . . . 0.0 110.898 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.67 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.643 2.229 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.5 m -45.19 170.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 71.6 mt -85.69 132.04 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.167 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' 1147 ' ' ALA . 44.8 t -50.91 132.61 27.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.833 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -37.92 -41.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' 1147 ' ' ALA . 16.1 mt-30 -34.39 -56.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.36 -48.28 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -40.85 -60.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -46.04 -60.72 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.2 m -42.16 -46.12 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -66.06 -43.8 86.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.1 -55.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.2 t -60.85 -43.2 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' 1222 ' ' PHE . 28.5 tp -60.66 -60.86 3.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' 1156 ' ' LEU . 64.5 t80 -35.29 -47.42 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -59.55 -51.97 55.88 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -50.12 -42.24 50.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.64 -51.58 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 95.5 t -45.66 -57.2 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.152 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.96 -57.5 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.38 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.57 -45.24 85.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.38 -54.01 50.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' 1167 ' ' HIS . 8.8 pttm -64.11 -38.62 91.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.469 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -61.71 -51.03 70.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.03 -53.49 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.98 -45.58 92.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1170 ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' 1170 ' ' LYS . 6.6 tmtm? -48.49 -51.18 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.551 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 50.0 mtm -91.53 15.36 12.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 36.9 t70 42.74 37.0 0.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1173 ' ' VAL . . . . . 0.47 ' CG2' HD13 ' A' 1178 ' ' LEU . 34.9 m -116.0 136.81 23.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.603 0.716 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.97 134.63 23.66 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.02 -16.41 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.372 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.84 -45.06 8.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.057 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.96 -45.05 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.551 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.9 tp -52.0 -69.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.06 114.85 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.6 t -64.89 176.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.67 -47.44 85.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -44.67 -55.28 5.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 91.9 mt -51.52 -62.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 71.3 mt -45.49 -56.89 4.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 62.9 t -41.06 -57.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' 1189 ' ' LYS . 4.2 m-20 -56.68 -57.28 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 70.0 mtp -43.94 -23.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1188 ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' 1186 ' ' ASP . . . -93.12 -32.24 14.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1189 ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' 1186 ' ' ASP . 0.2 OUTLIER -74.14 -48.86 26.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.464 ' HE1' ' CD1' ' A' 1201 ' ' ILE . 0.0 OUTLIER -85.4 -38.76 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 50.2 mtt85 68.74 54.98 0.58 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.2 Cg_endo -69.73 128.06 15.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 67.6 p -101.94 -24.22 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 70.2 p -102.66 135.74 43.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.538 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.5 p -53.3 -42.34 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.416 ' HA ' ' CE ' ' A' 1199 ' ' LYS . 27.0 mp0 -48.5 -35.35 12.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -84.43 -35.02 23.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.428 HG23 ' CE3' ' A' 1216 ' ' TRP . 91.8 t -62.22 -48.51 88.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1199 ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' 1196 ' ' GLU . 13.2 ptpt -54.46 -17.15 2.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -82.92 -30.68 28.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.464 ' CD1' ' HE1' ' A' 1190 ' ' MET . 47.9 mm -43.73 144.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.67 135.33 54.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.3 -45.99 1.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.5 p -81.38 137.04 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.145 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.0 t -100.07 156.05 17.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -47.69 151.32 0.87 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 77.93 -62.91 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' 1209 ' ' ALA . 10.5 ttmm -40.6 -50.46 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.765 0.316 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.74 -46.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.09 -64.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -48.46 -31.73 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' 1209 ' ' ALA . 41.5 mt -84.43 30.36 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.536 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.53 -55.17 15.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.566 0.698 . . . . 0.0 111.05 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' 1213 ' ' ALA . 65.8 Cg_exo -47.99 -17.59 0.87 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.697 2.265 . . . . 0.0 112.34 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1215 ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' 1215 ' ' LEU . 8.6 mp -79.95 -65.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.2 p90 -60.88 -26.99 67.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.507 ' N ' ' CD1' ' A' 1216 ' ' TRP . 22.8 mt-10 -55.08 -40.17 70.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -65.79 -42.14 91.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 70.3 mt -53.71 -49.66 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -51.02 -43.15 60.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.7 t60 -69.62 -47.75 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.567 ' CD2' HD11 ' A' 1156 ' ' LEU . 31.6 t80 -53.43 -61.23 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' 1227 ' ' SER . 17.9 p -53.15 -44.14 67.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -45.8 -63.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.5 m -67.69 -40.52 84.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.462 ' O ' ' C ' ' A' 1227 ' ' SER . 70.0 m-80 -81.76 13.59 3.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' 1223 ' ' CYS . 6.5 t 32.55 49.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' 1229 ' ' GLN . 71.2 t -99.07 138.37 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' 1228 ' ' VAL . 13.2 tp60 -64.81 162.68 15.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 53.3 p -146.69 178.16 8.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 38.7 t0 61.19 42.62 11.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.4 mt -82.91 40.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -85.79 -44.16 12.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 5.5 m -163.02 172.08 15.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 3.8 m -64.83 91.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 25.0 m -130.02 102.92 6.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1237 ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' 1238 ' ' PRO . 2.8 mptm? -67.98 -60.36 5.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.893 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1238 ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' 1237 ' ' LYS . 54.0 Cg_endo -69.79 163.62 37.61 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.342 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -85.7 -49.29 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 36.2 t -92.39 -42.87 9.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 68.71 -157.18 53.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.498 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 128.6 16.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.671 2.247 . . . . 0.0 112.333 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 74.3 m -130.31 154.08 48.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 8.1 t -173.35 157.12 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 80.4 p -81.0 129.62 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 97.0 p -93.86 119.88 33.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 159.97 40.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 65.5 m -80.55 125.33 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.866 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 5.4 t 45.26 42.16 6.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.865 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -64.87 96.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.469 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1140 ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' 1141 ' ' SER . 95.4 p -151.2 166.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1141 ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' 1140 ' ' SER . 32.6 m -36.72 146.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -109.04 146.36 33.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 0.0 110.95 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 164.19 35.5 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.738 2.292 . . . . 0.0 112.302 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 43.4 t -41.5 131.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.99 136.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 70.5 m -57.73 144.16 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -49.28 -48.19 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 3.3 pt20 -33.38 -49.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -96.62 -52.49 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -43.55 -56.59 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -52.73 -60.6 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 74.0 m -41.4 -46.62 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -61.92 -45.14 95.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.62 -63.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 93.7 t -48.63 -54.16 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' 1222 ' ' PHE . 9.7 tp -54.04 -63.14 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -38.06 -55.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -50.42 -42.99 43.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.5 -43.96 79.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 38.9 mt -60.14 -43.4 95.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 98.2 t -57.73 -38.1 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -55.18 -50.52 69.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -68.25 -48.92 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' 1178 ' ' LEU . 4.7 tmm_? -47.4 -35.13 7.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.6 -69.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' A' 1169 ' ' ASN . 14.8 ptpt -44.96 -34.44 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.452 ' HB3' ' CD2' ' A' 1178 ' ' LEU . 1.3 t-80 -60.65 -37.29 81.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.7 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1169 ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' 1170 ' ' LYS . 6.4 p30 -61.08 -49.2 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1170 ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' 1169 ' ' ASN . 0.1 OUTLIER -48.12 -53.07 17.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 34.6 mtm -78.18 -7.61 57.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.907 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 12.5 t0 68.92 26.65 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.8 m -112.66 140.67 24.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.0 139.99 19.46 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1175 ' ' PRO . . . . . 0.447 ' O ' ' NH1' ' A' 1164 ' ' ARG . 65.9 Cg_exo -48.0 -16.74 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.71 2.273 . . . . 0.0 112.317 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.16 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.8 mm -46.54 -39.45 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.518 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.9 tp -61.04 -72.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -160.17 123.42 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 15.3 t -67.37 162.94 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -52.81 -46.39 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -42.84 -57.81 2.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.9 mt -45.48 -64.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1184 ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' 1164 ' ' ARG . 95.6 mt -44.69 -52.14 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.3 t -47.15 -54.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.22 -46.6 75.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 36.1 mmm -50.86 -37.58 44.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.92 68.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 9.1 mptt -75.69 -60.91 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.533 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 14.6 mtt -70.37 -38.29 74.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' 1192 ' ' PRO . 32.0 mtt-85 66.66 52.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.8 137.67 35.9 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.25 . . . . 0.0 112.373 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 64.2 p -127.69 21.69 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 1.2 p -137.53 127.19 25.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.424 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . 14.1 p -43.28 -26.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -72.54 -64.59 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -47.65 -43.25 26.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.517 HG23 ' CE3' ' A' 1216 ' ' TRP . 90.2 t -52.43 -42.03 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -58.4 -26.29 63.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -73.83 -33.28 64.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' 1202 ' ' ASP . 43.5 mm -47.5 140.16 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.418 ' N ' HG23 ' A' 1201 ' ' ILE . 26.5 t0 -68.77 142.51 54.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.91 -41.38 2.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.539 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 8.4 p -78.62 137.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1205 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1206 ' ' GLU . 65.1 m -99.5 144.06 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1206 ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' 1205 ' ' SER . 22.7 tt0 -35.44 130.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.88 -59.8 3.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.7 ttmp? -38.41 -52.11 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.84 -52.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.5 -66.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.2 ptt? -47.44 -28.64 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 65.8 mt -85.4 30.73 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.565 ' HB2' ' CZ2' ' A' 1216 ' ' TRP . . . -63.47 -50.0 75.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' 1213 ' ' ALA . 64.5 Cg_exo -47.91 -18.94 1.27 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.329 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.64 -70.77 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' 1213 ' ' ALA . 1.1 p90 -56.55 -24.47 47.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.451 ' N ' ' CD1' ' A' 1216 ' ' TRP . 30.1 mt-10 -59.5 -35.34 73.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 63.6 t -68.24 -34.76 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.71 -42.92 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.35 -46.52 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -72.61 -41.69 65.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.488 ' CG ' HD11 ' A' 1156 ' ' LEU . 22.0 t80 -54.25 -42.83 70.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 23.7 p -81.36 -34.59 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -62.53 -33.68 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 3.1 t -89.72 -15.35 32.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' 1227 ' ' SER . 7.6 m-80 -118.65 20.15 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1226 ' ' ASN . 55.1 m 35.55 46.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' 1229 ' ' GLN . 41.0 t -93.72 140.43 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.15 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.442 ' N ' HG11 ' A' 1228 ' ' VAL . 16.7 pt20 -68.79 153.44 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 47.3 p -146.87 -179.89 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 61.93 45.62 7.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.64 35.79 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.533 ' CE2' ' SD ' ' A' 1190 ' ' MET . 49.2 m-85 -75.84 158.87 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 2.5 m -82.04 149.33 28.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 32.5 m 58.9 45.14 15.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 8.8 t -100.36 35.12 2.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 17.1 tptm -71.81 133.93 84.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.578 0.704 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 106.01 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.734 2.289 . . . . 0.0 112.292 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.34 139.75 52.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 59.0 p -143.21 119.53 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -148.04 144.48 12.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -43.36 2.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.296 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 45.5 p -51.43 162.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 63.0 m -107.56 -51.19 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.539 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 87.6 p -122.36 -50.12 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 17.0 t -77.4 -57.31 3.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -123.08 123.15 5.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 1.9 t -108.46 177.06 4.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.827 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 36.1 t -63.55 120.41 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -75.74 54.25 2.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 43.1 t -41.88 -61.51 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.827 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 49.0 m -59.17 -54.71 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -156.39 140.21 11.43 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.6 0.714 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 118.76 5.87 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.669 2.246 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 9.8 p -125.84 155.98 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 35.3 mt -87.45 154.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' 1147 ' ' ALA . 74.4 m -81.98 139.08 34.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.807 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.92 -46.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 76.5 mt-30 -35.95 -52.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1149 ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' 1150 ' ' GLN . 44.1 tt0 -99.89 -47.07 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1150 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' 1149 ' ' GLU . 20.3 tt0 -36.81 -50.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -54.54 -56.22 21.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 53.3 m -44.45 -46.74 9.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1153 ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 2.1 mm-40 -68.25 -35.1 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.38 -53.39 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 44.7 t -63.57 -39.7 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.61 -53.8 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.6 t80 -40.27 -44.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -55.0 -44.93 83.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1159 ' ' LYS . . . . . 0.476 ' HE2' ' CD1' ' A' 1222 ' ' PHE . 44.1 mttp -61.84 -46.16 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.6 mt -57.23 -40.73 78.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 96.3 t -62.59 -44.07 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -64.75 -45.89 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.86 95.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.453 ' CG ' HD23 ' A' 1178 ' ' LEU . 27.7 ttp180 -59.06 -46.13 89.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -56.58 -61.05 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 26.4 pttt -52.54 -26.89 14.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -47.85 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.14 -50.99 3.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -65.83 -46.18 79.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 66.1 tttt -45.55 -53.69 8.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 44.6 mtm -84.26 -1.95 56.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.88 30.57 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -113.19 138.74 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.99 136.74 23.21 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.679 2.252 . . . . 0.0 112.37 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.94 -16.79 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.45 -46.39 7.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.3 mm -53.28 -44.81 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.571 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.8 tp -54.08 -68.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -154.89 129.68 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 3.6 t -75.54 166.1 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.32 -44.44 84.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -48.82 -42.77 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.87 -45.16 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.72 -49.47 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 98.6 t -49.87 -50.95 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.22 -46.8 88.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 38.2 mtp -53.01 -43.39 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.52 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1189 ' ' LYS . . . . . 0.433 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 26.2 mttm -73.53 -63.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1190 ' ' MET . . . . . . . . . . . . . 21.5 mtt -59.1 -38.6 79.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 31.7 mtp180 62.24 55.02 2.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.584 0.707 . . . . 0.0 110.898 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.458 ' CB ' ' HB2' ' A' 1197 ' ' ASN . 53.7 Cg_endo -69.8 135.08 29.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.375 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1193 ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' 1216 ' ' TRP . 30.3 p -103.66 -36.91 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 2.8 p -99.99 164.27 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 14.8 p -62.15 -42.59 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -49.01 -50.83 34.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.458 ' HB2' ' CB ' ' A' 1192 ' ' PRO . 0.6 OUTLIER -59.34 -42.7 92.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' A' 1209 ' ' ALA . 58.7 t -59.14 -49.21 84.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 64.1 mttt -49.89 -35.87 25.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -71.43 -24.89 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' 1202 ' ' ASP . 23.9 mm -55.45 100.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' 1201 ' ' ILE . 6.7 t70 -34.8 143.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.2 -50.86 1.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1204 ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' 1201 ' ' ILE . 14.9 p -69.84 137.54 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1205 ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' 1206 ' ' GLU . 1.2 t -96.82 140.38 31.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1206 ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' 1205 ' ' SER . 22.4 tt0 -34.21 140.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.8 -54.01 4.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' 1209 ' ' ALA . 43.1 tttm -39.51 -57.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.12 -39.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.51 -66.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.99 -22.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.84 33.84 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.57 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -66.2 -53.32 33.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.723 . . . . 0.0 111.109 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.9 Cg_exo -48.03 -17.65 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.1 -65.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.57 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.2 p90 -61.02 -21.53 63.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.3 -44.37 95.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 97.6 t -67.21 -38.37 80.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.59 -39.42 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1220 ' ' LYS . . . . . 0.401 ' O ' ' SG ' ' A' 1223 ' ' CYS . 23.2 ttpt -64.53 -27.63 69.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1221 ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' 1224 ' ' GLN . 1.8 t-80 -81.9 -60.64 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.476 ' CD1' ' HE2' ' A' 1159 ' ' LYS . 59.3 t80 -38.36 -37.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -81.99 -33.79 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -66.33 -47.39 73.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' 1224 ' ' GLN . 9.0 t -71.32 -30.82 66.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' 1227 ' ' SER . 36.6 m-80 -105.6 14.01 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' 1223 ' ' CYS . 82.4 p 33.9 48.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' 1226 ' ' ASN . 60.1 t -98.99 147.63 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -65.22 146.62 54.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1230 ' ' THR . . . . . 0.428 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.9 p -145.38 -175.39 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1231 ' ' ASP . . . . . 0.428 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 47.18 50.14 14.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.73 49.34 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' 1197 ' ' ASN . 33.9 m-85 -86.04 155.52 20.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 3.5 m -44.43 148.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 30.7 t -72.87 80.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 15.3 t -125.99 145.18 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.143 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -58.36 134.68 85.13 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 166.13 28.72 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.342 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -115.61 134.55 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 8.0 t -74.87 169.87 17.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 102.33 62.38 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.523 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1242 ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' 1243 ' ' SER . 53.9 Cg_endo -69.77 -46.75 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.307 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1243 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1242 ' ' PRO . 43.6 t 35.19 43.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 97.0 p -109.57 97.26 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 22.3 m -141.57 111.27 6.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 72.6 p -129.78 145.24 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -131.28 -157.3 8.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 42.7 p -174.13 148.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 1.9 t -165.93 149.16 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -71.72 -170.29 12.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 3.1 m -126.7 41.89 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 3.2 t -160.79 128.31 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.793 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -121.3 111.49 33.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -173.53 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.2 m -77.01 146.6 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' 1150 ' ' GLN . 42.9 mt -90.88 129.69 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' 1147 ' ' ALA . 11.7 t -56.93 128.65 37.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' 1146 ' ' SER . . . -36.18 -46.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -40.8 -51.92 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -91.33 -49.27 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1150 ' ' GLN . . . . . 0.423 ' N ' HG21 ' A' 1145 ' ' ILE . 41.2 tt0 -41.55 -58.0 2.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.951 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -48.71 -61.65 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.3 m -42.65 -46.8 5.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1153 ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 18.4 mt-30 -64.82 -37.16 86.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.84 -57.52 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.0 t -56.08 -38.68 54.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' 1222 ' ' PHE . 33.7 tp -72.08 -61.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 70.2 t80 -36.79 -40.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.2 94.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -57.13 -44.64 83.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.69 -52.27 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 88.5 t -45.76 -45.18 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.64 -46.72 88.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.65 80.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -52.12 -46.45 65.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -57.73 -66.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' 1167 ' ' HIS . 10.3 pttp -47.58 -38.29 14.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.453 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.6 OUTLIER -65.9 -51.93 54.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.96 -58.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -57.29 -41.09 79.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.88 -55.23 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.458 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 39.6 mtm -80.83 -2.83 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.25 29.31 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.7 m -113.39 138.83 22.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.94 138.31 21.36 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 -16.93 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.603 2.202 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.0 -45.61 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.7 mm -51.82 -42.05 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.458 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.9 tp -57.54 -67.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.28 129.43 11.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1180 ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.3 t -83.69 150.62 25.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1181 ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' 1180 ' ' THR . 5.6 m120 -35.38 -48.7 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -45.1 -56.62 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 81.4 mt -52.28 -52.6 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 71.8 mt -46.36 -57.03 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 21.6 t -46.55 -50.31 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.454 ' CB ' HG21 ' A' 1201 ' ' ILE . 1.9 m-20 -56.22 -41.6 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 56.4 mtp -68.88 -22.6 64.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -90.27 -29.01 18.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1189 ' ' LYS . . . . . 0.421 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 9.2 ptmm? -85.39 -44.41 12.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' 1189 ' ' LYS . 15.8 mtm -88.07 -14.79 38.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.428 ' HG2' ' CD2' ' A' 1156 ' ' LEU . 47.9 mtm-85 39.62 54.87 5.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.77 138.79 38.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.9 p -131.45 22.33 4.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 13.3 p -138.24 126.27 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 9.6 p -49.08 -27.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -73.78 -30.5 62.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -89.84 -49.88 6.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.537 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.6 t -45.89 -44.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -58.04 -30.06 65.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -74.5 -14.03 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' 1202 ' ' ASP . 23.0 mm -59.58 138.69 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.477 ' N ' HG23 ' A' 1201 ' ' ILE . 16.4 t70 -60.23 136.99 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1204 ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' 1205 ' ' SER . 7.4 p -77.2 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.164 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1205 ' ' SER . . . . . 0.419 ' N ' HG21 ' A' 1204 ' ' VAL . 38.1 m -100.17 170.9 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -61.49 143.85 55.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.32 -57.68 4.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.409 ' HD3' ' CG2' ' A' 1204 ' ' VAL . 46.5 tttt -39.54 -45.31 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -39.77 -45.19 1.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.08 -65.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -50.15 -25.91 4.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 53.8 mt -88.99 32.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.514 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.33 -51.37 34.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 111.125 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.2 Cg_exo -48.03 -17.18 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1215 ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' 1215 ' ' LEU . 7.8 mp -82.35 -64.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.9 OUTLIER -64.47 -20.7 66.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.27 -37.15 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 76.7 t -68.53 -51.89 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 59.1 mt -47.15 -48.33 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -48.17 -48.51 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.34 -46.61 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' 1222 ' ' PHE . 3.3 t80 -54.01 -38.14 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' 1227 ' ' SER . 28.1 p -85.97 -31.16 22.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -69.0 -35.4 76.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 7.6 t -84.78 -20.36 31.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -108.88 -3.69 17.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' 1223 ' ' CYS . 3.5 t 61.06 33.22 19.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' 1229 ' ' GLN . 62.9 t -80.81 140.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.173 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.469 ' N ' HG11 ' A' 1228 ' ' VAL . 5.9 tp60 -71.43 151.3 44.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 75.9 p -144.88 173.71 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 68.72 47.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.78 43.61 1.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.42 -51.13 7.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 52.3 m -147.76 115.61 6.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 58.8 m -90.48 75.39 6.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1236 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1237 ' ' LYS . 55.2 p -145.98 167.02 24.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1237 ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' 1236 ' ' THR . 19.6 tptm -35.01 133.55 0.44 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -2.52 10.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.301 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -91.38 79.06 5.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 57.2 m -136.77 143.54 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -79.22 135.92 16.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.387 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 40.7 m -71.07 144.39 50.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 7.4 t -48.32 -45.6 35.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 2.7 t -132.29 104.04 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.876 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 49.3 m -116.61 99.91 7.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -51.81 104.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 19.5 m -54.71 142.04 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 36.9 p -140.91 151.12 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.818 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 171.27 120.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 22.3 p -124.83 107.6 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1141 ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' 1142 ' ' GLN . 7.1 m 57.19 43.82 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.84 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1142 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1141 ' ' SER . 26.4 mt-30 -35.85 124.52 0.67 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.651 0.739 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -175.86 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 98.1 t -71.24 138.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.106 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 53.3 mt -78.3 144.0 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 19.9 m -78.92 152.54 31.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -43.49 -47.43 7.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.7 pt20 -32.82 -51.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.06 -48.95 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -47.87 -67.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -40.82 -60.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.8 m -43.03 -52.03 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -61.77 -36.61 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.58 -58.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 88.4 t -60.15 -40.15 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.506 ' HB2' ' CE2' ' A' 1222 ' ' PHE . 38.6 tp -62.95 -56.88 13.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' 1156 ' ' LEU . 45.2 t80 -37.23 -42.24 0.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.93 -49.27 73.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.432 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 25.3 mttm -53.38 -40.89 65.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.81 -49.36 68.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 83.1 t -47.55 -41.37 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -62.66 -42.8 99.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.74 96.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -62.74 -43.28 99.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.66 -51.27 70.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1166 ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' 1167 ' ' HIS . 19.0 ptpt -64.89 -44.1 90.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.456 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.1 t-80 -60.54 -47.98 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.13 -53.12 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -61.37 -46.82 88.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1170 ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' 1170 ' ' LYS . 14.4 tmtt? -43.07 -54.74 4.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.472 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 29.2 mtm -82.86 -4.79 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 18.4 t0 67.27 32.02 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.0 m -115.26 137.79 23.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.606 0.717 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.93 138.88 20.69 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.96 -16.51 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 0.0 112.394 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.78 -47.38 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.93 -41.33 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.472 ' CD1' ' HE1' ' A' 1171 ' ' MET . 11.8 tp -57.55 -63.96 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -153.46 143.97 22.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 59.1 p -93.17 169.57 10.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -55.32 -37.65 67.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.86 -48.06 82.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.85 -39.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 77.3 mt -72.71 -48.13 41.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 93.2 t -52.24 -40.23 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -44.25 72.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 52.5 mtp -59.5 -37.19 77.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -72.4 -27.75 62.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 44.3 mttt -79.33 -63.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.584 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 15.2 mtt -64.92 -39.04 92.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' 1192 ' ' PRO . 29.1 mtm180 66.55 53.71 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.9 Cg_endo -69.77 141.23 44.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.708 2.272 . . . . 0.0 112.344 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -127.58 18.29 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 31.3 p -137.85 130.8 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.511 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 14.7 p -51.29 -24.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' 1195 ' ' VAL . 8.5 mm-40 -71.9 -64.16 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -51.53 -42.92 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 88.7 t -47.78 -45.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.9 mttp -52.06 -34.13 42.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -64.34 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1201 ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.33 153.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 31.7 t0 -80.69 133.46 35.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.0 -46.03 1.43 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 12.8 p -66.64 134.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 8.6 m -98.91 152.18 20.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -43.47 137.45 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.88 -62.91 4.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.441 ' HG3' ' CE ' ' A' 1211 ' ' MET . 40.1 tttt -34.97 -48.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.44 -48.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.09 -65.62 0.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1211 ' ' MET . . . . . 0.441 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 5.6 ptt? -46.16 -28.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' 1209 ' ' ALA . 51.2 mt -87.17 32.95 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.57 ' HB1' ' CZ2' ' A' 1216 ' ' TRP . . . -70.42 -54.86 8.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.567 0.699 . . . . 0.0 111.089 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' 1167 ' ' HIS . 65.2 Cg_exo -47.95 -17.57 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.91 -64.04 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.57 ' CZ2' ' HB1' ' A' 1213 ' ' ALA . 1.2 p90 -62.42 -21.86 65.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.403 ' N ' ' CD1' ' A' 1216 ' ' TRP . 55.1 mt-10 -60.43 -37.87 82.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.0 t -69.36 -57.9 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.085 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -38.71 -46.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -46.96 -55.23 8.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.04 -46.56 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' 1156 ' ' LEU . 64.1 t80 -46.65 -47.53 20.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 97.4 m -81.93 -46.87 13.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -46.86 -46.44 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.42 HG23 ' ND2' ' A' 1226 ' ' ASN . 15.4 t -70.96 -37.37 72.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.455 ' CB ' HG21 ' A' 1228 ' ' VAL . 15.6 m-80 -90.05 23.8 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 4.7 t 39.37 39.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1228 ' ' VAL . . . . . 0.455 HG21 ' CB ' ' A' 1226 ' ' ASN . 61.1 t -99.35 143.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1229 ' ' GLN . . . . . 0.44 ' N ' HG13 ' A' 1228 ' ' VAL . 17.7 tt0 -71.0 153.1 42.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 25.4 p -145.9 152.39 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.85 54.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 17.2 mt -85.35 25.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.584 ' CE2' ' SD ' ' A' 1190 ' ' MET . 0.7 OUTLIER -151.53 105.56 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 71.2 p -175.03 113.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.859 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 90.4 p -96.01 52.76 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 20.3 m -150.5 144.89 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 54.1 pttt -160.5 139.3 7.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.333 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -61.34 -45.54 93.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 57.4 p -105.86 171.56 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -126.58 176.2 17.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -45.64 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.288 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 58.7 m 41.47 43.59 2.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 69.2 m 41.64 42.19 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 40.0 t -146.35 148.91 32.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.826 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 59.5 p -42.14 125.08 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -56.16 119.38 14.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 25.8 t -95.23 126.3 40.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 6.5 t -54.43 -49.44 69.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 152.75 172.74 21.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 1.1 t 71.86 40.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 85.7 p -156.43 105.97 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -52.82 111.27 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 147.52 62.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 10.2 p -84.02 148.63 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.52 139.2 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1147 ' ' ALA . 89.2 p -54.11 124.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.12 -48.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -41.67 -49.4 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.52 -52.38 4.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1150 ' ' GLN . . . . . 0.461 ' NE2' ' HA ' ' A' 1150 ' ' GLN . 2.1 tp60 -42.22 -52.77 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.22 -60.09 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 70.7 m -41.0 -54.54 2.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -54.06 -40.81 67.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.13 -53.41 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.1 t -61.52 -42.04 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.511 HD13 ' CG ' ' A' 1222 ' ' PHE . 17.6 tp -62.22 -59.13 5.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' 1156 ' ' LEU . 55.8 t80 -35.74 -51.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.47 56.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 17.1 mttm -58.75 -38.82 79.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.07 -42.22 73.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 68.3 t -47.57 -51.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -56.84 -46.2 81.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.92 -44.96 95.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.409 ' HD3' ' CB ' ' A' 1179 ' ' ALA . 4.0 tpm_? -60.79 -29.37 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -80.7 -70.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -40.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1167 ' ' HIS . . . . . 0.493 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 0.5 OUTLIER -65.26 -54.57 27.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -37.26 -59.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.42 -35.88 76.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1170 ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' 1167 ' ' HIS . 43.0 tttp -52.61 -54.31 34.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.471 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 36.7 mtm -81.57 -1.77 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.18 37.37 8.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 25.6 m -119.62 142.39 32.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.98 135.64 23.6 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.97 -16.81 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.35 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.93 -45.49 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 35.9 mm -55.41 -38.79 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.471 ' CD1' ' HE1' ' A' 1171 ' ' MET . 14.0 tp -59.63 -64.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1179 ' ' ALA . . . . . 0.409 ' CB ' ' HD3' ' A' 1164 ' ' ARG . . . -168.66 127.41 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 11.0 t -67.82 170.28 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -63.78 -45.8 88.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -42.92 -57.34 2.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.6 mt -47.69 -48.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.87 -58.54 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 93.1 t -40.87 -53.49 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.7 -56.7 15.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 42.7 mtp -47.79 -43.5 27.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.0 79.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -71.36 -63.82 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.537 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 20.2 mtt -63.69 -39.64 94.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.3 mtm-85 65.61 54.67 1.07 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.578 0.704 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 143.73 51.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.33 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 6.2 p -124.87 15.5 8.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 16.9 p -140.03 134.91 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' 1196 ' ' GLU . 11.1 p -57.85 -29.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.456 ' N ' HG13 ' A' 1195 ' ' VAL . 3.0 pt-20 -67.47 -31.68 71.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -87.37 -37.78 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 90.4 t -53.37 -36.48 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.169 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -62.89 -27.36 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -68.21 -33.24 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' 1202 ' ' ASP . 46.9 mm -42.63 160.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' A' 1201 ' ' ILE . 16.8 t70 -87.36 134.51 33.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.06 -38.71 3.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 138.82 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 63.8 p -99.82 154.71 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.48 139.18 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 80.7 -56.68 4.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' 1209 ' ' ALA . 14.6 ttmm -36.98 -45.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.22 -45.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.46 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 9.7 ptt? -52.94 -17.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' 1209 ' ' ALA . 17.0 mt -90.88 31.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.553 ' HB3' ' CZ2' ' A' 1216 ' ' TRP . . . -76.8 -49.87 2.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 0.0 111.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' 1213 ' ' ALA . 66.2 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1215 ' ' LEU . . . . . 0.403 HD13 ' NH2' ' A' 1164 ' ' ARG . 6.8 mp -84.04 -70.94 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.564 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.0 OUTLIER -56.2 -19.18 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.02 -35.79 81.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 81.7 t -75.89 -51.79 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.0 -50.57 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -42.08 -45.22 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1221 ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.4 t-160 -75.59 -56.27 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1222 ' ' PHE . . . . . 0.511 ' CG ' HD13 ' A' 1156 ' ' LEU . 10.0 t80 -41.88 -32.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 83.1 m -90.96 -25.21 19.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' 1221 ' ' HIS . 2.9 pt20 -72.04 -46.95 55.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.493 HG22 ' ND2' ' A' 1226 ' ' ASN . 7.4 t -74.11 -24.66 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.493 ' ND2' HG22 ' A' 1225 ' ' THR . 36.3 m-80 -102.1 -0.79 32.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 32.1 t 55.37 36.65 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 74.9 t -83.09 153.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.11 145.95 51.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 23.6 p -143.58 165.62 27.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.13 46.65 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.36 43.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.537 ' CE2' ' SD ' ' A' 1190 ' ' MET . 58.2 m-85 -84.75 41.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1234 ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' 1233 ' ' PHE . 74.2 m 35.09 43.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 5.0 m -78.0 154.34 31.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.847 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 23.6 p -125.53 -25.07 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.162 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 153.32 55.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.646 0.736 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 143.52 51.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.326 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -63.77 -48.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 41.1 t -68.02 150.13 48.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -119.27 -164.23 12.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -50.14 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.366 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 82.7 p -148.17 151.9 36.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 44.0 p -48.81 160.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 13.0 m -103.77 160.95 14.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 2.8 m -82.85 -59.03 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.854 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 118.12 -140.33 15.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 30.2 t -162.42 144.99 11.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 5.2 t -96.37 146.22 24.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 108.46 158.99 19.66 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 2.5 m -54.72 -46.54 74.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 32.9 m -61.07 160.12 10.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.75 136.52 10.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 155.25 66.63 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.377 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 96.4 t -44.67 135.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 47.4 mt -73.79 138.62 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 19.3 m -58.93 137.19 57.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -39.48 -44.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 80.8 mt-30 -34.77 -56.91 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1149 ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' 1153 ' ' GLN . 27.9 tt0 -96.09 -44.56 7.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1150 ' ' GLN . . . . . 0.426 ' CD ' HD11 ' A' 1154 ' ' ILE . 4.3 tm0? -44.19 -54.2 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -70.79 -58.82 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 47.5 m -38.05 -53.51 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1153 ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' 1149 ' ' GLU . 61.6 mt-30 -60.07 -45.64 92.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1154 ' ' ILE . . . . . 0.426 HD11 ' CD ' ' A' 1150 ' ' GLN . 63.2 mt -57.99 -51.46 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 94.4 t -61.66 -42.06 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' 1157 ' ' TYR . 17.0 tp -63.73 -59.82 4.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.416 ' C ' ' O ' ' A' 1156 ' ' LEU . 61.4 t80 -36.58 -44.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.49 90.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -57.01 -40.44 76.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.59 -46.05 84.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 85.7 t -54.11 -41.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.05 -47.41 83.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1164 ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' 1164 ' ' ARG . 14.0 ttp-105 -62.86 -32.42 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -74.83 -55.22 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.12 -46.81 48.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.82 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.75 -45.74 91.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.2 tttp -48.72 -51.6 27.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.603 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 50.6 mtm -88.01 11.0 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 10.6 m-20 49.83 31.34 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 35.3 m -112.62 136.87 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 138.79 21.28 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 -17.42 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.91 -43.6 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.53 -45.45 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.603 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.3 tp -51.36 -67.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -152.77 134.12 14.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.1 t -78.86 159.24 27.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.04 -42.93 60.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -47.54 -44.55 26.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.55 -62.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 94.1 mt -40.01 -54.09 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 96.1 t -47.15 -57.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.415 ' CB ' HG22 ' A' 1201 ' ' ILE . 4.2 m-20 -53.73 -57.41 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1187 ' ' MET . . . . . 0.403 ' CE ' HD11 ' A' 1219 ' ' ILE . 65.7 mtp -43.98 -38.19 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.56 73.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -74.02 -58.31 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 14.3 mtt -69.79 -32.82 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.9 mtp180 55.7 53.36 8.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 135.02 29.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 45.3 p -102.05 -31.85 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.4 p -102.62 149.37 24.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.567 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -59.34 -39.15 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' 1195 ' ' VAL . 27.4 mm-40 -51.93 -25.12 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 79.8 m-20 -95.45 -39.31 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.462 HG21 ' CE3' ' A' 1216 ' ' TRP . 76.8 t -58.13 -47.58 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -54.64 -29.4 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -71.27 -19.93 62.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' 1202 ' ' ASP . 38.0 mm -55.58 149.38 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1202 ' ' ASP . . . . . 0.429 ' N ' HG21 ' A' 1201 ' ' ILE . 26.5 t0 -69.62 135.93 50.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.56 -48.82 1.23 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 10.3 p -73.59 135.99 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 18.2 m -99.47 150.58 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -41.62 141.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.19 -65.6 4.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' 1209 ' ' ALA . 32.3 ttpt -34.72 -54.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.96 -47.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.69 -64.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 6.6 ptt? -48.99 -30.36 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1212 ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' 1209 ' ' ALA . 43.5 mt -84.86 30.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.567 ' HB2' ' CZ2' ' A' 1216 ' ' TRP . . . -64.6 -52.52 51.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 111.11 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' 1213 ' ' ALA . 63.8 Cg_exo -47.95 -17.91 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.38 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -80.91 -65.32 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.567 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.0 OUTLIER -61.8 -23.15 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' 1216 ' ' TRP . 21.5 mm-40 -58.66 -38.94 79.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.7 t -70.02 -30.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1219 ' ' ILE . . . . . 0.403 HD11 ' CE ' ' A' 1187 ' ' MET . 68.1 mt -66.12 -44.7 91.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -54.77 -30.06 55.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1221 ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.3 t-160 -82.92 -56.93 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.0 t80 -39.94 -34.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1223 ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' 1227 ' ' SER . 22.2 p -86.89 -30.44 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1224 ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -70.53 -46.76 63.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1225 ' ' THR . . . . . 0.481 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.6 t -71.84 -13.49 61.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1226 ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' 1227 ' ' SER . 31.0 m-80 -127.08 14.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1227 ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' 1223 ' ' CYS . 7.6 t 34.75 48.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 76.4 t -94.65 147.79 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -66.7 144.19 56.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1230 ' ' THR . . . . . 0.453 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.0 p -141.1 -175.29 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1231 ' ' ASP . . . . . 0.453 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 48.36 53.39 12.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.51 42.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' 1190 ' ' MET . 17.2 m-85 -77.19 145.88 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 27.7 t -62.11 -44.16 97.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 2.7 t -45.08 134.61 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 31.0 m -90.73 138.88 31.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1237 ' ' LYS . . . . . 0.456 ' N ' ' CD ' ' A' 1238 ' ' PRO . 71.7 mmtt 47.1 53.79 14.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.556 0.693 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1238 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1237 ' ' LYS . 53.6 Cg_endo -69.71 81.1 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.334 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -141.28 140.46 33.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 22.0 t -161.05 131.58 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 53.03 85.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 108.9 2.18 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 3.7 t 44.63 39.62 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 49.9 m -125.43 165.21 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.445 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 11.9 t -167.12 145.99 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.862 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 57.1 p -79.79 133.2 36.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -144.14 146.02 16.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 37.7 t -150.14 121.4 7.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 110.885 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 3.8 t -107.14 158.56 16.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -83.43 79.17 1.94 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.433 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 73.6 m -116.08 167.43 10.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.856 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 22.8 t -61.5 -45.15 95.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -120.87 127.22 26.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.593 0.711 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 129.72 18.1 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.66 2.24 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.0 m -70.82 162.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1145 ' ' ILE . . . . . 0.485 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 35.1 mt -87.95 137.7 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.195 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1146 ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' 1147 ' ' ALA . 9.1 t -57.67 117.53 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1147 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1146 ' ' SER . . . -34.69 -46.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.054 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -37.63 -55.15 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1149 ' ' GLU . . . . . 0.485 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 17.5 pt-20 -89.34 -47.37 8.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -42.04 -62.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -42.81 -59.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 84.9 m -44.18 -49.96 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.1 -37.76 88.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 62.8 mt -63.3 -57.2 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 45.3 t -58.47 -40.69 79.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1156 ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' 1157 ' ' TYR . 40.1 tp -66.18 -60.98 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1157 ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' 1156 ' ' LEU . 56.8 t80 -37.81 -48.19 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.89 -45.65 61.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttp -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.18 -47.76 83.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 99.9 t -54.24 -44.65 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -63.74 -46.39 85.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.18 76.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -53.35 -41.59 65.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.9 -69.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -36.93 5.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 2.4 t60 -74.64 -43.84 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -45.32 -55.71 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.03 -36.68 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -53.89 53.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1171 ' ' MET . . . . . 0.467 ' HE1' ' CD1' ' A' 1178 ' ' LEU . 15.9 mtm -75.61 -6.44 50.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.14 33.63 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 27.0 m -121.54 138.97 29.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.133 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 136.62 22.97 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -20.59 2.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.52 -38.79 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 19.5 mm -58.91 -46.82 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1178 ' ' LEU . . . . . 0.467 ' CD1' ' HE1' ' A' 1171 ' ' MET . 13.1 tp -51.31 -61.75 2.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.4 148.83 28.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 76.6 p -94.91 165.95 12.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -60.05 -37.23 79.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -61.56 -48.87 79.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.25 -40.74 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.55 -54.12 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 94.4 t -55.2 -38.76 48.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1186 ' ' ASP . . . . . 0.43 ' O ' ' SD ' ' A' 1190 ' ' MET . 1.1 m-20 -59.08 -60.98 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 49.2 mtp -53.55 -28.15 30.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.99 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 22.2 mttt -97.42 -60.47 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1190 ' ' MET . . . . . 0.43 ' SD ' ' O ' ' A' 1186 ' ' ASP . 1.1 mpt? -64.61 -39.76 94.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1191 ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' 1192 ' ' PRO . 49.1 mtm-85 64.17 55.01 1.55 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1192 ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.78 119.61 6.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 52.4 p -92.2 -21.52 20.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 59.2 p -109.04 144.14 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1195 ' ' VAL . . . . . 0.513 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.3 p -56.06 -30.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.126 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1196 ' ' GLU . . . . . 0.442 ' N ' HG12 ' A' 1195 ' ' VAL . 25.1 mp0 -58.95 -41.32 87.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1197 ' ' ASN . . . . . 0.43 ' HB3' ' CE2' ' A' 1233 ' ' PHE . 57.4 m-20 -75.19 -37.09 61.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1198 ' ' VAL . . . . . 0.494 HG23 ' CE3' ' A' 1216 ' ' TRP . 58.6 t -59.11 -49.21 84.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -50.91 -28.77 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -70.38 -32.15 69.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1201 ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' 1186 ' ' ASP . 21.6 mm -49.57 146.11 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.07 142.17 49.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.22 -46.46 1.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 9.6 p -67.51 132.6 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 58.8 m -96.88 145.66 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -40.72 126.8 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 93.52 -59.7 2.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1208 ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.1 ttmp? -38.69 -48.69 1.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1209 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.67 -46.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -43.92 -66.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.8 ptt? -47.12 -26.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.09 32.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1213 ' ' ALA . . . . . 0.567 ' HA ' ' CZ3' ' A' 1216 ' ' TRP . . . -67.41 -53.75 21.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 111.102 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1214 ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.9 -17.26 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.715 2.276 . . . . 0.0 112.321 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.39 -60.53 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1216 ' ' TRP . . . . . 0.567 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -67.29 -28.28 67.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1217 ' ' GLU . . . . . 0.531 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.8 mt-10 -56.41 -33.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.4 t -70.17 -41.21 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.82 -53.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -45.77 -43.67 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -76.03 -43.95 41.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -54.18 -38.98 66.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -81.06 -26.47 36.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 9.3 t -87.06 -34.93 19.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1226 ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -91.43 8.19 37.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 43.1 t 42.04 43.51 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 70.6 t -89.03 148.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -76.09 151.86 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 71.0 p -145.05 174.64 10.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 20.1 t0 66.22 41.79 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.41 44.71 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1233 ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' 1197 ' ' ASN . 79.5 m-85 -87.17 148.94 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 11.7 t -76.57 86.49 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 46.3 t -156.4 134.76 11.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 19.2 m -88.03 40.64 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -148.39 106.44 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 110.869 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -40.06 5.68 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 0.0 112.331 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 40.13 40.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 99.8 p -50.97 123.23 8.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -149.15 80.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.68 13.62 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.703 2.268 . . . . 0.0 112.302 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 9.4 t -108.01 135.84 48.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 73.9 p -81.09 -45.45 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.705 0.288 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -41.86 -59.17 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -99.97 -37.37 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -42.49 -57.59 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.405 ' HA ' HD12 ' A' 1154 ' ' ILE . 13.6 tt0 -48.94 -57.3 6.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1152 ' ' THR . . . . . 0.401 HG21 HG11 ' A' 1228 ' ' VAL . 54.6 m -46.99 -43.4 19.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.169 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.9 -38.65 86.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.0 mt -62.71 -53.21 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 59.1 t -62.49 -40.13 87.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 20.9 tp -65.83 -59.33 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.1 t80 -37.55 -51.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.98 -42.64 60.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 31.8 mttm -61.96 -45.18 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 43.2 mt -59.53 -52.99 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 77.6 t -48.02 -47.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.55 -46.52 83.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.84 -53.0 62.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.516 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.8 ttp180 -47.59 -45.09 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1165 ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' 1168 ' ' ALA . 21.6 tt0 -59.08 -70.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -45.96 -26.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.92 -32.39 21.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.97 -50.22 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.55 -44.92 96.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.12 -52.18 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' HD11 ' A' 1178 ' ' LEU . 10.4 mtm -77.74 -6.02 52.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.96 39.41 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' 1168 ' ' ALA . 31.7 m -127.82 142.69 45.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 138.64 21.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.93 -23.26 4.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -91.23 -35.61 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.7 mm -59.0 -48.91 85.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.497 HD11 ' HE3' ' A' 1171 ' ' MET . 13.3 tp -49.34 -62.26 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.72 124.19 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.0 t -78.58 154.13 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.683 ' O ' HG23 ' A' 1185 ' ' VAL . 5.9 m-80 -45.86 -38.8 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -51.58 -45.08 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.93 -51.38 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.516 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.2 mt -52.53 -48.83 65.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' 1181 ' ' ASN . 90.6 t -52.73 -53.26 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.52 -50.39 70.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 82.2 mtp -56.54 -36.35 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -73.68 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -90.0 -54.73 3.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 17.5 mtt -75.06 -27.68 60.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.543 ' HB3' HG22 ' A' 1230 ' ' THR . 21.8 mtm180 54.89 54.85 10.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.1 Cg_endo -69.78 125.19 11.84 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 0.0 112.314 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.5 p -97.29 -24.51 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 77.6 p -107.61 138.52 43.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.54 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.4 p -52.94 -28.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -58.43 -50.08 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.2 -36.52 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 97.6 t -57.58 -47.16 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 18.0 mttp -50.94 -36.78 40.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -65.55 -23.9 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 32.5 mm -52.48 150.99 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.69 137.85 37.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 98.69 -37.99 3.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' 1201 ' ' ILE . 3.8 p -74.04 132.43 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 47.8 t -95.92 145.23 25.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -40.85 131.35 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 88.87 -58.45 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' 1209 ' ' ALA . 9.1 ttmm -37.63 -50.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.98 -48.74 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 2.0 ptt? -46.91 -28.11 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 70.9 mt -86.53 29.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.736 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.37 -51.66 41.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.711 . . . . 0.0 111.079 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.01 -22.54 3.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.61 -67.27 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.563 ' HA ' HD12 ' A' 1219 ' ' ILE . 1.0 OUTLIER -60.65 -30.09 69.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' 1216 ' ' TRP . 8.8 mm-40 -54.17 -34.63 60.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.3 t -74.0 -32.96 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.4 mt -65.7 -40.95 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1220 ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' 1224 ' ' GLN . 25.2 ttpt -59.84 -38.53 82.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.961 ' O ' HG22 ' A' 1225 ' ' THR . 10.9 t60 -77.99 -47.08 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 39.3 t80 -51.54 -41.46 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' 1230 ' ' THR . 21.5 p -84.11 -35.34 23.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.487 ' CG ' ' O ' ' A' 1220 ' ' LYS . 8.9 mm100 -64.22 -31.79 73.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.961 HG22 ' O ' ' A' 1221 ' ' HIS . 3.5 t -88.99 -15.67 33.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.402 ' OD1' HG23 ' A' 1225 ' ' THR . 6.2 m120 -119.78 15.03 12.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' 1223 ' ' CYS . 4.3 t 41.61 40.89 1.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.401 HG11 HG21 ' A' 1152 ' ' THR . 89.7 t -87.5 144.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -64.78 148.54 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1230 ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' 1191 ' ' ARG . 36.7 p -146.79 -175.5 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.53 49.93 4.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.719 0.295 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' 1147 ' ' ALA . 66.8 mt-30 -34.5 -47.05 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -97.68 -51.02 4.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -44.03 -59.15 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -47.63 -58.8 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1152 ' ' THR . . . . . 0.471 HG22 ' NH2' ' A' 1191 ' ' ARG . 89.4 m -43.76 -45.3 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1153 ' ' GLN . . . . . 0.412 ' HG3' ' NH2' ' A' 1191 ' ' ARG . 57.6 mt-30 -65.35 -38.54 90.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.6 -46.72 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -42.37 87.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.61 HD23 ' HE ' ' A' 1191 ' ' ARG . 22.2 tp -67.35 -57.82 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' 1161 ' ' VAL . 54.5 t80 -38.12 -50.83 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.2 -45.19 92.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 35.8 mttm -57.4 -45.21 84.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.29 -51.82 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.856 HG22 HD13 ' A' 1184 ' ' LEU . 100.0 t -52.4 -41.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.01 -55.16 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -46.86 -34.07 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -66.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' 1167 ' ' HIS . 12.5 pttp -53.48 -27.11 23.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.595 ' CE1' ' SD ' ' A' 1171 ' ' MET . 2.3 t60 -83.43 -35.19 25.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.615 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.84 -48.9 69.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.26 -37.21 83.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.6 tttt -51.42 -41.37 60.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.883 ' CE ' HD11 ' A' 1178 ' ' LEU . 3.2 mpp? -96.7 2.78 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 61.73 31.32 18.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.5 HG21 HD13 ' A' 1178 ' ' LEU . 34.8 m -112.02 138.27 21.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.693 . . . . 0.0 111.166 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 136.02 23.38 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -16.77 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.17 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.87 -39.83 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.883 HD11 ' CE ' ' A' 1171 ' ' MET . 15.8 tp -59.3 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.34 139.8 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1180 ' ' THR . . . . . 0.431 ' H ' HD12 ' A' 1183 ' ' ILE . 38.1 p -93.27 162.24 14.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' 1185 ' ' VAL . 2.7 m-20 -56.79 -36.16 69.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.62 -51.94 67.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1183 ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' 1180 ' ' THR . 78.4 mt -57.71 -48.35 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.856 HD13 HG22 ' A' 1161 ' ' VAL . 76.1 mt -54.04 -50.95 65.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.525 HG12 ' HD2' ' A' 1189 ' ' LYS . 79.8 t -56.74 -52.03 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.516 ' CB ' HG23 ' A' 1201 ' ' ILE . 51.8 m-20 -55.1 -46.68 75.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.99 -40.74 81.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1188 ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' 1191 ' ' ARG . . . -64.75 -31.56 72.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' 1185 ' ' VAL . 12.8 mtpp -80.04 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' 1201 ' ' ILE . 17.8 mtt -62.17 -38.39 88.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.61 ' HE ' HD23 ' A' 1156 ' ' LEU . 17.1 mmt85 65.28 52.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 131.96 22.38 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -120.54 24.56 10.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.924 ' O ' HG23 ' A' 1198 ' ' VAL . 19.1 p -138.36 134.72 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.12 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.564 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 7.1 p -52.98 -26.96 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -75.35 -67.93 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -44.11 -39.59 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' 1194 ' ' THR . 74.6 t -48.57 -43.58 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1199 ' ' LYS . . . . . 0.435 ' HA ' ' CG1' ' A' 1204 ' ' VAL . 6.0 mtmp? -56.67 -30.43 63.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -67.16 -29.16 68.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.57 HD13 ' SD ' ' A' 1190 ' ' MET . 13.7 mm -59.32 102.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1202 ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' 1201 ' ' ILE . 9.3 t70 -31.46 145.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.43 -41.83 2.08 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.694 HG23 ' HD2' ' A' 1208 ' ' LYS . 2.8 p -93.52 140.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1205 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1206 ' ' GLU . 12.9 t -100.2 138.96 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1206 ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' 1205 ' ' SER . 36.3 tt0 -34.26 129.61 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 100.17 -64.94 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.694 ' HD2' HG23 ' A' 1204 ' ' VAL . 16.6 ttmm -38.7 -48.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.8 -42.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.75 -65.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.7 ptt? -53.3 -24.59 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.08 34.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.51 -49.81 39.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.689 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -48.0 -20.14 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.69 -63.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.869 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.9 OUTLIER -65.37 -23.15 66.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.405 ' N ' ' CD1' ' A' 1216 ' ' TRP . 33.2 mt-10 -61.59 -36.23 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.1 t -67.28 -42.91 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.52 -40.29 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -60.63 -43.13 97.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -73.36 -44.54 58.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' 1228 ' ' VAL . 49.5 t80 -56.81 -46.13 81.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' 1227 ' ' SER . 28.4 p -70.09 -36.21 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -57.76 -34.65 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.439 HG22 ' O ' ' A' 1222 ' ' PHE . 5.3 t -93.13 -37.3 12.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' 1227 ' ' SER . 12.1 m120 -93.39 15.81 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' 1223 ' ' CYS . 17.6 m 35.49 46.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' 1222 ' ' PHE . 59.0 t -87.57 139.27 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -63.57 148.02 49.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1230 ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' 1231 ' ' ASP . 37.6 p -138.35 -175.39 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1231 ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' 1230 ' ' THR . 4.8 p-10 48.13 49.24 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.723 0.297 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -38.43 -49.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -93.32 -50.2 5.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -47.11 -60.06 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -42.7 -60.81 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 86.7 m -43.96 -46.02 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -62.26 -38.76 90.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.19 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 96.7 t -68.93 -43.73 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' 1222 ' ' PHE . 17.6 tp -63.72 -55.32 24.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 62.8 t80 -40.62 -49.51 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.17 92.78 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' 1162 ' ' GLU . 37.9 mttm -55.3 -33.46 63.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' 1161 ' ' VAL . 25.0 mt -74.13 -59.99 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' 1160 ' ' LEU . 97.3 t -37.17 -62.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.06 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1162 ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' 1159 ' ' LYS . 5.2 pt-20 -38.89 -54.71 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.51 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.644 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.0 ttp180 -54.47 -48.63 71.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -58.56 -65.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' 1167 ' ' HIS . 1.2 ptpm? -47.56 -44.9 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.448 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.7 OUTLIER -58.24 -42.84 87.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.23 -55.16 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -60.44 -47.3 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 57.4 tttp -42.68 -51.06 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.59 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 59.1 mtm -87.69 -5.62 58.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.59 32.62 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.433 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.4 m -114.63 141.31 26.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.596 0.712 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 136.68 23.29 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.97 -17.23 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.41 -40.79 9.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.2 mm -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.59 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.8 tp -53.78 -68.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.42 120.39 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.0 t -72.61 156.38 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -47.01 -43.75 19.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -48.61 -52.68 21.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.32 -40.88 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.644 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.5 mt -58.76 -61.51 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.6 t -41.46 -50.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -52.64 -51.52 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 93.8 mtp -55.95 -36.94 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.12 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -78.42 -63.37 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' HD13 ' A' 1201 ' ' ILE . 25.8 mtt -63.87 -39.33 93.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.7 mtt-85 66.31 54.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.594 0.712 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.78 129.35 17.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 58.2 p -104.89 -26.08 12.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 72.1 p -108.24 149.61 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.422 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.9 p -58.46 -26.89 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.85 -45.85 85.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -73.62 -44.1 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.813 HG21 ' CE3' ' A' 1216 ' ' TRP . 69.7 t -44.26 -45.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.2 mttm -57.38 -35.72 70.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -68.94 -26.12 64.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.842 ' O ' HG12 ' A' 1204 ' ' VAL . 27.2 mm -55.42 98.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1202 ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' 1201 ' ' ILE . 10.4 t0 -34.58 143.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.33 -46.55 1.43 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.52 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' 1201 ' ' ILE . 9.4 p -76.13 142.31 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 42.5 t -99.83 154.01 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 145.0 10.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.03 -55.72 5.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.5 ttmp? -44.62 -49.47 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -34.63 -49.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -38.16 -65.84 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.0 ptt? -52.67 -25.85 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' 1209 ' ' ALA . 52.7 mt -87.28 32.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.784 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.51 -53.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 111.078 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.5 Cg_exo -47.97 -17.74 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.71 -64.76 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.813 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -62.55 -24.17 67.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' 1216 ' ' TRP . 51.5 mt-10 -58.78 -39.4 80.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 93.3 t -69.21 -41.85 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' 1216 ' ' TRP . 77.5 mt -52.82 -48.45 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -54.66 -44.56 73.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 14.1 t60 -62.83 -56.4 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' 1156 ' ' LEU . 66.2 t80 -44.07 -67.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' 1227 ' ' SER . 61.6 m -50.83 -55.29 17.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' 1223 ' ' CYS . 30.2 mt-30 -35.32 -69.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -37.23 79.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' 1228 ' ' VAL . 2.1 m-80 -85.27 16.6 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.1 t 33.98 50.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' 1226 ' ' ASN . 85.3 t -103.26 141.84 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.61 155.53 40.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.2 p -143.02 -177.08 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 10.9 t0 54.91 51.24 13.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.718 0.294 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' 1147 ' ' ALA . 94.0 mm-40 -37.62 -53.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -94.23 -48.14 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.84 -58.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.1 tt0 -43.79 -60.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 85.1 m -44.41 -48.58 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.78 -33.24 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' 1151 ' ' GLU . 90.2 mt -67.02 -61.89 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 46.9 t -52.39 -43.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.482 HD21 HG12 ' A' 1219 ' ' ILE . 19.3 tp -64.86 -57.34 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.654 ' O ' HG23 ' A' 1161 ' ' VAL . 77.9 t80 -38.76 -42.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.7 -45.72 95.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 26.8 mttm -61.72 -44.09 97.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.599 HD11 HD11 ' A' 1219 ' ' ILE . 21.3 mt -59.97 -52.49 65.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' 1157 ' ' TYR . 85.0 t -48.24 -44.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.08 -45.51 83.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.2 98.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.59 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.8 ttp180 -58.19 -41.69 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1165 ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' 1166 ' ' LYS . 10.5 tm0? -64.37 -60.5 3.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.462 ' N ' ' OE1' ' A' 1165 ' ' GLN . 5.6 ptmm? -54.92 -35.98 64.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -46.94 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.31 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.28 -45.9 92.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 30.8 tttt -46.38 -55.64 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.901 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.531 ' HE1' ' HG3' ' A' 1211 ' ' MET . 29.3 mtm -79.61 -7.83 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.8 t70 68.43 30.87 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.441 ' O ' ' HB1' ' A' 1168 ' ' ALA . 34.8 m -113.61 139.66 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.692 0.758 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.96 136.7 23.02 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.395 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 -16.76 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.69 9.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.4 mm -56.68 -42.99 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.8 tp -57.35 -70.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.63 131.34 13.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.6 t -80.9 175.47 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' 1185 ' ' VAL . 17.6 p-10 -62.23 -46.73 87.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -53.21 17.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.18 -52.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.59 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.8 mt -52.44 -49.92 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' 1189 ' ' LYS . 95.5 t -49.92 -52.83 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -50.03 -55.27 15.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 71.1 mtp -47.47 -44.75 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.88 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.527 ' HD2' HG12 ' A' 1185 ' ' VAL . 29.6 mtpt -78.17 -62.16 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.77 -37.58 79.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' 1192 ' ' PRO . 27.2 mtp180 63.74 51.96 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.73 139.43 40.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 18.9 p -124.23 25.72 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.179 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.429 ' O ' HG23 ' A' 1198 ' ' VAL . 27.2 p -140.26 125.65 18.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.497 HG23 ' CH2' ' A' 1216 ' ' TRP . 13.3 p -44.59 -33.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.7 -62.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -48.68 -43.16 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.541 HG21 ' CE3' ' A' 1216 ' ' TRP . 87.1 t -50.53 -39.99 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -62.04 -23.54 66.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' 1204 ' ' VAL . 27.4 mm -61.53 142.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 32.6 t0 -67.46 139.65 57.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.03 -52.22 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' 1201 ' ' ILE . 6.1 p -65.59 137.05 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.1 t -100.06 145.42 27.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -38.86 135.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 86.5 -57.37 4.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.6 OUTLIER -40.53 -54.09 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' 1204 ' ' VAL . . . -34.79 -48.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.73 -62.65 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1211 ' ' MET . . . . . 0.531 ' HG3' ' HE1' ' A' 1171 ' ' MET . 4.3 ptt? -50.06 -22.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.69 35.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.54 -52.99 32.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 0.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.03 -67.38 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -59.2 -23.77 62.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.432 ' N ' ' CD1' ' A' 1216 ' ' TRP . 12.3 mm-40 -57.63 -45.28 85.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.65 -42.92 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.599 HD11 HD11 ' A' 1160 ' ' LEU . 87.8 mt -61.78 -26.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -68.26 -35.95 78.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -82.04 -49.3 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.42 ' HB3' ' NH2' ' A' 1191 ' ' ARG . 30.0 t80 -40.31 -42.49 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.6 p -77.54 -37.22 51.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -61.35 -43.84 98.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 7.1 t -75.43 -37.97 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.51 ' O ' HG23 ' A' 1228 ' ' VAL . 12.5 m120 -93.44 16.08 14.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' 1226 ' ' ASN . 22.6 t 34.9 51.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' 1226 ' ' ASN . 45.7 t -105.92 157.55 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1229 ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' 1228 ' ' VAL . 4.0 pm0 -81.11 152.49 27.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 67.9 p -145.78 -179.66 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.47 45.83 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.778 0.323 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 67.3 mt-30 -34.49 -51.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -96.17 -51.02 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -38.47 -63.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.627 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.9 tp10 -42.35 -62.86 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.3 m -40.14 -50.24 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.24 -39.39 82.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' 1151 ' ' GLU . 75.3 mt -60.64 -57.71 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.5 t -57.59 -43.21 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.647 HD13 ' CG ' ' A' 1222 ' ' PHE . 23.6 tp -63.84 -62.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' 1161 ' ' VAL . 65.9 t80 -35.84 -45.44 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.54 90.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 23.1 mttm -56.91 -44.18 82.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.601 HD21 HG13 ' A' 1219 ' ' ILE . 34.3 mt -62.92 -43.79 97.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' 1157 ' ' TYR . 84.4 t -56.54 -46.13 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -53.75 -39.1 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.8 -49.19 63.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.631 ' HG3' HD23 ' A' 1178 ' ' LEU . 18.7 ttp180 -53.68 -44.31 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.72 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' 1167 ' ' HIS . 0.5 OUTLIER -53.5 -41.96 66.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.467 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.8 OUTLIER -62.38 -45.05 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.61 -59.12 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -55.82 -45.53 78.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -43.78 -54.69 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.523 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 38.8 mtm -84.77 -1.92 56.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.68 29.52 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.7 m -111.62 141.24 24.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.98 138.54 21.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.236 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.96 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.302 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.14 -47.88 6.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.5 mm -48.01 -39.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.631 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.2 tp -58.78 -67.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -149.35 147.6 28.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.088 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 57.8 p -89.43 169.75 11.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' 1185 ' ' VAL . 6.7 m-80 -65.45 -33.84 76.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -62.45 -50.17 72.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 90.5 mt -55.75 -46.49 79.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.433 HD11 ' HD3' ' A' 1164 ' ' ARG . 83.5 mt -59.95 -53.29 59.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -48.41 -47.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.609 ' CB ' HG23 ' A' 1201 ' ' ILE . 67.7 m-20 -59.24 -45.56 90.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 89.4 mtp -58.1 -40.79 82.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.23 75.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -77.26 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 13.8 mtt -65.0 -41.2 95.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' A' 1192 ' ' PRO . 33.8 mtt-85 68.18 54.39 0.63 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.8 134.5 28.04 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.661 2.241 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.1 p -102.11 -33.17 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 60.8 p -101.82 149.92 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 12.5 p -57.23 -33.6 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.05 -47.43 68.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -66.5 -46.37 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.504 HG21 ' CE3' ' A' 1216 ' ' TRP . 99.1 t -50.74 -54.5 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.191 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -46.5 -36.29 6.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.19 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.609 HG23 ' CB ' ' A' 1186 ' ' ASP . 37.9 mm -43.21 148.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.56 139.69 43.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 97.46 -49.14 1.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.514 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' 1201 ' ' ILE . 6.3 p -66.13 131.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 7.7 t -95.77 173.74 7.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.31 143.39 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.83 -54.02 4.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' 1204 ' ' VAL . 28.5 ttmt -41.67 -53.78 3.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.2 -50.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.74 -66.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.13 -25.14 1.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 69.8 mt -89.44 32.26 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -69.12 -53.3 14.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 111.105 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.0 Cg_exo -47.9 -18.16 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.392 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.04 -69.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.1 p90 -57.36 -26.32 60.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.5 mt-10 -56.5 -37.28 70.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.2 t -71.13 -41.82 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.601 HG13 HD21 ' A' 1160 ' ' LEU . 89.3 mt -53.83 -53.45 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.102 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -45.12 -45.1 11.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -72.62 -46.58 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.647 ' CG ' HD13 ' A' 1156 ' ' LEU . 49.9 t80 -50.17 -59.59 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' 1227 ' ' SER . 25.7 p -54.89 -47.91 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -42.0 -69.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -62.01 -40.54 96.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.479 ' O ' HG23 ' A' 1228 ' ' VAL . 33.1 m120 -80.41 13.54 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' 1223 ' ' CYS . 79.0 p 33.7 51.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' 1226 ' ' ASN . 84.7 t -102.76 143.33 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.78 160.42 30.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 59.1 p -148.02 -179.23 6.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 39.8 t0 65.67 40.06 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.778 0.323 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 27.1 mt-30 -36.64 -50.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -94.37 -51.91 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -45.27 -56.06 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.663 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.5 tt0 -51.56 -58.4 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1152 ' ' THR . . . . . 0.481 HG22 ' NH1' ' A' 1191 ' ' ARG . 96.8 m -44.82 -41.78 7.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1153 ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 37.3 mt-30 -67.24 -37.22 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' 1151 ' ' GLU . 63.1 mt -62.96 -57.24 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 75.2 t -57.28 -45.1 84.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' 1157 ' ' TYR . 22.8 tp -62.16 -62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 54.4 t80 -36.58 -56.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -48.97 -43.79 31.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.472 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' 1222 ' ' PHE . 5.8 mtmp? -66.08 -40.25 90.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.927 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.2 t -56.3 -42.05 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -54.29 -53.78 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.26 96.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.728 ' HE ' HD11 ' A' 1184 ' ' LEU . 7.1 tmm_? -57.82 -26.41 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.802 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.24 -72.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' 1167 ' ' HIS . 2.3 pttm -40.7 -29.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.3 t60 -78.13 -45.53 23.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.458 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -47.63 -53.1 15.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -58.49 -40.24 82.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -48.63 -56.87 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' 1178 ' ' LEU . 69.5 mtm -80.35 4.64 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 49.7 m-20 58.51 36.29 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.1 m -114.95 141.59 27.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.677 0.751 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 133.58 23.06 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.383 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -47.95 -18.47 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.39 -40.44 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 25.1 mm -58.23 -47.73 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' 1171 ' ' MET . 14.4 tp -53.14 -63.86 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -153.13 120.3 5.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 6.4 t -75.9 146.04 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' 1185 ' ' VAL . 15.2 m120 -41.76 -44.57 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -46.06 -53.01 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.43 -56.49 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.728 HD11 ' HE ' ' A' 1164 ' ' ARG . 66.1 mt -51.26 -52.26 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' 1181 ' ' ASN . 89.6 t -44.68 -49.29 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.32 -44.48 91.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1187 ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' 1192 ' ' PRO . 74.7 mtp -55.72 -41.52 73.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.21 -30.82 69.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.423 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 6.3 mtpm? -77.25 -58.35 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 24.7 mtt -68.71 -40.86 79.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' 1152 ' ' THR . 35.1 mtt-85 68.74 55.08 0.58 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.81 137.31 35.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 0.0 112.334 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1193 ' ' THR . . . . . 0.434 HG23 ' HB ' ' A' 1230 ' ' THR . 50.7 p -105.59 -29.3 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 66.0 p -107.92 148.92 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.565 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.8 p -58.97 -39.7 78.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1196 ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' 1195 ' ' VAL . 7.4 mm-40 -47.33 -29.54 2.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -90.94 -39.16 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.772 HG21 ' CE3' ' A' 1216 ' ' TRP . 74.4 t -55.79 -49.02 77.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -56.31 -30.53 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.34 -24.22 62.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 35.3 mm -52.43 146.76 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -68.96 138.24 54.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.11 -51.95 1.02 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.645 HG23 ' HE2' ' A' 1208 ' ' LYS . 9.7 p -70.86 144.26 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 5.8 t -100.04 157.85 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -51.4 140.38 17.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 81.51 -55.49 4.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.645 ' HE2' HG23 ' A' 1204 ' ' VAL . 25.3 ttpt -39.61 -56.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.75 -43.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.36 -62.44 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 7.6 ptt? -55.88 -23.42 31.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 96.1 mt -89.85 34.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.654 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.79 -48.64 29.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.0 -17.15 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1215 ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' 1215 ' ' LEU . 6.4 mp -82.22 -66.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.772 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -61.48 -25.44 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.466 ' N ' ' CD1' ' A' 1216 ' ' TRP . 20.3 mt-10 -57.68 -36.5 72.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 99.0 t -68.8 -39.02 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.05 -53.04 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -46.21 -42.58 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -76.74 -45.39 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.418 ' HB2' ' NZ ' ' A' 1159 ' ' LYS . 17.0 t80 -52.99 -39.84 63.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -79.9 -29.0 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.69 -38.24 90.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.411 HG23 ' OD1' ' A' 1226 ' ' ASN . 4.5 t -87.07 -16.58 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' 1227 ' ' SER . 8.8 m120 -119.65 18.48 12.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' 1223 ' ' CYS . 14.8 m 34.23 46.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' 1223 ' ' CYS . 85.4 t -84.83 152.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1229 ' ' GLN . . . . . 0.492 ' HB3' HD21 ' A' 1232 ' ' LEU . 0.8 OUTLIER -74.12 140.58 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.935 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1230 ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' 1193 ' ' THR . 21.5 p -129.1 176.57 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 43.52 47.23 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1232 ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' 1229 ' ' GLN . 26.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.728 0.299 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' 1147 ' ' ALA . 87.2 mt-30 -37.63 -51.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.76 -48.96 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -44.36 -51.74 8.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' 1154 ' ' ILE . 4.1 tt0 -52.29 -57.94 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 78.0 m -44.17 -43.49 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -65.73 -37.16 85.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.1 mt -64.93 -43.16 96.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.8 t -70.82 -41.04 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' 1222 ' ' PHE . 21.6 tp -69.33 -55.81 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.602 ' O ' HG23 ' A' 1161 ' ' VAL . 43.2 t80 -37.44 -43.62 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.98 -47.53 88.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 46.3 mttm -56.61 -41.76 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.751 HD21 HD11 ' A' 1219 ' ' ILE . 28.2 mt -63.88 -42.8 97.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' 1157 ' ' TYR . 94.0 t -59.64 -42.15 87.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.35 -39.22 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.53 72.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.952 ' HG3' HD23 ' A' 1178 ' ' LEU . 43.3 ttm-85 -79.76 -43.12 23.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.34 -34.96 62.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.2 pttp -84.31 -38.34 20.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' 1170 ' ' LYS . 0.6 OUTLIER -63.97 -56.76 12.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -37.27 -53.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.68 -37.8 85.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1170 ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' 1167 ' ' HIS . 18.4 ttmt -55.95 -51.75 66.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1171 ' ' MET . . . . . . . . . . . . . 15.7 mtm -80.07 -1.4 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 68.19 30.09 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.618 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.2 m -119.66 134.53 23.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.99 141.86 16.41 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.97 -16.64 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.75 -47.01 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 12.7 mm -51.43 -42.76 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.952 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.4 tp -56.83 -57.34 12.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' 1164 ' ' ARG . . . -160.38 156.07 25.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 26.1 p -94.48 161.12 14.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.113 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' 1185 ' ' VAL . 79.1 m-20 -54.85 -28.64 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 26.7 tptt -62.62 -51.78 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 -40.06 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.855 HD21 ' HE ' ' A' 1164 ' ' ARG . 63.2 mt -60.76 -54.46 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' 1181 ' ' ASN . 79.9 t -49.31 -36.69 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.2 m-20 -60.65 -62.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 95.0 mtp -55.51 -20.55 13.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -75.12 -21.68 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 21.4 mttm -102.82 -51.97 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.45 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.1 OUTLIER -74.45 -20.91 59.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.633 HH21 HD11 ' A' 1232 ' ' LEU . 13.0 ptt180 33.65 55.05 1.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.78 149.48 66.81 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.391 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 61.6 p -127.35 24.11 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 120.97 14.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' 1216 ' ' TRP . 11.3 p -40.31 -39.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1196 ' ' GLU . . . . . 0.417 ' N ' HG13 ' A' 1195 ' ' VAL . 17.5 mt-10 -56.69 -66.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -48.25 -41.96 29.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.525 HG21 ' CE3' ' A' 1216 ' ' TRP . 94.9 t -50.17 -47.95 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.2 mttp -50.07 -30.92 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -70.98 -29.59 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' 1186 ' ' ASP . 26.0 mm -53.53 101.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1202 ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' 1201 ' ' ILE . 12.3 t70 -35.3 145.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 96.01 -41.05 2.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' 1201 ' ' ILE . 9.3 p -78.22 138.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 111.068 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 4.0 m -99.98 140.79 33.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -40.22 138.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.88 -58.82 5.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' 1209 ' ' ALA . 38.7 tttt -40.38 -55.71 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.638 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -33.93 -39.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.3 -65.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.1 ptt? -49.31 -25.51 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.1 mt -88.94 26.76 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.68 -52.36 26.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.565 0.698 . . . . 0.0 111.05 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -48.01 -16.94 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.678 2.252 . . . . 0.0 112.321 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1215 ' ' LEU . . . . . 0.565 ' CD2' ' NH2' ' A' 1164 ' ' ARG . 7.3 mp -82.24 -71.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -52.83 -15.8 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.26 -38.86 88.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -66.4 -50.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.751 HD11 HD21 ' A' 1160 ' ' LEU . 82.1 mt -46.49 -40.95 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -55.06 -40.39 70.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -76.84 -42.94 38.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.691 ' CD2' HD13 ' A' 1156 ' ' LEU . 17.9 t80 -53.95 -61.38 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' 1227 ' ' SER . 22.8 p -53.87 -45.67 71.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.874 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -43.4 -68.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -63.87 -39.45 94.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.454 ' O ' ' C ' ' A' 1227 ' ' SER . 2.6 m-80 -81.22 13.13 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' 1223 ' ' CYS . 72.2 m 33.84 50.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.539 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 84.2 t -97.5 149.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.93 154.77 40.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 20.5 p -145.56 158.77 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 43.4 t0 64.77 42.56 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1232 ' ' LEU . . . . . 0.633 HD11 HH21 ' A' 1191 ' ' ARG . 26.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 54.8 mt-30 -34.75 -52.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.57 -53.47 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -42.76 -59.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -42.75 -57.14 2.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1152 ' ' THR . . . . . 0.493 HG22 ' HE ' ' A' 1191 ' ' ARG . 90.9 m -46.71 -50.5 17.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.14 -40.86 95.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.73 -58.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 73.6 t -54.75 -39.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' 1222 ' ' PHE . 12.8 tp -66.32 -57.75 6.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' 1161 ' ' VAL . 75.1 t80 -38.34 -46.69 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.12 -46.23 91.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' 1162 ' ' GLU . 21.1 mttm -59.45 -33.22 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 25.2 mt -75.06 -52.67 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' 1157 ' ' TYR . 95.7 t -40.16 -62.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1162 ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' 1159 ' ' LYS . 4.6 pt-20 -40.47 -56.39 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.68 94.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.673 ' HG3' HD21 ' A' 1184 ' ' LEU . 7.2 tmm_? -59.15 -28.57 66.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1165 ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' 1168 ' ' ALA . 31.8 tt0 -82.0 -71.6 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 8.9 pttp -43.39 -29.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.525 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.9 t60 -78.02 -37.51 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.773 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.66 -61.71 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -55.7 -35.28 65.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 9.9 tttp -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.614 ' HE2' HD11 ' A' 1178 ' ' LEU . 27.3 mtm -76.41 6.27 5.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.36 29.15 18.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.3 m -114.57 139.75 24.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.94 140.23 18.78 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -48.05 -16.68 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.63 -52.34 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 32.9 mm -47.67 -46.7 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.773 HD22 ' CA ' ' A' 1168 ' ' ALA . 16.9 tp -49.46 -65.97 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -148.28 118.46 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1180 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.5 t -72.91 139.1 46.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' 1180 ' ' THR . 31.9 m120 -35.77 -46.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.9 tptm -43.34 -58.16 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.39 -59.16 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.673 HD21 ' HG3' ' A' 1164 ' ' ARG . 33.6 mt -47.38 -44.73 24.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 55.4 t -56.5 -55.03 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.486 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -58.89 -42.03 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.2 mtp -58.37 -35.69 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.1 74.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.436 ' CE ' ' HA ' ' A' 1186 ' ' ASP . 49.5 mtmt -76.75 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 13.9 mtt -67.07 -39.27 86.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.493 ' HE ' HG22 ' A' 1152 ' ' THR . 36.1 mtt85 64.31 53.4 1.33 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.639 0.733 . . . . 0.0 110.935 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.71 126.9 13.89 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 34.0 p -96.27 -32.08 12.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.45 ' O ' HG23 ' A' 1198 ' ' VAL . 73.3 p -101.24 147.58 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.572 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -57.52 -36.53 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.158 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -48.38 -52.02 23.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -68.19 -45.96 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' 1194 ' ' THR . 99.5 t -48.4 -52.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1199 ' ' LYS . . . . . 0.492 ' HD2' HG22 ' A' 1195 ' ' VAL . 4.8 mtpm? -49.53 -33.88 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -68.39 -27.97 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.795 ' O ' HG12 ' A' 1204 ' ' VAL . 30.7 mm -51.21 139.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 30.4 t0 -65.66 141.05 58.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.85 -48.45 1.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' 1201 ' ' ILE . 9.0 p -65.7 137.44 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 3.0 m -100.0 142.78 31.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -39.06 130.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.96 -63.64 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' 1207 ' ' GLY . 18.1 ttmt -34.36 -48.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.34 -49.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.94 -63.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.2 ptt? -53.0 -22.63 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' 1209 ' ' ALA . 84.1 mt -90.7 32.68 0.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.3 -52.32 12.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 111.132 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -47.99 -17.36 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.44 -67.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.572 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.1 p90 -58.74 -26.98 64.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' 1216 ' ' TRP . 10.1 mt-10 -54.89 -35.81 64.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 74.7 t -71.14 -35.77 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.5 mt -62.6 -46.93 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -47.36 -39.21 14.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.507 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.7 t-80 -80.64 -52.78 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.588 ' CG ' HD13 ' A' 1156 ' ' LEU . 47.2 t80 -38.95 -33.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' 1227 ' ' SER . 21.8 p -92.98 -28.64 16.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' 1221 ' ' HIS . 0.3 OUTLIER -66.52 -46.6 75.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.502 HG23 ' OD1' ' A' 1226 ' ' ASN . 9.0 t -76.7 -11.98 59.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.502 ' OD1' HG23 ' A' 1225 ' ' THR . 9.6 m120 -123.11 15.24 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' 1223 ' ' CYS . 58.7 p 36.2 49.29 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 89.1 t -93.03 142.17 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -69.56 148.0 50.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 72.6 p -137.48 -177.81 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 7.0 m-20 62.65 43.41 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1232 ' ' LEU . . . . . 0.435 HD11 HH12 ' A' 1191 ' ' ARG . 11.9 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.726 0.298 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -46.04 -52.45 11.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -99.7 -42.38 6.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -41.89 -57.03 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.7 tt0 -46.76 -56.19 6.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.0 m -50.21 -49.59 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.34 -33.93 71.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.0 mt -64.58 -56.7 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.4 t -59.37 -43.1 89.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' 1222 ' ' PHE . 23.1 tp -59.87 -60.41 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' 1156 ' ' LEU . 58.9 t80 -35.96 -47.97 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.06 -46.16 61.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 51.2 mttt -58.22 -42.37 86.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.704 HD21 HD11 ' A' 1219 ' ' ILE . 39.6 mt -62.74 -42.27 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.2 t -61.07 -44.11 97.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.94 -46.96 85.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.3 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.44 -41.62 76.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.46 -61.49 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 17.2 ptpt -52.27 -46.18 65.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.9 OUTLIER -61.23 -46.43 90.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.84 -51.79 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -61.9 -44.49 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 61.6 tttt -46.34 -56.99 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.493 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.0 mtm -79.68 0.91 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.94 42.62 19.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.6 m -125.14 141.78 39.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.61 0.719 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 135.98 23.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.228 . . . . 0.0 112.349 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.92 -17.45 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.23 -41.2 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.8 mm -54.37 -40.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.493 ' CD1' ' HE3' ' A' 1171 ' ' MET . 10.9 tp -60.13 -62.36 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.29 150.21 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 71.4 p -87.34 167.61 13.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.39 -38.53 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -50.32 73.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 69.9 mt -51.06 -46.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 61.3 mt -56.25 -50.59 70.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.8 t -49.45 -53.61 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.442 ' CB ' HG23 ' A' 1201 ' ' ILE . 9.3 m-20 -54.89 -51.04 67.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.9 mtp -53.69 -40.04 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.44 72.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 31.7 mttm -79.2 -63.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 19.4 mtt -61.29 -40.91 95.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.437 ' NH2' HD11 ' A' 1232 ' ' LEU . 39.2 mtm-85 66.08 55.04 0.99 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.708 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 141.84 46.34 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 57.0 p -110.34 -33.34 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.163 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 25.3 p -100.59 144.18 29.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.711 HG23 ' CZ3' ' A' 1216 ' ' TRP . 8.8 p -56.53 -23.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.49 -46.12 84.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -68.75 -37.75 79.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.521 HG21 ' CE3' ' A' 1216 ' ' TRP . 81.7 t -52.87 -45.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 25.3 mttp -52.18 -36.52 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -65.56 -24.37 67.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.698 ' O ' HG12 ' A' 1204 ' ' VAL . 37.6 mm -54.6 148.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.14 134.76 41.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.16 -44.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.506 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' 1201 ' ' ILE . 9.9 p -59.13 131.84 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.093 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1205 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1206 ' ' GLU . 48.9 m -99.97 137.89 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1206 ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' 1205 ' ' SER . 6.4 tp10 -36.41 127.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 92.51 -60.03 2.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' 1207 ' ' GLY . 0.9 OUTLIER -37.64 -49.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.77 -47.72 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.58 -63.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1211 ' ' MET . . . . . 0.466 ' HE3' HD12 ' A' 1178 ' ' LEU . 4.4 ptt? -50.82 -25.05 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' 1215 ' ' LEU . 70.2 mt -88.25 30.9 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.857 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.11 -55.74 19.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 111.096 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -47.96 -18.15 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.338 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1215 ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' 1212 ' ' LEU . 7.9 mp -79.22 -67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.711 ' CZ3' HG23 ' A' 1195 ' ' VAL . 1.2 p90 -59.19 -26.09 64.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' 1216 ' ' TRP . 14.1 mt-10 -60.08 -37.48 80.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.9 t -70.93 -43.6 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.704 HD11 HD21 ' A' 1160 ' ' LEU . 86.4 mt -56.31 -42.55 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.58 -45.8 63.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.476 ' O ' ' N ' ' A' 1224 ' ' GLN . 4.8 t-80 -74.91 -56.65 4.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' 1156 ' ' LEU . 73.3 t80 -34.09 -36.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' 1227 ' ' SER . 78.6 m -90.91 -37.44 13.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' 1225 ' ' THR . 2.9 pt20 -55.45 -49.34 72.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.524 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.7 t -68.36 -37.76 80.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.438 ' ND2' HG23 ' A' 1225 ' ' THR . 25.5 m-80 -86.71 -0.76 56.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' 1223 ' ' CYS . 38.8 t 56.08 36.48 27.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' 1229 ' ' GLN . 94.1 t -92.04 153.56 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1229 ' ' GLN . . . . . 0.423 ' N ' HG12 ' A' 1228 ' ' VAL . 6.3 tp60 -71.9 146.51 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 24.8 p -137.52 -179.01 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 2.2 p30 44.6 48.82 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1232 ' ' LEU . . . . . 0.437 HD11 ' NH2' ' A' 1191 ' ' ARG . 14.9 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.737 0.304 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.3 pt20 -33.07 -50.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -97.47 -51.53 4.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -43.12 -53.93 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.02 -60.35 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.0 m -42.46 -46.7 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.132 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -65.68 -39.33 91.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 80.9 mt -64.32 -52.13 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1155 ' ' VAL . . . . . 0.67 HG12 ' HZ1' ' A' 1159 ' ' LYS . 92.8 t -61.6 -39.14 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.127 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.937 HD13 ' CD2' ' A' 1222 ' ' PHE . 32.3 tp -69.02 -55.95 9.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' 1161 ' ' VAL . 74.4 t80 -36.62 -46.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -56.79 -50.15 65.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.67 ' HZ1' HG12 ' A' 1155 ' ' VAL . 40.2 mttp -52.82 -44.08 66.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.776 HD21 HD11 ' A' 1219 ' ' ILE . 29.0 mt -61.75 -52.23 65.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.95 HG22 HD13 ' A' 1184 ' ' LEU . 61.7 t -54.04 -42.76 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.69 -47.99 78.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.12 72.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' 1178 ' ' LEU . 10.0 ttp180 -50.25 -39.75 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -64.83 -68.01 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' 1167 ' ' HIS . 15.8 pttp -48.8 -41.44 32.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.473 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.1 t60 -66.35 -45.86 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -42.79 -62.75 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -50.73 -38.24 46.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -51.21 -56.7 11.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1171 ' ' MET . . . . . . . . . . . . . 44.8 mtm -82.13 7.15 14.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.8 t70 57.73 36.1 26.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.492 ' O ' ' HB1' ' A' 1168 ' ' ALA . 26.9 m -118.08 138.43 25.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1174 ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' 1175 ' ' PRO . 64.8 Cg_exo -47.96 136.61 23.08 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1175 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1174 ' ' PRO . 66.4 Cg_exo -48.05 -16.85 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.718 2.279 . . . . 0.0 112.288 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.01 -42.87 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.12 -46.78 77.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.4 tp -52.73 -66.04 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -143.61 127.23 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.7 t -83.95 165.46 18.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' 1185 ' ' VAL . 2.6 p30 -53.06 -45.0 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -49.49 -48.13 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -56.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.95 HD13 HG22 ' A' 1161 ' ' VAL . 77.5 mt -47.59 -54.34 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' 1181 ' ' ASN . 78.4 t -47.18 -47.69 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.151 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.69 -55.08 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 37.2 mtp -51.65 -16.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -87.15 -51.13 6.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' A' 1201 ' ' ILE . 0.0 OUTLIER -83.28 -18.13 40.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' 1190 ' ' MET . 15.5 ptt180 33.37 54.95 1.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.671 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.3 Cg_endo -69.79 151.57 68.91 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.69 2.26 . . . . 0.0 112.309 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.6 p -130.83 27.62 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.506 ' O ' HG23 ' A' 1198 ' ' VAL . 29.2 p -140.05 125.08 18.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' 1196 ' ' GLU . 11.5 p -42.14 -42.2 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1196 ' ' GLU . . . . . 0.448 ' N ' HG13 ' A' 1195 ' ' VAL . 16.1 mt-10 -57.75 -60.89 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.28 -40.49 61.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.736 HG21 ' CE3' ' A' 1216 ' ' TRP . 92.8 t -50.36 -38.98 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 21.8 mttm -59.61 -25.73 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -72.18 -26.49 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' 1192 ' ' PRO . 40.4 mm -51.63 142.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.89 135.13 43.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.05 -50.71 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.3 p -67.61 132.23 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 23.8 p -99.74 157.19 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -49.58 149.57 2.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.73 -54.08 4.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' 1209 ' ' ALA . 2.7 ttmp? -53.09 -49.03 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.04 -46.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -44.79 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -48.64 -23.82 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.02 34.85 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.661 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.54 -49.09 16.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.8 Cg_exo -47.99 -19.22 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1215 ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' 1215 ' ' LEU . 7.0 mp -79.89 -64.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.736 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.7 OUTLIER -64.83 -25.11 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.424 ' N ' ' CD1' ' A' 1216 ' ' TRP . 11.4 mt-10 -56.71 -43.52 80.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 71.9 t -67.06 -48.61 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.776 HD11 HD21 ' A' 1160 ' ' LEU . 68.8 mt -47.05 -37.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -36.72 75.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.636 ' O ' HG22 ' A' 1225 ' ' THR . 2.1 t-80 -79.82 -43.2 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.937 ' CD2' HD13 ' A' 1156 ' ' LEU . 30.0 t80 -55.68 -40.08 71.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.7 p -83.48 -31.71 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -63.46 -40.68 97.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.636 HG22 ' O ' ' A' 1221 ' ' HIS . 5.6 t -80.66 -23.61 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.45 ' O ' ' C ' ' A' 1227 ' ' SER . 6.4 m120 -108.88 22.05 16.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1226 ' ' ASN . 6.8 t 34.38 42.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' 1226 ' ' ASN . 95.1 t -89.6 144.18 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -70.64 162.49 28.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 76.7 p -151.66 -178.56 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.5 50.26 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' 1147 ' ' ALA . 14.6 mt-30 -35.81 -47.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.01 -48.97 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1150 ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' 1154 ' ' ILE . 11.8 tt0 -50.53 -61.1 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.585 ' HA ' HD12 ' A' 1154 ' ' ILE . 14.3 tt0 -40.01 -58.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.4 m -48.94 -47.17 43.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.159 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -65.5 -32.64 74.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' 1151 ' ' GLU . 77.0 mt -67.36 -54.62 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 60.9 t -60.96 -40.43 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.78 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.5 tp -65.36 -58.41 5.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.58 -57.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -47.42 -46.42 22.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttm -59.27 -42.45 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.671 HD21 HD11 ' A' 1219 ' ' ILE . 23.6 mt -62.4 -46.86 86.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.49 HG22 HD13 ' A' 1184 ' ' LEU . 70.2 t -54.23 -40.81 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.27 -50.95 71.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.68 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.4 ttp180 -52.74 -38.16 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1165 ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' 1166 ' ' LYS . 12.6 tm0? -69.04 -70.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' 1166 ' ' LYS . 0.2 OUTLIER -44.37 -39.32 4.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.501 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 1.6 t60 -70.42 -43.73 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.68 -62.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -52.94 -34.6 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -50.52 -53.45 30.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.594 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 66.2 mtm -83.15 -6.34 59.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.84 28.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 30.9 m -112.95 141.27 25.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.03 139.02 21.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.98 -17.77 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.23 -43.75 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1177 ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' 1177 ' ' ILE . 9.4 mm -51.16 -46.1 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.594 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.4 tp -54.85 -69.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -139.5 135.06 33.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1180 ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' 1181 ' ' ASN . 8.4 t -91.76 139.03 31.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' 1180 ' ' THR . 11.1 m-20 -34.65 -42.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -46.4 -51.23 15.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.1 -48.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' 1164 ' ' ARG . 81.2 mt -51.72 -56.03 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 84.7 t -45.54 -51.6 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.93 -44.51 94.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 48.8 mmm -54.73 -42.5 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.18 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.26 -64.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.459 ' CE ' HD13 ' A' 1201 ' ' ILE . 12.2 mtt -68.9 -42.18 77.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.473 ' NH1' HD11 ' A' 1232 ' ' LEU . 34.2 mtt85 70.61 52.7 0.39 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.76 136.27 32.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1193 ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' 1220 ' ' LYS . 17.9 p -123.7 23.16 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.18 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.408 ' O ' HG23 ' A' 1198 ' ' VAL . 12.0 p -139.77 138.14 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.571 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 6.8 p -54.91 -27.2 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.25 -54.05 14.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1197 ' ' ASN . . . . . 0.406 ' ND2' ' OD1' ' A' 1231 ' ' ASP . 34.9 m-20 -59.11 -49.36 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.793 HG21 ' HE3' ' A' 1216 ' ' TRP . 91.3 t -46.43 -37.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -63.68 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.33 -26.96 66.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.617 ' O ' HG12 ' A' 1204 ' ' VAL . 24.7 mm -56.23 145.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.73 145.57 53.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.59 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.466 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.736 HG23 ' HG2' ' A' 1208 ' ' LYS . 4.4 p -62.27 132.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 31.9 m -100.21 136.7 39.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.08 114.16 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 121.83 -70.6 0.4 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.736 ' HG2' HG23 ' A' 1204 ' ' VAL . 0.0 OUTLIER -32.98 -44.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.73 0.3 . . . . 0.0 110.876 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -30.43 -46.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.063 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.77 -62.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.103 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 15.4 ptt? -63.16 -23.3 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' 1209 ' ' ALA . 81.0 mt -85.77 31.47 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.88 -51.24 2.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.541 0.686 . . . . 0.0 111.122 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -48.02 -21.79 3.03 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.64 -67.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.793 ' HE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.05 -24.63 66.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' 1216 ' ' TRP . 6.4 mt-10 -60.31 -36.95 79.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 53.7 t -73.45 -43.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.671 HD11 HD21 ' A' 1160 ' ' LEU . 56.7 mt -55.1 -34.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1220 ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' 1193 ' ' THR . 13.7 ttpt -59.2 -48.12 82.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' 1225 ' ' THR . 13.4 t60 -73.75 -41.25 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' 1156 ' ' LEU . 36.3 t80 -53.25 -41.76 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.1 p -82.33 -34.51 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -64.98 -37.17 86.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.696 HG22 ' O ' ' A' 1221 ' ' HIS . 10.2 t -83.35 -18.8 37.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.452 ' OD1' HG23 ' A' 1225 ' ' THR . 7.0 m120 -116.93 21.2 13.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' 1226 ' ' ASN . 74.4 m 34.32 42.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' 1226 ' ' ASN . 57.6 t -91.02 147.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -73.81 147.55 43.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 38.7 p -143.4 173.8 11.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1231 ' ' ASP . . . . . 0.406 ' OD1' ' ND2' ' A' 1197 ' ' ASN . 4.2 m-20 60.81 51.6 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1232 ' ' LEU . . . . . 0.473 HD11 ' NH1' ' A' 1191 ' ' ARG . 11.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 49.5 mt-30 -35.55 -52.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.27 -51.42 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -43.05 -59.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' 1154 ' ' ILE . 9.4 tt0 -43.68 -61.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.6 m -43.37 -42.57 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -72.04 -36.21 69.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' 1151 ' ' GLU . 82.4 mt -64.56 -49.91 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1155 ' ' VAL . . . . . 0.709 HG12 ' HE2' ' A' 1159 ' ' LYS . 48.0 t -66.09 -40.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.8 tp -64.01 -57.15 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 65.6 t80 -40.51 -49.23 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.72 61.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' 1155 ' ' VAL . 33.8 mttm -59.19 -41.27 88.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.96 -52.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.7 t -49.39 -34.05 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.05 -51.42 58.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.2 -59.1 3.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.656 HH21 ' HB2' ' A' 1168 ' ' ALA . 0.0 OUTLIER -46.94 -44.14 19.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1165 ' ' GLN . . . . . 0.428 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 44.3 tt0 -63.35 -72.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' 1167 ' ' HIS . 9.3 ptpt -43.09 -28.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.423 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -60.66 -53.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.656 ' HB2' HH21 ' A' 1164 ' ' ARG . . . -37.14 -53.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -58.14 -46.8 85.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 29.6 tttt -47.99 -51.12 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.793 ' O ' HG13 ' A' 1173 ' ' VAL . 55.8 mtm -92.52 15.29 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 35.7 t70 43.04 40.79 2.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' 1171 ' ' MET . 32.9 m -117.34 141.42 28.64 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.626 0.727 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.9 132.92 22.56 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.356 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1175 ' ' PRO . . . . . 0.409 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 65.2 Cg_exo -48.0 -17.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.682 2.255 . . . . 0.0 112.325 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.81 -45.37 7.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.4 mm -51.2 -43.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.6 ' CD1' ' CE ' ' A' 1171 ' ' MET . 8.4 tp -64.69 -69.79 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.629 ' HB3' ' HD2' ' A' 1164 ' ' ARG . . . -150.66 147.38 27.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 70.2 p -94.06 173.79 7.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' 1185 ' ' VAL . 87.7 m-20 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -61.66 -52.44 64.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1183 ' ' ILE . . . . . 0.586 HG23 HG21 ' A' 1201 ' ' ILE . 92.0 mt -52.59 -51.29 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.0 mt -47.51 -53.98 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -45.19 -45.84 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -55.23 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 62.2 mmm -47.0 -41.23 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.0 95.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -71.26 -60.6 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.46 ' SD ' HD13 ' A' 1201 ' ' ILE . 38.1 mtt -63.9 -49.31 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.498 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 24.6 mtm180 69.39 54.78 0.52 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.568 0.699 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.5 Cg_endo -69.75 133.78 26.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.338 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1193 ' ' THR . . . . . 0.414 ' HB ' ' CD ' ' A' 1220 ' ' LYS . 33.1 p -104.16 -22.18 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.3 p -108.1 144.42 35.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 10.5 p -50.52 -35.63 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1196 ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' 1200 ' ' ARG . 14.8 mt-10 -55.82 -68.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1197 ' ' ASN . . . . . 0.421 ' C ' ' HD3' ' A' 1200 ' ' ARG . 84.9 m-20 -41.7 -36.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.485 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.6 t -63.05 -49.07 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.21 -29.58 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1200 ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' 1196 ' ' GLU . 2.1 mpt_? -67.57 -31.69 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' 1204 ' ' VAL . 23.8 mm -48.91 135.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.39 141.55 57.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.48 -44.27 1.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' 1201 ' ' ILE . 3.4 p -76.88 137.6 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 74.3 m -96.14 172.11 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.58 129.94 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 94.02 -59.66 2.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.448 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.596 ' HE2' HG23 ' A' 1204 ' ' VAL . 30.1 tttt -37.95 -47.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -38.13 -44.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.25 -59.82 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.5 ptt? -53.11 -24.8 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 33.89 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.83 -49.27 27.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.725 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -47.99 -19.14 1.41 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1215 ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' 1215 ' ' LEU . 7.1 mp -80.64 -68.35 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.8 OUTLIER -61.6 -19.19 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.06 -35.11 80.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.3 t -73.16 -45.48 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.4 mt -52.28 -56.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1220 ' ' LYS . . . . . 0.414 ' CD ' ' HB ' ' A' 1193 ' ' THR . 16.1 ttpp -43.05 -49.07 6.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -66.55 -53.52 33.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' 1156 ' ' LEU . 22.1 t80 -47.51 -52.26 17.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' 1230 ' ' THR . 26.4 p -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -61.82 -36.33 80.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.521 HG22 ' O ' ' A' 1222 ' ' PHE . 6.2 t -85.84 -27.58 25.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.448 ' CB ' HG23 ' A' 1228 ' ' VAL . 9.1 m120 -99.39 6.33 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.4 t 50.5 34.6 9.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.498 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 45.3 t -87.01 143.73 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.7 148.36 50.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1230 ' ' THR . . . . . 0.454 HG21 ' SG ' ' A' 1223 ' ' CYS . 22.0 p -149.17 175.5 11.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.69 51.94 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.731 0.301 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' 1147 ' ' ALA . 16.1 mt-30 -34.39 -56.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.36 -48.28 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -40.85 -60.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.0 tt0 -46.04 -60.72 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.2 m -42.16 -46.12 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -66.06 -43.8 86.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' 1151 ' ' GLU . 76.3 mt -57.1 -55.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.2 t -60.85 -43.2 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' 1222 ' ' PHE . 28.5 tp -60.66 -60.86 3.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' 1161 ' ' VAL . 64.5 t80 -35.29 -47.42 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -59.55 -51.97 55.88 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -50.12 -42.24 50.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.64 -51.58 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' 1157 ' ' TYR . 95.5 t -45.66 -57.2 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.152 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.96 -57.5 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.38 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.691 ' HD3' HD11 ' A' 1184 ' ' LEU . 16.9 ttp180 -57.57 -45.24 85.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.38 -54.01 50.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' 1167 ' ' HIS . 8.8 pttm -64.11 -38.62 91.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.479 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -61.71 -51.03 70.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.03 -53.49 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.98 -45.58 92.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1170 ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' 1170 ' ' LYS . 6.6 tmtm? -48.49 -51.18 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.819 ' O ' HG13 ' A' 1173 ' ' VAL . 50.0 mtm -91.53 15.36 12.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 36.9 t70 42.74 37.0 0.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' 1171 ' ' MET . 34.9 m -116.0 136.81 23.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.603 0.716 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.97 134.63 23.66 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.02 -16.41 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.372 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.84 -45.06 8.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.057 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.96 -45.05 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.595 ' CD1' ' HE2' ' A' 1171 ' ' MET . 10.9 tp -52.0 -69.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.06 114.85 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.6 t -64.89 176.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.631 ' O ' HG23 ' A' 1185 ' ' VAL . 5.3 m120 -61.67 -47.44 85.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -44.67 -55.28 5.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 91.9 mt -51.52 -62.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.691 HD11 ' HD3' ' A' 1164 ' ' ARG . 71.3 mt -45.49 -56.89 4.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' 1181 ' ' ASN . 62.9 t -41.06 -57.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' 1189 ' ' LYS . 4.2 m-20 -56.68 -57.28 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 70.0 mtp -43.94 -23.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1188 ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' 1186 ' ' ASP . . . -93.12 -32.24 14.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.566 ' HD3' HG12 ' A' 1185 ' ' VAL . 0.2 OUTLIER -74.14 -48.86 26.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -38.76 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 50.2 mtt85 68.74 54.98 0.58 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.2 Cg_endo -69.73 128.06 15.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 67.6 p -101.94 -24.22 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 70.2 p -102.66 135.74 43.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.546 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.5 p -53.3 -42.34 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1196 ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' 1195 ' ' VAL . 27.0 mp0 -48.5 -35.35 12.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -84.43 -35.02 23.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.469 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.8 t -62.22 -48.51 88.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1199 ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' 1196 ' ' GLU . 13.2 ptpt -54.46 -17.15 2.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -82.92 -30.68 28.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' 1204 ' ' VAL . 47.9 mm -43.73 144.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.67 135.33 54.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.3 -45.99 1.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1201 ' ' ILE . 3.5 p -81.38 137.04 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.145 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.0 t -100.07 156.05 17.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -47.69 151.32 0.87 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 77.93 -62.91 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' 1209 ' ' ALA . 10.5 ttmm -40.6 -50.46 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.765 0.316 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.74 -46.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.09 -64.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -48.46 -31.73 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' 1209 ' ' ALA . 41.5 mt -84.43 30.36 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.86 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.53 -55.17 15.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.566 0.698 . . . . 0.0 111.05 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.8 Cg_exo -47.99 -17.59 0.87 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.697 2.265 . . . . 0.0 112.34 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.95 -65.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.2 p90 -60.88 -26.99 67.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.507 ' N ' ' CD1' ' A' 1216 ' ' TRP . 22.8 mt-10 -55.08 -40.17 70.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -65.79 -42.14 91.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' 1216 ' ' TRP . 70.3 mt -53.71 -49.66 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -51.02 -43.15 60.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.7 t60 -69.62 -47.75 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' 1156 ' ' LEU . 31.6 t80 -53.43 -61.23 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' 1227 ' ' SER . 17.9 p -53.15 -44.14 67.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -45.8 -63.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.5 m -67.69 -40.52 84.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' 1228 ' ' VAL . 31.9 m120 -81.76 13.59 3.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' 1223 ' ' CYS . 6.5 t 32.55 49.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1226 ' ' ASN . 71.2 t -99.07 138.37 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -64.81 162.68 15.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 53.3 p -146.69 178.16 8.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 38.7 t0 61.19 42.62 11.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.913 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.754 0.311 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 3.3 pt20 -33.38 -49.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -96.62 -52.49 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -43.55 -56.59 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' 1154 ' ' ILE . 8.1 tt0 -52.73 -60.6 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1152 ' ' THR . . . . . 0.458 HG22 ' NH1' ' A' 1191 ' ' ARG . 74.0 m -41.4 -46.62 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -61.92 -45.14 95.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' 1151 ' ' GLU . 69.6 mt -55.62 -63.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1155 ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' 1159 ' ' LYS . 93.7 t -48.63 -54.16 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.557 HD21 HG23 ' A' 1219 ' ' ILE . 9.7 tp -54.04 -63.14 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' 1161 ' ' VAL . 44.2 t80 -38.06 -55.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -50.42 -42.99 43.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.528 ' HD2' HG12 ' A' 1155 ' ' VAL . 3.8 mtpm? -67.5 -43.96 79.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.806 HD21 HG13 ' A' 1219 ' ' ILE . 38.9 mt -60.14 -43.4 95.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.956 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' 1157 ' ' TYR . 98.2 t -57.73 -38.1 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -55.18 -50.52 69.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -68.25 -48.92 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.597 ' HG3' HD21 ' A' 1184 ' ' LEU . 4.7 tmm_? -47.4 -35.13 7.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.6 -69.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.477 ' HA ' ' ND2' ' A' 1169 ' ' ASN . 14.8 ptpt -44.96 -34.44 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.3 t-80 -60.65 -37.29 81.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.45 -53.7 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1169 ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' 1170 ' ' LYS . 6.4 p30 -61.08 -49.2 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1170 ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' 1169 ' ' ASN . 0.1 OUTLIER -48.12 -53.07 17.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 34.6 mtm -78.18 -7.61 57.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.907 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 12.5 t0 68.92 26.65 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.8 m -112.66 140.67 24.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.0 139.99 19.46 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1175 ' ' PRO . . . . . 0.447 ' O ' ' NH1' ' A' 1164 ' ' ARG . 65.9 Cg_exo -48.0 -16.74 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.71 2.273 . . . . 0.0 112.317 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.16 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.8 mm -46.54 -39.45 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.518 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.9 tp -61.04 -72.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -160.17 123.42 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 15.3 t -67.37 162.94 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -52.81 -46.39 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -42.84 -57.81 2.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.9 mt -45.48 -64.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.6 mt -44.69 -52.14 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.3 t -47.15 -54.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.22 -46.6 75.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 36.1 mmm -50.86 -37.58 44.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.92 68.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 9.1 mptt -75.69 -60.91 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.451 ' CE ' HD13 ' A' 1201 ' ' ILE . 14.6 mtt -70.37 -38.29 74.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' 1192 ' ' PRO . 32.0 mtt-85 66.66 52.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.8 137.67 35.9 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.25 . . . . 0.0 112.373 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 64.2 p -127.69 21.69 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 1.2 p -137.53 127.19 25.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' 1210 ' ' ALA . 14.1 p -43.28 -26.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -72.54 -64.59 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -47.65 -43.25 26.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.958 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.2 t -52.43 -42.03 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -58.4 -26.29 63.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -73.83 -33.28 64.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' 1204 ' ' VAL . 43.5 mm -47.5 140.16 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -68.77 142.51 54.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.91 -41.38 2.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.539 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' 1201 ' ' ILE . 8.4 p -78.62 137.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1205 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1206 ' ' GLU . 65.1 m -99.5 144.06 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1206 ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' 1205 ' ' SER . 22.7 tt0 -35.44 130.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.88 -59.8 3.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.7 ttmp? -38.41 -52.11 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.84 -52.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1210 ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' 1195 ' ' VAL . . . -40.5 -66.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1211 ' ' MET . . . . . 0.404 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 3.2 ptt? -47.44 -28.64 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 65.8 mt -85.4 30.73 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -63.47 -50.0 75.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.5 Cg_exo -47.91 -18.94 1.27 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.329 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.64 -70.77 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.958 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -56.55 -24.47 47.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.451 ' N ' ' CD1' ' A' 1216 ' ' TRP . 30.1 mt-10 -59.5 -35.34 73.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 63.6 t -68.24 -34.76 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.806 HG13 HD21 ' A' 1160 ' ' LEU . 62.5 mt -66.71 -42.92 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.35 -46.52 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.87 ' O ' HG22 ' A' 1225 ' ' THR . 5.2 t-160 -72.61 -41.69 65.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' 1156 ' ' LEU . 22.0 t80 -54.25 -42.83 70.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 23.7 p -81.36 -34.59 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -62.53 -33.68 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.87 HG22 ' O ' ' A' 1221 ' ' HIS . 3.1 t -89.72 -15.35 32.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' 1227 ' ' SER . 5.6 m120 -118.65 20.15 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1226 ' ' ASN . 55.1 m 35.55 46.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 41.0 t -93.72 140.43 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.79 153.44 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 47.3 p -146.87 -179.89 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 61.93 45.62 7.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.944 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.781 0.325 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 76.5 mt-30 -35.95 -52.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1149 ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' 1150 ' ' GLN . 44.1 tt0 -99.89 -47.07 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1150 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' 1149 ' ' GLU . 20.3 tt0 -36.81 -50.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -54.54 -56.22 21.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 53.3 m -44.45 -46.74 9.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1153 ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 2.1 mm-40 -68.25 -35.1 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.38 -53.39 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1155 ' ' VAL . . . . . 0.56 HG12 ' NZ ' ' A' 1159 ' ' LYS . 44.7 t -63.57 -39.7 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.492 HD22 ' NE ' ' A' 1191 ' ' ARG . 56.2 tp -66.61 -53.8 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' 1161 ' ' VAL . 74.6 t80 -40.27 -44.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -55.0 -44.93 83.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.56 ' NZ ' HG12 ' A' 1155 ' ' VAL . 44.1 mttp -61.84 -46.16 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.53 HD21 HD11 ' A' 1219 ' ' ILE . 33.6 mt -57.23 -40.73 78.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1157 ' ' TYR . 96.3 t -62.59 -44.07 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -64.75 -45.89 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.86 95.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.501 HH11 HD11 ' A' 1184 ' ' LEU . 27.7 ttp180 -59.06 -46.13 89.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -56.58 -61.05 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 26.4 pttt -52.54 -26.89 14.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -47.85 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.14 -50.99 3.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -65.83 -46.18 79.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 66.1 tttt -45.55 -53.69 8.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 44.6 mtm -84.26 -1.95 56.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.88 30.57 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -113.19 138.74 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.99 136.74 23.21 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.679 2.252 . . . . 0.0 112.37 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.94 -16.79 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.45 -46.39 7.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.3 mm -53.28 -44.81 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.571 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.8 tp -54.08 -68.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -154.89 129.68 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 3.6 t -75.54 166.1 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.32 -44.44 84.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -48.82 -42.77 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.87 -45.16 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.501 HD11 HH11 ' A' 1164 ' ' ARG . 53.2 mt -60.72 -49.47 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 98.6 t -49.87 -50.95 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.22 -46.8 88.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 38.2 mtp -53.01 -43.39 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.52 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.444 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 26.2 mttm -73.53 -63.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.708 ' SD ' HD13 ' A' 1201 ' ' ILE . 21.5 mtt -59.1 -38.6 79.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.492 ' NE ' HD22 ' A' 1156 ' ' LEU . 31.7 mtp180 62.24 55.02 2.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.584 0.707 . . . . 0.0 110.898 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' A' 1197 ' ' ASN . 53.7 Cg_endo -69.8 135.08 29.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.375 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1193 ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' 1216 ' ' TRP . 30.3 p -103.66 -36.91 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.409 ' O ' HG23 ' A' 1198 ' ' VAL . 2.8 p -99.99 164.27 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' 1196 ' ' GLU . 14.8 p -62.15 -42.59 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1196 ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' 1195 ' ' VAL . 27.2 mm-40 -49.01 -50.83 34.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1197 ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' 1192 ' ' PRO . 0.6 OUTLIER -59.34 -42.7 92.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.675 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.7 t -59.14 -49.21 84.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 64.1 mttt -49.89 -35.87 25.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -71.43 -24.89 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.954 ' O ' HG12 ' A' 1204 ' ' VAL . 23.9 mm -55.45 100.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1202 ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' 1201 ' ' ILE . 6.7 t70 -34.8 143.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.2 -50.86 1.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.954 HG12 ' O ' ' A' 1201 ' ' ILE . 14.9 p -69.84 137.54 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1205 ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' 1206 ' ' GLU . 1.2 t -96.82 140.38 31.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1206 ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' 1205 ' ' SER . 22.4 tt0 -34.21 140.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.8 -54.01 4.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' 1209 ' ' ALA . 43.1 tttm -39.51 -57.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.12 -39.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.51 -66.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.99 -22.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.488 HD21 ' HG ' ' A' 1178 ' ' LEU . 73.7 mt -91.84 33.84 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.2 -53.32 33.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.723 . . . . 0.0 111.109 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.9 Cg_exo -48.03 -17.65 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.1 -65.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.675 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.02 -21.53 63.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.3 -44.37 95.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 97.6 t -67.21 -38.37 80.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.53 HD11 HD21 ' A' 1160 ' ' LEU . 84.5 mt -59.59 -39.42 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1220 ' ' LYS . . . . . 0.401 ' CD ' ' HB ' ' A' 1193 ' ' THR . 23.2 ttpt -64.53 -27.63 69.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' 1224 ' ' GLN . 0.4 OUTLIER -81.9 -60.64 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.473 ' CD1' ' HE2' ' A' 1159 ' ' LYS . 59.3 t80 -38.36 -37.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -81.99 -33.79 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -66.33 -47.39 73.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' 1226 ' ' ASN . 9.0 t -71.32 -30.82 66.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' 1225 ' ' THR . 16.1 m120 -105.6 14.01 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' 1223 ' ' CYS . 82.4 p 33.9 48.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' 1226 ' ' ASN . 60.1 t -98.99 147.63 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -65.22 146.62 54.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1230 ' ' THR . . . . . 0.428 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.9 p -145.38 -175.39 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1231 ' ' ASP . . . . . 0.428 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 47.18 50.14 14.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.925 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.721 0.296 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -40.8 -51.92 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -91.33 -49.27 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -41.55 -58.0 2.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -48.71 -61.65 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.3 m -42.65 -46.8 5.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1153 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 18.4 mt-30 -64.82 -37.16 86.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.84 -57.52 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.0 t -56.08 -38.68 54.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.446 HD13 ' CG ' ' A' 1222 ' ' PHE . 33.7 tp -72.08 -61.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.677 ' O ' HG23 ' A' 1161 ' ' VAL . 70.2 t80 -36.79 -40.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.2 94.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -57.13 -44.64 83.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.69 -52.27 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' 1157 ' ' TYR . 88.5 t -45.76 -45.18 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.64 -46.72 88.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.65 80.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.489 ' HG3' HD23 ' A' 1178 ' ' LEU . 21.9 ttp180 -52.12 -46.45 65.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -57.73 -66.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 10.3 pttp -47.58 -38.29 14.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.6 OUTLIER -65.9 -51.93 54.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -38.96 -58.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -57.29 -41.09 79.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.88 -55.23 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.635 ' HE1' ' HG3' ' A' 1211 ' ' MET . 39.6 mtm -80.83 -2.83 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.25 29.31 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.7 m -113.39 138.83 22.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.94 138.31 21.36 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 -16.93 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.603 2.202 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.0 -45.61 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.7 mm -51.82 -42.05 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' 1164 ' ' ARG . 10.9 tp -57.54 -67.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.28 129.43 11.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1180 ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.3 t -83.69 150.62 25.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' 1180 ' ' THR . 5.6 m120 -35.38 -48.7 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -45.1 -56.62 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 81.4 mt -52.28 -52.6 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.546 HD13 HG22 ' A' 1161 ' ' VAL . 71.8 mt -46.36 -57.03 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' 1181 ' ' ASN . 21.6 t -46.55 -50.31 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.728 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -56.22 -41.6 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 56.4 mtp -68.88 -22.6 64.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -90.27 -29.01 18.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 9.2 ptmm? -85.39 -44.41 12.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' 1189 ' ' LYS . 15.8 mtm -88.07 -14.79 38.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' 1156 ' ' LEU . 47.9 mtm-85 39.62 54.87 5.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.632 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.7 Cg_endo -69.77 138.79 38.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.9 p -131.45 22.33 4.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 13.3 p -138.24 126.27 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 9.6 p -49.08 -27.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -73.78 -30.5 62.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -89.84 -49.88 6.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.6 t -45.89 -44.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -58.04 -30.06 65.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -74.5 -14.03 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' 1186 ' ' ASP . 23.0 mm -59.58 138.69 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.23 136.99 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.761 HG23 ' HD3' ' A' 1208 ' ' LYS . 7.4 p -77.2 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.164 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 38.1 m -100.17 170.9 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -61.49 143.85 55.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.32 -57.68 4.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.761 ' HD3' HG23 ' A' 1204 ' ' VAL . 46.5 tttt -39.54 -45.31 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -39.77 -45.19 1.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.08 -65.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1211 ' ' MET . . . . . 0.635 ' HG3' ' HE1' ' A' 1171 ' ' MET . 3.1 ptt? -50.15 -25.91 4.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 53.8 mt -88.99 32.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.33 -51.37 34.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 111.125 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -48.03 -17.18 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.35 -64.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.9 OUTLIER -64.47 -20.7 66.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.27 -37.15 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 76.7 t -68.53 -51.89 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' 1216 ' ' TRP . 59.1 mt -47.15 -48.33 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -48.17 -48.51 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.737 ' O ' HG22 ' A' 1225 ' ' THR . 3.4 t-160 -70.34 -46.61 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' 1222 ' ' PHE . 3.3 t80 -54.01 -38.14 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' 1227 ' ' SER . 28.1 p -85.97 -31.16 22.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -69.0 -35.4 76.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.737 HG22 ' O ' ' A' 1221 ' ' HIS . 7.6 t -84.78 -20.36 31.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.566 ' OD1' HG23 ' A' 1225 ' ' THR . 8.8 m120 -108.88 -3.69 17.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' 1223 ' ' CYS . 3.5 t 61.06 33.22 19.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 62.9 t -80.81 140.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.173 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -71.43 151.3 44.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 75.9 p -144.88 173.71 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 68.72 47.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.71 0.29 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.7 pt20 -32.82 -51.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.06 -48.95 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -47.87 -67.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.3 tp10 -40.82 -60.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.8 m -43.03 -52.03 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -61.77 -36.61 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.7 mt -61.58 -58.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 88.4 t -60.15 -40.15 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.939 HD13 ' CD2' ' A' 1222 ' ' PHE . 38.6 tp -62.95 -56.88 13.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' 1161 ' ' VAL . 45.2 t80 -37.23 -42.24 0.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.93 -49.27 73.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.432 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 25.3 mttm -53.38 -40.89 65.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.81 -49.36 68.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' 1157 ' ' TYR . 83.1 t -47.55 -41.37 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -62.66 -42.8 99.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.74 96.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' 1184 ' ' LEU . 30.3 ttp180 -62.74 -43.28 99.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.66 -51.27 70.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' 1167 ' ' HIS . 19.0 ptpt -64.89 -44.1 90.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.469 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.1 t-80 -60.54 -47.98 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -40.13 -53.12 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -61.37 -46.82 88.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1170 ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' 1170 ' ' LYS . 14.4 tmtt? -43.07 -54.74 4.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.2 mtm -82.86 -4.79 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 18.4 t0 67.27 32.02 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.0 m -115.26 137.79 23.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.606 0.717 . . . . 0.0 111.187 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.93 138.88 20.69 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.96 -16.51 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 0.0 112.394 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.78 -47.38 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.93 -41.33 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.497 ' CD1' ' HE3' ' A' 1171 ' ' MET . 11.8 tp -57.55 -63.96 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -153.46 143.97 22.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 59.1 p -93.17 169.57 10.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' 1185 ' ' VAL . 87.4 m-20 -55.32 -37.65 67.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.86 -48.06 82.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.85 -39.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.3 mt -72.71 -48.13 41.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' 1181 ' ' ASN . 93.2 t -52.24 -40.23 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -44.25 72.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 52.5 mtp -59.5 -37.19 77.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -72.4 -27.75 62.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 44.3 mttt -79.33 -63.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 15.2 mtt -64.92 -39.04 92.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' 1192 ' ' PRO . 29.1 mtm180 66.55 53.71 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.9 Cg_endo -69.77 141.23 44.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.708 2.272 . . . . 0.0 112.344 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -127.58 18.29 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.625 ' O ' HG23 ' A' 1198 ' ' VAL . 31.3 p -137.85 130.8 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.514 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 14.7 p -51.29 -24.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.9 -64.16 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -51.53 -42.92 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.66 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.7 t -47.78 -45.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.9 mttp -52.06 -34.13 42.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -64.34 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' 1202 ' ' ASP . 26.3 mm -43.33 153.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1202 ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' 1201 ' ' ILE . 31.7 t0 -80.69 133.46 35.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.0 -46.03 1.43 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 12.8 p -66.64 134.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 8.6 m -98.91 152.18 20.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -43.47 137.45 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.88 -62.91 4.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.648 ' HE2' HD11 ' A' 1212 ' ' LEU . 40.1 tttt -34.97 -48.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.44 -48.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.09 -65.62 0.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1211 ' ' MET . . . . . 0.462 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 5.6 ptt? -46.16 -28.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.648 HD11 ' HE2' ' A' 1208 ' ' LYS . 51.2 mt -87.17 32.95 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.845 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.42 -54.86 8.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.567 0.699 . . . . 0.0 111.089 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.845 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.57 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.91 -64.04 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.66 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -62.42 -21.86 65.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.403 ' N ' ' CD1' ' A' 1216 ' ' TRP . 55.1 mt-10 -60.43 -37.87 82.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.0 t -69.36 -57.9 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.085 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -38.71 -46.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -46.96 -55.23 8.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.51 ' O ' HG22 ' A' 1225 ' ' THR . 3.4 t-80 -68.04 -46.56 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.939 ' CD2' HD13 ' A' 1156 ' ' LEU . 64.1 t80 -46.65 -47.53 20.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 97.4 m -81.93 -46.87 13.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -46.86 -46.44 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.51 HG22 ' O ' ' A' 1221 ' ' HIS . 15.4 t -70.96 -37.37 72.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.569 ' O ' HG23 ' A' 1228 ' ' VAL . 8.5 m120 -90.05 23.8 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 4.7 t 39.37 39.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' 1226 ' ' ASN . 61.1 t -99.35 143.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -71.0 153.1 42.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 25.4 p -145.9 152.39 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.85 54.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.928 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -41.67 -49.4 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.52 -52.38 4.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1150 ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' 1150 ' ' GLN . 2.1 tp60 -42.22 -52.77 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' 1154 ' ' ILE . 19.7 tt0 -49.22 -60.09 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 70.7 m -41.0 -54.54 2.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -54.06 -40.81 67.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.4 mt -60.13 -53.41 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.1 t -61.52 -42.04 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.521 HD13 ' CG ' ' A' 1222 ' ' PHE . 17.6 tp -62.22 -59.13 5.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' 1156 ' ' LEU . 55.8 t80 -35.74 -51.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.47 56.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 17.1 mttm -58.75 -38.82 79.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.455 HD21 HD11 ' A' 1219 ' ' ILE . 38.5 mt -70.07 -42.22 73.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 68.3 t -47.57 -51.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -56.84 -46.2 81.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.92 -44.96 95.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.878 ' HD3' ' HB3' ' A' 1179 ' ' ALA . 4.0 tpm_? -60.79 -29.37 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -80.7 -70.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -40.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1167 ' ' HIS . . . . . 0.58 ' HB3' HD21 ' A' 1178 ' ' LEU . 0.5 OUTLIER -65.26 -54.57 27.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.76 ' HA ' HD22 ' A' 1178 ' ' LEU . . . -37.26 -59.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.42 -35.88 76.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1170 ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' 1167 ' ' HIS . 43.0 tttp -52.61 -54.31 34.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.429 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 36.7 mtm -81.57 -1.77 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.18 37.37 8.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 25.6 m -119.62 142.39 32.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.98 135.64 23.6 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.97 -16.81 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.35 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.93 -45.49 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 35.9 mm -55.41 -38.79 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.76 HD22 ' HA ' ' A' 1168 ' ' ALA . 14.0 tp -59.63 -64.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1179 ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' 1164 ' ' ARG . . . -168.66 127.41 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 11.0 t -67.82 170.28 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -63.78 -45.8 88.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -42.92 -57.34 2.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.6 mt -47.69 -48.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.87 -58.54 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.492 HG12 ' HD2' ' A' 1189 ' ' LYS . 93.1 t -40.87 -53.49 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.7 -56.7 15.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1187 ' ' MET . . . . . 0.46 ' HE3' ' HB3' ' A' 1216 ' ' TRP . 42.7 mtp -47.79 -43.5 27.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.0 79.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1189 ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' 1185 ' ' VAL . 15.3 mtpp -71.36 -63.82 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.489 ' SD ' HD13 ' A' 1201 ' ' ILE . 20.2 mtt -63.69 -39.64 94.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.3 mtm-85 65.61 54.67 1.07 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.578 0.704 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 143.73 51.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.33 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 6.2 p -124.87 15.5 8.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1194 ' ' THR . . . . . 0.567 ' O ' HG23 ' A' 1198 ' ' VAL . 16.9 p -140.03 134.91 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.417 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 11.1 p -57.85 -29.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -67.47 -31.68 71.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -87.37 -37.78 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.728 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.4 t -53.37 -36.48 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.169 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -62.89 -27.36 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -68.21 -33.24 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' 1202 ' ' ASP . 46.9 mm -42.63 160.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1202 ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' 1201 ' ' ILE . 16.8 t70 -87.36 134.51 33.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.06 -38.71 3.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' 1198 ' ' VAL . 7.3 p -68.45 138.82 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 63.8 p -99.82 154.71 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.48 139.18 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 80.7 -56.68 4.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' 1209 ' ' ALA . 14.6 ttmm -36.98 -45.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -35.22 -45.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.46 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 9.7 ptt? -52.94 -17.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.0 mt -90.88 31.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.8 -49.87 2.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 0.0 111.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 66.2 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1215 ' ' LEU . . . . . 0.748 HD11 ' NH2' ' A' 1164 ' ' ARG . 6.8 mp -84.04 -70.94 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.728 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -56.2 -19.18 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.02 -35.79 81.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 81.7 t -75.89 -51.79 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.455 HD11 HD21 ' A' 1160 ' ' LEU . 66.3 mt -49.0 -50.57 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -42.08 -45.22 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' 1224 ' ' GLN . 4.2 t-80 -75.59 -56.27 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' 1156 ' ' LEU . 10.0 t80 -41.88 -32.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 83.1 m -90.96 -25.21 19.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' 1221 ' ' HIS . 2.9 pt20 -72.04 -46.95 55.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' 1224 ' ' GLN . 7.4 t -74.11 -24.66 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' 1225 ' ' THR . 36.3 m-80 -102.1 -0.79 32.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 32.1 t 55.37 36.65 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1228 ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' 1229 ' ' GLN . 74.9 t -83.09 153.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1229 ' ' GLN . . . . . 0.404 ' N ' HG12 ' A' 1228 ' ' VAL . 1.8 mp0 -70.11 145.95 51.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 23.6 p -143.58 165.62 27.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.13 46.65 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.924 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.746 0.308 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 80.8 mt-30 -34.77 -56.91 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.09 -44.56 7.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -44.19 -54.2 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -70.79 -58.82 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 47.5 m -38.05 -53.51 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -60.07 -45.64 92.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.99 -51.46 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 94.4 t -61.66 -42.06 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.523 HD22 ' NE ' ' A' 1191 ' ' ARG . 17.0 tp -63.73 -59.82 4.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' 1161 ' ' VAL . 61.4 t80 -36.58 -44.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.49 90.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -57.01 -40.44 76.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1160 ' ' LEU . . . . . 0.474 HD21 HD11 ' A' 1219 ' ' ILE . 42.4 mt -64.59 -46.05 84.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.797 HG13 HH12 ' A' 1164 ' ' ARG . 85.7 t -54.11 -41.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.05 -47.41 83.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1163 ' ' ALA . . . . . 0.418 ' HA ' ' CG ' ' A' 1166 ' ' LYS . . . -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1164 ' ' ARG . . . . . 0.797 HH12 HG13 ' A' 1161 ' ' VAL . 14.0 ttp-105 -62.86 -32.42 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -74.83 -55.22 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1166 ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' 1163 ' ' ALA . 0.0 OUTLIER -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.12 -46.81 48.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -41.38 -52.82 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.75 -45.74 91.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.2 tttp -48.72 -51.6 27.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.636 ' O ' HG13 ' A' 1173 ' ' VAL . 50.6 mtm -88.01 11.0 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 10.6 m-20 49.83 31.34 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' 1171 ' ' MET . 35.3 m -112.62 136.87 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 138.79 21.28 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 -17.42 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.91 -43.6 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.53 -45.45 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.603 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.3 tp -51.36 -67.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -152.77 134.12 14.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1180 ' ' THR . . . . . 0.459 ' H ' HD12 ' A' 1183 ' ' ILE . 12.1 t -78.86 159.24 27.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.04 -42.93 60.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -47.54 -44.55 26.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1183 ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' 1180 ' ' THR . 74.7 mt -62.55 -62.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' 1164 ' ' ARG . 94.1 mt -40.01 -54.09 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 96.1 t -47.15 -57.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.405 ' CB ' HG23 ' A' 1201 ' ' ILE . 4.2 m-20 -53.73 -57.41 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 65.7 mtp -43.98 -38.19 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.56 73.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -74.02 -58.31 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -69.79 -32.82 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.523 ' NE ' HD22 ' A' 1156 ' ' LEU . 25.9 mtp180 55.7 53.36 8.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 135.02 29.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 45.3 p -102.05 -31.85 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.4 p -102.62 149.37 24.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.575 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -59.34 -39.15 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -51.93 -25.12 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.45 -39.31 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 76.8 t -58.13 -47.58 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -54.64 -29.4 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -71.27 -19.93 62.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' 1204 ' ' VAL . 38.0 mm -55.58 149.38 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.62 135.93 50.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.56 -48.82 1.23 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' 1201 ' ' ILE . 10.3 p -73.59 135.99 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 18.2 m -99.47 150.58 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -41.62 141.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.19 -65.6 4.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' 1209 ' ' ALA . 32.3 ttpt -34.72 -54.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.96 -47.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.69 -64.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 6.6 ptt? -48.99 -30.36 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' 1209 ' ' ALA . 43.5 mt -84.86 30.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -64.6 -52.52 51.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 111.11 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 63.8 Cg_exo -47.95 -17.91 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.38 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -80.91 -65.32 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.575 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.0 OUTLIER -61.8 -23.15 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' 1216 ' ' TRP . 21.5 mm-40 -58.66 -38.94 79.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.7 t -70.02 -30.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.1 mt -66.12 -44.7 91.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -54.77 -30.06 55.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1221 ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.3 t-160 -82.92 -56.93 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.0 t80 -39.94 -34.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1223 ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' 1227 ' ' SER . 22.2 p -86.89 -30.44 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1224 ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -70.53 -46.76 63.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.481 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.6 t -71.84 -13.49 61.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.456 ' OD1' HG23 ' A' 1225 ' ' THR . 11.2 m120 -127.08 14.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1227 ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' 1223 ' ' CYS . 7.6 t 34.75 48.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 76.4 t -94.65 147.79 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -66.7 144.19 56.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1230 ' ' THR . . . . . 0.453 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.0 p -141.1 -175.29 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1231 ' ' ASP . . . . . 0.453 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 48.36 53.39 12.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.721 0.296 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -37.63 -55.15 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.34 -47.37 8.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1150 ' ' GLN . . . . . 0.577 ' HG2' HD11 ' A' 1154 ' ' ILE . 28.5 tt0 -42.04 -62.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1151 ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' 1154 ' ' ILE . 0.3 OUTLIER -42.81 -59.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 84.9 m -44.18 -49.96 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.1 -37.76 88.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1154 ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.8 mt -63.3 -57.2 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1155 ' ' VAL . . . . . 0.437 HG12 ' HZ2' ' A' 1159 ' ' LYS . 45.3 t -58.47 -40.69 79.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1156 ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' 1222 ' ' PHE . 40.1 tp -66.18 -60.98 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1157 ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' 1161 ' ' VAL . 56.8 t80 -37.81 -48.19 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.89 -45.65 61.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1159 ' ' LYS . . . . . 0.437 ' HZ2' HG12 ' A' 1155 ' ' VAL . 29.7 mttp -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.18 -47.76 83.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1161 ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' 1157 ' ' TYR . 99.9 t -54.24 -44.65 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -63.74 -46.39 85.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.18 76.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -53.35 -41.59 65.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.9 -69.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -36.93 5.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 2.4 t60 -74.64 -43.84 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1168 ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -45.32 -55.71 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.03 -36.68 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -53.89 53.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1171 ' ' MET . . . . . 0.504 ' CE ' HD11 ' A' 1178 ' ' LEU . 15.9 mtm -75.61 -6.44 50.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.14 33.63 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1173 ' ' VAL . . . . . 0.429 ' O ' ' HB1' ' A' 1168 ' ' ALA . 27.0 m -121.54 138.97 29.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 136.62 22.97 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -20.59 2.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.52 -38.79 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1177 ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' 1177 ' ' ILE . 19.5 mm -58.91 -46.82 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1178 ' ' LEU . . . . . 0.504 HD11 ' CE ' ' A' 1171 ' ' MET . 13.1 tp -51.31 -61.75 2.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.4 148.83 28.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 76.6 p -94.91 165.95 12.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1181 ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' 1185 ' ' VAL . 20.2 m-80 -60.05 -37.23 79.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -61.56 -48.87 79.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.25 -40.74 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1184 ' ' LEU . . . . . 0.447 HD13 HG22 ' A' 1161 ' ' VAL . 83.3 mt -63.55 -54.12 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1185 ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' 1181 ' ' ASN . 94.4 t -55.2 -38.76 48.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1186 ' ' ASP . . . . . 0.553 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -59.08 -60.98 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 49.2 mtp -53.55 -28.15 30.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.99 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 22.2 mttt -97.42 -60.47 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1190 ' ' MET . . . . . 0.43 ' SD ' ' O ' ' A' 1186 ' ' ASP . 1.1 mpt? -64.61 -39.76 94.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1191 ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' 1192 ' ' PRO . 49.1 mtm-85 64.17 55.01 1.55 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1192 ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.78 119.61 6.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 52.4 p -92.2 -21.52 20.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 59.2 p -109.04 144.14 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1195 ' ' VAL . . . . . 0.519 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.3 p -56.06 -30.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.126 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -58.95 -41.32 87.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -75.19 -37.09 61.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1198 ' ' VAL . . . . . 0.51 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.6 t -59.11 -49.21 84.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -50.91 -28.77 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -70.38 -32.15 69.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1201 ' ' ILE . . . . . 0.706 ' O ' HG12 ' A' 1204 ' ' VAL . 21.6 mm -49.57 146.11 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.07 142.17 49.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.22 -46.46 1.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1204 ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' 1201 ' ' ILE . 9.6 p -67.51 132.6 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 58.8 m -96.88 145.66 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -40.72 126.8 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 93.52 -59.7 2.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1208 ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.1 ttmp? -38.69 -48.69 1.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1209 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.67 -46.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -43.92 -66.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.8 ptt? -47.12 -26.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1212 ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' 1178 ' ' LEU . 72.5 mt -89.09 32.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.41 -53.75 21.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 111.102 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1214 ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.9 -17.26 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.715 2.276 . . . . 0.0 112.321 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.39 -60.53 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -67.29 -28.28 67.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1217 ' ' GLU . . . . . 0.531 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.8 mt-10 -56.41 -33.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.4 t -70.17 -41.21 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1219 ' ' ILE . . . . . 0.45 HG12 HD11 ' A' 1156 ' ' LEU . 83.7 mt -59.82 -53.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -45.77 -43.67 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -76.03 -43.95 41.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1222 ' ' PHE . . . . . 0.689 ' CD2' HD13 ' A' 1156 ' ' LEU . 27.6 t80 -54.18 -38.98 66.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -81.06 -26.47 36.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1225 ' ' THR . . . . . 0.5 HG23 ' OD1' ' A' 1226 ' ' ASN . 9.3 t -87.06 -34.93 19.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1226 ' ' ASN . . . . . 0.5 ' OD1' HG23 ' A' 1225 ' ' THR . 9.9 m120 -91.43 8.19 37.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 43.1 t 42.04 43.51 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 70.6 t -89.03 148.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -76.09 151.86 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 71.0 p -145.05 174.64 10.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 20.1 t0 66.22 41.79 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 77.5 p -136.29 169.42 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.822 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 3.1 m -137.92 109.74 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -72.23 -177.15 29.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 42.9 p -152.03 175.7 12.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.856 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 29.4 t -110.89 160.4 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -107.72 -177.64 22.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.439 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 67.0 p -76.11 179.46 5.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.867 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 90.4 p -143.92 127.14 16.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 149.94 54.61 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 154.71 67.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.31 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 24.3 m -51.21 157.38 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.472 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 54.3 mt -86.32 135.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 28.3 p -59.15 127.83 34.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . -38.38 -34.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -41.86 -59.17 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1149 ' ' GLU . . . . . 0.472 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 7.3 pt-20 -99.97 -37.37 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -42.49 -57.59 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.405 ' HA ' HD12 ' A' 1154 ' ' ILE . 13.6 tt0 -48.94 -57.3 6.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1152 ' ' THR . . . . . 0.401 HG21 HG11 ' A' 1228 ' ' VAL . 54.6 m -46.99 -43.4 19.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.169 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.9 -38.65 86.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.0 mt -62.71 -53.21 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 59.1 t -62.49 -40.13 87.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 20.9 tp -65.83 -59.33 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.1 t80 -37.55 -51.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.98 -42.64 60.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 31.8 mttm -61.96 -45.18 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 43.2 mt -59.53 -52.99 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 77.6 t -48.02 -47.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.55 -46.52 83.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.84 -53.0 62.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.516 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.8 ttp180 -47.59 -45.09 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1165 ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' 1168 ' ' ALA . 21.6 tt0 -59.08 -70.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -45.96 -26.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.92 -32.39 21.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.97 -50.22 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.55 -44.92 96.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.12 -52.18 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' HD11 ' A' 1178 ' ' LEU . 10.4 mtm -77.74 -6.02 52.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.96 39.41 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' 1168 ' ' ALA . 31.7 m -127.82 142.69 45.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 138.64 21.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.93 -23.26 4.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -91.23 -35.61 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.7 mm -59.0 -48.91 85.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.497 HD11 ' HE3' ' A' 1171 ' ' MET . 13.3 tp -49.34 -62.26 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.72 124.19 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.0 t -78.58 154.13 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.683 ' O ' HG23 ' A' 1185 ' ' VAL . 5.9 m-80 -45.86 -38.8 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -51.58 -45.08 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.93 -51.38 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.516 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.2 mt -52.53 -48.83 65.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' 1181 ' ' ASN . 90.6 t -52.73 -53.26 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.52 -50.39 70.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 82.2 mtp -56.54 -36.35 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -73.68 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -90.0 -54.73 3.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.559 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 17.5 mtt -75.06 -27.68 60.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.543 ' HB3' HG22 ' A' 1230 ' ' THR . 21.8 mtm180 54.89 54.85 10.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.1 Cg_endo -69.78 125.19 11.84 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 0.0 112.314 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.5 p -97.29 -24.51 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 77.6 p -107.61 138.52 43.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.54 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.4 p -52.94 -28.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -58.43 -50.08 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.2 -36.52 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 97.6 t -57.58 -47.16 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 18.0 mttp -50.94 -36.78 40.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -65.55 -23.9 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 32.5 mm -52.48 150.99 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.69 137.85 37.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 98.69 -37.99 3.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' 1201 ' ' ILE . 3.8 p -74.04 132.43 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 47.8 t -95.92 145.23 25.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -40.85 131.35 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 88.87 -58.45 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' 1209 ' ' ALA . 9.1 ttmm -37.63 -50.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.98 -48.74 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 2.0 ptt? -46.91 -28.11 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 70.9 mt -86.53 29.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.736 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.37 -51.66 41.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.711 . . . . 0.0 111.079 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.01 -22.54 3.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.61 -67.27 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.563 ' HA ' HD12 ' A' 1219 ' ' ILE . 1.0 OUTLIER -60.65 -30.09 69.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' 1216 ' ' TRP . 8.8 mm-40 -54.17 -34.63 60.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.3 t -74.0 -32.96 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.4 mt -65.7 -40.95 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1220 ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' 1224 ' ' GLN . 25.2 ttpt -59.84 -38.53 82.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.961 ' O ' HG22 ' A' 1225 ' ' THR . 10.9 t60 -77.99 -47.08 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 39.3 t80 -51.54 -41.46 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' 1230 ' ' THR . 21.5 p -84.11 -35.34 23.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.487 ' CG ' ' O ' ' A' 1220 ' ' LYS . 8.9 mm100 -64.22 -31.79 73.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.961 HG22 ' O ' ' A' 1221 ' ' HIS . 3.5 t -88.99 -15.67 33.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.402 ' OD1' HG23 ' A' 1225 ' ' THR . 6.2 m120 -119.78 15.03 12.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' 1223 ' ' CYS . 4.3 t 41.61 40.89 1.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.401 HG11 HG21 ' A' 1152 ' ' THR . 89.7 t -87.5 144.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -64.78 148.54 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1230 ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' 1191 ' ' ARG . 36.7 p -146.79 -175.5 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.53 49.93 4.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.9 mt -81.37 42.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' 1190 ' ' MET . 21.9 m-85 -82.61 175.9 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 41.6 p -93.97 -51.63 4.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 39.4 t -96.36 91.12 5.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 14.7 t -97.72 176.43 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.098 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.61 143.88 34.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 0.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -175.34 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -128.14 84.68 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 73.2 p -89.12 -0.4 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 65.63 81.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 177.11 5.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.747 2.298 . . . . 0.0 112.369 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 112.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 3.1 m -142.6 171.63 13.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.456 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 35.2 p -74.51 104.59 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 32.2 t -133.58 164.17 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 176.73 42.81 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 82.5 p -86.86 109.05 19.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 0.0 110.823 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 94.4 p -86.32 172.66 10.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -140.69 -163.62 9.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.473 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 80.0 p -115.96 157.38 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 84.0 p -54.09 127.97 28.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -138.93 150.71 66.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.713 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -173.29 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.256 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.2 m -71.68 165.7 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 66.5 mt -86.48 139.04 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1147 ' ' ALA . 22.7 t -45.92 119.41 2.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.73 -48.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' 1147 ' ' ALA . 66.8 mt-30 -34.5 -47.05 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -97.68 -51.02 4.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -44.03 -59.15 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -47.63 -58.8 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1152 ' ' THR . . . . . 0.471 HG22 ' NH2' ' A' 1191 ' ' ARG . 89.4 m -43.76 -45.3 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1153 ' ' GLN . . . . . 0.412 ' HG3' ' NH2' ' A' 1191 ' ' ARG . 57.6 mt-30 -65.35 -38.54 90.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.6 -46.72 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -42.37 87.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.61 HD23 ' HE ' ' A' 1191 ' ' ARG . 22.2 tp -67.35 -57.82 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' 1161 ' ' VAL . 54.5 t80 -38.12 -50.83 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.2 -45.19 92.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 35.8 mttm -57.4 -45.21 84.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.29 -51.82 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.856 HG22 HD13 ' A' 1184 ' ' LEU . 100.0 t -52.4 -41.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.01 -55.16 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -46.86 -34.07 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -66.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' 1167 ' ' HIS . 12.5 pttp -53.48 -27.11 23.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.595 ' CE1' ' SD ' ' A' 1171 ' ' MET . 2.3 t60 -83.43 -35.19 25.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.615 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.84 -48.9 69.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.26 -37.21 83.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.6 tttt -51.42 -41.37 60.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.883 ' CE ' HD11 ' A' 1178 ' ' LEU . 3.2 mpp? -96.7 2.78 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 61.73 31.32 18.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.5 HG21 HD13 ' A' 1178 ' ' LEU . 34.8 m -112.02 138.27 21.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.693 . . . . 0.0 111.166 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 136.02 23.38 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -16.77 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.17 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.87 -39.83 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.883 HD11 ' CE ' ' A' 1171 ' ' MET . 15.8 tp -59.3 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.34 139.8 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1180 ' ' THR . . . . . 0.431 ' H ' HD12 ' A' 1183 ' ' ILE . 38.1 p -93.27 162.24 14.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' 1185 ' ' VAL . 2.7 m-20 -56.79 -36.16 69.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.62 -51.94 67.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1183 ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' 1180 ' ' THR . 78.4 mt -57.71 -48.35 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.856 HD13 HG22 ' A' 1161 ' ' VAL . 76.1 mt -54.04 -50.95 65.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.525 HG12 ' HD2' ' A' 1189 ' ' LYS . 79.8 t -56.74 -52.03 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.516 ' CB ' HG23 ' A' 1201 ' ' ILE . 51.8 m-20 -55.1 -46.68 75.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.99 -40.74 81.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1188 ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' 1191 ' ' ARG . . . -64.75 -31.56 72.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' 1185 ' ' VAL . 12.8 mtpp -80.04 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' 1201 ' ' ILE . 17.8 mtt -62.17 -38.39 88.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.61 ' HE ' HD23 ' A' 1156 ' ' LEU . 17.1 mmt85 65.28 52.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 131.96 22.38 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -120.54 24.56 10.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.924 ' O ' HG23 ' A' 1198 ' ' VAL . 19.1 p -138.36 134.72 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.12 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.564 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 7.1 p -52.98 -26.96 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -75.35 -67.93 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -44.11 -39.59 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' 1194 ' ' THR . 74.6 t -48.57 -43.58 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1199 ' ' LYS . . . . . 0.435 ' HA ' ' CG1' ' A' 1204 ' ' VAL . 6.0 mtmp? -56.67 -30.43 63.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -67.16 -29.16 68.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.57 HD13 ' SD ' ' A' 1190 ' ' MET . 13.7 mm -59.32 102.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1202 ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' 1201 ' ' ILE . 9.3 t70 -31.46 145.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.43 -41.83 2.08 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.694 HG23 ' HD2' ' A' 1208 ' ' LYS . 2.8 p -93.52 140.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1205 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1206 ' ' GLU . 12.9 t -100.2 138.96 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1206 ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' 1205 ' ' SER . 36.3 tt0 -34.26 129.61 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 100.17 -64.94 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.694 ' HD2' HG23 ' A' 1204 ' ' VAL . 16.6 ttmm -38.7 -48.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.8 -42.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.75 -65.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.7 ptt? -53.3 -24.59 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.08 34.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.51 -49.81 39.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.689 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -48.0 -20.14 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.69 -63.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.869 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.9 OUTLIER -65.37 -23.15 66.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.405 ' N ' ' CD1' ' A' 1216 ' ' TRP . 33.2 mt-10 -61.59 -36.23 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.1 t -67.28 -42.91 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.52 -40.29 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -60.63 -43.13 97.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -73.36 -44.54 58.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' 1228 ' ' VAL . 49.5 t80 -56.81 -46.13 81.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' 1227 ' ' SER . 28.4 p -70.09 -36.21 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -57.76 -34.65 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.439 HG22 ' O ' ' A' 1222 ' ' PHE . 5.3 t -93.13 -37.3 12.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' 1227 ' ' SER . 12.1 m120 -93.39 15.81 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' 1223 ' ' CYS . 17.6 m 35.49 46.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' 1222 ' ' PHE . 59.0 t -87.57 139.27 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -63.57 148.02 49.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1230 ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' 1231 ' ' ASP . 37.6 p -138.35 -175.39 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1231 ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' 1230 ' ' THR . 4.8 p-10 48.13 49.24 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 47.51 1.0 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -102.0 177.17 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 3.1 m -44.87 -43.54 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 12.0 t 69.03 39.67 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 11.6 t -78.6 149.45 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.161 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.15 150.69 10.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.3 12.01 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -59.21 96.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 74.7 p -49.42 132.19 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -159.15 83.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.26 6.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.645 2.23 . . . . 0.0 112.383 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 1.4 t -96.01 126.12 41.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 31.4 m -101.49 -56.35 2.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.526 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 16.9 m -159.48 131.85 6.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.381 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 13.9 m -98.95 163.44 12.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -122.4 -141.7 6.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 58.7 m -130.93 144.75 51.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 110.827 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 8.2 t -167.59 171.68 10.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -107.17 50.47 0.79 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.523 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1140 ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' 1141 ' ' SER . 49.6 m -159.7 107.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1141 ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' 1140 ' ' SER . 56.4 p -37.98 124.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -87.74 154.42 53.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 166.74 26.59 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 69.5 t -40.65 145.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.538 HD12 ' OE1' ' A' 1150 ' ' GLN . 60.5 mt -84.18 137.78 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.167 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 1.9 t -50.29 131.42 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . -42.89 -45.94 5.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -38.43 -49.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -93.32 -50.2 5.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.538 ' OE1' HD12 ' A' 1145 ' ' ILE . 3.0 tp60 -47.11 -60.06 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -42.7 -60.81 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 86.7 m -43.96 -46.02 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -62.26 -38.76 90.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.19 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 96.7 t -68.93 -43.73 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' 1222 ' ' PHE . 17.6 tp -63.72 -55.32 24.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 62.8 t80 -40.62 -49.51 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.17 92.78 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' 1162 ' ' GLU . 37.9 mttm -55.3 -33.46 63.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' 1161 ' ' VAL . 25.0 mt -74.13 -59.99 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' 1160 ' ' LEU . 97.3 t -37.17 -62.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.06 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1162 ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' 1159 ' ' LYS . 5.2 pt-20 -38.89 -54.71 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.51 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.644 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.0 ttp180 -54.47 -48.63 71.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -58.56 -65.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' 1167 ' ' HIS . 1.2 ptpm? -47.56 -44.9 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.448 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.7 OUTLIER -58.24 -42.84 87.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.23 -55.16 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -60.44 -47.3 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 57.4 tttp -42.68 -51.06 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.59 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 59.1 mtm -87.69 -5.62 58.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.59 32.62 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.433 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.4 m -114.63 141.31 26.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.596 0.712 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 136.68 23.29 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.97 -17.23 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.41 -40.79 9.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.2 mm -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.59 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.8 tp -53.78 -68.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.42 120.39 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.0 t -72.61 156.38 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -47.01 -43.75 19.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -48.61 -52.68 21.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.32 -40.88 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.644 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.5 mt -58.76 -61.51 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.6 t -41.46 -50.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -52.64 -51.52 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 93.8 mtp -55.95 -36.94 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.12 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -78.42 -63.37 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' HD13 ' A' 1201 ' ' ILE . 25.8 mtt -63.87 -39.33 93.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.7 mtt-85 66.31 54.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.594 0.712 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.78 129.35 17.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 58.2 p -104.89 -26.08 12.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 72.1 p -108.24 149.61 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.422 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.9 p -58.46 -26.89 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.85 -45.85 85.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.564 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 37.0 m-80 -73.62 -44.1 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.813 HG21 ' CE3' ' A' 1216 ' ' TRP . 69.7 t -44.26 -45.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.2 mttm -57.38 -35.72 70.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -68.94 -26.12 64.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.842 ' O ' HG12 ' A' 1204 ' ' VAL . 27.2 mm -55.42 98.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1202 ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' 1201 ' ' ILE . 10.4 t0 -34.58 143.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.33 -46.55 1.43 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.52 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' 1201 ' ' ILE . 9.4 p -76.13 142.31 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 42.5 t -99.83 154.01 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 145.0 10.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.03 -55.72 5.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.5 ttmp? -44.62 -49.47 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -34.63 -49.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -38.16 -65.84 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.0 ptt? -52.67 -25.85 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' 1209 ' ' ALA . 52.7 mt -87.28 32.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.784 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.51 -53.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 111.078 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.5 Cg_exo -47.97 -17.74 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.71 -64.76 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.813 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -62.55 -24.17 67.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' 1216 ' ' TRP . 51.5 mt-10 -58.78 -39.4 80.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 93.3 t -69.21 -41.85 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' 1216 ' ' TRP . 77.5 mt -52.82 -48.45 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -54.66 -44.56 73.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 14.1 t60 -62.83 -56.4 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' 1156 ' ' LEU . 66.2 t80 -44.07 -67.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' 1227 ' ' SER . 61.6 m -50.83 -55.29 17.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' 1223 ' ' CYS . 30.2 mt-30 -35.32 -69.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -37.23 79.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' 1228 ' ' VAL . 2.1 m-80 -85.27 16.6 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.1 t 33.98 50.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' 1226 ' ' ASN . 85.3 t -103.26 141.84 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.61 155.53 40.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.2 p -143.02 -177.08 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 10.9 t0 54.91 51.24 13.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.49 43.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' 1197 ' ' ASN . 2.6 m-85 -92.58 -48.45 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 2.9 m -92.94 89.18 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 68.8 p -50.42 -47.93 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 69.8 p -106.76 142.62 36.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -151.94 149.66 24.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -31.12 21.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.716 2.277 . . . . 0.0 112.29 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1239 ' ' GLN . . . . . 0.43 ' C ' ' CD ' ' A' 1239 ' ' GLN . 2.8 pp0? -174.87 158.42 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 1.8 m -95.29 101.52 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -136.96 -93.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.5 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 171.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.326 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 7.8 t 61.24 44.39 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 82.7 p -144.72 142.08 29.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.448 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 76.2 p -100.25 169.28 9.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.846 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 35.8 t -98.81 -58.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 119.58 -178.21 16.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 31.8 t -156.68 143.66 18.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.885 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 9.1 t -66.13 117.23 8.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 53.74 99.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.434 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 87.3 p -158.77 177.48 11.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 53.1 p -93.89 81.81 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -55.07 150.19 21.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.572 0.701 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 125.75 12.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 33.8 m -49.41 168.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.12 139.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' 1147 ' ' ALA . 15.4 t -58.02 127.58 32.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' 1146 ' ' SER . . . -34.07 -43.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' 1147 ' ' ALA . 94.0 mm-40 -37.62 -53.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -94.23 -48.14 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.84 -58.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.1 tt0 -43.79 -60.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 85.1 m -44.41 -48.58 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.78 -33.24 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' 1151 ' ' GLU . 90.2 mt -67.02 -61.89 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 46.9 t -52.39 -43.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.482 HD21 HG12 ' A' 1219 ' ' ILE . 19.3 tp -64.86 -57.34 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.654 ' O ' HG23 ' A' 1161 ' ' VAL . 77.9 t80 -38.76 -42.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.7 -45.72 95.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 26.8 mttm -61.72 -44.09 97.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.599 HD11 HD11 ' A' 1219 ' ' ILE . 21.3 mt -59.97 -52.49 65.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' 1157 ' ' TYR . 85.0 t -48.24 -44.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.08 -45.51 83.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.2 98.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.59 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.8 ttp180 -58.19 -41.69 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1165 ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' 1166 ' ' LYS . 10.5 tm0? -64.37 -60.5 3.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.462 ' N ' ' OE1' ' A' 1165 ' ' GLN . 5.6 ptmm? -54.92 -35.98 64.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -46.94 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.31 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.28 -45.9 92.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 30.8 tttt -46.38 -55.64 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.901 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.531 ' HE1' ' HG3' ' A' 1211 ' ' MET . 29.3 mtm -79.61 -7.83 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.8 t70 68.43 30.87 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.441 ' O ' ' HB1' ' A' 1168 ' ' ALA . 34.8 m -113.61 139.66 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.692 0.758 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.96 136.7 23.02 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.395 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 -16.76 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.69 9.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.4 mm -56.68 -42.99 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.8 tp -57.35 -70.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.63 131.34 13.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.6 t -80.9 175.47 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' 1185 ' ' VAL . 17.6 p-10 -62.23 -46.73 87.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -53.21 17.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.18 -52.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.59 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.8 mt -52.44 -49.92 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' 1189 ' ' LYS . 95.5 t -49.92 -52.83 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -50.03 -55.27 15.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 71.1 mtp -47.47 -44.75 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.88 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.527 ' HD2' HG12 ' A' 1185 ' ' VAL . 29.6 mtpt -78.17 -62.16 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.77 -37.58 79.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' 1192 ' ' PRO . 27.2 mtp180 63.74 51.96 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.73 139.43 40.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 18.9 p -124.23 25.72 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.179 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.429 ' O ' HG23 ' A' 1198 ' ' VAL . 27.2 p -140.26 125.65 18.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.497 HG23 ' CH2' ' A' 1216 ' ' TRP . 13.3 p -44.59 -33.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.7 -62.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -48.68 -43.16 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.541 HG21 ' CE3' ' A' 1216 ' ' TRP . 87.1 t -50.53 -39.99 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -62.04 -23.54 66.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' 1204 ' ' VAL . 27.4 mm -61.53 142.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 32.6 t0 -67.46 139.65 57.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.03 -52.22 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' 1201 ' ' ILE . 6.1 p -65.59 137.05 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.1 t -100.06 145.42 27.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -38.86 135.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 86.5 -57.37 4.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.6 OUTLIER -40.53 -54.09 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' 1204 ' ' VAL . . . -34.79 -48.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.73 -62.65 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1211 ' ' MET . . . . . 0.531 ' HG3' ' HE1' ' A' 1171 ' ' MET . 4.3 ptt? -50.06 -22.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.69 35.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.54 -52.99 32.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 0.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.03 -67.38 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -59.2 -23.77 62.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.432 ' N ' ' CD1' ' A' 1216 ' ' TRP . 12.3 mm-40 -57.63 -45.28 85.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.65 -42.92 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.599 HD11 HD11 ' A' 1160 ' ' LEU . 87.8 mt -61.78 -26.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -68.26 -35.95 78.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -82.04 -49.3 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.42 ' HB3' ' NH2' ' A' 1191 ' ' ARG . 30.0 t80 -40.31 -42.49 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.6 p -77.54 -37.22 51.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -61.35 -43.84 98.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 7.1 t -75.43 -37.97 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.51 ' O ' HG23 ' A' 1228 ' ' VAL . 12.5 m120 -93.44 16.08 14.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' 1226 ' ' ASN . 22.6 t 34.9 51.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' 1226 ' ' ASN . 45.7 t -105.92 157.55 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1229 ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' 1228 ' ' VAL . 4.0 pm0 -81.11 152.49 27.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 67.9 p -145.78 -179.66 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.47 45.83 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.28 50.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -90.13 -59.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 1.3 t -75.62 115.93 15.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 33.0 p -48.7 -31.32 6.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.832 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 58.6 p -52.07 117.3 2.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' 1238 ' ' PRO . 0.8 OUTLIER -61.32 -58.55 18.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.613 0.72 . . . . 0.0 110.941 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1238 ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' 1237 ' ' LYS . 53.8 Cg_endo -69.74 134.73 28.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.65 2.233 . . . . 0.0 112.349 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -80.98 86.98 6.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 39.9 t -94.63 147.31 23.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 64.63 85.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 104.2 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 17.4 m -132.44 90.58 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 1.9 m -163.42 133.92 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.506 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 92.1 p -118.42 -44.08 2.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 53.2 m 38.01 42.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -44.38 156.24 0.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.492 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 2.7 m -130.51 157.59 42.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.371 . . . . 0.0 110.851 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 46.8 t -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.868 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 135.79 -122.85 2.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 17.2 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.823 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1141 ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' 1142 ' ' GLN . 52.3 p -168.43 115.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.852 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1142 ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' 1141 ' ' SER . 6.2 mm100 -32.5 96.0 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1143 ' ' PRO . . . . . 0.44 ' N ' ' O ' ' A' 1141 ' ' SER . 54.0 Cg_endo -69.77 163.62 37.59 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 93.6 t -76.6 150.99 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.11 143.96 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.163 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 4.9 m -51.59 130.31 27.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -41.87 -48.17 4.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 67.3 mt-30 -34.49 -51.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -96.17 -51.02 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -38.47 -63.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.627 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.9 tp10 -42.35 -62.86 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.3 m -40.14 -50.24 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.24 -39.39 82.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' 1151 ' ' GLU . 75.3 mt -60.64 -57.71 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.5 t -57.59 -43.21 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.647 HD13 ' CG ' ' A' 1222 ' ' PHE . 23.6 tp -63.84 -62.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' 1161 ' ' VAL . 65.9 t80 -35.84 -45.44 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.54 90.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 23.1 mttm -56.91 -44.18 82.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.601 HD21 HG13 ' A' 1219 ' ' ILE . 34.3 mt -62.92 -43.79 97.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' 1157 ' ' TYR . 84.4 t -56.54 -46.13 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -53.75 -39.1 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.8 -49.19 63.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.631 ' HG3' HD23 ' A' 1178 ' ' LEU . 18.7 ttp180 -53.68 -44.31 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.72 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' 1167 ' ' HIS . 0.5 OUTLIER -53.5 -41.96 66.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.467 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.8 OUTLIER -62.38 -45.05 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.61 -59.12 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -55.82 -45.53 78.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -43.78 -54.69 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.523 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 38.8 mtm -84.77 -1.92 56.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.68 29.52 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.7 m -111.62 141.24 24.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.98 138.54 21.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.236 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.96 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.302 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.14 -47.88 6.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.5 mm -48.01 -39.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.631 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.2 tp -58.78 -67.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -149.35 147.6 28.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.088 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 57.8 p -89.43 169.75 11.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' 1185 ' ' VAL . 6.7 m-80 -65.45 -33.84 76.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -62.45 -50.17 72.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 90.5 mt -55.75 -46.49 79.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.433 HD11 ' HD3' ' A' 1164 ' ' ARG . 83.5 mt -59.95 -53.29 59.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -48.41 -47.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.609 ' CB ' HG23 ' A' 1201 ' ' ILE . 67.7 m-20 -59.24 -45.56 90.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 89.4 mtp -58.1 -40.79 82.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.23 75.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -77.26 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 13.8 mtt -65.0 -41.2 95.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' A' 1192 ' ' PRO . 33.8 mtt-85 68.18 54.39 0.63 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.8 134.5 28.04 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.661 2.241 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.1 p -102.11 -33.17 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 60.8 p -101.82 149.92 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 12.5 p -57.23 -33.6 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.05 -47.43 68.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.463 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 85.9 m-20 -66.5 -46.37 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.504 HG21 ' CE3' ' A' 1216 ' ' TRP . 99.1 t -50.74 -54.5 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.191 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -46.5 -36.29 6.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.19 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.609 HG23 ' CB ' ' A' 1186 ' ' ASP . 37.9 mm -43.21 148.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.56 139.69 43.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 97.46 -49.14 1.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.514 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' 1201 ' ' ILE . 6.3 p -66.13 131.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 7.7 t -95.77 173.74 7.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.31 143.39 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.83 -54.02 4.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' 1204 ' ' VAL . 28.5 ttmt -41.67 -53.78 3.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.2 -50.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.74 -66.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.13 -25.14 1.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 69.8 mt -89.44 32.26 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -69.12 -53.3 14.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 111.105 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.0 Cg_exo -47.9 -18.16 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.392 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.04 -69.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.1 p90 -57.36 -26.32 60.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.5 mt-10 -56.5 -37.28 70.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.2 t -71.13 -41.82 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.601 HG13 HD21 ' A' 1160 ' ' LEU . 89.3 mt -53.83 -53.45 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.102 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -45.12 -45.1 11.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -72.62 -46.58 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.647 ' CG ' HD13 ' A' 1156 ' ' LEU . 49.9 t80 -50.17 -59.59 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' 1227 ' ' SER . 25.7 p -54.89 -47.91 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -42.0 -69.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -62.01 -40.54 96.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.479 ' O ' HG23 ' A' 1228 ' ' VAL . 33.1 m120 -80.41 13.54 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' 1223 ' ' CYS . 79.0 p 33.7 51.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' 1226 ' ' ASN . 84.7 t -102.76 143.33 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.78 160.42 30.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 59.1 p -148.02 -179.23 6.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 39.8 t0 65.67 40.06 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.38 44.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' 1190 ' ' MET . 6.6 m-85 -96.05 178.74 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 17.2 m -106.52 80.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.831 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 6.4 m -118.23 176.3 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1236 ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' 1237 ' ' LYS . 1.4 t -125.14 106.95 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' 1238 ' ' PRO . 0.0 OUTLIER 35.38 54.7 2.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.929 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1238 ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' 1237 ' ' LYS . 54.0 Cg_endo -69.74 117.45 5.09 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -96.63 86.87 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 4.7 m -75.41 138.52 41.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -123.73 146.27 16.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1242 ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' 1243 ' ' SER . 53.1 Cg_endo -69.81 2.65 3.37 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1243 ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' 1242 ' ' PRO . 94.2 p -35.22 130.06 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 2.7 m -67.87 136.96 54.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.458 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 46.6 m -55.39 170.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.889 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 11.0 t -132.61 147.3 52.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -64.31 -148.14 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 97.5 p -76.94 120.68 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.366 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 39.7 m -102.62 163.64 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -65.92 -159.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 25.6 p -55.52 -53.49 55.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.859 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 44.0 m 52.81 42.51 31.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1142 ' ' GLN . . . . . 0.449 ' NE2' ' HD2' ' A' 1143 ' ' PRO . 56.5 tp60 -72.39 118.95 72.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.942 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1143 ' ' PRO . . . . . 0.449 ' HD2' ' NE2' ' A' 1142 ' ' GLN . 53.8 Cg_endo -69.74 -176.15 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.679 2.253 . . . . 0.0 112.374 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 35.3 m -81.96 168.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' 1150 ' ' GLN . 76.4 mt -84.82 128.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' 1147 ' ' ALA . 75.6 p -62.6 132.41 52.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -36.79 -49.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 27.1 mt-30 -36.64 -50.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -94.37 -51.91 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.503 ' HB2' HG22 ' A' 1145 ' ' ILE . 19.9 tt0 -45.27 -56.06 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.663 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.5 tt0 -51.56 -58.4 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1152 ' ' THR . . . . . 0.481 HG22 ' NH1' ' A' 1191 ' ' ARG . 96.8 m -44.82 -41.78 7.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1153 ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 37.3 mt-30 -67.24 -37.22 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' 1151 ' ' GLU . 63.1 mt -62.96 -57.24 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 75.2 t -57.28 -45.1 84.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' 1157 ' ' TYR . 22.8 tp -62.16 -62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 54.4 t80 -36.58 -56.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -48.97 -43.79 31.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.472 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' 1222 ' ' PHE . 5.8 mtmp? -66.08 -40.25 90.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.927 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.2 t -56.3 -42.05 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -54.29 -53.78 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.26 96.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.728 ' HE ' HD11 ' A' 1184 ' ' LEU . 7.1 tmm_? -57.82 -26.41 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.802 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.24 -72.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' 1167 ' ' HIS . 2.3 pttm -40.7 -29.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.3 t60 -78.13 -45.53 23.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.458 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -47.63 -53.1 15.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -58.49 -40.24 82.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -48.63 -56.87 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' 1178 ' ' LEU . 69.5 mtm -80.35 4.64 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 49.7 m-20 58.51 36.29 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.1 m -114.95 141.59 27.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.677 0.751 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 133.58 23.06 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.383 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -47.95 -18.47 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.39 -40.44 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 25.1 mm -58.23 -47.73 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' 1171 ' ' MET . 14.4 tp -53.14 -63.86 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -153.13 120.3 5.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 6.4 t -75.9 146.04 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' 1185 ' ' VAL . 15.2 m120 -41.76 -44.57 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -46.06 -53.01 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.43 -56.49 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.728 HD11 ' HE ' ' A' 1164 ' ' ARG . 66.1 mt -51.26 -52.26 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' 1181 ' ' ASN . 89.6 t -44.68 -49.29 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.32 -44.48 91.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1187 ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' 1192 ' ' PRO . 74.7 mtp -55.72 -41.52 73.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.21 -30.82 69.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.423 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 6.3 mtpm? -77.25 -58.35 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.578 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 24.7 mtt -68.71 -40.86 79.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' 1152 ' ' THR . 35.1 mtt-85 68.74 55.08 0.58 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.81 137.31 35.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 0.0 112.334 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1193 ' ' THR . . . . . 0.434 HG23 ' HB ' ' A' 1230 ' ' THR . 50.7 p -105.59 -29.3 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 66.0 p -107.92 148.92 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.565 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.8 p -58.97 -39.7 78.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1196 ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' 1195 ' ' VAL . 7.4 mm-40 -47.33 -29.54 2.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.514 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 57.6 m-20 -90.94 -39.16 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.772 HG21 ' CE3' ' A' 1216 ' ' TRP . 74.4 t -55.79 -49.02 77.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -56.31 -30.53 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.34 -24.22 62.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 35.3 mm -52.43 146.76 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -68.96 138.24 54.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.11 -51.95 1.02 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.645 HG23 ' HE2' ' A' 1208 ' ' LYS . 9.7 p -70.86 144.26 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 5.8 t -100.04 157.85 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -51.4 140.38 17.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 81.51 -55.49 4.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.645 ' HE2' HG23 ' A' 1204 ' ' VAL . 25.3 ttpt -39.61 -56.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.75 -43.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.36 -62.44 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 7.6 ptt? -55.88 -23.42 31.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 96.1 mt -89.85 34.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.654 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.79 -48.64 29.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.0 -17.15 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1215 ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' 1215 ' ' LEU . 6.4 mp -82.22 -66.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.772 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -61.48 -25.44 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.466 ' N ' ' CD1' ' A' 1216 ' ' TRP . 20.3 mt-10 -57.68 -36.5 72.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 99.0 t -68.8 -39.02 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.05 -53.04 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -46.21 -42.58 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -76.74 -45.39 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.418 ' HB2' ' NZ ' ' A' 1159 ' ' LYS . 17.0 t80 -52.99 -39.84 63.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -79.9 -29.0 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.69 -38.24 90.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.411 HG23 ' OD1' ' A' 1226 ' ' ASN . 4.5 t -87.07 -16.58 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' 1227 ' ' SER . 8.8 m120 -119.65 18.48 12.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' 1223 ' ' CYS . 14.8 m 34.23 46.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' 1223 ' ' CYS . 85.4 t -84.83 152.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1229 ' ' GLN . . . . . 0.492 ' HB3' HD21 ' A' 1232 ' ' LEU . 0.8 OUTLIER -74.12 140.58 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.935 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1230 ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' 1193 ' ' THR . 21.5 p -129.1 176.57 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 43.52 47.23 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1232 ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' 1229 ' ' GLN . 26.8 mt -86.83 40.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.578 ' CE2' ' SD ' ' A' 1190 ' ' MET . 14.1 m-85 -75.0 -55.83 5.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 69.2 p -104.19 103.28 13.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 56.5 m -42.42 -45.04 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.869 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 15.2 t -74.34 149.73 40.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.8 142.46 31.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.559 0.695 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 141.75 45.94 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -73.63 107.81 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 3.1 t -72.38 124.34 24.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -121.63 -160.78 11.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 106.51 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.335 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 44.0 p -174.18 171.91 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 88.9 p -110.75 -43.5 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.521 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 58.9 p -129.1 42.5 3.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 2.6 m -93.62 160.41 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -125.21 -135.09 4.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 6.3 t -119.5 80.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.885 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 60.3 p -168.32 154.83 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 150.36 -118.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 48.1 m 58.02 42.57 22.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 1.4 t -127.77 70.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.3 160.63 30.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.511 0.672 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 175.5 8.01 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.676 2.251 . . . . 0.0 112.368 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 99.8 t -42.77 149.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.57 HD12 ' OE1' ' A' 1150 ' ' GLN . 51.1 mt -91.76 143.36 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 8.3 t -58.58 131.05 49.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -41.06 -44.14 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' 1147 ' ' ALA . 87.2 mt-30 -37.63 -51.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.76 -48.96 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.57 ' OE1' HD12 ' A' 1145 ' ' ILE . 17.5 tp60 -44.36 -51.74 8.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' 1154 ' ' ILE . 4.1 tt0 -52.29 -57.94 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 78.0 m -44.17 -43.49 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -65.73 -37.16 85.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.1 mt -64.93 -43.16 96.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.8 t -70.82 -41.04 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' 1222 ' ' PHE . 21.6 tp -69.33 -55.81 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.602 ' O ' HG23 ' A' 1161 ' ' VAL . 43.2 t80 -37.44 -43.62 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.98 -47.53 88.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 46.3 mttm -56.61 -41.76 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.751 HD21 HD11 ' A' 1219 ' ' ILE . 28.2 mt -63.88 -42.8 97.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' 1157 ' ' TYR . 94.0 t -59.64 -42.15 87.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.35 -39.22 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.53 72.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.952 ' HG3' HD23 ' A' 1178 ' ' LEU . 43.3 ttm-85 -79.76 -43.12 23.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.34 -34.96 62.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.2 pttp -84.31 -38.34 20.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' 1170 ' ' LYS . 0.6 OUTLIER -63.97 -56.76 12.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -37.27 -53.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.68 -37.8 85.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1170 ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' 1167 ' ' HIS . 18.4 ttmt -55.95 -51.75 66.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1171 ' ' MET . . . . . . . . . . . . . 15.7 mtm -80.07 -1.4 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 68.19 30.09 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.618 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.2 m -119.66 134.53 23.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.99 141.86 16.41 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.97 -16.64 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.75 -47.01 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 12.7 mm -51.43 -42.76 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.952 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.4 tp -56.83 -57.34 12.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' 1164 ' ' ARG . . . -160.38 156.07 25.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 26.1 p -94.48 161.12 14.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.113 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' 1185 ' ' VAL . 79.1 m-20 -54.85 -28.64 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 26.7 tptt -62.62 -51.78 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 -40.06 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.855 HD21 ' HE ' ' A' 1164 ' ' ARG . 63.2 mt -60.76 -54.46 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' 1181 ' ' ASN . 79.9 t -49.31 -36.69 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.2 m-20 -60.65 -62.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 95.0 mtp -55.51 -20.55 13.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -75.12 -21.68 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 21.4 mttm -102.82 -51.97 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.45 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.1 OUTLIER -74.45 -20.91 59.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.633 HH21 HD11 ' A' 1232 ' ' LEU . 13.0 ptt180 33.65 55.05 1.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.78 149.48 66.81 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.391 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 61.6 p -127.35 24.11 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 120.97 14.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' 1216 ' ' TRP . 11.3 p -40.31 -39.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1196 ' ' GLU . . . . . 0.417 ' N ' HG13 ' A' 1195 ' ' VAL . 17.5 mt-10 -56.69 -66.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -48.25 -41.96 29.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.525 HG21 ' CE3' ' A' 1216 ' ' TRP . 94.9 t -50.17 -47.95 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.2 mttp -50.07 -30.92 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -70.98 -29.59 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' 1186 ' ' ASP . 26.0 mm -53.53 101.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1202 ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' 1201 ' ' ILE . 12.3 t70 -35.3 145.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 96.01 -41.05 2.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' 1201 ' ' ILE . 9.3 p -78.22 138.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 111.068 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 4.0 m -99.98 140.79 33.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -40.22 138.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.88 -58.82 5.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' 1209 ' ' ALA . 38.7 tttt -40.38 -55.71 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.638 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -33.93 -39.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.3 -65.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.1 ptt? -49.31 -25.51 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.1 mt -88.94 26.76 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.68 -52.36 26.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.565 0.698 . . . . 0.0 111.05 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -48.01 -16.94 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.678 2.252 . . . . 0.0 112.321 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1215 ' ' LEU . . . . . 0.565 ' CD2' ' NH2' ' A' 1164 ' ' ARG . 7.3 mp -82.24 -71.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -52.83 -15.8 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.26 -38.86 88.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -66.4 -50.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.751 HD11 HD21 ' A' 1160 ' ' LEU . 82.1 mt -46.49 -40.95 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -55.06 -40.39 70.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -76.84 -42.94 38.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.691 ' CD2' HD13 ' A' 1156 ' ' LEU . 17.9 t80 -53.95 -61.38 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' 1227 ' ' SER . 22.8 p -53.87 -45.67 71.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.874 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -43.4 -68.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -63.87 -39.45 94.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.454 ' O ' ' C ' ' A' 1227 ' ' SER . 2.6 m-80 -81.22 13.13 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' 1223 ' ' CYS . 72.2 m 33.84 50.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.539 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 84.2 t -97.5 149.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.93 154.77 40.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 20.5 p -145.56 158.77 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 43.4 t0 64.77 42.56 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1232 ' ' LEU . . . . . 0.633 HD11 HH21 ' A' 1191 ' ' ARG . 26.0 mt -83.97 41.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -93.72 136.54 33.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 30.2 t -108.6 95.49 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 47.4 p -143.64 167.2 22.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 28.3 m -103.97 95.77 6.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.445 ' CG ' ' HD2' ' A' 1238 ' ' PRO . 22.2 tttp -145.53 142.54 18.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1238 ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' 1237 ' ' LYS . 53.5 Cg_endo -69.77 133.12 24.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.652 2.235 . . . . 0.0 112.358 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1239 ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' 1240 ' ' SER . 51.1 tt0 -44.36 -45.09 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1240 ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' 1239 ' ' GLN . 99.5 p -37.23 134.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -140.92 -178.99 17.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -176.29 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 39.9 p -56.56 -52.47 64.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.821 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 11.5 m -54.34 117.84 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 12.2 m -123.29 135.06 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 45.5 p -162.03 143.04 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -137.82 112.29 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 83.0 p -69.2 93.79 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 101.71 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1139 ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' 1140 ' ' SER . . . 134.07 -129.79 5.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1140 ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' 1139 ' ' GLY . 47.6 p 36.47 47.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 58.3 p -78.67 159.86 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.72 146.32 40.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 179.57 3.6 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 84.1 t -41.6 147.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.166 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 47.2 mt -92.65 137.68 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 73.1 m -53.07 132.79 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -45.18 -48.55 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 54.8 mt-30 -34.75 -52.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.57 -53.47 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -42.76 -59.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -42.75 -57.14 2.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1152 ' ' THR . . . . . 0.493 HG22 ' HE ' ' A' 1191 ' ' ARG . 90.9 m -46.71 -50.5 17.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.14 -40.86 95.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.73 -58.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 73.6 t -54.75 -39.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' 1222 ' ' PHE . 12.8 tp -66.32 -57.75 6.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' 1161 ' ' VAL . 75.1 t80 -38.34 -46.69 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.12 -46.23 91.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' 1162 ' ' GLU . 21.1 mttm -59.45 -33.22 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 25.2 mt -75.06 -52.67 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' 1157 ' ' TYR . 95.7 t -40.16 -62.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1162 ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' 1159 ' ' LYS . 4.6 pt-20 -40.47 -56.39 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.68 94.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.673 ' HG3' HD21 ' A' 1184 ' ' LEU . 7.2 tmm_? -59.15 -28.57 66.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1165 ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' 1168 ' ' ALA . 31.8 tt0 -82.0 -71.6 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 8.9 pttp -43.39 -29.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.525 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.9 t60 -78.02 -37.51 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.773 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.66 -61.71 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -55.7 -35.28 65.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 9.9 tttp -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.614 ' HE2' HD11 ' A' 1178 ' ' LEU . 27.3 mtm -76.41 6.27 5.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.36 29.15 18.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.3 m -114.57 139.75 24.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.94 140.23 18.78 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -48.05 -16.68 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.63 -52.34 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 32.9 mm -47.67 -46.7 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.773 HD22 ' CA ' ' A' 1168 ' ' ALA . 16.9 tp -49.46 -65.97 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -148.28 118.46 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1180 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.5 t -72.91 139.1 46.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' 1180 ' ' THR . 31.9 m120 -35.77 -46.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.9 tptm -43.34 -58.16 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.39 -59.16 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.673 HD21 ' HG3' ' A' 1164 ' ' ARG . 33.6 mt -47.38 -44.73 24.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 55.4 t -56.5 -55.03 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.486 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -58.89 -42.03 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.2 mtp -58.37 -35.69 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.1 74.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.436 ' CE ' ' HA ' ' A' 1186 ' ' ASP . 49.5 mtmt -76.75 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 13.9 mtt -67.07 -39.27 86.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.493 ' HE ' HG22 ' A' 1152 ' ' THR . 36.1 mtt85 64.31 53.4 1.33 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.639 0.733 . . . . 0.0 110.935 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.71 126.9 13.89 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 34.0 p -96.27 -32.08 12.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.45 ' O ' HG23 ' A' 1198 ' ' VAL . 73.3 p -101.24 147.58 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.572 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -57.52 -36.53 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.158 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -48.38 -52.02 23.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 66.4 m-20 -68.19 -45.96 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' 1194 ' ' THR . 99.5 t -48.4 -52.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1199 ' ' LYS . . . . . 0.492 ' HD2' HG22 ' A' 1195 ' ' VAL . 4.8 mtpm? -49.53 -33.88 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -68.39 -27.97 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.795 ' O ' HG12 ' A' 1204 ' ' VAL . 30.7 mm -51.21 139.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 30.4 t0 -65.66 141.05 58.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.85 -48.45 1.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' 1201 ' ' ILE . 9.0 p -65.7 137.44 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 3.0 m -100.0 142.78 31.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -39.06 130.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.96 -63.64 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' 1207 ' ' GLY . 18.1 ttmt -34.36 -48.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.34 -49.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.94 -63.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.2 ptt? -53.0 -22.63 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' 1209 ' ' ALA . 84.1 mt -90.7 32.68 0.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.3 -52.32 12.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 111.132 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -47.99 -17.36 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.44 -67.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.572 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.1 p90 -58.74 -26.98 64.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' 1216 ' ' TRP . 10.1 mt-10 -54.89 -35.81 64.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 74.7 t -71.14 -35.77 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.5 mt -62.6 -46.93 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -47.36 -39.21 14.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.507 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.7 t-80 -80.64 -52.78 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.588 ' CG ' HD13 ' A' 1156 ' ' LEU . 47.2 t80 -38.95 -33.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' 1227 ' ' SER . 21.8 p -92.98 -28.64 16.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' 1221 ' ' HIS . 0.3 OUTLIER -66.52 -46.6 75.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.502 HG23 ' OD1' ' A' 1226 ' ' ASN . 9.0 t -76.7 -11.98 59.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.502 ' OD1' HG23 ' A' 1225 ' ' THR . 9.6 m120 -123.11 15.24 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' 1223 ' ' CYS . 58.7 p 36.2 49.29 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 89.1 t -93.03 142.17 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -69.56 148.0 50.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 72.6 p -137.48 -177.81 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 7.0 m-20 62.65 43.41 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1232 ' ' LEU . . . . . 0.435 HD11 HH12 ' A' 1191 ' ' ARG . 11.9 mt -84.14 41.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' 1190 ' ' MET . 9.6 m-85 -80.53 158.29 25.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 53.9 p -89.53 41.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 3.4 t -154.42 158.25 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 40.4 p -118.76 107.05 13.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -135.97 133.21 19.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.53 0.681 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -178.8 2.52 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 2.23 . . . . 0.0 112.327 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -114.43 134.25 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 4.2 m -156.67 126.62 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -121.64 83.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.62 30.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.273 . . . . 0.0 112.334 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 12.9 t -78.71 92.23 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 89.7 p -66.57 174.4 2.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.821 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 51.9 p -142.05 129.0 20.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.882 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 1.4 t -154.5 130.32 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.829 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -155.51 -144.25 3.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 70.3 m -80.46 44.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 50.6 m -122.87 171.04 9.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1139 ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' 1140 ' ' SER . . . -163.73 148.27 14.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1140 ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' 1139 ' ' GLY . 2.1 m -35.8 132.54 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.879 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 29.0 t -81.73 -59.49 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1142 ' ' GLN . . . . . 0.463 ' CG ' ' HD2' ' A' 1143 ' ' PRO . 40.2 tt0 -169.6 140.19 1.78 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1143 ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' 1142 ' ' GLN . 54.1 Cg_endo -69.71 162.0 43.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.29 . . . . 0.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1144 ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' 1143 ' ' PRO . 12.1 p -36.19 143.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.496 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 17.2 mt -81.64 154.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' 1148 ' ' GLN . 25.7 m -98.95 129.95 45.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' 1146 ' ' SER . . . -33.54 -35.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' 1146 ' ' SER . 28.0 mt-30 -46.04 -52.45 11.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1149 ' ' GLU . . . . . 0.496 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 7.8 pt-20 -99.7 -42.38 6.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -41.89 -57.03 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.7 tt0 -46.76 -56.19 6.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.0 m -50.21 -49.59 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.34 -33.93 71.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.0 mt -64.58 -56.7 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.4 t -59.37 -43.1 89.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' 1222 ' ' PHE . 23.1 tp -59.87 -60.41 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' 1156 ' ' LEU . 58.9 t80 -35.96 -47.97 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.06 -46.16 61.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 51.2 mttt -58.22 -42.37 86.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.704 HD21 HD11 ' A' 1219 ' ' ILE . 39.6 mt -62.74 -42.27 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.2 t -61.07 -44.11 97.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.94 -46.96 85.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.3 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.44 -41.62 76.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.46 -61.49 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 17.2 ptpt -52.27 -46.18 65.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.9 OUTLIER -61.23 -46.43 90.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.84 -51.79 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -61.9 -44.49 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 61.6 tttt -46.34 -56.99 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.493 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.0 mtm -79.68 0.91 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.94 42.62 19.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.6 m -125.14 141.78 39.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.61 0.719 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 135.98 23.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.228 . . . . 0.0 112.349 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.92 -17.45 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.23 -41.2 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.8 mm -54.37 -40.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.493 ' CD1' ' HE3' ' A' 1171 ' ' MET . 10.9 tp -60.13 -62.36 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.29 150.21 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 71.4 p -87.34 167.61 13.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.39 -38.53 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -50.32 73.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 69.9 mt -51.06 -46.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 61.3 mt -56.25 -50.59 70.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.8 t -49.45 -53.61 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.442 ' CB ' HG23 ' A' 1201 ' ' ILE . 9.3 m-20 -54.89 -51.04 67.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.9 mtp -53.69 -40.04 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.44 72.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 31.7 mttm -79.2 -63.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 19.4 mtt -61.29 -40.91 95.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.437 ' NH2' HD11 ' A' 1232 ' ' LEU . 39.2 mtm-85 66.08 55.04 0.99 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.708 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 141.84 46.34 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 57.0 p -110.34 -33.34 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.163 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 25.3 p -100.59 144.18 29.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.711 HG23 ' CZ3' ' A' 1216 ' ' TRP . 8.8 p -56.53 -23.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.49 -46.12 84.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -68.75 -37.75 79.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.521 HG21 ' CE3' ' A' 1216 ' ' TRP . 81.7 t -52.87 -45.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 25.3 mttp -52.18 -36.52 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -65.56 -24.37 67.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.698 ' O ' HG12 ' A' 1204 ' ' VAL . 37.6 mm -54.6 148.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.14 134.76 41.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.16 -44.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.506 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' 1201 ' ' ILE . 9.9 p -59.13 131.84 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.093 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1205 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1206 ' ' GLU . 48.9 m -99.97 137.89 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1206 ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' 1205 ' ' SER . 6.4 tp10 -36.41 127.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 92.51 -60.03 2.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' 1207 ' ' GLY . 0.9 OUTLIER -37.64 -49.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.77 -47.72 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.58 -63.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1211 ' ' MET . . . . . 0.466 ' HE3' HD12 ' A' 1178 ' ' LEU . 4.4 ptt? -50.82 -25.05 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' 1215 ' ' LEU . 70.2 mt -88.25 30.9 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.857 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.11 -55.74 19.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 111.096 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -47.96 -18.15 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.338 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1215 ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' 1212 ' ' LEU . 7.9 mp -79.22 -67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.711 ' CZ3' HG23 ' A' 1195 ' ' VAL . 1.2 p90 -59.19 -26.09 64.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' 1216 ' ' TRP . 14.1 mt-10 -60.08 -37.48 80.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.9 t -70.93 -43.6 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.704 HD11 HD21 ' A' 1160 ' ' LEU . 86.4 mt -56.31 -42.55 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.58 -45.8 63.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.476 ' O ' ' N ' ' A' 1224 ' ' GLN . 4.8 t-80 -74.91 -56.65 4.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' 1156 ' ' LEU . 73.3 t80 -34.09 -36.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' 1227 ' ' SER . 78.6 m -90.91 -37.44 13.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' 1225 ' ' THR . 2.9 pt20 -55.45 -49.34 72.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.524 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.7 t -68.36 -37.76 80.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.438 ' ND2' HG23 ' A' 1225 ' ' THR . 25.5 m-80 -86.71 -0.76 56.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' 1223 ' ' CYS . 38.8 t 56.08 36.48 27.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' 1229 ' ' GLN . 94.1 t -92.04 153.56 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1229 ' ' GLN . . . . . 0.423 ' N ' HG12 ' A' 1228 ' ' VAL . 6.3 tp60 -71.9 146.51 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 24.8 p -137.52 -179.01 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 2.2 p30 44.6 48.82 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1232 ' ' LEU . . . . . 0.437 HD11 ' NH2' ' A' 1191 ' ' ARG . 14.9 mt -77.18 48.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' 1190 ' ' MET . 16.4 m-85 -94.95 173.87 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 89.1 p -94.77 44.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 91.0 p -111.88 147.49 35.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 39.4 p -116.72 39.44 3.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.18 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' 1238 ' ' PRO . 11.8 ttmm -109.85 92.08 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 110.889 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1238 ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' 1239 ' ' GLN . 54.6 Cg_endo -69.72 -2.38 10.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1239 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' 1238 ' ' PRO . 10.6 tt0 -35.77 125.55 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 1.3 t -149.23 156.94 42.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 176.62 -163.86 33.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 173.66 10.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 31.5 p -124.72 170.46 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 51.1 p -104.43 169.98 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.494 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 21.5 m -97.31 144.75 26.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 13.9 t -120.67 -57.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 130.0 166.53 11.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.475 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 19.7 m -121.55 -52.91 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 38.7 m -112.16 90.1 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -129.69 -85.39 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 37.1 p -67.44 -59.9 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.381 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 79.6 p -116.56 108.25 15.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -110.58 88.1 7.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 143.83 51.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.71 2.274 . . . . 0.0 112.349 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 13.6 p -47.28 153.77 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' 1150 ' ' GLN . 67.5 mt -87.85 137.93 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' 1147 ' ' ALA . 20.8 m -65.34 126.84 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -35.89 -52.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.3 pt20 -33.07 -50.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -97.47 -51.53 4.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.426 ' HB2' HG22 ' A' 1145 ' ' ILE . 20.2 tt0 -43.12 -53.93 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.02 -60.35 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.0 m -42.46 -46.7 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.132 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -65.68 -39.33 91.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 80.9 mt -64.32 -52.13 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1155 ' ' VAL . . . . . 0.67 HG12 ' HZ1' ' A' 1159 ' ' LYS . 92.8 t -61.6 -39.14 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.127 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.937 HD13 ' CD2' ' A' 1222 ' ' PHE . 32.3 tp -69.02 -55.95 9.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' 1161 ' ' VAL . 74.4 t80 -36.62 -46.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -56.79 -50.15 65.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.67 ' HZ1' HG12 ' A' 1155 ' ' VAL . 40.2 mttp -52.82 -44.08 66.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.776 HD21 HD11 ' A' 1219 ' ' ILE . 29.0 mt -61.75 -52.23 65.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.95 HG22 HD13 ' A' 1184 ' ' LEU . 61.7 t -54.04 -42.76 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.69 -47.99 78.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.12 72.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' 1178 ' ' LEU . 10.0 ttp180 -50.25 -39.75 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -64.83 -68.01 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' 1167 ' ' HIS . 15.8 pttp -48.8 -41.44 32.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.473 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.1 t60 -66.35 -45.86 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -42.79 -62.75 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -50.73 -38.24 46.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -51.21 -56.7 11.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1171 ' ' MET . . . . . . . . . . . . . 44.8 mtm -82.13 7.15 14.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.8 t70 57.73 36.1 26.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.492 ' O ' ' HB1' ' A' 1168 ' ' ALA . 26.9 m -118.08 138.43 25.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1174 ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' 1175 ' ' PRO . 64.8 Cg_exo -47.96 136.61 23.08 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1175 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1174 ' ' PRO . 66.4 Cg_exo -48.05 -16.85 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.718 2.279 . . . . 0.0 112.288 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.01 -42.87 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.12 -46.78 77.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.4 tp -52.73 -66.04 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -143.61 127.23 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.7 t -83.95 165.46 18.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' 1185 ' ' VAL . 2.6 p30 -53.06 -45.0 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -49.49 -48.13 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -56.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.95 HD13 HG22 ' A' 1161 ' ' VAL . 77.5 mt -47.59 -54.34 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' 1181 ' ' ASN . 78.4 t -47.18 -47.69 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.151 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.69 -55.08 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 37.2 mtp -51.65 -16.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -87.15 -51.13 6.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' A' 1201 ' ' ILE . 0.0 OUTLIER -83.28 -18.13 40.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' 1190 ' ' MET . 15.5 ptt180 33.37 54.95 1.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.671 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.3 Cg_endo -69.79 151.57 68.91 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.69 2.26 . . . . 0.0 112.309 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.6 p -130.83 27.62 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.506 ' O ' HG23 ' A' 1198 ' ' VAL . 29.2 p -140.05 125.08 18.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' 1196 ' ' GLU . 11.5 p -42.14 -42.2 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1196 ' ' GLU . . . . . 0.448 ' N ' HG13 ' A' 1195 ' ' VAL . 16.1 mt-10 -57.75 -60.89 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.28 -40.49 61.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.736 HG21 ' CE3' ' A' 1216 ' ' TRP . 92.8 t -50.36 -38.98 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 21.8 mttm -59.61 -25.73 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1200 ' ' ARG . . . . . 0.561 ' HB2' ' CE2' ' A' 1233 ' ' PHE . 41.5 mtp85 -72.18 -26.49 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' 1192 ' ' PRO . 40.4 mm -51.63 142.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.89 135.13 43.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.05 -50.71 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.3 p -67.61 132.23 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 23.8 p -99.74 157.19 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -49.58 149.57 2.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.73 -54.08 4.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' 1209 ' ' ALA . 2.7 ttmp? -53.09 -49.03 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.04 -46.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -44.79 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -48.64 -23.82 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.02 34.85 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.661 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.54 -49.09 16.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.8 Cg_exo -47.99 -19.22 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1215 ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' 1215 ' ' LEU . 7.0 mp -79.89 -64.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.736 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.7 OUTLIER -64.83 -25.11 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.424 ' N ' ' CD1' ' A' 1216 ' ' TRP . 11.4 mt-10 -56.71 -43.52 80.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 71.9 t -67.06 -48.61 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.776 HD11 HD21 ' A' 1160 ' ' LEU . 68.8 mt -47.05 -37.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -36.72 75.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.636 ' O ' HG22 ' A' 1225 ' ' THR . 2.1 t-80 -79.82 -43.2 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.937 ' CD2' HD13 ' A' 1156 ' ' LEU . 30.0 t80 -55.68 -40.08 71.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.7 p -83.48 -31.71 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -63.46 -40.68 97.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.636 HG22 ' O ' ' A' 1221 ' ' HIS . 5.6 t -80.66 -23.61 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.45 ' O ' ' C ' ' A' 1227 ' ' SER . 6.4 m120 -108.88 22.05 16.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1226 ' ' ASN . 6.8 t 34.38 42.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' 1226 ' ' ASN . 95.1 t -89.6 144.18 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -70.64 162.49 28.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 76.7 p -151.66 -178.56 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.5 50.26 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.13 40.88 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' 1233 ' ' PHE . 0.1 OUTLIER -174.97 109.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 58.7 m -155.03 147.49 24.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 31.0 t -94.68 83.48 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 46.6 m -92.45 136.06 33.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.87 150.52 50.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 126.3 13.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -140.69 148.14 40.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 50.6 m -68.2 118.57 11.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 79.47 70.97 1.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 1.24 4.63 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 5.2 t -100.31 162.64 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 33.6 p -56.26 -57.59 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 87.8 p -106.87 153.41 22.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 11.2 m -160.49 123.05 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -168.19 -58.11 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 31.1 p -108.04 42.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 0.0 110.863 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 47.0 t -113.78 98.85 7.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -92.68 93.83 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.421 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 1.5 t -167.35 145.03 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.342 . . . . 0.0 110.879 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 2.3 t -50.59 126.4 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -114.83 143.84 30.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.609 0.719 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -174.54 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 61.2 t -46.75 140.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.83 129.04 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 44.9 m -50.03 136.19 19.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -44.16 -45.72 8.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' 1147 ' ' ALA . 14.6 mt-30 -35.81 -47.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.01 -48.97 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' 1154 ' ' ILE . 11.8 tt0 -50.53 -61.1 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.585 ' HA ' HD12 ' A' 1154 ' ' ILE . 14.3 tt0 -40.01 -58.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.4 m -48.94 -47.17 43.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.159 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -65.5 -32.64 74.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' 1151 ' ' GLU . 77.0 mt -67.36 -54.62 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 60.9 t -60.96 -40.43 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.78 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.5 tp -65.36 -58.41 5.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.58 -57.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -47.42 -46.42 22.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttm -59.27 -42.45 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.671 HD21 HD11 ' A' 1219 ' ' ILE . 23.6 mt -62.4 -46.86 86.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.49 HG22 HD13 ' A' 1184 ' ' LEU . 70.2 t -54.23 -40.81 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.27 -50.95 71.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.68 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.4 ttp180 -52.74 -38.16 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1165 ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' 1166 ' ' LYS . 12.6 tm0? -69.04 -70.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' 1166 ' ' LYS . 0.2 OUTLIER -44.37 -39.32 4.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.501 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 1.6 t60 -70.42 -43.73 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.68 -62.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -52.94 -34.6 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -50.52 -53.45 30.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.594 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 66.2 mtm -83.15 -6.34 59.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.84 28.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 30.9 m -112.95 141.27 25.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.03 139.02 21.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.98 -17.77 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.23 -43.75 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1177 ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' 1177 ' ' ILE . 9.4 mm -51.16 -46.1 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.594 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.4 tp -54.85 -69.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -139.5 135.06 33.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1180 ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' 1181 ' ' ASN . 8.4 t -91.76 139.03 31.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' 1180 ' ' THR . 11.1 m-20 -34.65 -42.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -46.4 -51.23 15.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.1 -48.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' 1164 ' ' ARG . 81.2 mt -51.72 -56.03 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 84.7 t -45.54 -51.6 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.93 -44.51 94.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 48.8 mmm -54.73 -42.5 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.18 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.26 -64.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' 1233 ' ' PHE . 12.2 mtt -68.9 -42.18 77.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.473 ' NH1' HD11 ' A' 1232 ' ' LEU . 34.2 mtt85 70.61 52.7 0.39 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.76 136.27 32.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1193 ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' 1220 ' ' LYS . 17.9 p -123.7 23.16 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.18 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.408 ' O ' HG23 ' A' 1198 ' ' VAL . 12.0 p -139.77 138.14 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.571 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 6.8 p -54.91 -27.2 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.25 -54.05 14.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 34.9 m-20 -59.11 -49.36 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.793 HG21 ' HE3' ' A' 1216 ' ' TRP . 91.3 t -46.43 -37.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -63.68 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1200 ' ' ARG . . . . . 0.466 ' HB2' ' CE2' ' A' 1233 ' ' PHE . 91.8 mtt180 -67.33 -26.96 66.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.617 ' O ' HG12 ' A' 1204 ' ' VAL . 24.7 mm -56.23 145.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.73 145.57 53.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.59 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.466 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.736 HG23 ' HG2' ' A' 1208 ' ' LYS . 4.4 p -62.27 132.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 31.9 m -100.21 136.7 39.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.08 114.16 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 121.83 -70.6 0.4 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.736 ' HG2' HG23 ' A' 1204 ' ' VAL . 0.0 OUTLIER -32.98 -44.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.73 0.3 . . . . 0.0 110.876 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -30.43 -46.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.063 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.77 -62.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.103 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 15.4 ptt? -63.16 -23.3 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' 1209 ' ' ALA . 81.0 mt -85.77 31.47 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.88 -51.24 2.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.541 0.686 . . . . 0.0 111.122 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -48.02 -21.79 3.03 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.64 -67.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.793 ' HE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.05 -24.63 66.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' 1216 ' ' TRP . 6.4 mt-10 -60.31 -36.95 79.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 53.7 t -73.45 -43.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.671 HD11 HD21 ' A' 1160 ' ' LEU . 56.7 mt -55.1 -34.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1220 ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' 1193 ' ' THR . 13.7 ttpt -59.2 -48.12 82.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' 1225 ' ' THR . 13.4 t60 -73.75 -41.25 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' 1156 ' ' LEU . 36.3 t80 -53.25 -41.76 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.1 p -82.33 -34.51 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -64.98 -37.17 86.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.696 HG22 ' O ' ' A' 1221 ' ' HIS . 10.2 t -83.35 -18.8 37.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.452 ' OD1' HG23 ' A' 1225 ' ' THR . 7.0 m120 -116.93 21.2 13.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' 1226 ' ' ASN . 74.4 m 34.32 42.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' 1226 ' ' ASN . 57.6 t -91.02 147.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -73.81 147.55 43.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 38.7 p -143.4 173.8 11.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1231 ' ' ASP . . . . . 0.406 ' OD1' ' ND2' ' A' 1197 ' ' ASN . 4.2 m-20 60.81 51.6 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1232 ' ' LEU . . . . . 0.473 HD11 ' NH1' ' A' 1191 ' ' ARG . 11.3 mt -83.32 37.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' 1233 ' ' PHE . 0.1 OUTLIER -174.99 119.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1234 ' ' SER . . . . . 0.415 ' HA ' ' NH1' ' A' 1200 ' ' ARG . 3.9 t -160.51 110.34 1.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 88.9 p -100.83 121.85 42.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 24.6 m -158.21 120.52 3.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -76.21 138.86 68.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.529 0.681 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 86.57 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.632 2.221 . . . . 0.0 112.354 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -106.46 131.73 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 54.1 m -66.74 -49.04 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -76.41 139.16 23.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -25.72 28.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 9.2 t 52.73 40.4 30.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 10.6 t -95.75 -54.12 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 97.1 p -89.26 135.38 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 110.827 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 5.5 t -95.41 101.68 13.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -172.72 -179.64 43.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 22.5 m -96.51 98.97 10.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 0.0 110.87 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 47.6 p -122.0 137.7 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -143.59 94.4 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 15.9 m -130.94 140.0 50.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.886 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 60.9 m -100.72 136.25 40.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -112.59 150.8 43.24 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.46 25.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 89.6 t -42.54 136.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 48.2 mt -76.66 136.63 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 24.2 p -59.02 135.66 57.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -38.85 -48.12 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 49.5 mt-30 -35.55 -52.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.27 -51.42 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -43.05 -59.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' 1154 ' ' ILE . 9.4 tt0 -43.68 -61.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.6 m -43.37 -42.57 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -72.04 -36.21 69.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' 1151 ' ' GLU . 82.4 mt -64.56 -49.91 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1155 ' ' VAL . . . . . 0.709 HG12 ' HE2' ' A' 1159 ' ' LYS . 48.0 t -66.09 -40.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.8 tp -64.01 -57.15 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 65.6 t80 -40.51 -49.23 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.72 61.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' 1155 ' ' VAL . 33.8 mttm -59.19 -41.27 88.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.96 -52.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.7 t -49.39 -34.05 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.05 -51.42 58.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.2 -59.1 3.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.656 HH21 ' HB2' ' A' 1168 ' ' ALA . 0.0 OUTLIER -46.94 -44.14 19.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1165 ' ' GLN . . . . . 0.428 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 44.3 tt0 -63.35 -72.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' 1167 ' ' HIS . 9.3 ptpt -43.09 -28.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.423 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -60.66 -53.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.656 ' HB2' HH21 ' A' 1164 ' ' ARG . . . -37.14 -53.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -58.14 -46.8 85.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 29.6 tttt -47.99 -51.12 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.793 ' O ' HG13 ' A' 1173 ' ' VAL . 55.8 mtm -92.52 15.29 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 35.7 t70 43.04 40.79 2.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' 1171 ' ' MET . 32.9 m -117.34 141.42 28.64 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.626 0.727 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.9 132.92 22.56 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.356 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1175 ' ' PRO . . . . . 0.409 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 65.2 Cg_exo -48.0 -17.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.682 2.255 . . . . 0.0 112.325 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.81 -45.37 7.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.4 mm -51.2 -43.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.6 ' CD1' ' CE ' ' A' 1171 ' ' MET . 8.4 tp -64.69 -69.79 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.629 ' HB3' ' HD2' ' A' 1164 ' ' ARG . . . -150.66 147.38 27.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 70.2 p -94.06 173.79 7.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' 1185 ' ' VAL . 87.7 m-20 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -61.66 -52.44 64.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1183 ' ' ILE . . . . . 0.586 HG23 HG21 ' A' 1201 ' ' ILE . 92.0 mt -52.59 -51.29 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.0 mt -47.51 -53.98 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -45.19 -45.84 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -55.23 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 62.2 mmm -47.0 -41.23 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.0 95.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -71.26 -60.6 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.583 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 38.1 mtt -63.9 -49.31 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.498 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 24.6 mtm180 69.39 54.78 0.52 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.568 0.699 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.541 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 53.5 Cg_endo -69.75 133.78 26.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.338 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1193 ' ' THR . . . . . 0.414 ' HB ' ' CD ' ' A' 1220 ' ' LYS . 33.1 p -104.16 -22.18 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.3 p -108.1 144.42 35.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 10.5 p -50.52 -35.63 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1196 ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' 1200 ' ' ARG . 14.8 mt-10 -55.82 -68.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' 1233 ' ' PHE . 84.9 m-20 -41.7 -36.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.485 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.6 t -63.05 -49.07 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.21 -29.58 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1200 ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' 1196 ' ' GLU . 2.1 mpt_? -67.57 -31.69 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' 1204 ' ' VAL . 23.8 mm -48.91 135.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.39 141.55 57.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.48 -44.27 1.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' 1201 ' ' ILE . 3.4 p -76.88 137.6 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 74.3 m -96.14 172.11 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.58 129.94 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 94.02 -59.66 2.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.448 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.596 ' HE2' HG23 ' A' 1204 ' ' VAL . 30.1 tttt -37.95 -47.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -38.13 -44.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.25 -59.82 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.5 ptt? -53.11 -24.8 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 33.89 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.83 -49.27 27.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.725 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -47.99 -19.14 1.41 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1215 ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' 1215 ' ' LEU . 7.1 mp -80.64 -68.35 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.8 OUTLIER -61.6 -19.19 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.06 -35.11 80.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.3 t -73.16 -45.48 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.4 mt -52.28 -56.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1220 ' ' LYS . . . . . 0.414 ' CD ' ' HB ' ' A' 1193 ' ' THR . 16.1 ttpp -43.05 -49.07 6.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -66.55 -53.52 33.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' 1156 ' ' LEU . 22.1 t80 -47.51 -52.26 17.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' 1230 ' ' THR . 26.4 p -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -61.82 -36.33 80.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.521 HG22 ' O ' ' A' 1222 ' ' PHE . 6.2 t -85.84 -27.58 25.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.448 ' CB ' HG23 ' A' 1228 ' ' VAL . 9.1 m120 -99.39 6.33 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.4 t 50.5 34.6 9.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.498 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 45.3 t -87.01 143.73 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.7 148.36 50.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1230 ' ' THR . . . . . 0.454 HG21 ' SG ' ' A' 1223 ' ' CYS . 22.0 p -149.17 175.5 11.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.69 51.94 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.74 38.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' 1197 ' ' ASN . 3.3 m-85 -98.0 -35.61 10.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 36.5 m -110.38 115.39 29.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 39.7 t -110.96 -44.37 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 93.9 m -53.56 -52.13 60.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -75.47 122.63 87.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.573 0.701 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -51.6 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.359 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -92.06 80.67 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 51.1 p -39.64 -57.3 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -169.19 127.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.53 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -0.41 6.86 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.656 2.237 . . . . 0.0 112.353 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 1.9 m -161.9 117.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 94.7 p -44.58 148.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 27.2 p -142.81 139.36 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 15.7 m -106.03 103.73 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 129.04 133.24 3.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 6.0 t -126.85 -57.64 1.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.844 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 3.6 t -98.24 136.27 38.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -166.51 -53.2 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 2.4 t 50.55 42.31 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 2.8 m -162.06 129.62 3.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.828 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -165.82 137.6 3.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.591 0.71 . . . . 0.0 110.898 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.67 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.643 2.229 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.5 m -45.19 170.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 71.6 mt -85.69 132.04 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.167 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' 1147 ' ' ALA . 44.8 t -50.91 132.61 27.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.833 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -37.92 -41.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' 1147 ' ' ALA . 16.1 mt-30 -34.39 -56.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.36 -48.28 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -40.85 -60.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.0 tt0 -46.04 -60.72 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.2 m -42.16 -46.12 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -66.06 -43.8 86.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' 1151 ' ' GLU . 76.3 mt -57.1 -55.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.2 t -60.85 -43.2 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' 1222 ' ' PHE . 28.5 tp -60.66 -60.86 3.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' 1161 ' ' VAL . 64.5 t80 -35.29 -47.42 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -59.55 -51.97 55.88 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -50.12 -42.24 50.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.64 -51.58 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' 1157 ' ' TYR . 95.5 t -45.66 -57.2 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.152 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.96 -57.5 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.38 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.691 ' HD3' HD11 ' A' 1184 ' ' LEU . 16.9 ttp180 -57.57 -45.24 85.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.38 -54.01 50.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' 1167 ' ' HIS . 8.8 pttm -64.11 -38.62 91.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.479 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -61.71 -51.03 70.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.03 -53.49 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.98 -45.58 92.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1170 ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' 1170 ' ' LYS . 6.6 tmtm? -48.49 -51.18 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.819 ' O ' HG13 ' A' 1173 ' ' VAL . 50.0 mtm -91.53 15.36 12.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 36.9 t70 42.74 37.0 0.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' 1171 ' ' MET . 34.9 m -116.0 136.81 23.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.603 0.716 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.97 134.63 23.66 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.02 -16.41 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.372 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.84 -45.06 8.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.057 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.96 -45.05 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.595 ' CD1' ' HE2' ' A' 1171 ' ' MET . 10.9 tp -52.0 -69.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.06 114.85 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.6 t -64.89 176.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.631 ' O ' HG23 ' A' 1185 ' ' VAL . 5.3 m120 -61.67 -47.44 85.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -44.67 -55.28 5.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 91.9 mt -51.52 -62.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.691 HD11 ' HD3' ' A' 1164 ' ' ARG . 71.3 mt -45.49 -56.89 4.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' 1181 ' ' ASN . 62.9 t -41.06 -57.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' 1189 ' ' LYS . 4.2 m-20 -56.68 -57.28 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 70.0 mtp -43.94 -23.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1188 ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' 1186 ' ' ASP . . . -93.12 -32.24 14.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.566 ' HD3' HG12 ' A' 1185 ' ' VAL . 0.2 OUTLIER -74.14 -48.86 26.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1190 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -38.76 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 50.2 mtt85 68.74 54.98 0.58 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.2 Cg_endo -69.73 128.06 15.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 67.6 p -101.94 -24.22 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 70.2 p -102.66 135.74 43.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.546 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.5 p -53.3 -42.34 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1196 ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' 1195 ' ' VAL . 27.0 mp0 -48.5 -35.35 12.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -84.43 -35.02 23.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.469 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.8 t -62.22 -48.51 88.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1199 ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' 1196 ' ' GLU . 13.2 ptpt -54.46 -17.15 2.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -82.92 -30.68 28.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' 1204 ' ' VAL . 47.9 mm -43.73 144.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.67 135.33 54.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.3 -45.99 1.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1201 ' ' ILE . 3.5 p -81.38 137.04 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.145 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.0 t -100.07 156.05 17.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -47.69 151.32 0.87 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 77.93 -62.91 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' 1209 ' ' ALA . 10.5 ttmm -40.6 -50.46 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.765 0.316 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.74 -46.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.09 -64.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -48.46 -31.73 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' 1209 ' ' ALA . 41.5 mt -84.43 30.36 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.86 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.53 -55.17 15.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.566 0.698 . . . . 0.0 111.05 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.8 Cg_exo -47.99 -17.59 0.87 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.697 2.265 . . . . 0.0 112.34 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.95 -65.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' 1216 ' ' TRP . 1.2 p90 -60.88 -26.99 67.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.507 ' N ' ' CD1' ' A' 1216 ' ' TRP . 22.8 mt-10 -55.08 -40.17 70.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -65.79 -42.14 91.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' 1216 ' ' TRP . 70.3 mt -53.71 -49.66 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -51.02 -43.15 60.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.7 t60 -69.62 -47.75 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' 1156 ' ' LEU . 31.6 t80 -53.43 -61.23 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' 1227 ' ' SER . 17.9 p -53.15 -44.14 67.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -45.8 -63.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.5 m -67.69 -40.52 84.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' 1228 ' ' VAL . 31.9 m120 -81.76 13.59 3.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' 1223 ' ' CYS . 6.5 t 32.55 49.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1226 ' ' ASN . 71.2 t -99.07 138.37 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -64.81 162.68 15.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 53.3 p -146.69 178.16 8.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 38.7 t0 61.19 42.62 11.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.4 mt -82.91 40.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -85.79 -44.16 12.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 5.5 m -163.02 172.08 15.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 3.8 m -64.83 91.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1236 ' ' THR . . . . . 0.462 HG22 ' O ' ' A' 1238 ' ' PRO . 25.0 m -130.02 102.92 6.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' 1238 ' ' PRO . 2.8 mptm? -67.98 -60.36 5.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.893 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1238 ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' 1237 ' ' LYS . 54.0 Cg_endo -69.79 163.62 37.61 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.342 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -85.7 -49.29 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 36.2 t -92.39 -42.87 9.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 68.71 -157.18 53.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.498 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 128.6 16.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.671 2.247 . . . . 0.0 112.333 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 74.3 m -130.31 154.08 48.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 8.1 t -173.35 157.12 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 80.4 p -81.0 129.62 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 97.0 p -93.86 119.88 33.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 159.97 40.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 65.5 m -80.55 125.33 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.866 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 5.4 t 45.26 42.16 6.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.865 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -64.87 96.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.469 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1140 ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' 1141 ' ' SER . 95.4 p -151.2 166.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1141 ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' 1140 ' ' SER . 32.6 m -36.72 146.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -109.04 146.36 33.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 0.0 110.95 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 164.19 35.5 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.738 2.292 . . . . 0.0 112.302 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 43.4 t -41.5 131.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.99 136.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 70.5 m -57.73 144.16 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -49.28 -48.19 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 3.3 pt20 -33.38 -49.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -96.62 -52.49 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -43.55 -56.59 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' 1154 ' ' ILE . 8.1 tt0 -52.73 -60.6 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1152 ' ' THR . . . . . 0.458 HG22 ' NH1' ' A' 1191 ' ' ARG . 74.0 m -41.4 -46.62 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -61.92 -45.14 95.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' 1151 ' ' GLU . 69.6 mt -55.62 -63.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1155 ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' 1159 ' ' LYS . 93.7 t -48.63 -54.16 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.557 HD21 HG23 ' A' 1219 ' ' ILE . 9.7 tp -54.04 -63.14 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' 1161 ' ' VAL . 44.2 t80 -38.06 -55.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -50.42 -42.99 43.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.528 ' HD2' HG12 ' A' 1155 ' ' VAL . 3.8 mtpm? -67.5 -43.96 79.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.806 HD21 HG13 ' A' 1219 ' ' ILE . 38.9 mt -60.14 -43.4 95.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.956 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' 1157 ' ' TYR . 98.2 t -57.73 -38.1 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -55.18 -50.52 69.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -68.25 -48.92 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.597 ' HG3' HD21 ' A' 1184 ' ' LEU . 4.7 tmm_? -47.4 -35.13 7.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.6 -69.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.477 ' HA ' ' ND2' ' A' 1169 ' ' ASN . 14.8 ptpt -44.96 -34.44 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.3 t-80 -60.65 -37.29 81.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.45 -53.7 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1169 ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' 1170 ' ' LYS . 6.4 p30 -61.08 -49.2 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1170 ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' 1169 ' ' ASN . 0.1 OUTLIER -48.12 -53.07 17.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 34.6 mtm -78.18 -7.61 57.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.907 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 12.5 t0 68.92 26.65 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.8 m -112.66 140.67 24.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.0 139.99 19.46 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1175 ' ' PRO . . . . . 0.447 ' O ' ' NH1' ' A' 1164 ' ' ARG . 65.9 Cg_exo -48.0 -16.74 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.71 2.273 . . . . 0.0 112.317 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.16 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.8 mm -46.54 -39.45 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.518 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.9 tp -61.04 -72.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -160.17 123.42 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 15.3 t -67.37 162.94 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -52.81 -46.39 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -42.84 -57.81 2.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.9 mt -45.48 -64.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.6 mt -44.69 -52.14 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.3 t -47.15 -54.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.22 -46.6 75.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 36.1 mmm -50.86 -37.58 44.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.92 68.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 9.1 mptt -75.69 -60.91 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.533 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 14.6 mtt -70.37 -38.29 74.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' 1192 ' ' PRO . 32.0 mtt-85 66.66 52.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.8 137.67 35.9 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.25 . . . . 0.0 112.373 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 64.2 p -127.69 21.69 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 1.2 p -137.53 127.19 25.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' 1210 ' ' ALA . 14.1 p -43.28 -26.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -72.54 -64.59 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -47.65 -43.25 26.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.958 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.2 t -52.43 -42.03 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -58.4 -26.29 63.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -73.83 -33.28 64.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' 1204 ' ' VAL . 43.5 mm -47.5 140.16 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -68.77 142.51 54.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.91 -41.38 2.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.539 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' 1201 ' ' ILE . 8.4 p -78.62 137.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1205 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1206 ' ' GLU . 65.1 m -99.5 144.06 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1206 ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' 1205 ' ' SER . 22.7 tt0 -35.44 130.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.88 -59.8 3.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.7 ttmp? -38.41 -52.11 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.84 -52.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1210 ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' 1195 ' ' VAL . . . -40.5 -66.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1211 ' ' MET . . . . . 0.404 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 3.2 ptt? -47.44 -28.64 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 65.8 mt -85.4 30.73 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -63.47 -50.0 75.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.5 Cg_exo -47.91 -18.94 1.27 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.329 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.64 -70.77 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.958 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -56.55 -24.47 47.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.451 ' N ' ' CD1' ' A' 1216 ' ' TRP . 30.1 mt-10 -59.5 -35.34 73.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 63.6 t -68.24 -34.76 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.806 HG13 HD21 ' A' 1160 ' ' LEU . 62.5 mt -66.71 -42.92 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.35 -46.52 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.87 ' O ' HG22 ' A' 1225 ' ' THR . 5.2 t-160 -72.61 -41.69 65.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' 1156 ' ' LEU . 22.0 t80 -54.25 -42.83 70.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 23.7 p -81.36 -34.59 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -62.53 -33.68 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.87 HG22 ' O ' ' A' 1221 ' ' HIS . 3.1 t -89.72 -15.35 32.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' 1227 ' ' SER . 5.6 m120 -118.65 20.15 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1226 ' ' ASN . 55.1 m 35.55 46.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 41.0 t -93.72 140.43 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.79 153.44 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 47.3 p -146.87 -179.89 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 61.93 45.62 7.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.64 35.79 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.533 ' CE2' ' SD ' ' A' 1190 ' ' MET . 49.2 m-85 -75.84 158.87 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 2.5 m -82.04 149.33 28.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 32.5 m 58.9 45.14 15.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 8.8 t -100.36 35.12 2.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 17.1 tptm -71.81 133.93 84.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.578 0.704 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 106.01 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.734 2.289 . . . . 0.0 112.292 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.34 139.75 52.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 59.0 p -143.21 119.53 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -148.04 144.48 12.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -43.36 2.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.296 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 45.5 p -51.43 162.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 63.0 m -107.56 -51.19 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.539 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 87.6 p -122.36 -50.12 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 17.0 t -77.4 -57.31 3.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -123.08 123.15 5.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 1.9 t -108.46 177.06 4.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.827 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 36.1 t -63.55 120.41 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -75.74 54.25 2.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 43.1 t -41.88 -61.51 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.827 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 49.0 m -59.17 -54.71 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -156.39 140.21 11.43 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.6 0.714 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 118.76 5.87 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.669 2.246 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1144 ' ' VAL . . . . . 0.406 HG22 ' N ' ' A' 1145 ' ' ILE . 9.8 p -125.84 155.98 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' 1146 ' ' SER . 35.3 mt -87.45 154.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.422 ' N ' HG22 ' A' 1145 ' ' ILE . 74.4 m -81.98 139.08 34.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.807 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.92 -46.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 76.5 mt-30 -35.95 -52.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1149 ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' 1150 ' ' GLN . 44.1 tt0 -99.89 -47.07 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' 1149 ' ' GLU . 20.3 tt0 -36.81 -50.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -54.54 -56.22 21.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 53.3 m -44.45 -46.74 9.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1153 ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 2.1 mm-40 -68.25 -35.1 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.38 -53.39 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1155 ' ' VAL . . . . . 0.56 HG12 ' NZ ' ' A' 1159 ' ' LYS . 44.7 t -63.57 -39.7 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.492 HD22 ' NE ' ' A' 1191 ' ' ARG . 56.2 tp -66.61 -53.8 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' 1161 ' ' VAL . 74.6 t80 -40.27 -44.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -55.0 -44.93 83.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.56 ' NZ ' HG12 ' A' 1155 ' ' VAL . 44.1 mttp -61.84 -46.16 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.53 HD21 HD11 ' A' 1219 ' ' ILE . 33.6 mt -57.23 -40.73 78.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1157 ' ' TYR . 96.3 t -62.59 -44.07 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -64.75 -45.89 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.86 95.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.501 HH11 HD11 ' A' 1184 ' ' LEU . 27.7 ttp180 -59.06 -46.13 89.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -56.58 -61.05 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 26.4 pttt -52.54 -26.89 14.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -47.85 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.14 -50.99 3.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -65.83 -46.18 79.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 66.1 tttt -45.55 -53.69 8.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 44.6 mtm -84.26 -1.95 56.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.88 30.57 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -113.19 138.74 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.99 136.74 23.21 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.679 2.252 . . . . 0.0 112.37 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.94 -16.79 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.45 -46.39 7.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.3 mm -53.28 -44.81 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.571 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.8 tp -54.08 -68.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -154.89 129.68 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 3.6 t -75.54 166.1 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.32 -44.44 84.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -48.82 -42.77 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.87 -45.16 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.501 HD11 HH11 ' A' 1164 ' ' ARG . 53.2 mt -60.72 -49.47 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 98.6 t -49.87 -50.95 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.22 -46.8 88.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 38.2 mtp -53.01 -43.39 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.52 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.444 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 26.2 mttm -73.53 -63.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.708 ' SD ' HD13 ' A' 1201 ' ' ILE . 21.5 mtt -59.1 -38.6 79.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.492 ' NE ' HD22 ' A' 1156 ' ' LEU . 31.7 mtp180 62.24 55.02 2.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.584 0.707 . . . . 0.0 110.898 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' A' 1197 ' ' ASN . 53.7 Cg_endo -69.8 135.08 29.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.375 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1193 ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' 1216 ' ' TRP . 30.3 p -103.66 -36.91 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.409 ' O ' HG23 ' A' 1198 ' ' VAL . 2.8 p -99.99 164.27 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' 1196 ' ' GLU . 14.8 p -62.15 -42.59 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1196 ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' 1195 ' ' VAL . 27.2 mm-40 -49.01 -50.83 34.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' 1192 ' ' PRO . 0.6 OUTLIER -59.34 -42.7 92.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.675 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.7 t -59.14 -49.21 84.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 64.1 mttt -49.89 -35.87 25.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -71.43 -24.89 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.954 ' O ' HG12 ' A' 1204 ' ' VAL . 23.9 mm -55.45 100.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1202 ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' 1201 ' ' ILE . 6.7 t70 -34.8 143.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.2 -50.86 1.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.954 HG12 ' O ' ' A' 1201 ' ' ILE . 14.9 p -69.84 137.54 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1205 ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' 1206 ' ' GLU . 1.2 t -96.82 140.38 31.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1206 ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' 1205 ' ' SER . 22.4 tt0 -34.21 140.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.8 -54.01 4.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' 1209 ' ' ALA . 43.1 tttm -39.51 -57.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.12 -39.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.51 -66.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.99 -22.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.488 HD21 ' HG ' ' A' 1178 ' ' LEU . 73.7 mt -91.84 33.84 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.2 -53.32 33.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.723 . . . . 0.0 111.109 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.9 Cg_exo -48.03 -17.65 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.1 -65.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.675 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.02 -21.53 63.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.3 -44.37 95.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 97.6 t -67.21 -38.37 80.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.53 HD11 HD21 ' A' 1160 ' ' LEU . 84.5 mt -59.59 -39.42 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1220 ' ' LYS . . . . . 0.401 ' CD ' ' HB ' ' A' 1193 ' ' THR . 23.2 ttpt -64.53 -27.63 69.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' 1224 ' ' GLN . 0.4 OUTLIER -81.9 -60.64 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.473 ' CD1' ' HE2' ' A' 1159 ' ' LYS . 59.3 t80 -38.36 -37.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -81.99 -33.79 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -66.33 -47.39 73.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' 1226 ' ' ASN . 9.0 t -71.32 -30.82 66.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' 1225 ' ' THR . 16.1 m120 -105.6 14.01 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' 1223 ' ' CYS . 82.4 p 33.9 48.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' 1226 ' ' ASN . 60.1 t -98.99 147.63 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -65.22 146.62 54.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1230 ' ' THR . . . . . 0.428 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.9 p -145.38 -175.39 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1231 ' ' ASP . . . . . 0.428 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 47.18 50.14 14.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.73 49.34 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' 1197 ' ' ASN . 33.9 m-85 -86.04 155.52 20.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 3.5 m -44.43 148.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 30.7 t -72.87 80.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 15.3 t -125.99 145.18 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.143 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -58.36 134.68 85.13 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 166.13 28.72 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.342 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -115.61 134.55 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 8.0 t -74.87 169.87 17.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 102.33 62.38 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.523 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1242 ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' 1243 ' ' SER . 53.9 Cg_endo -69.77 -46.75 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.307 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1243 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1242 ' ' PRO . 43.6 t 35.19 43.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 97.0 p -109.57 97.26 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 22.3 m -141.57 111.27 6.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 72.6 p -129.78 145.24 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -131.28 -157.3 8.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 42.7 p -174.13 148.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 1.9 t -165.93 149.16 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -71.72 -170.29 12.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 3.1 m -126.7 41.89 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 3.2 t -160.79 128.31 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.793 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1142 ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' A' 1143 ' ' PRO . 21.2 mt-30 -121.3 111.49 33.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1143 ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' 1142 ' ' GLN . 54.2 Cg_endo -69.77 -173.53 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.37 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.2 m -77.01 146.6 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.88 129.69 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' 1147 ' ' ALA . 11.7 t -56.93 128.65 37.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' 1146 ' ' SER . . . -36.18 -46.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -40.8 -51.92 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -91.33 -49.27 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -41.55 -58.0 2.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -48.71 -61.65 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.3 m -42.65 -46.8 5.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1153 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 18.4 mt-30 -64.82 -37.16 86.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.84 -57.52 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.0 t -56.08 -38.68 54.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.446 HD13 ' CG ' ' A' 1222 ' ' PHE . 33.7 tp -72.08 -61.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.677 ' O ' HG23 ' A' 1161 ' ' VAL . 70.2 t80 -36.79 -40.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.2 94.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -57.13 -44.64 83.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.69 -52.27 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' 1157 ' ' TYR . 88.5 t -45.76 -45.18 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.64 -46.72 88.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.65 80.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.489 ' HG3' HD23 ' A' 1178 ' ' LEU . 21.9 ttp180 -52.12 -46.45 65.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -57.73 -66.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 10.3 pttp -47.58 -38.29 14.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.6 OUTLIER -65.9 -51.93 54.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -38.96 -58.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -57.29 -41.09 79.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.88 -55.23 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.635 ' HE1' ' HG3' ' A' 1211 ' ' MET . 39.6 mtm -80.83 -2.83 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.25 29.31 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.7 m -113.39 138.83 22.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.94 138.31 21.36 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 -16.93 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.603 2.202 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.0 -45.61 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.7 mm -51.82 -42.05 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' 1164 ' ' ARG . 10.9 tp -57.54 -67.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.28 129.43 11.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1180 ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.3 t -83.69 150.62 25.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' 1180 ' ' THR . 5.6 m120 -35.38 -48.7 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -45.1 -56.62 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 81.4 mt -52.28 -52.6 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.546 HD13 HG22 ' A' 1161 ' ' VAL . 71.8 mt -46.36 -57.03 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' 1181 ' ' ASN . 21.6 t -46.55 -50.31 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.728 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -56.22 -41.6 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 56.4 mtp -68.88 -22.6 64.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -90.27 -29.01 18.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 9.2 ptmm? -85.39 -44.41 12.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' 1189 ' ' LYS . 15.8 mtm -88.07 -14.79 38.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' 1156 ' ' LEU . 47.9 mtm-85 39.62 54.87 5.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.632 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.7 Cg_endo -69.77 138.79 38.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.9 p -131.45 22.33 4.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 13.3 p -138.24 126.27 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 9.6 p -49.08 -27.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -73.78 -30.5 62.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -89.84 -49.88 6.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.6 t -45.89 -44.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -58.04 -30.06 65.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -74.5 -14.03 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' 1186 ' ' ASP . 23.0 mm -59.58 138.69 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.23 136.99 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.761 HG23 ' HD3' ' A' 1208 ' ' LYS . 7.4 p -77.2 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.164 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 38.1 m -100.17 170.9 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -61.49 143.85 55.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.32 -57.68 4.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.761 ' HD3' HG23 ' A' 1204 ' ' VAL . 46.5 tttt -39.54 -45.31 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -39.77 -45.19 1.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.08 -65.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1211 ' ' MET . . . . . 0.635 ' HG3' ' HE1' ' A' 1171 ' ' MET . 3.1 ptt? -50.15 -25.91 4.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 53.8 mt -88.99 32.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.33 -51.37 34.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 111.125 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -48.03 -17.18 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.35 -64.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' 1216 ' ' TRP . 0.9 OUTLIER -64.47 -20.7 66.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.27 -37.15 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 76.7 t -68.53 -51.89 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' 1216 ' ' TRP . 59.1 mt -47.15 -48.33 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -48.17 -48.51 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.737 ' O ' HG22 ' A' 1225 ' ' THR . 3.4 t-160 -70.34 -46.61 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' 1222 ' ' PHE . 3.3 t80 -54.01 -38.14 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' 1227 ' ' SER . 28.1 p -85.97 -31.16 22.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -69.0 -35.4 76.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.737 HG22 ' O ' ' A' 1221 ' ' HIS . 7.6 t -84.78 -20.36 31.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.566 ' OD1' HG23 ' A' 1225 ' ' THR . 8.8 m120 -108.88 -3.69 17.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' 1223 ' ' CYS . 3.5 t 61.06 33.22 19.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 62.9 t -80.81 140.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.173 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -71.43 151.3 44.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 75.9 p -144.88 173.71 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 68.72 47.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.78 43.61 1.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.42 -51.13 7.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 52.3 m -147.76 115.61 6.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 58.8 m -90.48 75.39 6.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1236 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1237 ' ' LYS . 55.2 p -145.98 167.02 24.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' 1236 ' ' THR . 19.6 tptm -35.01 133.55 0.44 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -2.52 10.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.301 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -91.38 79.06 5.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 57.2 m -136.77 143.54 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -79.22 135.92 16.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.387 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 40.7 m -71.07 144.39 50.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 7.4 t -48.32 -45.6 35.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 2.7 t -132.29 104.04 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.876 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 49.3 m -116.61 99.91 7.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -51.81 104.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 19.5 m -54.71 142.04 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 36.9 p -140.91 151.12 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.818 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 171.27 120.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 22.3 p -124.83 107.6 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1141 ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' 1142 ' ' GLN . 7.1 m 57.19 43.82 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.84 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1142 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1141 ' ' SER . 26.4 mt-30 -35.85 124.52 0.67 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.651 0.739 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -175.86 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 98.1 t -71.24 138.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.106 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 53.3 mt -78.3 144.0 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 19.9 m -78.92 152.54 31.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -43.49 -47.43 7.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.7 pt20 -32.82 -51.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.06 -48.95 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -47.87 -67.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.3 tp10 -40.82 -60.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.8 m -43.03 -52.03 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -61.77 -36.61 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.7 mt -61.58 -58.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 88.4 t -60.15 -40.15 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.939 HD13 ' CD2' ' A' 1222 ' ' PHE . 38.6 tp -62.95 -56.88 13.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' 1161 ' ' VAL . 45.2 t80 -37.23 -42.24 0.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.93 -49.27 73.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.432 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 25.3 mttm -53.38 -40.89 65.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.81 -49.36 68.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' 1157 ' ' TYR . 83.1 t -47.55 -41.37 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -62.66 -42.8 99.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.74 96.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' 1184 ' ' LEU . 30.3 ttp180 -62.74 -43.28 99.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.66 -51.27 70.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' 1167 ' ' HIS . 19.0 ptpt -64.89 -44.1 90.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.469 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.1 t-80 -60.54 -47.98 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -40.13 -53.12 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -61.37 -46.82 88.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1170 ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' 1170 ' ' LYS . 14.4 tmtt? -43.07 -54.74 4.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.2 mtm -82.86 -4.79 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 18.4 t0 67.27 32.02 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.0 m -115.26 137.79 23.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.606 0.717 . . . . 0.0 111.187 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.93 138.88 20.69 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.96 -16.51 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 0.0 112.394 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.78 -47.38 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.93 -41.33 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.497 ' CD1' ' HE3' ' A' 1171 ' ' MET . 11.8 tp -57.55 -63.96 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -153.46 143.97 22.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 59.1 p -93.17 169.57 10.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' 1185 ' ' VAL . 87.4 m-20 -55.32 -37.65 67.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.86 -48.06 82.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.85 -39.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.3 mt -72.71 -48.13 41.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' 1181 ' ' ASN . 93.2 t -52.24 -40.23 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -44.25 72.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 52.5 mtp -59.5 -37.19 77.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -72.4 -27.75 62.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 44.3 mttt -79.33 -63.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.584 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 15.2 mtt -64.92 -39.04 92.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' 1192 ' ' PRO . 29.1 mtm180 66.55 53.71 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.9 Cg_endo -69.77 141.23 44.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.708 2.272 . . . . 0.0 112.344 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -127.58 18.29 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.625 ' O ' HG23 ' A' 1198 ' ' VAL . 31.3 p -137.85 130.8 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.514 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 14.7 p -51.29 -24.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.9 -64.16 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -51.53 -42.92 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.66 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.7 t -47.78 -45.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.9 mttp -52.06 -34.13 42.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -64.34 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' 1202 ' ' ASP . 26.3 mm -43.33 153.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1202 ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' 1201 ' ' ILE . 31.7 t0 -80.69 133.46 35.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.0 -46.03 1.43 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 12.8 p -66.64 134.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 8.6 m -98.91 152.18 20.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -43.47 137.45 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.88 -62.91 4.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.648 ' HE2' HD11 ' A' 1212 ' ' LEU . 40.1 tttt -34.97 -48.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.44 -48.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.09 -65.62 0.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1211 ' ' MET . . . . . 0.462 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 5.6 ptt? -46.16 -28.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.648 HD11 ' HE2' ' A' 1208 ' ' LYS . 51.2 mt -87.17 32.95 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.845 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.42 -54.86 8.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.567 0.699 . . . . 0.0 111.089 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.845 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.57 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.91 -64.04 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.66 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -62.42 -21.86 65.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.403 ' N ' ' CD1' ' A' 1216 ' ' TRP . 55.1 mt-10 -60.43 -37.87 82.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.0 t -69.36 -57.9 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.085 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -38.71 -46.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -46.96 -55.23 8.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.51 ' O ' HG22 ' A' 1225 ' ' THR . 3.4 t-80 -68.04 -46.56 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.939 ' CD2' HD13 ' A' 1156 ' ' LEU . 64.1 t80 -46.65 -47.53 20.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 97.4 m -81.93 -46.87 13.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -46.86 -46.44 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.51 HG22 ' O ' ' A' 1221 ' ' HIS . 15.4 t -70.96 -37.37 72.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.569 ' O ' HG23 ' A' 1228 ' ' VAL . 8.5 m120 -90.05 23.8 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 4.7 t 39.37 39.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' 1226 ' ' ASN . 61.1 t -99.35 143.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -71.0 153.1 42.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 25.4 p -145.9 152.39 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.85 54.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 17.2 mt -85.35 25.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.584 ' CE2' ' SD ' ' A' 1190 ' ' MET . 0.7 OUTLIER -151.53 105.56 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 71.2 p -175.03 113.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.859 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 90.4 p -96.01 52.76 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 20.3 m -150.5 144.89 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 54.1 pttt -160.5 139.3 7.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.333 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -61.34 -45.54 93.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 57.4 p -105.86 171.56 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -126.58 176.2 17.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -45.64 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.288 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 58.7 m 41.47 43.59 2.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 69.2 m 41.64 42.19 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 40.0 t -146.35 148.91 32.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.826 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 59.5 p -42.14 125.08 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -56.16 119.38 14.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 25.8 t -95.23 126.3 40.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 6.5 t -54.43 -49.44 69.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 152.75 172.74 21.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 1.1 t 71.86 40.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 85.7 p -156.43 105.97 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -52.82 111.27 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 147.52 62.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 10.2 p -84.02 148.63 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.52 139.2 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1147 ' ' ALA . 89.2 p -54.11 124.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.12 -48.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -41.67 -49.4 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.52 -52.38 4.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' 1150 ' ' GLN . 2.1 tp60 -42.22 -52.77 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' 1154 ' ' ILE . 19.7 tt0 -49.22 -60.09 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 70.7 m -41.0 -54.54 2.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -54.06 -40.81 67.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.4 mt -60.13 -53.41 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.1 t -61.52 -42.04 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.521 HD13 ' CG ' ' A' 1222 ' ' PHE . 17.6 tp -62.22 -59.13 5.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' 1156 ' ' LEU . 55.8 t80 -35.74 -51.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.47 56.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 17.1 mttm -58.75 -38.82 79.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.455 HD21 HD11 ' A' 1219 ' ' ILE . 38.5 mt -70.07 -42.22 73.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 68.3 t -47.57 -51.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -56.84 -46.2 81.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.92 -44.96 95.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.878 ' HD3' ' HB3' ' A' 1179 ' ' ALA . 4.0 tpm_? -60.79 -29.37 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -80.7 -70.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -40.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1167 ' ' HIS . . . . . 0.58 ' HB3' HD21 ' A' 1178 ' ' LEU . 0.5 OUTLIER -65.26 -54.57 27.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.76 ' HA ' HD22 ' A' 1178 ' ' LEU . . . -37.26 -59.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.42 -35.88 76.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1170 ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' 1167 ' ' HIS . 43.0 tttp -52.61 -54.31 34.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.429 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 36.7 mtm -81.57 -1.77 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.18 37.37 8.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 25.6 m -119.62 142.39 32.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.98 135.64 23.6 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.97 -16.81 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.35 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.93 -45.49 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 35.9 mm -55.41 -38.79 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.76 HD22 ' HA ' ' A' 1168 ' ' ALA . 14.0 tp -59.63 -64.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1179 ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' 1164 ' ' ARG . . . -168.66 127.41 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 11.0 t -67.82 170.28 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -63.78 -45.8 88.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -42.92 -57.34 2.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.6 mt -47.69 -48.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.87 -58.54 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.492 HG12 ' HD2' ' A' 1189 ' ' LYS . 93.1 t -40.87 -53.49 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.7 -56.7 15.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1187 ' ' MET . . . . . 0.46 ' HE3' ' HB3' ' A' 1216 ' ' TRP . 42.7 mtp -47.79 -43.5 27.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.0 79.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1189 ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' 1185 ' ' VAL . 15.3 mtpp -71.36 -63.82 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.537 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 20.2 mtt -63.69 -39.64 94.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.3 mtm-85 65.61 54.67 1.07 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.578 0.704 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 143.73 51.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.33 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 6.2 p -124.87 15.5 8.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1194 ' ' THR . . . . . 0.567 ' O ' HG23 ' A' 1198 ' ' VAL . 16.9 p -140.03 134.91 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.417 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 11.1 p -57.85 -29.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -67.47 -31.68 71.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -87.37 -37.78 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.728 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.4 t -53.37 -36.48 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.169 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -62.89 -27.36 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -68.21 -33.24 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' 1202 ' ' ASP . 46.9 mm -42.63 160.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1202 ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' 1201 ' ' ILE . 16.8 t70 -87.36 134.51 33.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.06 -38.71 3.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' 1198 ' ' VAL . 7.3 p -68.45 138.82 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 63.8 p -99.82 154.71 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.48 139.18 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 80.7 -56.68 4.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' 1209 ' ' ALA . 14.6 ttmm -36.98 -45.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -35.22 -45.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.46 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 9.7 ptt? -52.94 -17.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.0 mt -90.88 31.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.8 -49.87 2.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 0.0 111.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 66.2 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1215 ' ' LEU . . . . . 0.748 HD11 ' NH2' ' A' 1164 ' ' ARG . 6.8 mp -84.04 -70.94 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.728 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -56.2 -19.18 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.02 -35.79 81.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 81.7 t -75.89 -51.79 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.455 HD11 HD21 ' A' 1160 ' ' LEU . 66.3 mt -49.0 -50.57 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -42.08 -45.22 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' 1224 ' ' GLN . 4.2 t-80 -75.59 -56.27 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' 1156 ' ' LEU . 10.0 t80 -41.88 -32.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 83.1 m -90.96 -25.21 19.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' 1221 ' ' HIS . 2.9 pt20 -72.04 -46.95 55.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' 1224 ' ' GLN . 7.4 t -74.11 -24.66 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' 1225 ' ' THR . 36.3 m-80 -102.1 -0.79 32.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 32.1 t 55.37 36.65 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1228 ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' 1229 ' ' GLN . 74.9 t -83.09 153.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1229 ' ' GLN . . . . . 0.404 ' N ' HG12 ' A' 1228 ' ' VAL . 1.8 mp0 -70.11 145.95 51.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 23.6 p -143.58 165.62 27.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.13 46.65 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.36 43.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.537 ' CE2' ' SD ' ' A' 1190 ' ' MET . 58.2 m-85 -84.75 41.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1234 ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' 1233 ' ' PHE . 74.2 m 35.09 43.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 5.0 m -78.0 154.34 31.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.847 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 23.6 p -125.53 -25.07 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.162 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 153.32 55.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.646 0.736 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 143.52 51.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.326 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -63.77 -48.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 41.1 t -68.02 150.13 48.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -119.27 -164.23 12.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -50.14 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.366 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 82.7 p -148.17 151.9 36.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 44.0 p -48.81 160.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 13.0 m -103.77 160.95 14.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 2.8 m -82.85 -59.03 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.854 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 118.12 -140.33 15.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 30.2 t -162.42 144.99 11.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 5.2 t -96.37 146.22 24.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 108.46 158.99 19.66 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 2.5 m -54.72 -46.54 74.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 32.9 m -61.07 160.12 10.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.75 136.52 10.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 155.25 66.63 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.377 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 96.4 t -44.67 135.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 47.4 mt -73.79 138.62 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 19.3 m -58.93 137.19 57.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -39.48 -44.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 80.8 mt-30 -34.77 -56.91 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.09 -44.56 7.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -44.19 -54.2 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -70.79 -58.82 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 47.5 m -38.05 -53.51 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -60.07 -45.64 92.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.99 -51.46 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 94.4 t -61.66 -42.06 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.523 HD22 ' NE ' ' A' 1191 ' ' ARG . 17.0 tp -63.73 -59.82 4.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' 1161 ' ' VAL . 61.4 t80 -36.58 -44.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.49 90.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -57.01 -40.44 76.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1160 ' ' LEU . . . . . 0.474 HD21 HD11 ' A' 1219 ' ' ILE . 42.4 mt -64.59 -46.05 84.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.797 HG13 HH12 ' A' 1164 ' ' ARG . 85.7 t -54.11 -41.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.05 -47.41 83.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1163 ' ' ALA . . . . . 0.418 ' HA ' ' CG ' ' A' 1166 ' ' LYS . . . -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1164 ' ' ARG . . . . . 0.797 HH12 HG13 ' A' 1161 ' ' VAL . 14.0 ttp-105 -62.86 -32.42 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -74.83 -55.22 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1166 ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' 1163 ' ' ALA . 0.0 OUTLIER -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.12 -46.81 48.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -41.38 -52.82 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.75 -45.74 91.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.2 tttp -48.72 -51.6 27.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.636 ' O ' HG13 ' A' 1173 ' ' VAL . 50.6 mtm -88.01 11.0 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 10.6 m-20 49.83 31.34 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' 1171 ' ' MET . 35.3 m -112.62 136.87 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 138.79 21.28 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 -17.42 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.91 -43.6 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.53 -45.45 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.603 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.3 tp -51.36 -67.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -152.77 134.12 14.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1180 ' ' THR . . . . . 0.459 ' H ' HD12 ' A' 1183 ' ' ILE . 12.1 t -78.86 159.24 27.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.04 -42.93 60.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -47.54 -44.55 26.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1183 ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' 1180 ' ' THR . 74.7 mt -62.55 -62.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' 1164 ' ' ARG . 94.1 mt -40.01 -54.09 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 96.1 t -47.15 -57.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.405 ' CB ' HG23 ' A' 1201 ' ' ILE . 4.2 m-20 -53.73 -57.41 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 65.7 mtp -43.98 -38.19 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.56 73.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -74.02 -58.31 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 14.3 mtt -69.79 -32.82 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.523 ' NE ' HD22 ' A' 1156 ' ' LEU . 25.9 mtp180 55.7 53.36 8.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 135.02 29.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 45.3 p -102.05 -31.85 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.4 p -102.62 149.37 24.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.575 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -59.34 -39.15 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -51.93 -25.12 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.417 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 79.8 m-20 -95.45 -39.31 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 76.8 t -58.13 -47.58 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -54.64 -29.4 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -71.27 -19.93 62.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' 1204 ' ' VAL . 38.0 mm -55.58 149.38 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.62 135.93 50.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.56 -48.82 1.23 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' 1201 ' ' ILE . 10.3 p -73.59 135.99 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 18.2 m -99.47 150.58 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -41.62 141.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.19 -65.6 4.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' 1209 ' ' ALA . 32.3 ttpt -34.72 -54.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.96 -47.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.69 -64.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 6.6 ptt? -48.99 -30.36 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' 1209 ' ' ALA . 43.5 mt -84.86 30.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -64.6 -52.52 51.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 111.11 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 63.8 Cg_exo -47.95 -17.91 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.38 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -80.91 -65.32 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.575 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.0 OUTLIER -61.8 -23.15 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' 1216 ' ' TRP . 21.5 mm-40 -58.66 -38.94 79.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.7 t -70.02 -30.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.1 mt -66.12 -44.7 91.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -54.77 -30.06 55.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1221 ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.3 t-160 -82.92 -56.93 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.0 t80 -39.94 -34.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1223 ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' 1227 ' ' SER . 22.2 p -86.89 -30.44 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1224 ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -70.53 -46.76 63.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.481 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.6 t -71.84 -13.49 61.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.456 ' OD1' HG23 ' A' 1225 ' ' THR . 11.2 m120 -127.08 14.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1227 ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' 1223 ' ' CYS . 7.6 t 34.75 48.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 76.4 t -94.65 147.79 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -66.7 144.19 56.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1230 ' ' THR . . . . . 0.453 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.0 p -141.1 -175.29 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1231 ' ' ASP . . . . . 0.453 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 48.36 53.39 12.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.51 42.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' 1190 ' ' MET . 17.2 m-85 -77.19 145.88 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 27.7 t -62.11 -44.16 97.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 2.7 t -45.08 134.61 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 31.0 m -90.73 138.88 31.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1237 ' ' LYS . . . . . 0.456 ' N ' ' CD ' ' A' 1238 ' ' PRO . 71.7 mmtt 47.1 53.79 14.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.556 0.693 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1238 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1237 ' ' LYS . 53.6 Cg_endo -69.71 81.1 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.334 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -141.28 140.46 33.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 22.0 t -161.05 131.58 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 53.03 85.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 108.9 2.18 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 3.7 t 44.63 39.62 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 49.9 m -125.43 165.21 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.445 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 11.9 t -167.12 145.99 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.862 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 57.1 p -79.79 133.2 36.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -144.14 146.02 16.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 37.7 t -150.14 121.4 7.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 110.885 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 3.8 t -107.14 158.56 16.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -83.43 79.17 1.94 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.433 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 73.6 m -116.08 167.43 10.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.856 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 22.8 t -61.5 -45.15 95.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -120.87 127.22 26.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.593 0.711 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 129.72 18.1 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.66 2.24 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.0 m -70.82 162.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1145 ' ' ILE . . . . . 0.495 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 35.1 mt -87.95 137.7 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.195 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1146 ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' 1147 ' ' ALA . 9.1 t -57.67 117.53 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1147 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1146 ' ' SER . . . -34.69 -46.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.054 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -37.63 -55.15 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1149 ' ' GLU . . . . . 0.495 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 17.5 pt-20 -89.34 -47.37 8.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1150 ' ' GLN . . . . . 0.577 ' HG2' HD11 ' A' 1154 ' ' ILE . 28.5 tt0 -42.04 -62.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1151 ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' 1154 ' ' ILE . 0.3 OUTLIER -42.81 -59.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 84.9 m -44.18 -49.96 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.1 -37.76 88.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1154 ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.8 mt -63.3 -57.2 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1155 ' ' VAL . . . . . 0.437 HG12 ' HZ2' ' A' 1159 ' ' LYS . 45.3 t -58.47 -40.69 79.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1156 ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' 1222 ' ' PHE . 40.1 tp -66.18 -60.98 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1157 ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' 1161 ' ' VAL . 56.8 t80 -37.81 -48.19 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.89 -45.65 61.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1159 ' ' LYS . . . . . 0.437 ' HZ2' HG12 ' A' 1155 ' ' VAL . 29.7 mttp -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.18 -47.76 83.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1161 ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' 1157 ' ' TYR . 99.9 t -54.24 -44.65 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -63.74 -46.39 85.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.18 76.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -53.35 -41.59 65.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.9 -69.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -36.93 5.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 2.4 t60 -74.64 -43.84 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1168 ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -45.32 -55.71 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.03 -36.68 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -53.89 53.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1171 ' ' MET . . . . . 0.504 ' CE ' HD11 ' A' 1178 ' ' LEU . 15.9 mtm -75.61 -6.44 50.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.14 33.63 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1173 ' ' VAL . . . . . 0.429 ' O ' ' HB1' ' A' 1168 ' ' ALA . 27.0 m -121.54 138.97 29.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 136.62 22.97 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -20.59 2.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.52 -38.79 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1177 ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' 1177 ' ' ILE . 19.5 mm -58.91 -46.82 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1178 ' ' LEU . . . . . 0.504 HD11 ' CE ' ' A' 1171 ' ' MET . 13.1 tp -51.31 -61.75 2.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.4 148.83 28.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 76.6 p -94.91 165.95 12.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1181 ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' 1185 ' ' VAL . 20.2 m-80 -60.05 -37.23 79.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -61.56 -48.87 79.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.25 -40.74 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1184 ' ' LEU . . . . . 0.447 HD13 HG22 ' A' 1161 ' ' VAL . 83.3 mt -63.55 -54.12 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1185 ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' 1181 ' ' ASN . 94.4 t -55.2 -38.76 48.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1186 ' ' ASP . . . . . 0.553 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -59.08 -60.98 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 49.2 mtp -53.55 -28.15 30.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.99 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 22.2 mttt -97.42 -60.47 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1190 ' ' MET . . . . . 0.43 ' SD ' ' O ' ' A' 1186 ' ' ASP . 1.1 mpt? -64.61 -39.76 94.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1191 ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' 1192 ' ' PRO . 49.1 mtm-85 64.17 55.01 1.55 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1192 ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.78 119.61 6.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 52.4 p -92.2 -21.52 20.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 59.2 p -109.04 144.14 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1195 ' ' VAL . . . . . 0.519 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.3 p -56.06 -30.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.126 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -58.95 -41.32 87.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1197 ' ' ASN . . . . . 0.428 ' HB3' ' CE2' ' A' 1233 ' ' PHE . 57.4 m-20 -75.19 -37.09 61.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1198 ' ' VAL . . . . . 0.51 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.6 t -59.11 -49.21 84.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -50.91 -28.77 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -70.38 -32.15 69.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1201 ' ' ILE . . . . . 0.706 ' O ' HG12 ' A' 1204 ' ' VAL . 21.6 mm -49.57 146.11 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.07 142.17 49.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.22 -46.46 1.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1204 ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' 1201 ' ' ILE . 9.6 p -67.51 132.6 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 58.8 m -96.88 145.66 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -40.72 126.8 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 93.52 -59.7 2.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1208 ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.1 ttmp? -38.69 -48.69 1.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1209 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.67 -46.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -43.92 -66.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.8 ptt? -47.12 -26.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1212 ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' 1178 ' ' LEU . 72.5 mt -89.09 32.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.41 -53.75 21.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 111.102 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1214 ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.9 -17.26 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.715 2.276 . . . . 0.0 112.321 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.39 -60.53 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -67.29 -28.28 67.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1217 ' ' GLU . . . . . 0.531 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.8 mt-10 -56.41 -33.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.4 t -70.17 -41.21 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1219 ' ' ILE . . . . . 0.45 HG12 HD11 ' A' 1156 ' ' LEU . 83.7 mt -59.82 -53.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -45.77 -43.67 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -76.03 -43.95 41.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1222 ' ' PHE . . . . . 0.689 ' CD2' HD13 ' A' 1156 ' ' LEU . 27.6 t80 -54.18 -38.98 66.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -81.06 -26.47 36.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1225 ' ' THR . . . . . 0.5 HG23 ' OD1' ' A' 1226 ' ' ASN . 9.3 t -87.06 -34.93 19.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1226 ' ' ASN . . . . . 0.5 ' OD1' HG23 ' A' 1225 ' ' THR . 9.9 m120 -91.43 8.19 37.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 43.1 t 42.04 43.51 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 70.6 t -89.03 148.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -76.09 151.86 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 71.0 p -145.05 174.64 10.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 20.1 t0 66.22 41.79 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.41 44.71 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1233 ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' 1197 ' ' ASN . 79.5 m-85 -87.17 148.94 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 11.7 t -76.57 86.49 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 46.3 t -156.4 134.76 11.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1236 ' ' THR . . . . . 0.563 HG22 ' O ' ' A' 1236 ' ' THR . 19.2 m -88.03 40.64 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.181 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -148.39 106.44 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 110.869 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -40.06 5.68 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 0.0 112.331 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 40.13 40.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 99.8 p -50.97 123.23 8.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -149.15 80.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.68 13.62 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.703 2.268 . . . . 0.0 112.302 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 9.4 t -108.01 135.84 48.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 73.9 p -81.09 -45.45 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.705 0.288 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -41.86 -59.17 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -99.97 -37.37 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -42.49 -57.59 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.405 ' HA ' HD12 ' A' 1154 ' ' ILE . 13.6 tt0 -48.94 -57.3 6.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . 0.401 HG21 HG11 ' A' 1228 ' ' VAL . 54.6 m -46.99 -43.4 19.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.169 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.9 -38.65 86.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.0 mt -62.71 -53.21 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 59.1 t -62.49 -40.13 87.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 20.9 tp -65.83 -59.33 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.1 t80 -37.55 -51.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.98 -42.64 60.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 31.8 mttm -61.96 -45.18 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 43.2 mt -59.53 -52.99 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 77.6 t -48.02 -47.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.55 -46.52 83.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.84 -53.0 62.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.516 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.8 ttp180 -47.59 -45.09 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' 1168 ' ' ALA . 21.6 tt0 -59.08 -70.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -45.96 -26.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.92 -32.39 21.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.97 -50.22 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.55 -44.92 96.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.12 -52.18 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' HD11 ' A' 1178 ' ' LEU . 10.4 mtm -77.74 -6.02 52.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.96 39.41 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' 1168 ' ' ALA . 31.7 m -127.82 142.69 45.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 138.64 21.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.93 -23.26 4.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -91.23 -35.61 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.7 mm -59.0 -48.91 85.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.497 HD11 ' HE3' ' A' 1171 ' ' MET . 13.3 tp -49.34 -62.26 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.72 124.19 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.0 t -78.58 154.13 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.683 ' O ' HG23 ' A' 1185 ' ' VAL . 5.9 m-80 -45.86 -38.8 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -51.58 -45.08 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.93 -51.38 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.516 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.2 mt -52.53 -48.83 65.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' 1181 ' ' ASN . 90.6 t -52.73 -53.26 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.52 -50.39 70.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 82.2 mtp -56.54 -36.35 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -73.68 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -90.0 -54.73 3.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 17.5 mtt -75.06 -27.68 60.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.543 ' HB3' HG22 ' A' 1230 ' ' THR . 21.8 mtm180 54.89 54.85 10.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.1 Cg_endo -69.78 125.19 11.84 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 0.0 112.314 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.5 p -97.29 -24.51 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 77.6 p -107.61 138.52 43.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.54 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.4 p -52.94 -28.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -58.43 -50.08 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.2 -36.52 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 97.6 t -57.58 -47.16 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 18.0 mttp -50.94 -36.78 40.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -65.55 -23.9 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 32.5 mm -52.48 150.99 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.69 137.85 37.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 98.69 -37.99 3.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' 1201 ' ' ILE . 3.8 p -74.04 132.43 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 47.8 t -95.92 145.23 25.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -40.85 131.35 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 88.87 -58.45 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' 1209 ' ' ALA . 9.1 ttmm -37.63 -50.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.98 -48.74 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 2.0 ptt? -46.91 -28.11 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 70.9 mt -86.53 29.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.736 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.37 -51.66 41.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.711 . . . . 0.0 111.079 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.01 -22.54 3.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.61 -67.27 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.563 ' HA ' HD12 ' A' 1219 ' ' ILE . 1.0 OUTLIER -60.65 -30.09 69.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' 1216 ' ' TRP . 8.8 mm-40 -54.17 -34.63 60.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.3 t -74.0 -32.96 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.4 mt -65.7 -40.95 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' 1224 ' ' GLN . 25.2 ttpt -59.84 -38.53 82.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.961 ' O ' HG22 ' A' 1225 ' ' THR . 10.9 t60 -77.99 -47.08 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 39.3 t80 -51.54 -41.46 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' 1230 ' ' THR . 21.5 p -84.11 -35.34 23.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.487 ' CG ' ' O ' ' A' 1220 ' ' LYS . 8.9 mm100 -64.22 -31.79 73.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.961 HG22 ' O ' ' A' 1221 ' ' HIS . 3.5 t -88.99 -15.67 33.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.872 HD22 HG23 ' A' 1225 ' ' THR . 5.8 m-80 -119.78 15.03 12.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' 1223 ' ' CYS . 4.3 t 41.61 40.89 1.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.401 HG11 HG21 ' A' 1152 ' ' THR . 89.7 t -87.5 144.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -64.78 148.54 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' 1191 ' ' ARG . 36.7 p -146.79 -175.5 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.53 49.93 4.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.719 0.295 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' 1147 ' ' ALA . 66.8 mt-30 -34.5 -47.05 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -97.68 -51.02 4.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -44.03 -59.15 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -47.63 -58.8 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . 0.471 HG22 ' NH2' ' A' 1191 ' ' ARG . 89.4 m -43.76 -45.3 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . 0.412 ' HG3' ' NH2' ' A' 1191 ' ' ARG . 57.6 mt-30 -65.35 -38.54 90.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.6 -46.72 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -42.37 87.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.61 HD23 ' HE ' ' A' 1191 ' ' ARG . 22.2 tp -67.35 -57.82 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' 1161 ' ' VAL . 54.5 t80 -38.12 -50.83 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.2 -45.19 92.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 35.8 mttm -57.4 -45.21 84.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.29 -51.82 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.856 HG22 HD13 ' A' 1184 ' ' LEU . 100.0 t -52.4 -41.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.01 -55.16 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -46.86 -34.07 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -66.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' 1167 ' ' HIS . 12.5 pttp -53.48 -27.11 23.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.595 ' CE1' ' SD ' ' A' 1171 ' ' MET . 2.3 t60 -83.43 -35.19 25.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.615 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.84 -48.9 69.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.26 -37.21 83.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.6 tttt -51.42 -41.37 60.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.883 ' CE ' HD11 ' A' 1178 ' ' LEU . 3.2 mpp? -96.7 2.78 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 61.73 31.32 18.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.5 HG21 HD13 ' A' 1178 ' ' LEU . 34.8 m -112.02 138.27 21.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.693 . . . . 0.0 111.166 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 136.02 23.38 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -16.77 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.17 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.87 -39.83 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.883 HD11 ' CE ' ' A' 1171 ' ' MET . 15.8 tp -59.3 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.34 139.8 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . 0.431 ' H ' HD12 ' A' 1183 ' ' ILE . 38.1 p -93.27 162.24 14.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' 1185 ' ' VAL . 2.7 m-20 -56.79 -36.16 69.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.62 -51.94 67.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' 1180 ' ' THR . 78.4 mt -57.71 -48.35 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.856 HD13 HG22 ' A' 1161 ' ' VAL . 76.1 mt -54.04 -50.95 65.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.525 HG12 ' HD2' ' A' 1189 ' ' LYS . 79.8 t -56.74 -52.03 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.516 ' CB ' HG23 ' A' 1201 ' ' ILE . 51.8 m-20 -55.1 -46.68 75.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.99 -40.74 81.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' 1191 ' ' ARG . . . -64.75 -31.56 72.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' 1185 ' ' VAL . 12.8 mtpp -80.04 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' 1201 ' ' ILE . 17.8 mtt -62.17 -38.39 88.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.61 ' HE ' HD23 ' A' 1156 ' ' LEU . 17.1 mmt85 65.28 52.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 131.96 22.38 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -120.54 24.56 10.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.924 ' O ' HG23 ' A' 1198 ' ' VAL . 19.1 p -138.36 134.72 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.12 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.564 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 7.1 p -52.98 -26.96 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -75.35 -67.93 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -44.11 -39.59 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' 1194 ' ' THR . 74.6 t -48.57 -43.58 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . 0.435 ' HA ' ' CG1' ' A' 1204 ' ' VAL . 6.0 mtmp? -56.67 -30.43 63.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -67.16 -29.16 68.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.57 HD13 ' SD ' ' A' 1190 ' ' MET . 13.7 mm -59.32 102.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' 1201 ' ' ILE . 9.3 t70 -31.46 145.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.43 -41.83 2.08 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.694 HG23 ' HD2' ' A' 1208 ' ' LYS . 2.8 p -93.52 140.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1206 ' ' GLU . 12.9 t -100.2 138.96 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' 1205 ' ' SER . 36.3 tt0 -34.26 129.61 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 100.17 -64.94 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.694 ' HD2' HG23 ' A' 1204 ' ' VAL . 16.6 ttmm -38.7 -48.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.8 -42.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.75 -65.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.7 ptt? -53.3 -24.59 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.08 34.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.51 -49.81 39.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.689 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -48.0 -20.14 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.69 -63.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.869 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.9 OUTLIER -65.37 -23.15 66.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.405 ' N ' ' CD1' ' A' 1216 ' ' TRP . 33.2 mt-10 -61.59 -36.23 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.1 t -67.28 -42.91 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.52 -40.29 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -60.63 -43.13 97.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.36 -44.54 58.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' 1228 ' ' VAL . 49.5 t80 -56.81 -46.13 81.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' 1227 ' ' SER . 28.4 p -70.09 -36.21 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -57.76 -34.65 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.446 HG23 ' ND2' ' A' 1226 ' ' ASN . 5.3 t -93.13 -37.3 12.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.446 ' ND2' HG23 ' A' 1225 ' ' THR . 34.4 m-80 -93.39 15.81 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' 1223 ' ' CYS . 17.6 m 35.49 46.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' 1222 ' ' PHE . 59.0 t -87.57 139.27 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -63.57 148.02 49.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' 1231 ' ' ASP . 37.6 p -138.35 -175.39 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' 1230 ' ' THR . 4.8 p-10 48.13 49.24 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.723 0.297 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -38.43 -49.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -93.32 -50.2 5.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . 0.452 ' HA ' ' NE2' ' A' 1150 ' ' GLN . 3.0 tp60 -47.11 -60.06 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -42.7 -60.81 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 86.7 m -43.96 -46.02 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -62.26 -38.76 90.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.19 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 96.7 t -68.93 -43.73 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' 1222 ' ' PHE . 17.6 tp -63.72 -55.32 24.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 62.8 t80 -40.62 -49.51 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.17 92.78 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' 1162 ' ' GLU . 37.9 mttm -55.3 -33.46 63.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' 1161 ' ' VAL . 25.0 mt -74.13 -59.99 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' 1160 ' ' LEU . 97.3 t -37.17 -62.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.06 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' 1159 ' ' LYS . 5.2 pt-20 -38.89 -54.71 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.51 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.644 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.0 ttp180 -54.47 -48.63 71.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -58.56 -65.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' 1167 ' ' HIS . 1.2 ptpm? -47.56 -44.9 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.448 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.7 OUTLIER -58.24 -42.84 87.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.23 -55.16 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -60.44 -47.3 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 57.4 tttp -42.68 -51.06 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.59 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 59.1 mtm -87.69 -5.62 58.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.59 32.62 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.433 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.4 m -114.63 141.31 26.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.596 0.712 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 136.68 23.29 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.97 -17.23 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.41 -40.79 9.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.2 mm -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.59 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.8 tp -53.78 -68.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.42 120.39 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.0 t -72.61 156.38 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -47.01 -43.75 19.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -48.61 -52.68 21.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.32 -40.88 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.644 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.5 mt -58.76 -61.51 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.6 t -41.46 -50.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -52.64 -51.52 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 93.8 mtp -55.95 -36.94 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.12 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -78.42 -63.37 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' HD13 ' A' 1201 ' ' ILE . 25.8 mtt -63.87 -39.33 93.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.7 mtt-85 66.31 54.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.594 0.712 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.78 129.35 17.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 58.2 p -104.89 -26.08 12.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 72.1 p -108.24 149.61 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.422 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.9 p -58.46 -26.89 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.85 -45.85 85.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -73.62 -44.1 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.813 HG21 ' CE3' ' A' 1216 ' ' TRP . 69.7 t -44.26 -45.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.2 mttm -57.38 -35.72 70.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -68.94 -26.12 64.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.842 ' O ' HG12 ' A' 1204 ' ' VAL . 27.2 mm -55.42 98.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' 1201 ' ' ILE . 10.4 t0 -34.58 143.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.33 -46.55 1.43 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.52 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' 1201 ' ' ILE . 9.4 p -76.13 142.31 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 42.5 t -99.83 154.01 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 145.0 10.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.03 -55.72 5.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.5 ttmp? -44.62 -49.47 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -34.63 -49.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -38.16 -65.84 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.0 ptt? -52.67 -25.85 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' 1209 ' ' ALA . 52.7 mt -87.28 32.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.784 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.51 -53.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 111.078 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.5 Cg_exo -47.97 -17.74 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.71 -64.76 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.813 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -62.55 -24.17 67.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' 1216 ' ' TRP . 51.5 mt-10 -58.78 -39.4 80.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 93.3 t -69.21 -41.85 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' 1216 ' ' TRP . 77.5 mt -52.82 -48.45 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -54.66 -44.56 73.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 14.1 t60 -62.83 -56.4 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' 1156 ' ' LEU . 66.2 t80 -44.07 -67.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' 1227 ' ' SER . 61.6 m -50.83 -55.29 17.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' 1223 ' ' CYS . 30.2 mt-30 -35.32 -69.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -37.23 79.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' 1228 ' ' VAL . 2.1 m-80 -85.27 16.6 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.1 t 33.98 50.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' 1226 ' ' ASN . 85.3 t -103.26 141.84 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.61 155.53 40.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.2 p -143.02 -177.08 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 10.9 t0 54.91 51.24 13.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.718 0.294 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' 1147 ' ' ALA . 94.0 mm-40 -37.62 -53.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -94.23 -48.14 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.84 -58.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.1 tt0 -43.79 -60.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 85.1 m -44.41 -48.58 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.78 -33.24 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' 1151 ' ' GLU . 90.2 mt -67.02 -61.89 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 46.9 t -52.39 -43.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.482 HD21 HG12 ' A' 1219 ' ' ILE . 19.3 tp -64.86 -57.34 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.654 ' O ' HG23 ' A' 1161 ' ' VAL . 77.9 t80 -38.76 -42.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.7 -45.72 95.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 26.8 mttm -61.72 -44.09 97.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.599 HD11 HD11 ' A' 1219 ' ' ILE . 21.3 mt -59.97 -52.49 65.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' 1157 ' ' TYR . 85.0 t -48.24 -44.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.08 -45.51 83.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.2 98.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.59 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.8 ttp180 -58.19 -41.69 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' 1166 ' ' LYS . 10.5 tm0? -64.37 -60.5 3.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.462 ' N ' ' OE1' ' A' 1165 ' ' GLN . 5.6 ptmm? -54.92 -35.98 64.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -46.94 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.31 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.28 -45.9 92.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 30.8 tttt -46.38 -55.64 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.901 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.531 ' HE1' ' HG3' ' A' 1211 ' ' MET . 29.3 mtm -79.61 -7.83 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.8 t70 68.43 30.87 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.441 ' O ' ' HB1' ' A' 1168 ' ' ALA . 34.8 m -113.61 139.66 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.692 0.758 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.96 136.7 23.02 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.395 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 -16.76 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.69 9.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.4 mm -56.68 -42.99 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.8 tp -57.35 -70.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.63 131.34 13.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.6 t -80.9 175.47 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' 1185 ' ' VAL . 17.6 p-10 -62.23 -46.73 87.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -53.21 17.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.18 -52.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.59 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.8 mt -52.44 -49.92 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' 1189 ' ' LYS . 95.5 t -49.92 -52.83 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -50.03 -55.27 15.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 71.1 mtp -47.47 -44.75 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.88 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.527 ' HD2' HG12 ' A' 1185 ' ' VAL . 29.6 mtpt -78.17 -62.16 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.77 -37.58 79.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' 1192 ' ' PRO . 27.2 mtp180 63.74 51.96 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.73 139.43 40.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 18.9 p -124.23 25.72 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.179 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.429 ' O ' HG23 ' A' 1198 ' ' VAL . 27.2 p -140.26 125.65 18.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.497 HG23 ' CH2' ' A' 1216 ' ' TRP . 13.3 p -44.59 -33.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.7 -62.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -48.68 -43.16 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.541 HG21 ' CE3' ' A' 1216 ' ' TRP . 87.1 t -50.53 -39.99 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -62.04 -23.54 66.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' 1204 ' ' VAL . 27.4 mm -61.53 142.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 32.6 t0 -67.46 139.65 57.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.03 -52.22 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' 1201 ' ' ILE . 6.1 p -65.59 137.05 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.1 t -100.06 145.42 27.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -38.86 135.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 86.5 -57.37 4.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.6 OUTLIER -40.53 -54.09 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' 1204 ' ' VAL . . . -34.79 -48.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.73 -62.65 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . 0.531 ' HG3' ' HE1' ' A' 1171 ' ' MET . 4.3 ptt? -50.06 -22.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.69 35.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.54 -52.99 32.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 0.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.03 -67.38 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -59.2 -23.77 62.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.432 ' N ' ' CD1' ' A' 1216 ' ' TRP . 12.3 mm-40 -57.63 -45.28 85.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.65 -42.92 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.599 HD11 HD11 ' A' 1160 ' ' LEU . 87.8 mt -61.78 -26.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -68.26 -35.95 78.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -82.04 -49.3 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.42 ' HB3' ' NH2' ' A' 1191 ' ' ARG . 30.0 t80 -40.31 -42.49 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.6 p -77.54 -37.22 51.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -61.35 -43.84 98.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.533 HG23 ' ND2' ' A' 1226 ' ' ASN . 7.1 t -75.43 -37.97 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.533 ' ND2' HG23 ' A' 1225 ' ' THR . 33.8 m-80 -93.44 16.08 14.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' 1226 ' ' ASN . 22.6 t 34.9 51.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' 1226 ' ' ASN . 45.7 t -105.92 157.55 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' 1228 ' ' VAL . 4.0 pm0 -81.11 152.49 27.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 67.9 p -145.78 -179.66 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.47 45.83 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.778 0.323 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 67.3 mt-30 -34.49 -51.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -96.17 -51.02 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -38.47 -63.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.627 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.9 tp10 -42.35 -62.86 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.3 m -40.14 -50.24 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.24 -39.39 82.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' 1151 ' ' GLU . 75.3 mt -60.64 -57.71 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.5 t -57.59 -43.21 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.647 HD13 ' CG ' ' A' 1222 ' ' PHE . 23.6 tp -63.84 -62.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' 1161 ' ' VAL . 65.9 t80 -35.84 -45.44 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.54 90.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 23.1 mttm -56.91 -44.18 82.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.601 HD21 HG13 ' A' 1219 ' ' ILE . 34.3 mt -62.92 -43.79 97.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' 1157 ' ' TYR . 84.4 t -56.54 -46.13 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -53.75 -39.1 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.8 -49.19 63.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.631 ' HG3' HD23 ' A' 1178 ' ' LEU . 18.7 ttp180 -53.68 -44.31 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.72 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' 1167 ' ' HIS . 0.5 OUTLIER -53.5 -41.96 66.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.467 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.8 OUTLIER -62.38 -45.05 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.61 -59.12 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -55.82 -45.53 78.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -43.78 -54.69 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.523 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 38.8 mtm -84.77 -1.92 56.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.68 29.52 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.7 m -111.62 141.24 24.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.98 138.54 21.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.236 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.96 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.302 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.14 -47.88 6.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.5 mm -48.01 -39.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.631 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.2 tp -58.78 -67.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -149.35 147.6 28.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.088 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 57.8 p -89.43 169.75 11.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' 1185 ' ' VAL . 6.7 m-80 -65.45 -33.84 76.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -62.45 -50.17 72.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 90.5 mt -55.75 -46.49 79.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.433 HD11 ' HD3' ' A' 1164 ' ' ARG . 83.5 mt -59.95 -53.29 59.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -48.41 -47.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.609 ' CB ' HG23 ' A' 1201 ' ' ILE . 67.7 m-20 -59.24 -45.56 90.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 89.4 mtp -58.1 -40.79 82.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.23 75.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -77.26 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 13.8 mtt -65.0 -41.2 95.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' A' 1192 ' ' PRO . 33.8 mtt-85 68.18 54.39 0.63 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.8 134.5 28.04 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.661 2.241 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.1 p -102.11 -33.17 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 60.8 p -101.82 149.92 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 12.5 p -57.23 -33.6 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.05 -47.43 68.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -66.5 -46.37 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.504 HG21 ' CE3' ' A' 1216 ' ' TRP . 99.1 t -50.74 -54.5 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.191 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -46.5 -36.29 6.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.19 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.609 HG23 ' CB ' ' A' 1186 ' ' ASP . 37.9 mm -43.21 148.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.56 139.69 43.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 97.46 -49.14 1.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.514 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' 1201 ' ' ILE . 6.3 p -66.13 131.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 7.7 t -95.77 173.74 7.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.31 143.39 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.83 -54.02 4.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' 1204 ' ' VAL . 28.5 ttmt -41.67 -53.78 3.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.2 -50.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.74 -66.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.13 -25.14 1.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 69.8 mt -89.44 32.26 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -69.12 -53.3 14.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 111.105 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.0 Cg_exo -47.9 -18.16 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.392 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.04 -69.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.554 ' C ' ' CD1' ' A' 1216 ' ' TRP . 1.1 p90 -57.36 -26.32 60.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.5 mt-10 -56.5 -37.28 70.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.2 t -71.13 -41.82 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.601 HG13 HD21 ' A' 1160 ' ' LEU . 89.3 mt -53.83 -53.45 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.102 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -45.12 -45.1 11.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -72.62 -46.58 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.647 ' CG ' HD13 ' A' 1156 ' ' LEU . 49.9 t80 -50.17 -59.59 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' 1227 ' ' SER . 25.7 p -54.89 -47.91 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -42.0 -69.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -62.01 -40.54 96.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.479 ' O ' HG23 ' A' 1228 ' ' VAL . 72.1 m-80 -80.41 13.54 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' 1223 ' ' CYS . 79.0 p 33.7 51.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' 1226 ' ' ASN . 84.7 t -102.76 143.33 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.78 160.42 30.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 59.1 p -148.02 -179.23 6.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 39.8 t0 65.67 40.06 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.778 0.323 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 27.1 mt-30 -36.64 -50.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -94.37 -51.91 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -45.27 -56.06 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.663 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.5 tt0 -51.56 -58.4 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . 0.481 HG22 ' NH1' ' A' 1191 ' ' ARG . 96.8 m -44.82 -41.78 7.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 37.3 mt-30 -67.24 -37.22 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' 1151 ' ' GLU . 63.1 mt -62.96 -57.24 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 75.2 t -57.28 -45.1 84.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' 1157 ' ' TYR . 22.8 tp -62.16 -62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 54.4 t80 -36.58 -56.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -48.97 -43.79 31.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.472 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' 1222 ' ' PHE . 5.8 mtmp? -66.08 -40.25 90.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.927 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.2 t -56.3 -42.05 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -54.29 -53.78 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.26 96.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.728 ' HE ' HD11 ' A' 1184 ' ' LEU . 7.1 tmm_? -57.82 -26.41 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.802 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.24 -72.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' 1167 ' ' HIS . 2.3 pttm -40.7 -29.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.3 t60 -78.13 -45.53 23.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.458 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -47.63 -53.1 15.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -58.49 -40.24 82.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -48.63 -56.87 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' 1178 ' ' LEU . 69.5 mtm -80.35 4.64 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 49.7 m-20 58.51 36.29 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.1 m -114.95 141.59 27.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.677 0.751 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 133.58 23.06 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.383 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -47.95 -18.47 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.39 -40.44 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 25.1 mm -58.23 -47.73 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' 1171 ' ' MET . 14.4 tp -53.14 -63.86 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -153.13 120.3 5.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 6.4 t -75.9 146.04 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' 1185 ' ' VAL . 26.8 m-80 -41.76 -44.57 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -46.06 -53.01 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.43 -56.49 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.728 HD11 ' HE ' ' A' 1164 ' ' ARG . 66.1 mt -51.26 -52.26 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' 1181 ' ' ASN . 89.6 t -44.68 -49.29 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.32 -44.48 91.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' 1192 ' ' PRO . 74.7 mtp -55.72 -41.52 73.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.21 -30.82 69.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.423 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 6.3 mtpm? -77.25 -58.35 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 24.7 mtt -68.71 -40.86 79.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' 1152 ' ' THR . 35.1 mtt-85 68.74 55.08 0.58 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.81 137.31 35.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 0.0 112.334 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . 0.434 HG23 ' HB ' ' A' 1230 ' ' THR . 50.7 p -105.59 -29.3 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 66.0 p -107.92 148.92 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.565 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.8 p -58.97 -39.7 78.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' 1195 ' ' VAL . 7.4 mm-40 -47.33 -29.54 2.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -90.94 -39.16 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.772 HG21 ' CE3' ' A' 1216 ' ' TRP . 74.4 t -55.79 -49.02 77.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -56.31 -30.53 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.34 -24.22 62.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 35.3 mm -52.43 146.76 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -68.96 138.24 54.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.11 -51.95 1.02 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.645 HG23 ' HE2' ' A' 1208 ' ' LYS . 9.7 p -70.86 144.26 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 5.8 t -100.04 157.85 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -51.4 140.38 17.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 81.51 -55.49 4.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.645 ' HE2' HG23 ' A' 1204 ' ' VAL . 25.3 ttpt -39.61 -56.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.75 -43.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.36 -62.44 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 7.6 ptt? -55.88 -23.42 31.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 96.1 mt -89.85 34.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.654 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.79 -48.64 29.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.0 -17.15 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' 1215 ' ' LEU . 6.4 mp -82.22 -66.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.772 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -61.48 -25.44 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.466 ' N ' ' CD1' ' A' 1216 ' ' TRP . 20.3 mt-10 -57.68 -36.5 72.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 99.0 t -68.8 -39.02 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.05 -53.04 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -46.21 -42.58 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -76.74 -45.39 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.418 ' HB2' ' NZ ' ' A' 1159 ' ' LYS . 17.0 t80 -52.99 -39.84 63.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -79.9 -29.0 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.69 -38.24 90.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.761 HG23 HD22 ' A' 1226 ' ' ASN . 4.5 t -87.07 -16.58 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.761 HD22 HG23 ' A' 1225 ' ' THR . 18.3 m-80 -119.65 18.48 12.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' 1223 ' ' CYS . 14.8 m 34.23 46.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' 1223 ' ' CYS . 85.4 t -84.83 152.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . 0.492 ' HB3' HD21 ' A' 1232 ' ' LEU . 0.8 OUTLIER -74.12 140.58 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.935 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' 1193 ' ' THR . 21.5 p -129.1 176.57 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 43.52 47.23 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' 1229 ' ' GLN . 26.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.728 0.299 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' 1147 ' ' ALA . 87.2 mt-30 -37.63 -51.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.76 -48.96 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -44.36 -51.74 8.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' 1154 ' ' ILE . 4.1 tt0 -52.29 -57.94 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 78.0 m -44.17 -43.49 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -65.73 -37.16 85.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.1 mt -64.93 -43.16 96.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.8 t -70.82 -41.04 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' 1222 ' ' PHE . 21.6 tp -69.33 -55.81 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.602 ' O ' HG23 ' A' 1161 ' ' VAL . 43.2 t80 -37.44 -43.62 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.98 -47.53 88.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 46.3 mttm -56.61 -41.76 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.751 HD21 HD11 ' A' 1219 ' ' ILE . 28.2 mt -63.88 -42.8 97.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' 1157 ' ' TYR . 94.0 t -59.64 -42.15 87.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.35 -39.22 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.53 72.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.952 ' HG3' HD23 ' A' 1178 ' ' LEU . 43.3 ttm-85 -79.76 -43.12 23.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.34 -34.96 62.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.2 pttp -84.31 -38.34 20.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' 1170 ' ' LYS . 0.6 OUTLIER -63.97 -56.76 12.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -37.27 -53.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.68 -37.8 85.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' 1167 ' ' HIS . 18.4 ttmt -55.95 -51.75 66.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . . . . . . . . . 15.7 mtm -80.07 -1.4 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 68.19 30.09 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.618 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.2 m -119.66 134.53 23.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.99 141.86 16.41 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.97 -16.64 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.75 -47.01 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 12.7 mm -51.43 -42.76 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.952 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.4 tp -56.83 -57.34 12.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' 1164 ' ' ARG . . . -160.38 156.07 25.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 26.1 p -94.48 161.12 14.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.113 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' 1185 ' ' VAL . 79.1 m-20 -54.85 -28.64 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 26.7 tptt -62.62 -51.78 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 -40.06 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.855 HD21 ' HE ' ' A' 1164 ' ' ARG . 63.2 mt -60.76 -54.46 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' 1181 ' ' ASN . 79.9 t -49.31 -36.69 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.2 m-20 -60.65 -62.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 95.0 mtp -55.51 -20.55 13.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -75.12 -21.68 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 21.4 mttm -102.82 -51.97 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.45 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.1 OUTLIER -74.45 -20.91 59.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.633 HH21 HD11 ' A' 1232 ' ' LEU . 13.0 ptt180 33.65 55.05 1.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.78 149.48 66.81 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.391 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 61.6 p -127.35 24.11 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 120.97 14.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' 1216 ' ' TRP . 11.3 p -40.31 -39.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . 0.417 ' N ' HG13 ' A' 1195 ' ' VAL . 17.5 mt-10 -56.69 -66.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -48.25 -41.96 29.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.525 HG21 ' CE3' ' A' 1216 ' ' TRP . 94.9 t -50.17 -47.95 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.2 mttp -50.07 -30.92 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -70.98 -29.59 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' 1186 ' ' ASP . 26.0 mm -53.53 101.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' 1201 ' ' ILE . 12.3 t70 -35.3 145.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 96.01 -41.05 2.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' 1201 ' ' ILE . 9.3 p -78.22 138.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 111.068 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 4.0 m -99.98 140.79 33.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -40.22 138.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.88 -58.82 5.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' 1209 ' ' ALA . 38.7 tttt -40.38 -55.71 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.638 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -33.93 -39.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.3 -65.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.1 ptt? -49.31 -25.51 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.1 mt -88.94 26.76 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.68 -52.36 26.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.565 0.698 . . . . 0.0 111.05 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -48.01 -16.94 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.678 2.252 . . . . 0.0 112.321 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . 0.565 ' CD2' ' NH2' ' A' 1164 ' ' ARG . 7.3 mp -82.24 -71.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -52.83 -15.8 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.26 -38.86 88.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -66.4 -50.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.751 HD11 HD21 ' A' 1160 ' ' LEU . 82.1 mt -46.49 -40.95 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -55.06 -40.39 70.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -76.84 -42.94 38.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.691 ' CD2' HD13 ' A' 1156 ' ' LEU . 17.9 t80 -53.95 -61.38 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' 1227 ' ' SER . 22.8 p -53.87 -45.67 71.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.874 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -43.4 -68.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -63.87 -39.45 94.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.454 ' O ' ' C ' ' A' 1227 ' ' SER . 2.6 m-80 -81.22 13.13 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' 1223 ' ' CYS . 72.2 m 33.84 50.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.539 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 84.2 t -97.5 149.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.93 154.77 40.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 20.5 p -145.56 158.77 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 43.4 t0 64.77 42.56 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . 0.633 HD11 HH21 ' A' 1191 ' ' ARG . 26.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 54.8 mt-30 -34.75 -52.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.57 -53.47 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -42.76 -59.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -42.75 -57.14 2.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . 0.493 HG22 ' HE ' ' A' 1191 ' ' ARG . 90.9 m -46.71 -50.5 17.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.14 -40.86 95.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.73 -58.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 73.6 t -54.75 -39.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' 1222 ' ' PHE . 12.8 tp -66.32 -57.75 6.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' 1161 ' ' VAL . 75.1 t80 -38.34 -46.69 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.12 -46.23 91.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' 1162 ' ' GLU . 21.1 mttm -59.45 -33.22 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 25.2 mt -75.06 -52.67 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' 1157 ' ' TYR . 95.7 t -40.16 -62.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' 1159 ' ' LYS . 4.6 pt-20 -40.47 -56.39 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.68 94.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.673 ' HG3' HD21 ' A' 1184 ' ' LEU . 7.2 tmm_? -59.15 -28.57 66.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' 1168 ' ' ALA . 31.8 tt0 -82.0 -71.6 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 8.9 pttp -43.39 -29.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.525 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.9 t60 -78.02 -37.51 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.773 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.66 -61.71 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -55.7 -35.28 65.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 9.9 tttp -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.614 ' HE2' HD11 ' A' 1178 ' ' LEU . 27.3 mtm -76.41 6.27 5.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.36 29.15 18.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.3 m -114.57 139.75 24.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.94 140.23 18.78 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -48.05 -16.68 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.63 -52.34 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 32.9 mm -47.67 -46.7 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.773 HD22 ' CA ' ' A' 1168 ' ' ALA . 16.9 tp -49.46 -65.97 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -148.28 118.46 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.5 t -72.91 139.1 46.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' 1180 ' ' THR . 31.9 m120 -35.77 -46.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.9 tptm -43.34 -58.16 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.39 -59.16 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.673 HD21 ' HG3' ' A' 1164 ' ' ARG . 33.6 mt -47.38 -44.73 24.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 55.4 t -56.5 -55.03 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.486 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -58.89 -42.03 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.2 mtp -58.37 -35.69 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.1 74.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.436 ' CE ' ' HA ' ' A' 1186 ' ' ASP . 49.5 mtmt -76.75 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 13.9 mtt -67.07 -39.27 86.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.493 ' HE ' HG22 ' A' 1152 ' ' THR . 36.1 mtt85 64.31 53.4 1.33 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.639 0.733 . . . . 0.0 110.935 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.71 126.9 13.89 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 34.0 p -96.27 -32.08 12.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.45 ' O ' HG23 ' A' 1198 ' ' VAL . 73.3 p -101.24 147.58 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.572 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -57.52 -36.53 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.158 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -48.38 -52.02 23.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -68.19 -45.96 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' 1194 ' ' THR . 99.5 t -48.4 -52.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . 0.492 ' HD2' HG22 ' A' 1195 ' ' VAL . 4.8 mtpm? -49.53 -33.88 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -68.39 -27.97 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.795 ' O ' HG12 ' A' 1204 ' ' VAL . 30.7 mm -51.21 139.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 30.4 t0 -65.66 141.05 58.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.85 -48.45 1.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' 1201 ' ' ILE . 9.0 p -65.7 137.44 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 3.0 m -100.0 142.78 31.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -39.06 130.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.96 -63.64 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' 1207 ' ' GLY . 18.1 ttmt -34.36 -48.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.34 -49.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.94 -63.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.2 ptt? -53.0 -22.63 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' 1209 ' ' ALA . 84.1 mt -90.7 32.68 0.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.3 -52.32 12.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 111.132 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -47.99 -17.36 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.44 -67.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.572 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.1 p90 -58.74 -26.98 64.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' 1216 ' ' TRP . 10.1 mt-10 -54.89 -35.81 64.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 74.7 t -71.14 -35.77 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.5 mt -62.6 -46.93 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -47.36 -39.21 14.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.54 ' CD2' ' HG2' ' A' 1224 ' ' GLN . 3.4 t-160 -80.64 -52.78 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.588 ' CG ' HD13 ' A' 1156 ' ' LEU . 47.2 t80 -38.95 -33.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' 1227 ' ' SER . 21.8 p -92.98 -28.64 16.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.54 ' HG2' ' CD2' ' A' 1221 ' ' HIS . 3.5 pt20 -66.52 -46.6 75.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.715 HG23 HD22 ' A' 1226 ' ' ASN . 9.0 t -76.7 -11.98 59.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.715 HD22 HG23 ' A' 1225 ' ' THR . 23.0 m-80 -123.11 15.24 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' 1223 ' ' CYS . 58.7 p 36.2 49.29 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 89.1 t -93.03 142.17 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -69.56 148.0 50.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 72.6 p -137.48 -177.81 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 7.0 m-20 62.65 43.41 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . 0.435 HD11 HH12 ' A' 1191 ' ' ARG . 11.9 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.726 0.298 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -46.04 -52.45 11.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -99.7 -42.38 6.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . 0.46 HE21 HD11 ' A' 1154 ' ' ILE . 26.4 tt0 -41.89 -57.03 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.7 tt0 -46.76 -56.19 6.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.0 m -50.21 -49.59 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.34 -33.93 71.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.0 mt -64.58 -56.7 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.4 t -59.37 -43.1 89.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' 1222 ' ' PHE . 23.1 tp -59.87 -60.41 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' 1156 ' ' LEU . 58.9 t80 -35.96 -47.97 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.06 -46.16 61.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 51.2 mttt -58.22 -42.37 86.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.704 HD21 HD11 ' A' 1219 ' ' ILE . 39.6 mt -62.74 -42.27 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.2 t -61.07 -44.11 97.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.94 -46.96 85.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.3 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.44 -41.62 76.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.46 -61.49 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 17.2 ptpt -52.27 -46.18 65.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.9 OUTLIER -61.23 -46.43 90.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.84 -51.79 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -61.9 -44.49 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 61.6 tttt -46.34 -56.99 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.493 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.0 mtm -79.68 0.91 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.94 42.62 19.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.6 m -125.14 141.78 39.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.61 0.719 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 135.98 23.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.228 . . . . 0.0 112.349 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.92 -17.45 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.23 -41.2 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.8 mm -54.37 -40.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.493 ' CD1' ' HE3' ' A' 1171 ' ' MET . 10.9 tp -60.13 -62.36 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.29 150.21 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 71.4 p -87.34 167.61 13.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.39 -38.53 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -50.32 73.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 69.9 mt -51.06 -46.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 61.3 mt -56.25 -50.59 70.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.8 t -49.45 -53.61 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.442 ' CB ' HG23 ' A' 1201 ' ' ILE . 9.3 m-20 -54.89 -51.04 67.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.9 mtp -53.69 -40.04 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.44 72.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 31.7 mttm -79.2 -63.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 19.4 mtt -61.29 -40.91 95.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.437 ' NH2' HD11 ' A' 1232 ' ' LEU . 39.2 mtm-85 66.08 55.04 0.99 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.708 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 141.84 46.34 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 57.0 p -110.34 -33.34 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.163 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 25.3 p -100.59 144.18 29.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.711 HG23 ' CZ3' ' A' 1216 ' ' TRP . 8.8 p -56.53 -23.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.49 -46.12 84.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -68.75 -37.75 79.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.521 HG21 ' CE3' ' A' 1216 ' ' TRP . 81.7 t -52.87 -45.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 25.3 mttp -52.18 -36.52 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -65.56 -24.37 67.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.698 ' O ' HG12 ' A' 1204 ' ' VAL . 37.6 mm -54.6 148.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.14 134.76 41.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.16 -44.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.506 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' 1201 ' ' ILE . 9.9 p -59.13 131.84 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.093 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1206 ' ' GLU . 48.9 m -99.97 137.89 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' 1205 ' ' SER . 6.4 tp10 -36.41 127.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 92.51 -60.03 2.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' 1207 ' ' GLY . 0.9 OUTLIER -37.64 -49.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.77 -47.72 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.58 -63.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . 0.466 ' HE3' HD12 ' A' 1178 ' ' LEU . 4.4 ptt? -50.82 -25.05 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' 1215 ' ' LEU . 70.2 mt -88.25 30.9 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.857 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.11 -55.74 19.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 111.096 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -47.96 -18.15 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.338 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' 1212 ' ' LEU . 7.9 mp -79.22 -67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.711 ' CZ3' HG23 ' A' 1195 ' ' VAL . 1.2 p90 -59.19 -26.09 64.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' 1216 ' ' TRP . 14.1 mt-10 -60.08 -37.48 80.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.9 t -70.93 -43.6 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.704 HD11 HD21 ' A' 1160 ' ' LEU . 86.4 mt -56.31 -42.55 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.58 -45.8 63.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.481 ' CD2' ' HG2' ' A' 1224 ' ' GLN . 3.0 t-160 -74.91 -56.65 4.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' 1156 ' ' LEU . 73.3 t80 -34.09 -36.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' 1227 ' ' SER . 78.6 m -90.91 -37.44 13.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' 1225 ' ' THR . 0.2 OUTLIER -55.45 -49.34 72.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.524 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.7 t -68.36 -37.76 80.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.438 ' ND2' HG23 ' A' 1225 ' ' THR . 25.5 m-80 -86.71 -0.76 56.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' 1223 ' ' CYS . 38.8 t 56.08 36.48 27.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' 1229 ' ' GLN . 94.1 t -92.04 153.56 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . 0.423 ' N ' HG12 ' A' 1228 ' ' VAL . 6.3 tp60 -71.9 146.51 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 24.8 p -137.52 -179.01 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 2.2 p30 44.6 48.82 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . 0.437 HD11 ' NH2' ' A' 1191 ' ' ARG . 14.9 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.737 0.304 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.3 pt20 -33.07 -50.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -97.47 -51.53 4.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -43.12 -53.93 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.02 -60.35 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.0 m -42.46 -46.7 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.132 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.68 -39.33 91.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 80.9 mt -64.32 -52.13 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . 0.67 HG12 ' HZ1' ' A' 1159 ' ' LYS . 92.8 t -61.6 -39.14 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.127 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.937 HD13 ' CD2' ' A' 1222 ' ' PHE . 32.3 tp -69.02 -55.95 9.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' 1161 ' ' VAL . 74.4 t80 -36.62 -46.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -56.79 -50.15 65.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.67 ' HZ1' HG12 ' A' 1155 ' ' VAL . 40.2 mttp -52.82 -44.08 66.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.776 HD21 HD11 ' A' 1219 ' ' ILE . 29.0 mt -61.75 -52.23 65.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.95 HG22 HD13 ' A' 1184 ' ' LEU . 61.7 t -54.04 -42.76 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.69 -47.99 78.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.12 72.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' 1178 ' ' LEU . 10.0 ttp180 -50.25 -39.75 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -64.83 -68.01 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' 1167 ' ' HIS . 15.8 pttp -48.8 -41.44 32.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.473 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.1 t60 -66.35 -45.86 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -42.79 -62.75 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -50.73 -38.24 46.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -51.21 -56.7 11.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . . . . . . . . . 44.8 mtm -82.13 7.15 14.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.8 t70 57.73 36.1 26.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.492 ' O ' ' HB1' ' A' 1168 ' ' ALA . 26.9 m -118.08 138.43 25.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' 1175 ' ' PRO . 64.8 Cg_exo -47.96 136.61 23.08 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1174 ' ' PRO . 66.4 Cg_exo -48.05 -16.85 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.718 2.279 . . . . 0.0 112.288 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.01 -42.87 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.12 -46.78 77.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.4 tp -52.73 -66.04 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -143.61 127.23 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.7 t -83.95 165.46 18.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' 1185 ' ' VAL . 2.6 p30 -53.06 -45.0 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -49.49 -48.13 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -56.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.95 HD13 HG22 ' A' 1161 ' ' VAL . 77.5 mt -47.59 -54.34 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' 1181 ' ' ASN . 78.4 t -47.18 -47.69 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.151 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.69 -55.08 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 37.2 mtp -51.65 -16.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -87.15 -51.13 6.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' A' 1201 ' ' ILE . 0.0 OUTLIER -83.28 -18.13 40.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' 1190 ' ' MET . 15.5 ptt180 33.37 54.95 1.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.671 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.3 Cg_endo -69.79 151.57 68.91 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.69 2.26 . . . . 0.0 112.309 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.6 p -130.83 27.62 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.506 ' O ' HG23 ' A' 1198 ' ' VAL . 29.2 p -140.05 125.08 18.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' 1196 ' ' GLU . 11.5 p -42.14 -42.2 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . 0.448 ' N ' HG13 ' A' 1195 ' ' VAL . 16.1 mt-10 -57.75 -60.89 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.28 -40.49 61.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.736 HG21 ' CE3' ' A' 1216 ' ' TRP . 92.8 t -50.36 -38.98 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 21.8 mttm -59.61 -25.73 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -72.18 -26.49 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' 1192 ' ' PRO . 40.4 mm -51.63 142.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.89 135.13 43.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.05 -50.71 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.3 p -67.61 132.23 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 23.8 p -99.74 157.19 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -49.58 149.57 2.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.73 -54.08 4.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' 1209 ' ' ALA . 2.7 ttmp? -53.09 -49.03 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.04 -46.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -44.79 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -48.64 -23.82 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.02 34.85 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.661 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.54 -49.09 16.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.8 Cg_exo -47.99 -19.22 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' 1215 ' ' LEU . 7.0 mp -79.89 -64.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.736 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.7 OUTLIER -64.83 -25.11 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.424 ' N ' ' CD1' ' A' 1216 ' ' TRP . 11.4 mt-10 -56.71 -43.52 80.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 71.9 t -67.06 -48.61 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.776 HD11 HD21 ' A' 1160 ' ' LEU . 68.8 mt -47.05 -37.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -36.72 75.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.636 ' O ' HG22 ' A' 1225 ' ' THR . 3.1 t-160 -79.82 -43.2 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.937 ' CD2' HD13 ' A' 1156 ' ' LEU . 30.0 t80 -55.68 -40.08 71.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.7 p -83.48 -31.71 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -63.46 -40.68 97.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.732 HG23 HD22 ' A' 1226 ' ' ASN . 5.6 t -80.66 -23.61 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.732 HD22 HG23 ' A' 1225 ' ' THR . 10.9 m-80 -108.88 22.05 16.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1226 ' ' ASN . 6.8 t 34.38 42.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' 1226 ' ' ASN . 95.1 t -89.6 144.18 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -70.64 162.49 28.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 76.7 p -151.66 -178.56 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.5 50.26 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' 1147 ' ' ALA . 14.6 mt-30 -35.81 -47.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.01 -48.97 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' 1154 ' ' ILE . 11.8 tt0 -50.53 -61.1 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.585 ' HA ' HD12 ' A' 1154 ' ' ILE . 14.3 tt0 -40.01 -58.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.4 m -48.94 -47.17 43.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.159 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -65.5 -32.64 74.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' 1151 ' ' GLU . 77.0 mt -67.36 -54.62 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 60.9 t -60.96 -40.43 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.78 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.5 tp -65.36 -58.41 5.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.58 -57.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -47.42 -46.42 22.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttm -59.27 -42.45 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.671 HD21 HD11 ' A' 1219 ' ' ILE . 23.6 mt -62.4 -46.86 86.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.49 HG22 HD13 ' A' 1184 ' ' LEU . 70.2 t -54.23 -40.81 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.27 -50.95 71.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.68 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.4 ttp180 -52.74 -38.16 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' 1166 ' ' LYS . 12.6 tm0? -69.04 -70.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' 1166 ' ' LYS . 0.2 OUTLIER -44.37 -39.32 4.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.501 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 1.6 t60 -70.42 -43.73 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.68 -62.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -52.94 -34.6 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -50.52 -53.45 30.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.594 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 66.2 mtm -83.15 -6.34 59.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.84 28.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 30.9 m -112.95 141.27 25.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.03 139.02 21.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.98 -17.77 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.23 -43.75 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' 1177 ' ' ILE . 9.4 mm -51.16 -46.1 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.594 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.4 tp -54.85 -69.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -139.5 135.06 33.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' 1181 ' ' ASN . 8.4 t -91.76 139.03 31.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' 1180 ' ' THR . 11.1 m-20 -34.65 -42.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -46.4 -51.23 15.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.1 -48.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' 1164 ' ' ARG . 81.2 mt -51.72 -56.03 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 84.7 t -45.54 -51.6 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.93 -44.51 94.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 48.8 mmm -54.73 -42.5 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.18 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.26 -64.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.459 ' CE ' HD13 ' A' 1201 ' ' ILE . 12.2 mtt -68.9 -42.18 77.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.473 ' NH1' HD11 ' A' 1232 ' ' LEU . 34.2 mtt85 70.61 52.7 0.39 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.76 136.27 32.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' 1220 ' ' LYS . 17.9 p -123.7 23.16 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.18 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.408 ' O ' HG23 ' A' 1198 ' ' VAL . 12.0 p -139.77 138.14 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.571 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 6.8 p -54.91 -27.2 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.25 -54.05 14.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . 0.406 ' ND2' ' OD1' ' A' 1231 ' ' ASP . 34.9 m-20 -59.11 -49.36 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.793 HG21 ' HE3' ' A' 1216 ' ' TRP . 91.3 t -46.43 -37.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -63.68 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.33 -26.96 66.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.617 ' O ' HG12 ' A' 1204 ' ' VAL . 24.7 mm -56.23 145.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.73 145.57 53.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.59 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.466 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.736 HG23 ' HG2' ' A' 1208 ' ' LYS . 4.4 p -62.27 132.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 31.9 m -100.21 136.7 39.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.08 114.16 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 121.83 -70.6 0.4 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.736 ' HG2' HG23 ' A' 1204 ' ' VAL . 0.0 OUTLIER -32.98 -44.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.73 0.3 . . . . 0.0 110.876 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -30.43 -46.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.063 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.77 -62.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.103 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 15.4 ptt? -63.16 -23.3 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' 1209 ' ' ALA . 81.0 mt -85.77 31.47 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.88 -51.24 2.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.541 0.686 . . . . 0.0 111.122 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -48.02 -21.79 3.03 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.64 -67.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.793 ' HE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.05 -24.63 66.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' 1216 ' ' TRP . 6.4 mt-10 -60.31 -36.95 79.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 53.7 t -73.45 -43.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.671 HD11 HD21 ' A' 1160 ' ' LEU . 56.7 mt -55.1 -34.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' 1193 ' ' THR . 13.7 ttpt -59.2 -48.12 82.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' 1225 ' ' THR . 13.4 t60 -73.75 -41.25 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' 1156 ' ' LEU . 36.3 t80 -53.25 -41.76 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.1 p -82.33 -34.51 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -64.98 -37.17 86.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.785 HG23 HD22 ' A' 1226 ' ' ASN . 10.2 t -83.35 -18.8 37.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.785 HD22 HG23 ' A' 1225 ' ' THR . 12.7 m-80 -116.93 21.2 13.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' 1226 ' ' ASN . 74.4 m 34.32 42.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' 1226 ' ' ASN . 57.6 t -91.02 147.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -73.81 147.55 43.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 38.7 p -143.4 173.8 11.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . 0.406 ' OD1' ' ND2' ' A' 1197 ' ' ASN . 4.2 m-20 60.81 51.6 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . 0.473 HD11 ' NH1' ' A' 1191 ' ' ARG . 11.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 49.5 mt-30 -35.55 -52.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.27 -51.42 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -43.05 -59.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' 1154 ' ' ILE . 9.4 tt0 -43.68 -61.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.6 m -43.37 -42.57 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -72.04 -36.21 69.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' 1151 ' ' GLU . 82.4 mt -64.56 -49.91 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . 0.709 HG12 ' HE2' ' A' 1159 ' ' LYS . 48.0 t -66.09 -40.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.8 tp -64.01 -57.15 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 65.6 t80 -40.51 -49.23 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.72 61.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' 1155 ' ' VAL . 33.8 mttm -59.19 -41.27 88.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.96 -52.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.7 t -49.39 -34.05 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.05 -51.42 58.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.2 -59.1 3.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.656 HH21 ' HB2' ' A' 1168 ' ' ALA . 0.0 OUTLIER -46.94 -44.14 19.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . 0.428 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 44.3 tt0 -63.35 -72.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' 1167 ' ' HIS . 9.3 ptpt -43.09 -28.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.423 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -60.66 -53.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.656 ' HB2' HH21 ' A' 1164 ' ' ARG . . . -37.14 -53.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -58.14 -46.8 85.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 29.6 tttt -47.99 -51.12 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.793 ' O ' HG13 ' A' 1173 ' ' VAL . 55.8 mtm -92.52 15.29 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 35.7 t70 43.04 40.79 2.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' 1171 ' ' MET . 32.9 m -117.34 141.42 28.64 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.626 0.727 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.9 132.92 22.56 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.356 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . 0.409 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 65.2 Cg_exo -48.0 -17.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.682 2.255 . . . . 0.0 112.325 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.81 -45.37 7.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.4 mm -51.2 -43.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.6 ' CD1' ' CE ' ' A' 1171 ' ' MET . 8.4 tp -64.69 -69.79 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.629 ' HB3' ' HD2' ' A' 1164 ' ' ARG . . . -150.66 147.38 27.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 70.2 p -94.06 173.79 7.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' 1185 ' ' VAL . 87.7 m-20 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -61.66 -52.44 64.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . 0.586 HG23 HG21 ' A' 1201 ' ' ILE . 92.0 mt -52.59 -51.29 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.0 mt -47.51 -53.98 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -45.19 -45.84 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -55.23 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 62.2 mmm -47.0 -41.23 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.0 95.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -71.26 -60.6 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.46 ' SD ' HD13 ' A' 1201 ' ' ILE . 38.1 mtt -63.9 -49.31 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.498 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 24.6 mtm180 69.39 54.78 0.52 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.568 0.699 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.5 Cg_endo -69.75 133.78 26.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.338 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . 0.414 ' HB ' ' CD ' ' A' 1220 ' ' LYS . 33.1 p -104.16 -22.18 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.3 p -108.1 144.42 35.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 10.5 p -50.52 -35.63 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' 1200 ' ' ARG . 14.8 mt-10 -55.82 -68.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . 0.421 ' C ' ' HD3' ' A' 1200 ' ' ARG . 84.9 m-20 -41.7 -36.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.485 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.6 t -63.05 -49.07 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.21 -29.58 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' 1196 ' ' GLU . 2.1 mpt_? -67.57 -31.69 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' 1204 ' ' VAL . 23.8 mm -48.91 135.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.39 141.55 57.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.48 -44.27 1.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' 1201 ' ' ILE . 3.4 p -76.88 137.6 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 74.3 m -96.14 172.11 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.58 129.94 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 94.02 -59.66 2.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.448 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.596 ' HE2' HG23 ' A' 1204 ' ' VAL . 30.1 tttt -37.95 -47.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -38.13 -44.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.25 -59.82 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.5 ptt? -53.11 -24.8 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 33.89 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.83 -49.27 27.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.725 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -47.99 -19.14 1.41 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' 1215 ' ' LEU . 7.1 mp -80.64 -68.35 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.576 ' C ' ' CD1' ' A' 1216 ' ' TRP . 0.8 OUTLIER -61.6 -19.19 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.06 -35.11 80.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.3 t -73.16 -45.48 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.4 mt -52.28 -56.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . 0.414 ' CD ' ' HB ' ' A' 1193 ' ' THR . 16.1 ttpp -43.05 -49.07 6.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.55 -53.52 33.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' 1156 ' ' LEU . 22.1 t80 -47.51 -52.26 17.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' 1230 ' ' THR . 26.4 p -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -61.82 -36.33 80.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.521 HG22 ' O ' ' A' 1222 ' ' PHE . 6.2 t -85.84 -27.58 25.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.448 ' CB ' HG23 ' A' 1228 ' ' VAL . 24.1 m-80 -99.39 6.33 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.4 t 50.5 34.6 9.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.498 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 45.3 t -87.01 143.73 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.7 148.36 50.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . 0.454 HG21 ' SG ' ' A' 1223 ' ' CYS . 22.0 p -149.17 175.5 11.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.69 51.94 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.731 0.301 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' 1147 ' ' ALA . 16.1 mt-30 -34.39 -56.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.36 -48.28 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -40.85 -60.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.0 tt0 -46.04 -60.72 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.2 m -42.16 -46.12 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -66.06 -43.8 86.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' 1151 ' ' GLU . 76.3 mt -57.1 -55.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.2 t -60.85 -43.2 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' 1222 ' ' PHE . 28.5 tp -60.66 -60.86 3.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' 1161 ' ' VAL . 64.5 t80 -35.29 -47.42 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -59.55 -51.97 55.88 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -50.12 -42.24 50.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.64 -51.58 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' 1157 ' ' TYR . 95.5 t -45.66 -57.2 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.152 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.96 -57.5 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.38 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.691 ' HD3' HD11 ' A' 1184 ' ' LEU . 16.9 ttp180 -57.57 -45.24 85.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.38 -54.01 50.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' 1167 ' ' HIS . 8.8 pttm -64.11 -38.62 91.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.479 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -61.71 -51.03 70.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.03 -53.49 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.98 -45.58 92.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' 1170 ' ' LYS . 6.6 tmtm? -48.49 -51.18 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.819 ' O ' HG13 ' A' 1173 ' ' VAL . 50.0 mtm -91.53 15.36 12.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 36.9 t70 42.74 37.0 0.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' 1171 ' ' MET . 34.9 m -116.0 136.81 23.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.603 0.716 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.97 134.63 23.66 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.02 -16.41 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.372 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.84 -45.06 8.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.057 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.96 -45.05 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.595 ' CD1' ' HE2' ' A' 1171 ' ' MET . 10.9 tp -52.0 -69.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.06 114.85 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.6 t -64.89 176.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.631 ' O ' HG23 ' A' 1185 ' ' VAL . 5.3 m120 -61.67 -47.44 85.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -44.67 -55.28 5.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 91.9 mt -51.52 -62.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.691 HD11 ' HD3' ' A' 1164 ' ' ARG . 71.3 mt -45.49 -56.89 4.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' 1181 ' ' ASN . 62.9 t -41.06 -57.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' 1189 ' ' LYS . 4.2 m-20 -56.68 -57.28 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 70.0 mtp -43.94 -23.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' 1186 ' ' ASP . . . -93.12 -32.24 14.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.566 ' HD3' HG12 ' A' 1185 ' ' VAL . 0.2 OUTLIER -74.14 -48.86 26.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -38.76 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 50.2 mtt85 68.74 54.98 0.58 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.2 Cg_endo -69.73 128.06 15.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 67.6 p -101.94 -24.22 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 70.2 p -102.66 135.74 43.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.546 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.5 p -53.3 -42.34 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' 1195 ' ' VAL . 27.0 mp0 -48.5 -35.35 12.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -84.43 -35.02 23.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.469 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.8 t -62.22 -48.51 88.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' 1196 ' ' GLU . 13.2 ptpt -54.46 -17.15 2.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -82.92 -30.68 28.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' 1204 ' ' VAL . 47.9 mm -43.73 144.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.67 135.33 54.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.3 -45.99 1.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1201 ' ' ILE . 3.5 p -81.38 137.04 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.145 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.0 t -100.07 156.05 17.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -47.69 151.32 0.87 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 77.93 -62.91 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' 1209 ' ' ALA . 10.5 ttmm -40.6 -50.46 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.765 0.316 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.74 -46.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.09 -64.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -48.46 -31.73 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' 1209 ' ' ALA . 41.5 mt -84.43 30.36 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.86 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.53 -55.17 15.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.566 0.698 . . . . 0.0 111.05 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.8 Cg_exo -47.99 -17.59 0.87 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.697 2.265 . . . . 0.0 112.34 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.95 -65.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.548 ' C ' ' CD1' ' A' 1216 ' ' TRP . 1.2 p90 -60.88 -26.99 67.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.507 ' N ' ' CD1' ' A' 1216 ' ' TRP . 22.8 mt-10 -55.08 -40.17 70.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -65.79 -42.14 91.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' 1216 ' ' TRP . 70.3 mt -53.71 -49.66 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -51.02 -43.15 60.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.7 t60 -69.62 -47.75 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' 1156 ' ' LEU . 31.6 t80 -53.43 -61.23 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' 1227 ' ' SER . 17.9 p -53.15 -44.14 67.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -45.8 -63.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.5 m -67.69 -40.52 84.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' 1228 ' ' VAL . 70.0 m-80 -81.76 13.59 3.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' 1223 ' ' CYS . 6.5 t 32.55 49.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1226 ' ' ASN . 71.2 t -99.07 138.37 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -64.81 162.68 15.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 53.3 p -146.69 178.16 8.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 38.7 t0 61.19 42.62 11.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.913 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.754 0.311 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 3.3 pt20 -33.38 -49.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -96.62 -52.49 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -43.55 -56.59 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' 1154 ' ' ILE . 8.1 tt0 -52.73 -60.6 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . 0.458 HG22 ' NH1' ' A' 1191 ' ' ARG . 74.0 m -41.4 -46.62 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -61.92 -45.14 95.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' 1151 ' ' GLU . 69.6 mt -55.62 -63.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' 1159 ' ' LYS . 93.7 t -48.63 -54.16 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.557 HD21 HG23 ' A' 1219 ' ' ILE . 9.7 tp -54.04 -63.14 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' 1161 ' ' VAL . 44.2 t80 -38.06 -55.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -50.42 -42.99 43.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.528 ' HD2' HG12 ' A' 1155 ' ' VAL . 3.8 mtpm? -67.5 -43.96 79.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.806 HD21 HG13 ' A' 1219 ' ' ILE . 38.9 mt -60.14 -43.4 95.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.956 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' 1157 ' ' TYR . 98.2 t -57.73 -38.1 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -55.18 -50.52 69.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -68.25 -48.92 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.597 ' HG3' HD21 ' A' 1184 ' ' LEU . 4.7 tmm_? -47.4 -35.13 7.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.6 -69.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.477 ' HA ' ' ND2' ' A' 1169 ' ' ASN . 14.8 ptpt -44.96 -34.44 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.3 t-80 -60.65 -37.29 81.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.45 -53.7 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' 1170 ' ' LYS . 6.4 p30 -61.08 -49.2 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' 1169 ' ' ASN . 0.1 OUTLIER -48.12 -53.07 17.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 34.6 mtm -78.18 -7.61 57.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.907 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 12.5 t0 68.92 26.65 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.8 m -112.66 140.67 24.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.0 139.99 19.46 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . 0.447 ' O ' ' NH1' ' A' 1164 ' ' ARG . 65.9 Cg_exo -48.0 -16.74 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.71 2.273 . . . . 0.0 112.317 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.16 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.8 mm -46.54 -39.45 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.518 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.9 tp -61.04 -72.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -160.17 123.42 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 15.3 t -67.37 162.94 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -52.81 -46.39 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -42.84 -57.81 2.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.9 mt -45.48 -64.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.6 mt -44.69 -52.14 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.3 t -47.15 -54.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.22 -46.6 75.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 36.1 mmm -50.86 -37.58 44.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.92 68.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 9.1 mptt -75.69 -60.91 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.451 ' CE ' HD13 ' A' 1201 ' ' ILE . 14.6 mtt -70.37 -38.29 74.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' 1192 ' ' PRO . 32.0 mtt-85 66.66 52.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.8 137.67 35.9 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.25 . . . . 0.0 112.373 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 64.2 p -127.69 21.69 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 1.2 p -137.53 127.19 25.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' 1210 ' ' ALA . 14.1 p -43.28 -26.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -72.54 -64.59 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -47.65 -43.25 26.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.958 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.2 t -52.43 -42.03 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -58.4 -26.29 63.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -73.83 -33.28 64.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' 1204 ' ' VAL . 43.5 mm -47.5 140.16 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -68.77 142.51 54.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.91 -41.38 2.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.539 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' 1201 ' ' ILE . 8.4 p -78.62 137.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1206 ' ' GLU . 65.1 m -99.5 144.06 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' 1205 ' ' SER . 22.7 tt0 -35.44 130.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.88 -59.8 3.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.7 ttmp? -38.41 -52.11 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.84 -52.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' 1195 ' ' VAL . . . -40.5 -66.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . 0.404 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 3.2 ptt? -47.44 -28.64 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 65.8 mt -85.4 30.73 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -63.47 -50.0 75.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.5 Cg_exo -47.91 -18.94 1.27 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.329 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.64 -70.77 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.958 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -56.55 -24.47 47.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.451 ' N ' ' CD1' ' A' 1216 ' ' TRP . 30.1 mt-10 -59.5 -35.34 73.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 63.6 t -68.24 -34.76 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.806 HG13 HD21 ' A' 1160 ' ' LEU . 62.5 mt -66.71 -42.92 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.35 -46.52 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.87 ' O ' HG22 ' A' 1225 ' ' THR . 5.2 t-160 -72.61 -41.69 65.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' 1156 ' ' LEU . 22.0 t80 -54.25 -42.83 70.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 23.7 p -81.36 -34.59 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -62.53 -33.68 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.87 HG22 ' O ' ' A' 1221 ' ' HIS . 3.1 t -89.72 -15.35 32.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.757 HD22 HG23 ' A' 1225 ' ' THR . 7.6 m-80 -118.65 20.15 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1226 ' ' ASN . 55.1 m 35.55 46.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 41.0 t -93.72 140.43 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.79 153.44 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 47.3 p -146.87 -179.89 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 61.93 45.62 7.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.944 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.781 0.325 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 76.5 mt-30 -35.95 -52.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' 1150 ' ' GLN . 44.1 tt0 -99.89 -47.07 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' 1149 ' ' GLU . 20.3 tt0 -36.81 -50.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -54.54 -56.22 21.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 53.3 m -44.45 -46.74 9.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 2.1 mm-40 -68.25 -35.1 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.38 -53.39 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . 0.56 HG12 ' NZ ' ' A' 1159 ' ' LYS . 44.7 t -63.57 -39.7 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.492 HD22 ' NE ' ' A' 1191 ' ' ARG . 56.2 tp -66.61 -53.8 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' 1161 ' ' VAL . 74.6 t80 -40.27 -44.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -55.0 -44.93 83.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.56 ' NZ ' HG12 ' A' 1155 ' ' VAL . 44.1 mttp -61.84 -46.16 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.53 HD21 HD11 ' A' 1219 ' ' ILE . 33.6 mt -57.23 -40.73 78.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1157 ' ' TYR . 96.3 t -62.59 -44.07 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -64.75 -45.89 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.86 95.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.501 HH11 HD11 ' A' 1184 ' ' LEU . 27.7 ttp180 -59.06 -46.13 89.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -56.58 -61.05 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 26.4 pttt -52.54 -26.89 14.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -47.85 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.14 -50.99 3.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -65.83 -46.18 79.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 66.1 tttt -45.55 -53.69 8.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 44.6 mtm -84.26 -1.95 56.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.88 30.57 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -113.19 138.74 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.99 136.74 23.21 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.679 2.252 . . . . 0.0 112.37 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.94 -16.79 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.45 -46.39 7.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.3 mm -53.28 -44.81 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.571 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.8 tp -54.08 -68.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -154.89 129.68 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 3.6 t -75.54 166.1 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.32 -44.44 84.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -48.82 -42.77 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.87 -45.16 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.501 HD11 HH11 ' A' 1164 ' ' ARG . 53.2 mt -60.72 -49.47 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 98.6 t -49.87 -50.95 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.22 -46.8 88.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 38.2 mtp -53.01 -43.39 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.52 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.444 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 26.2 mttm -73.53 -63.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.708 ' SD ' HD13 ' A' 1201 ' ' ILE . 21.5 mtt -59.1 -38.6 79.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.492 ' NE ' HD22 ' A' 1156 ' ' LEU . 31.7 mtp180 62.24 55.02 2.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.584 0.707 . . . . 0.0 110.898 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' A' 1197 ' ' ASN . 53.7 Cg_endo -69.8 135.08 29.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.375 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' 1216 ' ' TRP . 30.3 p -103.66 -36.91 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.409 ' O ' HG23 ' A' 1198 ' ' VAL . 2.8 p -99.99 164.27 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' 1196 ' ' GLU . 14.8 p -62.15 -42.59 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' 1195 ' ' VAL . 27.2 mm-40 -49.01 -50.83 34.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' 1192 ' ' PRO . 0.6 OUTLIER -59.34 -42.7 92.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.675 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.7 t -59.14 -49.21 84.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 64.1 mttt -49.89 -35.87 25.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -71.43 -24.89 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.954 ' O ' HG12 ' A' 1204 ' ' VAL . 23.9 mm -55.45 100.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' 1201 ' ' ILE . 6.7 t70 -34.8 143.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.2 -50.86 1.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.954 HG12 ' O ' ' A' 1201 ' ' ILE . 14.9 p -69.84 137.54 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' 1206 ' ' GLU . 1.2 t -96.82 140.38 31.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' 1205 ' ' SER . 22.4 tt0 -34.21 140.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.8 -54.01 4.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' 1209 ' ' ALA . 43.1 tttm -39.51 -57.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.12 -39.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.51 -66.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.99 -22.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.488 HD21 ' HG ' ' A' 1178 ' ' LEU . 73.7 mt -91.84 33.84 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.2 -53.32 33.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.723 . . . . 0.0 111.109 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.9 Cg_exo -48.03 -17.65 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.1 -65.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.675 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.02 -21.53 63.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.3 -44.37 95.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 97.6 t -67.21 -38.37 80.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.53 HD11 HD21 ' A' 1160 ' ' LEU . 84.5 mt -59.59 -39.42 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . 0.401 ' CD ' ' HB ' ' A' 1193 ' ' THR . 23.2 ttpt -64.53 -27.63 69.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' 1224 ' ' GLN . 1.8 t-80 -81.9 -60.64 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.473 ' CD1' ' HE2' ' A' 1159 ' ' LYS . 59.3 t80 -38.36 -37.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -81.99 -33.79 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -66.33 -47.39 73.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.767 HG23 ' ND2' ' A' 1226 ' ' ASN . 9.0 t -71.32 -30.82 66.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.767 ' ND2' HG23 ' A' 1225 ' ' THR . 36.6 m-80 -105.6 14.01 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' 1223 ' ' CYS . 82.4 p 33.9 48.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' 1226 ' ' ASN . 60.1 t -98.99 147.63 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -65.22 146.62 54.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . 0.428 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.9 p -145.38 -175.39 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . 0.428 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 47.18 50.14 14.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.925 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.721 0.296 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -40.8 -51.92 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -91.33 -49.27 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -41.55 -58.0 2.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -48.71 -61.65 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.3 m -42.65 -46.8 5.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 18.4 mt-30 -64.82 -37.16 86.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.84 -57.52 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.0 t -56.08 -38.68 54.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.446 HD13 ' CG ' ' A' 1222 ' ' PHE . 33.7 tp -72.08 -61.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.677 ' O ' HG23 ' A' 1161 ' ' VAL . 70.2 t80 -36.79 -40.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.2 94.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -57.13 -44.64 83.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.69 -52.27 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' 1157 ' ' TYR . 88.5 t -45.76 -45.18 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.64 -46.72 88.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.65 80.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.489 ' HG3' HD23 ' A' 1178 ' ' LEU . 21.9 ttp180 -52.12 -46.45 65.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -57.73 -66.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 10.3 pttp -47.58 -38.29 14.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.6 OUTLIER -65.9 -51.93 54.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -38.96 -58.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -57.29 -41.09 79.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.88 -55.23 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.635 ' HE1' ' HG3' ' A' 1211 ' ' MET . 39.6 mtm -80.83 -2.83 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.25 29.31 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.7 m -113.39 138.83 22.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.94 138.31 21.36 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 -16.93 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.603 2.202 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.0 -45.61 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.7 mm -51.82 -42.05 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' 1164 ' ' ARG . 10.9 tp -57.54 -67.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.28 129.43 11.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.3 t -83.69 150.62 25.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' 1180 ' ' THR . 5.6 m120 -35.38 -48.7 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -45.1 -56.62 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 81.4 mt -52.28 -52.6 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.546 HD13 HG22 ' A' 1161 ' ' VAL . 71.8 mt -46.36 -57.03 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' 1181 ' ' ASN . 21.6 t -46.55 -50.31 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.728 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -56.22 -41.6 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 56.4 mtp -68.88 -22.6 64.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -90.27 -29.01 18.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 9.2 ptmm? -85.39 -44.41 12.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' 1189 ' ' LYS . 15.8 mtm -88.07 -14.79 38.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' 1156 ' ' LEU . 47.9 mtm-85 39.62 54.87 5.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.632 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.7 Cg_endo -69.77 138.79 38.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.9 p -131.45 22.33 4.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 13.3 p -138.24 126.27 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 9.6 p -49.08 -27.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -73.78 -30.5 62.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -89.84 -49.88 6.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.6 t -45.89 -44.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -58.04 -30.06 65.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -74.5 -14.03 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' 1186 ' ' ASP . 23.0 mm -59.58 138.69 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.23 136.99 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.761 HG23 ' HD3' ' A' 1208 ' ' LYS . 7.4 p -77.2 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.164 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 38.1 m -100.17 170.9 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -61.49 143.85 55.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.32 -57.68 4.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.761 ' HD3' HG23 ' A' 1204 ' ' VAL . 46.5 tttt -39.54 -45.31 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -39.77 -45.19 1.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.08 -65.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . 0.635 ' HG3' ' HE1' ' A' 1171 ' ' MET . 3.1 ptt? -50.15 -25.91 4.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 53.8 mt -88.99 32.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.33 -51.37 34.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 111.125 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -48.03 -17.18 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.35 -64.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.566 ' C ' ' CD1' ' A' 1216 ' ' TRP . 0.9 OUTLIER -64.47 -20.7 66.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.27 -37.15 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 76.7 t -68.53 -51.89 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' 1216 ' ' TRP . 59.1 mt -47.15 -48.33 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -48.17 -48.51 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.737 ' O ' HG22 ' A' 1225 ' ' THR . 3.4 t-160 -70.34 -46.61 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' 1222 ' ' PHE . 3.3 t80 -54.01 -38.14 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' 1227 ' ' SER . 28.1 p -85.97 -31.16 22.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -69.0 -35.4 76.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.747 HG23 HD22 ' A' 1226 ' ' ASN . 7.6 t -84.78 -20.36 31.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.747 HD22 HG23 ' A' 1225 ' ' THR . 10.7 m-80 -108.88 -3.69 17.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' 1223 ' ' CYS . 3.5 t 61.06 33.22 19.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 62.9 t -80.81 140.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.173 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -71.43 151.3 44.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 75.9 p -144.88 173.71 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 68.72 47.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.71 0.29 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.7 pt20 -32.82 -51.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.06 -48.95 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -47.87 -67.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.3 tp10 -40.82 -60.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.8 m -43.03 -52.03 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -61.77 -36.61 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.7 mt -61.58 -58.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 88.4 t -60.15 -40.15 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.939 HD13 ' CD2' ' A' 1222 ' ' PHE . 38.6 tp -62.95 -56.88 13.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' 1161 ' ' VAL . 45.2 t80 -37.23 -42.24 0.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.93 -49.27 73.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.432 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 25.3 mttm -53.38 -40.89 65.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.81 -49.36 68.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' 1157 ' ' TYR . 83.1 t -47.55 -41.37 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -62.66 -42.8 99.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.74 96.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' 1184 ' ' LEU . 30.3 ttp180 -62.74 -43.28 99.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.66 -51.27 70.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' 1167 ' ' HIS . 19.0 ptpt -64.89 -44.1 90.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.469 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.1 t-80 -60.54 -47.98 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -40.13 -53.12 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -61.37 -46.82 88.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' 1170 ' ' LYS . 14.4 tmtt? -43.07 -54.74 4.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.2 mtm -82.86 -4.79 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 18.4 t0 67.27 32.02 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.0 m -115.26 137.79 23.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.606 0.717 . . . . 0.0 111.187 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.93 138.88 20.69 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.96 -16.51 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 0.0 112.394 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.78 -47.38 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.93 -41.33 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.497 ' CD1' ' HE3' ' A' 1171 ' ' MET . 11.8 tp -57.55 -63.96 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -153.46 143.97 22.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 59.1 p -93.17 169.57 10.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' 1185 ' ' VAL . 87.4 m-20 -55.32 -37.65 67.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.86 -48.06 82.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.85 -39.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.3 mt -72.71 -48.13 41.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' 1181 ' ' ASN . 93.2 t -52.24 -40.23 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -44.25 72.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 52.5 mtp -59.5 -37.19 77.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -72.4 -27.75 62.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 44.3 mttt -79.33 -63.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 15.2 mtt -64.92 -39.04 92.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' 1192 ' ' PRO . 29.1 mtm180 66.55 53.71 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.9 Cg_endo -69.77 141.23 44.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.708 2.272 . . . . 0.0 112.344 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -127.58 18.29 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.625 ' O ' HG23 ' A' 1198 ' ' VAL . 31.3 p -137.85 130.8 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.514 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 14.7 p -51.29 -24.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.9 -64.16 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -51.53 -42.92 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.66 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.7 t -47.78 -45.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.9 mttp -52.06 -34.13 42.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -64.34 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' 1202 ' ' ASP . 26.3 mm -43.33 153.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' 1201 ' ' ILE . 31.7 t0 -80.69 133.46 35.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.0 -46.03 1.43 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 12.8 p -66.64 134.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 8.6 m -98.91 152.18 20.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -43.47 137.45 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.88 -62.91 4.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.648 ' HE2' HD11 ' A' 1212 ' ' LEU . 40.1 tttt -34.97 -48.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.44 -48.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.09 -65.62 0.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . 0.462 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 5.6 ptt? -46.16 -28.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.648 HD11 ' HE2' ' A' 1208 ' ' LYS . 51.2 mt -87.17 32.95 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.845 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.42 -54.86 8.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.567 0.699 . . . . 0.0 111.089 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.845 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.57 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.91 -64.04 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.66 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -62.42 -21.86 65.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.403 ' N ' ' CD1' ' A' 1216 ' ' TRP . 55.1 mt-10 -60.43 -37.87 82.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.0 t -69.36 -57.9 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.085 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -38.71 -46.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -46.96 -55.23 8.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.51 ' O ' HG22 ' A' 1225 ' ' THR . 3.1 t-160 -68.04 -46.56 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.939 ' CD2' HD13 ' A' 1156 ' ' LEU . 64.1 t80 -46.65 -47.53 20.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 97.4 m -81.93 -46.87 13.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -46.86 -46.44 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.552 HG23 ' ND2' ' A' 1226 ' ' ASN . 15.4 t -70.96 -37.37 72.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.569 ' O ' HG23 ' A' 1228 ' ' VAL . 15.6 m-80 -90.05 23.8 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 4.7 t 39.37 39.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' 1226 ' ' ASN . 61.1 t -99.35 143.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -71.0 153.1 42.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 25.4 p -145.9 152.39 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.85 54.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.928 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -41.67 -49.4 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.52 -52.38 4.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' 1150 ' ' GLN . 2.1 tp60 -42.22 -52.77 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' 1154 ' ' ILE . 19.7 tt0 -49.22 -60.09 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 70.7 m -41.0 -54.54 2.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -54.06 -40.81 67.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.4 mt -60.13 -53.41 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.1 t -61.52 -42.04 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.521 HD13 ' CG ' ' A' 1222 ' ' PHE . 17.6 tp -62.22 -59.13 5.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' 1156 ' ' LEU . 55.8 t80 -35.74 -51.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.47 56.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 17.1 mttm -58.75 -38.82 79.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.455 HD21 HD11 ' A' 1219 ' ' ILE . 38.5 mt -70.07 -42.22 73.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 68.3 t -47.57 -51.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -56.84 -46.2 81.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.92 -44.96 95.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.878 ' HD3' ' HB3' ' A' 1179 ' ' ALA . 4.0 tpm_? -60.79 -29.37 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -80.7 -70.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -40.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . 0.58 ' HB3' HD21 ' A' 1178 ' ' LEU . 0.5 OUTLIER -65.26 -54.57 27.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.76 ' HA ' HD22 ' A' 1178 ' ' LEU . . . -37.26 -59.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.42 -35.88 76.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' 1167 ' ' HIS . 43.0 tttp -52.61 -54.31 34.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.429 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 36.7 mtm -81.57 -1.77 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.18 37.37 8.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 25.6 m -119.62 142.39 32.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.98 135.64 23.6 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.97 -16.81 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.35 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.93 -45.49 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 35.9 mm -55.41 -38.79 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.76 HD22 ' HA ' ' A' 1168 ' ' ALA . 14.0 tp -59.63 -64.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' 1164 ' ' ARG . . . -168.66 127.41 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 11.0 t -67.82 170.28 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -63.78 -45.8 88.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -42.92 -57.34 2.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.6 mt -47.69 -48.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.87 -58.54 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.492 HG12 ' HD2' ' A' 1189 ' ' LYS . 93.1 t -40.87 -53.49 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.7 -56.7 15.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . 0.46 ' HE3' ' HB3' ' A' 1216 ' ' TRP . 42.7 mtp -47.79 -43.5 27.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.0 79.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' 1185 ' ' VAL . 15.3 mtpp -71.36 -63.82 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.489 ' SD ' HD13 ' A' 1201 ' ' ILE . 20.2 mtt -63.69 -39.64 94.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.3 mtm-85 65.61 54.67 1.07 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.578 0.704 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 143.73 51.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.33 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 6.2 p -124.87 15.5 8.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . 0.567 ' O ' HG23 ' A' 1198 ' ' VAL . 16.9 p -140.03 134.91 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.417 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 11.1 p -57.85 -29.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -67.47 -31.68 71.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -87.37 -37.78 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.728 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.4 t -53.37 -36.48 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.169 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -62.89 -27.36 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -68.21 -33.24 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' 1202 ' ' ASP . 46.9 mm -42.63 160.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' 1201 ' ' ILE . 16.8 t70 -87.36 134.51 33.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.06 -38.71 3.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' 1198 ' ' VAL . 7.3 p -68.45 138.82 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 63.8 p -99.82 154.71 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.48 139.18 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 80.7 -56.68 4.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' 1209 ' ' ALA . 14.6 ttmm -36.98 -45.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -35.22 -45.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.46 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 9.7 ptt? -52.94 -17.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.0 mt -90.88 31.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.8 -49.87 2.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 0.0 111.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 66.2 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . 0.748 HD11 ' NH2' ' A' 1164 ' ' ARG . 6.8 mp -84.04 -70.94 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.728 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -56.2 -19.18 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.02 -35.79 81.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 81.7 t -75.89 -51.79 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.455 HD11 HD21 ' A' 1160 ' ' LEU . 66.3 mt -49.0 -50.57 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -42.08 -45.22 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.4 t-160 -75.59 -56.27 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' 1156 ' ' LEU . 10.0 t80 -41.88 -32.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 83.1 m -90.96 -25.21 19.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' 1221 ' ' HIS . 2.9 pt20 -72.04 -46.95 55.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' 1224 ' ' GLN . 7.4 t -74.11 -24.66 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' 1225 ' ' THR . 36.3 m-80 -102.1 -0.79 32.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 32.1 t 55.37 36.65 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' 1229 ' ' GLN . 74.9 t -83.09 153.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . 0.404 ' N ' HG12 ' A' 1228 ' ' VAL . 1.8 mp0 -70.11 145.95 51.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 23.6 p -143.58 165.62 27.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.13 46.65 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.746 0.308 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 80.8 mt-30 -34.77 -56.91 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' 1153 ' ' GLN . 27.9 tt0 -96.09 -44.56 7.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -44.19 -54.2 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -70.79 -58.82 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 47.5 m -38.05 -53.51 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' 1149 ' ' GLU . 61.6 mt-30 -60.07 -45.64 92.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.99 -51.46 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 94.4 t -61.66 -42.06 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.523 HD22 ' NE ' ' A' 1191 ' ' ARG . 17.0 tp -63.73 -59.82 4.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' 1161 ' ' VAL . 61.4 t80 -36.58 -44.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.49 90.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -57.01 -40.44 76.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . 0.474 HD21 HD11 ' A' 1219 ' ' ILE . 42.4 mt -64.59 -46.05 84.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.797 HG13 HH12 ' A' 1164 ' ' ARG . 85.7 t -54.11 -41.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.05 -47.41 83.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . 0.418 ' HA ' ' CG ' ' A' 1166 ' ' LYS . . . -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . 0.797 HH12 HG13 ' A' 1161 ' ' VAL . 14.0 ttp-105 -62.86 -32.42 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -74.83 -55.22 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' 1163 ' ' ALA . 0.0 OUTLIER -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.12 -46.81 48.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -41.38 -52.82 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.75 -45.74 91.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.2 tttp -48.72 -51.6 27.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.636 ' O ' HG13 ' A' 1173 ' ' VAL . 50.6 mtm -88.01 11.0 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 10.6 m-20 49.83 31.34 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' 1171 ' ' MET . 35.3 m -112.62 136.87 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 138.79 21.28 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 -17.42 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.91 -43.6 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.53 -45.45 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.603 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.3 tp -51.36 -67.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -152.77 134.12 14.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . 0.459 ' H ' HD12 ' A' 1183 ' ' ILE . 12.1 t -78.86 159.24 27.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.04 -42.93 60.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -47.54 -44.55 26.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' 1180 ' ' THR . 74.7 mt -62.55 -62.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' 1164 ' ' ARG . 94.1 mt -40.01 -54.09 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 96.1 t -47.15 -57.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.405 ' CB ' HG23 ' A' 1201 ' ' ILE . 4.2 m-20 -53.73 -57.41 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 65.7 mtp -43.98 -38.19 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.56 73.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -74.02 -58.31 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -69.79 -32.82 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.523 ' NE ' HD22 ' A' 1156 ' ' LEU . 25.9 mtp180 55.7 53.36 8.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 135.02 29.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 45.3 p -102.05 -31.85 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.4 p -102.62 149.37 24.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.575 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -59.34 -39.15 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -51.93 -25.12 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.45 -39.31 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 76.8 t -58.13 -47.58 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -54.64 -29.4 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -71.27 -19.93 62.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' 1204 ' ' VAL . 38.0 mm -55.58 149.38 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.62 135.93 50.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.56 -48.82 1.23 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' 1201 ' ' ILE . 10.3 p -73.59 135.99 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 18.2 m -99.47 150.58 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -41.62 141.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.19 -65.6 4.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' 1209 ' ' ALA . 32.3 ttpt -34.72 -54.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.96 -47.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.69 -64.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 6.6 ptt? -48.99 -30.36 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' 1209 ' ' ALA . 43.5 mt -84.86 30.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -64.6 -52.52 51.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 111.11 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 63.8 Cg_exo -47.95 -17.91 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.38 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -80.91 -65.32 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.575 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.0 OUTLIER -61.8 -23.15 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' 1216 ' ' TRP . 21.5 mm-40 -58.66 -38.94 79.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.7 t -70.02 -30.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.1 mt -66.12 -44.7 91.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -54.77 -30.06 55.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.3 t-160 -82.92 -56.93 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.0 t80 -39.94 -34.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' 1227 ' ' SER . 22.2 p -86.89 -30.44 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -70.53 -46.76 63.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.756 HG23 HD22 ' A' 1226 ' ' ASN . 6.6 t -71.84 -13.49 61.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.756 HD22 HG23 ' A' 1225 ' ' THR . 31.0 m-80 -127.08 14.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' 1223 ' ' CYS . 7.6 t 34.75 48.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 76.4 t -94.65 147.79 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -66.7 144.19 56.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . 0.453 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.0 p -141.1 -175.29 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . 0.453 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 48.36 53.39 12.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.721 0.296 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -37.63 -55.15 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.34 -47.37 8.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1150 ' ' GLN . . . . . 0.577 ' HG2' HD11 ' A' 1154 ' ' ILE . 28.5 tt0 -42.04 -62.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1151 ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' 1154 ' ' ILE . 0.3 OUTLIER -42.81 -59.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1152 ' ' THR . . . . . . . . . . . . . 84.9 m -44.18 -49.96 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.1 -37.76 88.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1154 ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.8 mt -63.3 -57.2 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1155 ' ' VAL . . . . . 0.437 HG12 ' HZ2' ' A' 1159 ' ' LYS . 45.3 t -58.47 -40.69 79.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1156 ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' 1222 ' ' PHE . 40.1 tp -66.18 -60.98 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1157 ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' 1161 ' ' VAL . 56.8 t80 -37.81 -48.19 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.89 -45.65 61.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1159 ' ' LYS . . . . . 0.437 ' HZ2' HG12 ' A' 1155 ' ' VAL . 29.7 mttp -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.18 -47.76 83.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1161 ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' 1157 ' ' TYR . 99.9 t -54.24 -44.65 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -63.74 -46.39 85.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.18 76.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -53.35 -41.59 65.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.9 -69.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -36.93 5.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 2.4 t60 -74.64 -43.84 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1168 ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -45.32 -55.71 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.03 -36.68 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -53.89 53.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1171 ' ' MET . . . . . 0.504 ' CE ' HD11 ' A' 1178 ' ' LEU . 15.9 mtm -75.61 -6.44 50.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.14 33.63 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1173 ' ' VAL . . . . . 0.429 ' O ' ' HB1' ' A' 1168 ' ' ALA . 27.0 m -121.54 138.97 29.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 136.62 22.97 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -20.59 2.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.52 -38.79 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1177 ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' 1177 ' ' ILE . 19.5 mm -58.91 -46.82 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1178 ' ' LEU . . . . . 0.504 HD11 ' CE ' ' A' 1171 ' ' MET . 13.1 tp -51.31 -61.75 2.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.4 148.83 28.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1180 ' ' THR . . . . . . . . . . . . . 76.6 p -94.91 165.95 12.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1181 ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' 1185 ' ' VAL . 20.2 m-80 -60.05 -37.23 79.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -61.56 -48.87 79.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.25 -40.74 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1184 ' ' LEU . . . . . 0.447 HD13 HG22 ' A' 1161 ' ' VAL . 83.3 mt -63.55 -54.12 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1185 ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' 1181 ' ' ASN . 94.4 t -55.2 -38.76 48.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1186 ' ' ASP . . . . . 0.553 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -59.08 -60.98 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1187 ' ' MET . . . . . . . . . . . . . 49.2 mtp -53.55 -28.15 30.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.99 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 22.2 mttt -97.42 -60.47 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1190 ' ' MET . . . . . 0.43 ' SD ' ' O ' ' A' 1186 ' ' ASP . 1.1 mpt? -64.61 -39.76 94.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1191 ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' 1192 ' ' PRO . 49.1 mtm-85 64.17 55.01 1.55 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1192 ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.78 119.61 6.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1193 ' ' THR . . . . . . . . . . . . . 52.4 p -92.2 -21.52 20.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1194 ' ' THR . . . . . . . . . . . . . 59.2 p -109.04 144.14 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1195 ' ' VAL . . . . . 0.519 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.3 p -56.06 -30.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.126 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -58.95 -41.32 87.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -75.19 -37.09 61.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1198 ' ' VAL . . . . . 0.51 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.6 t -59.11 -49.21 84.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -50.91 -28.77 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -70.38 -32.15 69.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1201 ' ' ILE . . . . . 0.706 ' O ' HG12 ' A' 1204 ' ' VAL . 21.6 mm -49.57 146.11 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.07 142.17 49.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.22 -46.46 1.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1204 ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' 1201 ' ' ILE . 9.6 p -67.51 132.6 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1205 ' ' SER . . . . . . . . . . . . . 58.8 m -96.88 145.66 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -40.72 126.8 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 93.52 -59.7 2.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1208 ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.1 ttmp? -38.69 -48.69 1.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1209 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.67 -46.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -43.92 -66.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.8 ptt? -47.12 -26.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1212 ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' 1178 ' ' LEU . 72.5 mt -89.09 32.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.41 -53.75 21.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 111.102 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1214 ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.9 -17.26 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.715 2.276 . . . . 0.0 112.321 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.39 -60.53 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -67.29 -28.28 67.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1217 ' ' GLU . . . . . 0.531 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.8 mt-10 -56.41 -33.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.4 t -70.17 -41.21 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1219 ' ' ILE . . . . . 0.45 HG12 HD11 ' A' 1156 ' ' LEU . 83.7 mt -59.82 -53.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -45.77 -43.67 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -76.03 -43.95 41.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1222 ' ' PHE . . . . . 0.689 ' CD2' HD13 ' A' 1156 ' ' LEU . 27.6 t80 -54.18 -38.98 66.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -81.06 -26.47 36.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1225 ' ' THR . . . . . 0.644 HG23 ' ND2' ' A' 1226 ' ' ASN . 9.3 t -87.06 -34.93 19.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1226 ' ' ASN . . . . . 0.644 ' ND2' HG23 ' A' 1225 ' ' THR . 14.5 m-80 -91.43 8.19 37.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1227 ' ' SER . . . . . . . . . . . . . 43.1 t 42.04 43.51 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 70.6 t -89.03 148.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -76.09 151.86 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1230 ' ' THR . . . . . . . . . . . . . 71.0 p -145.05 174.64 10.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 20.1 t0 66.22 41.79 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 77.5 p -136.29 169.42 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.822 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 3.1 m -137.92 109.74 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -72.23 -177.15 29.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 42.9 p -152.03 175.7 12.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.856 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 29.4 t -110.89 160.4 16.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -107.72 -177.64 22.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.439 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 67.0 p -76.11 179.46 5.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.867 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 90.4 p -143.92 127.14 16.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 149.94 54.61 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 154.71 67.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.31 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 24.3 m -51.21 157.38 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.472 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 54.3 mt -86.32 135.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 28.3 p -59.15 127.83 34.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . -38.38 -34.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -41.86 -59.17 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . 0.472 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 7.3 pt-20 -99.97 -37.37 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -42.49 -57.59 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.405 ' HA ' HD12 ' A' 1154 ' ' ILE . 13.6 tt0 -48.94 -57.3 6.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . 0.401 HG21 HG11 ' A' 1228 ' ' VAL . 54.6 m -46.99 -43.4 19.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.169 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.9 -38.65 86.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.0 mt -62.71 -53.21 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 59.1 t -62.49 -40.13 87.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . . . . . . . . . 20.9 tp -65.83 -59.33 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 74.1 t80 -37.55 -51.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.98 -42.64 60.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 31.8 mttm -61.96 -45.18 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 43.2 mt -59.53 -52.99 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 77.6 t -48.02 -47.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.55 -46.52 83.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.84 -53.0 62.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.516 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.8 ttp180 -47.59 -45.09 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' 1168 ' ' ALA . 21.6 tt0 -59.08 -70.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -45.96 -26.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.92 -32.39 21.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.97 -50.22 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.55 -44.92 96.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.12 -52.18 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' HD11 ' A' 1178 ' ' LEU . 10.4 mtm -77.74 -6.02 52.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.96 39.41 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' 1168 ' ' ALA . 31.7 m -127.82 142.69 45.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 138.64 21.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.93 -23.26 4.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -91.23 -35.61 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.7 mm -59.0 -48.91 85.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.497 HD11 ' HE3' ' A' 1171 ' ' MET . 13.3 tp -49.34 -62.26 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.72 124.19 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.0 t -78.58 154.13 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.683 ' O ' HG23 ' A' 1185 ' ' VAL . 5.9 m-80 -45.86 -38.8 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -51.58 -45.08 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.93 -51.38 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.135 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.516 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.2 mt -52.53 -48.83 65.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' 1181 ' ' ASN . 90.6 t -52.73 -53.26 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.52 -50.39 70.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 82.2 mtp -56.54 -36.35 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -73.68 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -90.0 -54.73 3.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.559 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 17.5 mtt -75.06 -27.68 60.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.543 ' HB3' HG22 ' A' 1230 ' ' THR . 21.8 mtm180 54.89 54.85 10.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.1 Cg_endo -69.78 125.19 11.84 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 0.0 112.314 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.5 p -97.29 -24.51 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 77.6 p -107.61 138.52 43.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.54 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.4 p -52.94 -28.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -58.43 -50.08 74.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.2 -36.52 81.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . . . . . . . . . 97.6 t -57.58 -47.16 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 18.0 mttp -50.94 -36.78 40.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -65.55 -23.9 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 32.5 mm -52.48 150.99 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.69 137.85 37.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 98.69 -37.99 3.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' 1201 ' ' ILE . 3.8 p -74.04 132.43 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 47.8 t -95.92 145.23 25.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -40.85 131.35 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 88.87 -58.45 4.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' 1209 ' ' ALA . 9.1 ttmm -37.63 -50.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -33.98 -48.74 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 2.0 ptt? -46.91 -28.11 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 70.9 mt -86.53 29.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.736 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.37 -51.66 41.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.711 . . . . 0.0 111.079 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.01 -22.54 3.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -75.61 -67.27 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.563 ' HA ' HD12 ' A' 1219 ' ' ILE . 1.0 OUTLIER -60.65 -30.09 69.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' 1216 ' ' TRP . 8.8 mm-40 -54.17 -34.63 60.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.3 t -74.0 -32.96 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.4 mt -65.7 -40.95 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' 1224 ' ' GLN . 25.2 ttpt -59.84 -38.53 82.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.961 ' O ' HG22 ' A' 1225 ' ' THR . 10.9 t60 -77.99 -47.08 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 39.3 t80 -51.54 -41.46 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' 1230 ' ' THR . 21.5 p -84.11 -35.34 23.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.487 ' CG ' ' O ' ' A' 1220 ' ' LYS . 8.9 mm100 -64.22 -31.79 73.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.961 HG22 ' O ' ' A' 1221 ' ' HIS . 3.5 t -88.99 -15.67 33.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.872 HD22 HG23 ' A' 1225 ' ' THR . 5.8 m-80 -119.78 15.03 12.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' 1223 ' ' CYS . 4.3 t 41.61 40.89 1.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.401 HG11 HG21 ' A' 1152 ' ' THR . 89.7 t -87.5 144.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -64.78 148.54 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' 1191 ' ' ARG . 36.7 p -146.79 -175.5 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.53 49.93 4.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.9 mt -81.37 42.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' 1190 ' ' MET . 21.9 m-85 -82.61 175.9 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 41.6 p -93.97 -51.63 4.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 39.4 t -96.36 91.12 5.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 14.7 t -97.72 176.43 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.098 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.61 143.88 34.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 0.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -175.34 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -128.14 84.68 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 73.2 p -89.12 -0.4 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 65.63 81.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 177.11 5.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.747 2.298 . . . . 0.0 112.369 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 112.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 3.1 m -142.6 171.63 13.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.456 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 35.2 p -74.51 104.59 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 32.2 t -133.58 164.17 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 176.73 42.81 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 82.5 p -86.86 109.05 19.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 0.0 110.823 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 94.4 p -86.32 172.66 10.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -140.69 -163.62 9.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.473 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 80.0 p -115.96 157.38 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 84.0 p -54.09 127.97 28.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -138.93 150.71 66.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.713 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -173.29 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.256 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.2 m -71.68 165.7 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 66.5 mt -86.48 139.04 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1147 ' ' ALA . 22.7 t -45.92 119.41 2.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.73 -48.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' 1147 ' ' ALA . 66.8 mt-30 -34.5 -47.05 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -97.68 -51.02 4.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -44.03 -59.15 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -47.63 -58.8 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . 0.471 HG22 ' NH2' ' A' 1191 ' ' ARG . 89.4 m -43.76 -45.3 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . 0.412 ' HG3' ' NH2' ' A' 1191 ' ' ARG . 57.6 mt-30 -65.35 -38.54 90.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.6 -46.72 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -42.37 87.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.61 HD23 ' HE ' ' A' 1191 ' ' ARG . 22.2 tp -67.35 -57.82 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' 1161 ' ' VAL . 54.5 t80 -38.12 -50.83 1.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.2 -45.19 92.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 35.8 mttm -57.4 -45.21 84.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.29 -51.82 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.894 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.856 HG22 HD13 ' A' 1184 ' ' LEU . 100.0 t -52.4 -41.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -59.34 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.01 -55.16 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -46.86 -34.07 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -66.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' 1167 ' ' HIS . 12.5 pttp -53.48 -27.11 23.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.595 ' CE1' ' SD ' ' A' 1171 ' ' MET . 2.3 t60 -83.43 -35.19 25.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.615 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.84 -48.9 69.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.26 -37.21 83.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.6 tttt -51.42 -41.37 60.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.883 ' CE ' HD11 ' A' 1178 ' ' LEU . 3.2 mpp? -96.7 2.78 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 61.73 31.32 18.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.5 HG21 HD13 ' A' 1178 ' ' LEU . 34.8 m -112.02 138.27 21.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.693 . . . . 0.0 111.166 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 136.02 23.38 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -16.77 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.17 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.87 -39.83 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.883 HD11 ' CE ' ' A' 1171 ' ' MET . 15.8 tp -59.3 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -150.34 139.8 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . 0.431 ' H ' HD12 ' A' 1183 ' ' ILE . 38.1 p -93.27 162.24 14.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' 1185 ' ' VAL . 2.7 m-20 -56.79 -36.16 69.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.62 -51.94 67.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' 1180 ' ' THR . 78.4 mt -57.71 -48.35 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.856 HD13 HG22 ' A' 1161 ' ' VAL . 76.1 mt -54.04 -50.95 65.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.525 HG12 ' HD2' ' A' 1189 ' ' LYS . 79.8 t -56.74 -52.03 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.516 ' CB ' HG23 ' A' 1201 ' ' ILE . 51.8 m-20 -55.1 -46.68 75.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.99 -40.74 81.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' 1191 ' ' ARG . . . -64.75 -31.56 72.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' 1185 ' ' VAL . 12.8 mtpp -80.04 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' 1201 ' ' ILE . 17.8 mtt -62.17 -38.39 88.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.61 ' HE ' HD23 ' A' 1156 ' ' LEU . 17.1 mmt85 65.28 52.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 131.96 22.38 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -120.54 24.56 10.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.153 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.924 ' O ' HG23 ' A' 1198 ' ' VAL . 19.1 p -138.36 134.72 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.12 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.564 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 7.1 p -52.98 -26.96 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -75.35 -67.93 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -44.11 -39.59 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' 1194 ' ' THR . 74.6 t -48.57 -43.58 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . 0.435 ' HA ' ' CG1' ' A' 1204 ' ' VAL . 6.0 mtmp? -56.67 -30.43 63.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -67.16 -29.16 68.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.57 HD13 ' SD ' ' A' 1190 ' ' MET . 13.7 mm -59.32 102.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' 1201 ' ' ILE . 9.3 t70 -31.46 145.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.43 -41.83 2.08 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.694 HG23 ' HD2' ' A' 1208 ' ' LYS . 2.8 p -93.52 140.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' 1206 ' ' GLU . 12.9 t -100.2 138.96 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' 1205 ' ' SER . 36.3 tt0 -34.26 129.61 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 100.17 -64.94 0.6 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.694 ' HD2' HG23 ' A' 1204 ' ' VAL . 16.6 ttmm -38.7 -48.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.8 -42.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.75 -65.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.7 ptt? -53.3 -24.59 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.08 34.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.51 -49.81 39.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.689 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -48.0 -20.14 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.69 -63.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.869 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.9 OUTLIER -65.37 -23.15 66.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.405 ' N ' ' CD1' ' A' 1216 ' ' TRP . 33.2 mt-10 -61.59 -36.23 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.1 t -67.28 -42.91 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.52 -40.29 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -60.63 -43.13 97.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.36 -44.54 58.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' 1228 ' ' VAL . 49.5 t80 -56.81 -46.13 81.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' 1227 ' ' SER . 28.4 p -70.09 -36.21 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -57.76 -34.65 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.446 HG23 ' ND2' ' A' 1226 ' ' ASN . 5.3 t -93.13 -37.3 12.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.446 ' ND2' HG23 ' A' 1225 ' ' THR . 34.4 m-80 -93.39 15.81 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' 1223 ' ' CYS . 17.6 m 35.49 46.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' 1222 ' ' PHE . 59.0 t -87.57 139.27 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -63.57 148.02 49.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' 1231 ' ' ASP . 37.6 p -138.35 -175.39 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' 1230 ' ' THR . 4.8 p-10 48.13 49.24 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 47.51 1.0 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -102.0 177.17 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 3.1 m -44.87 -43.54 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 12.0 t 69.03 39.67 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 11.6 t -78.6 149.45 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.161 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.15 150.69 10.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 0.0 110.883 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.3 12.01 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -59.21 96.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 74.7 p -49.42 132.19 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -159.15 83.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.26 6.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.645 2.23 . . . . 0.0 112.383 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 1.4 t -96.01 126.12 41.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 31.4 m -101.49 -56.35 2.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.526 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 16.9 m -159.48 131.85 6.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.381 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 13.9 m -98.95 163.44 12.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -122.4 -141.7 6.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 58.7 m -130.93 144.75 51.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 110.827 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 8.2 t -167.59 171.68 10.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -107.17 50.47 0.79 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.523 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' 1141 ' ' SER . 49.6 m -159.7 107.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' 1140 ' ' SER . 56.4 p -37.98 124.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -87.74 154.42 53.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 166.74 26.59 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 69.5 t -40.65 145.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.538 HD12 ' OE1' ' A' 1150 ' ' GLN . 60.5 mt -84.18 137.78 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.167 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 1.9 t -50.29 131.42 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . . . . . . . . . . . -42.89 -45.94 5.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -38.43 -49.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -93.32 -50.2 5.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.538 ' OE1' HD12 ' A' 1145 ' ' ILE . 3.0 tp60 -47.11 -60.06 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -42.7 -60.81 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 86.7 m -43.96 -46.02 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -62.26 -38.76 90.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.19 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 96.7 t -68.93 -43.73 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' 1222 ' ' PHE . 17.6 tp -63.72 -55.32 24.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 62.8 t80 -40.62 -49.51 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.001 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.17 92.78 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' 1162 ' ' GLU . 37.9 mttm -55.3 -33.46 63.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' 1161 ' ' VAL . 25.0 mt -74.13 -59.99 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' 1160 ' ' LEU . 97.3 t -37.17 -62.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.06 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' 1159 ' ' LYS . 5.2 pt-20 -38.89 -54.71 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.51 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.644 ' HD3' HD11 ' A' 1184 ' ' LEU . 15.0 ttp180 -54.47 -48.63 71.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -58.56 -65.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' 1167 ' ' HIS . 1.2 ptpm? -47.56 -44.9 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.448 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.7 OUTLIER -58.24 -42.84 87.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.23 -55.16 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -60.44 -47.3 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 57.4 tttp -42.68 -51.06 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.59 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 59.1 mtm -87.69 -5.62 58.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.59 32.62 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.433 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.4 m -114.63 141.31 26.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.596 0.712 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 136.68 23.29 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.97 -17.23 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.41 -40.79 9.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.2 mm -57.67 -43.3 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.59 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.8 tp -53.78 -68.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.42 120.39 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.0 t -72.61 156.38 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -47.01 -43.75 19.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -48.61 -52.68 21.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.32 -40.88 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.644 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.5 mt -58.76 -61.51 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.6 t -41.46 -50.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -52.64 -51.52 59.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 93.8 mtp -55.95 -36.94 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.12 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -78.42 -63.37 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' HD13 ' A' 1201 ' ' ILE . 25.8 mtt -63.87 -39.33 93.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' 1192 ' ' PRO . 25.7 mtt-85 66.31 54.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.594 0.712 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.78 129.35 17.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.354 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 58.2 p -104.89 -26.08 12.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 72.1 p -108.24 149.61 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.422 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.9 p -58.46 -26.89 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.85 -45.85 85.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.564 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 37.0 m-80 -73.62 -44.1 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.813 HG21 ' CE3' ' A' 1216 ' ' TRP . 69.7 t -44.26 -45.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.2 mttm -57.38 -35.72 70.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -68.94 -26.12 64.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.842 ' O ' HG12 ' A' 1204 ' ' VAL . 27.2 mm -55.42 98.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' 1201 ' ' ILE . 10.4 t0 -34.58 143.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.33 -46.55 1.43 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.52 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' 1201 ' ' ILE . 9.4 p -76.13 142.31 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 42.5 t -99.83 154.01 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 145.0 10.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.03 -55.72 5.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.5 ttmp? -44.62 -49.47 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -34.63 -49.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -38.16 -65.84 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.0 ptt? -52.67 -25.85 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' 1209 ' ' ALA . 52.7 mt -87.28 32.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.784 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.51 -53.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 111.078 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.5 Cg_exo -47.97 -17.74 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.71 -64.76 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.813 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -62.55 -24.17 67.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' 1216 ' ' TRP . 51.5 mt-10 -58.78 -39.4 80.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 93.3 t -69.21 -41.85 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' 1216 ' ' TRP . 77.5 mt -52.82 -48.45 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -54.66 -44.56 73.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.943 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 14.1 t60 -62.83 -56.4 17.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' 1156 ' ' LEU . 66.2 t80 -44.07 -67.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' 1227 ' ' SER . 61.6 m -50.83 -55.29 17.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' 1223 ' ' CYS . 30.2 mt-30 -35.32 -69.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -37.23 79.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' 1228 ' ' VAL . 2.1 m-80 -85.27 16.6 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.1 t 33.98 50.83 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' 1226 ' ' ASN . 85.3 t -103.26 141.84 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.61 155.53 40.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 36.2 p -143.02 -177.08 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 10.9 t0 54.91 51.24 13.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.49 43.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' 1197 ' ' ASN . 2.6 m-85 -92.58 -48.45 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 2.9 m -92.94 89.18 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 68.8 p -50.42 -47.93 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 69.8 p -106.76 142.62 36.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -151.94 149.66 24.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -31.12 21.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.716 2.277 . . . . 0.0 112.29 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . 0.43 ' CD ' ' C ' ' A' 1239 ' ' GLN . 2.8 pp0? -174.87 158.42 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 1.8 m -95.29 101.52 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -136.96 -93.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.5 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 171.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.326 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 7.8 t 61.24 44.39 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 82.7 p -144.72 142.08 29.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.448 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 76.2 p -100.25 169.28 9.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.846 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 35.8 t -98.81 -58.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 119.58 -178.21 16.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 31.8 t -156.68 143.66 18.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.885 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 9.1 t -66.13 117.23 8.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 53.74 99.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.434 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 87.3 p -158.77 177.48 11.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 53.1 p -93.89 81.81 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -55.07 150.19 21.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.572 0.701 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 125.75 12.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 33.8 m -49.41 168.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.12 139.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' 1147 ' ' ALA . 15.4 t -58.02 127.58 32.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' 1146 ' ' SER . . . -34.07 -43.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' 1147 ' ' ALA . 94.0 mm-40 -37.62 -53.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -94.23 -48.14 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -39.84 -58.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.1 tt0 -43.79 -60.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 85.1 m -44.41 -48.58 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.78 -33.24 73.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' 1151 ' ' GLU . 90.2 mt -67.02 -61.89 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 46.9 t -52.39 -43.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.482 HD21 HG12 ' A' 1219 ' ' ILE . 19.3 tp -64.86 -57.34 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.654 ' O ' HG23 ' A' 1161 ' ' VAL . 77.9 t80 -38.76 -42.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.7 -45.72 95.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 26.8 mttm -61.72 -44.09 97.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.599 HD11 HD11 ' A' 1219 ' ' ILE . 21.3 mt -59.97 -52.49 65.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' 1157 ' ' TYR . 85.0 t -48.24 -44.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.08 -45.51 83.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.2 98.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.59 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.8 ttp180 -58.19 -41.69 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' 1166 ' ' LYS . 10.5 tm0? -64.37 -60.5 3.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.462 ' N ' ' OE1' ' A' 1165 ' ' GLN . 5.6 ptmm? -54.92 -35.98 64.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -46.94 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -44.31 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.28 -45.9 92.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 30.8 tttt -46.38 -55.64 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.901 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.531 ' HE1' ' HG3' ' A' 1211 ' ' MET . 29.3 mtm -79.61 -7.83 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 2.8 t70 68.43 30.87 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.441 ' O ' ' HB1' ' A' 1168 ' ' ALA . 34.8 m -113.61 139.66 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.692 0.758 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.96 136.7 23.02 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.395 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.97 -16.76 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.69 9.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.4 mm -56.68 -42.99 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.8 tp -57.35 -70.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.63 131.34 13.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 9.6 t -80.9 175.47 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' 1185 ' ' VAL . 17.6 p-10 -62.23 -46.73 87.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -53.21 17.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.18 -52.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.59 HD11 ' HD3' ' A' 1164 ' ' ARG . 95.8 mt -52.44 -49.92 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' 1189 ' ' LYS . 95.5 t -49.92 -52.83 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -50.03 -55.27 15.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 71.1 mtp -47.47 -44.75 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.09 -29.88 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.527 ' HD2' HG12 ' A' 1185 ' ' VAL . 29.6 mtpt -78.17 -62.16 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.77 -37.58 79.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' 1192 ' ' PRO . 27.2 mtp180 63.74 51.96 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.73 139.43 40.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 18.9 p -124.23 25.72 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.179 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.429 ' O ' HG23 ' A' 1198 ' ' VAL . 27.2 p -140.26 125.65 18.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.497 HG23 ' CH2' ' A' 1216 ' ' TRP . 13.3 p -44.59 -33.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.7 -62.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -48.68 -43.16 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.541 HG21 ' CE3' ' A' 1216 ' ' TRP . 87.1 t -50.53 -39.99 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -62.04 -23.54 66.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' 1204 ' ' VAL . 27.4 mm -61.53 142.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 32.6 t0 -67.46 139.65 57.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.03 -52.22 1.01 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' 1201 ' ' ILE . 6.1 p -65.59 137.05 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.1 t -100.06 145.42 27.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -38.86 135.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 86.5 -57.37 4.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' 1209 ' ' ALA . 0.6 OUTLIER -40.53 -54.09 2.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' 1204 ' ' VAL . . . -34.79 -48.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.73 -62.65 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . 0.531 ' HG3' ' HE1' ' A' 1171 ' ' MET . 4.3 ptt? -50.06 -22.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.69 35.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.54 -52.99 32.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 0.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.261 . . . . 0.0 112.373 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.03 -67.38 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.0 OUTLIER -59.2 -23.77 62.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.432 ' N ' ' CD1' ' A' 1216 ' ' TRP . 12.3 mm-40 -57.63 -45.28 85.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 75.5 t -60.65 -42.92 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.599 HD11 HD11 ' A' 1160 ' ' LEU . 87.8 mt -61.78 -26.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -68.26 -35.95 78.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -82.04 -49.3 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.42 ' HB3' ' NH2' ' A' 1191 ' ' ARG . 30.0 t80 -40.31 -42.49 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.6 p -77.54 -37.22 51.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -61.35 -43.84 98.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.533 HG23 ' ND2' ' A' 1226 ' ' ASN . 7.1 t -75.43 -37.97 60.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.533 ' ND2' HG23 ' A' 1225 ' ' THR . 33.8 m-80 -93.44 16.08 14.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' 1226 ' ' ASN . 22.6 t 34.9 51.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' 1226 ' ' ASN . 45.7 t -105.92 157.55 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . 0.476 ' N ' HG12 ' A' 1228 ' ' VAL . 4.0 pm0 -81.11 152.49 27.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 67.9 p -145.78 -179.66 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.47 45.83 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.28 50.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -90.13 -59.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 1.3 t -75.62 115.93 15.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 33.0 p -48.7 -31.32 6.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.832 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 58.6 p -52.07 117.3 2.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' 1238 ' ' PRO . 0.8 OUTLIER -61.32 -58.55 18.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.613 0.72 . . . . 0.0 110.941 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' 1237 ' ' LYS . 53.8 Cg_endo -69.74 134.73 28.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.65 2.233 . . . . 0.0 112.349 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -80.98 86.98 6.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 39.9 t -94.63 147.31 23.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 64.63 85.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 104.2 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 17.4 m -132.44 90.58 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 1.9 m -163.42 133.92 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.506 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 92.1 p -118.42 -44.08 2.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 53.2 m 38.01 42.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -44.38 156.24 0.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.492 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 2.7 m -130.51 157.59 42.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.371 . . . . 0.0 110.851 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 46.8 t -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.868 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 135.79 -122.85 2.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 17.2 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.823 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' 1142 ' ' GLN . 52.3 p -168.43 115.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.852 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' 1141 ' ' SER . 6.2 mm100 -32.5 96.0 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 0.0 110.906 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . 0.44 ' N ' ' O ' ' A' 1141 ' ' SER . 54.0 Cg_endo -69.77 163.62 37.59 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 93.6 t -76.6 150.99 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.11 143.96 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.163 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 4.9 m -51.59 130.31 27.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -41.87 -48.17 4.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 67.3 mt-30 -34.49 -51.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -96.17 -51.02 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -38.47 -63.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.627 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.9 tp10 -42.35 -62.86 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.3 m -40.14 -50.24 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.24 -39.39 82.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' 1151 ' ' GLU . 75.3 mt -60.64 -57.71 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.5 t -57.59 -43.21 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.647 HD13 ' CG ' ' A' 1222 ' ' PHE . 23.6 tp -63.84 -62.3 1.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.941 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' 1161 ' ' VAL . 65.9 t80 -35.84 -45.44 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.54 90.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 23.1 mttm -56.91 -44.18 82.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.601 HD21 HG13 ' A' 1219 ' ' ILE . 34.3 mt -62.92 -43.79 97.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' 1157 ' ' TYR . 84.4 t -56.54 -46.13 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -53.75 -39.1 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.8 -49.19 63.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.631 ' HG3' HD23 ' A' 1178 ' ' LEU . 18.7 ttp180 -53.68 -44.31 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.72 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' 1167 ' ' HIS . 0.5 OUTLIER -53.5 -41.96 66.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.467 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.8 OUTLIER -62.38 -45.05 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -40.61 -59.12 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -55.82 -45.53 78.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -43.78 -54.69 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.523 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 38.8 mtm -84.77 -1.92 56.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.68 29.52 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.7 m -111.62 141.24 24.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 111.137 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.98 138.54 21.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.236 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.96 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.302 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.14 -47.88 6.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.5 mm -48.01 -39.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.631 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.2 tp -58.78 -67.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -149.35 147.6 28.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.088 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 57.8 p -89.43 169.75 11.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' 1185 ' ' VAL . 6.7 m-80 -65.45 -33.84 76.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -62.45 -50.17 72.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 90.5 mt -55.75 -46.49 79.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.433 HD11 ' HD3' ' A' 1164 ' ' ARG . 83.5 mt -59.95 -53.29 59.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -48.41 -47.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.609 ' CB ' HG23 ' A' 1201 ' ' ILE . 67.7 m-20 -59.24 -45.56 90.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 89.4 mtp -58.1 -40.79 82.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.23 75.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -77.26 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.587 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 13.8 mtt -65.0 -41.2 95.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' A' 1192 ' ' PRO . 33.8 mtt-85 68.18 54.39 0.63 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.601 0.715 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.3 Cg_endo -69.8 134.5 28.04 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.661 2.241 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.1 p -102.11 -33.17 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 60.8 p -101.82 149.92 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 12.5 p -57.23 -33.6 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.05 -47.43 68.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.463 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 85.9 m-20 -66.5 -46.37 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.504 HG21 ' CE3' ' A' 1216 ' ' TRP . 99.1 t -50.74 -54.5 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.191 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -46.5 -36.29 6.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.19 -34.58 78.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.609 HG23 ' CB ' ' A' 1186 ' ' ASP . 37.9 mm -43.21 148.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.56 139.69 43.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 97.46 -49.14 1.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.514 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' 1201 ' ' ILE . 6.3 p -66.13 131.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 7.7 t -95.77 173.74 7.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.31 143.39 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.83 -54.02 4.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' 1204 ' ' VAL . 28.5 ttmt -41.67 -53.78 3.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.2 -50.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.74 -66.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.13 -25.14 1.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 69.8 mt -89.44 32.26 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -69.12 -53.3 14.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 111.105 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.0 Cg_exo -47.9 -18.16 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.392 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.04 -69.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.554 ' C ' ' CD1' ' A' 1216 ' ' TRP . 1.1 p90 -57.36 -26.32 60.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.5 mt-10 -56.5 -37.28 70.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.2 t -71.13 -41.82 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.601 HG13 HD21 ' A' 1160 ' ' LEU . 89.3 mt -53.83 -53.45 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.102 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -45.12 -45.1 11.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -72.62 -46.58 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.647 ' CG ' HD13 ' A' 1156 ' ' LEU . 49.9 t80 -50.17 -59.59 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' 1227 ' ' SER . 25.7 p -54.89 -47.91 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -42.0 -69.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.944 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -62.01 -40.54 96.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.479 ' O ' HG23 ' A' 1228 ' ' VAL . 72.1 m-80 -80.41 13.54 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' 1223 ' ' CYS . 79.0 p 33.7 51.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' 1226 ' ' ASN . 84.7 t -102.76 143.33 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.78 160.42 30.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 59.1 p -148.02 -179.23 6.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 39.8 t0 65.67 40.06 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 11.3 mt -83.38 44.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.587 ' CE2' ' SD ' ' A' 1190 ' ' MET . 6.6 m-85 -96.05 178.74 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 17.2 m -106.52 80.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.831 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 6.4 m -118.23 176.3 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' 1237 ' ' LYS . 1.4 t -125.14 106.95 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' 1238 ' ' PRO . 0.0 OUTLIER 35.38 54.7 2.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.929 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' 1237 ' ' LYS . 54.0 Cg_endo -69.74 117.45 5.09 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -96.63 86.87 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 4.7 m -75.41 138.52 41.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -123.73 146.27 16.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' 1243 ' ' SER . 53.1 Cg_endo -69.81 2.65 3.37 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' 1242 ' ' PRO . 94.2 p -35.22 130.06 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 2.7 m -67.87 136.96 54.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.458 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 46.6 m -55.39 170.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.889 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 11.0 t -132.61 147.3 52.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -64.31 -148.14 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 97.5 p -76.94 120.68 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.366 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 39.7 m -102.62 163.64 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -65.92 -159.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 25.6 p -55.52 -53.49 55.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.859 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 44.0 m 52.81 42.51 31.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . 0.449 ' NE2' ' HD2' ' A' 1143 ' ' PRO . 56.5 tp60 -72.39 118.95 72.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.942 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . 0.449 ' HD2' ' NE2' ' A' 1142 ' ' GLN . 53.8 Cg_endo -69.74 -176.15 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.679 2.253 . . . . 0.0 112.374 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 35.3 m -81.96 168.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' 1150 ' ' GLN . 76.4 mt -84.82 128.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' 1147 ' ' ALA . 75.6 p -62.6 132.41 52.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -36.79 -49.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 27.1 mt-30 -36.64 -50.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -94.37 -51.91 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.503 ' HB2' HG22 ' A' 1145 ' ' ILE . 19.9 tt0 -45.27 -56.06 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.663 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.5 tt0 -51.56 -58.4 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . 0.481 HG22 ' NH1' ' A' 1191 ' ' ARG . 96.8 m -44.82 -41.78 7.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 37.3 mt-30 -67.24 -37.22 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' 1151 ' ' GLU . 63.1 mt -62.96 -57.24 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 75.2 t -57.28 -45.1 84.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' 1157 ' ' TYR . 22.8 tp -62.16 -62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' 1156 ' ' LEU . 54.4 t80 -36.58 -56.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -48.97 -43.79 31.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.472 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' 1222 ' ' PHE . 5.8 mtmp? -66.08 -40.25 90.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.927 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 84.2 t -56.3 -42.05 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -54.29 -53.78 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.26 96.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.728 ' HE ' HD11 ' A' 1184 ' ' LEU . 7.1 tmm_? -57.82 -26.41 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.802 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.24 -72.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' 1167 ' ' HIS . 2.3 pttm -40.7 -29.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.3 t60 -78.13 -45.53 23.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.458 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -47.63 -53.1 15.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -58.49 -40.24 82.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -48.63 -56.87 7.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' 1178 ' ' LEU . 69.5 mtm -80.35 4.64 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 49.7 m-20 58.51 36.29 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.1 m -114.95 141.59 27.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.677 0.751 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 133.58 23.06 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.383 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -47.95 -18.47 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.39 -40.44 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 25.1 mm -58.23 -47.73 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' 1171 ' ' MET . 14.4 tp -53.14 -63.86 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -153.13 120.3 5.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 6.4 t -75.9 146.04 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' 1185 ' ' VAL . 26.8 m-80 -41.76 -44.57 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -46.06 -53.01 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.43 -56.49 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.728 HD11 ' HE ' ' A' 1164 ' ' ARG . 66.1 mt -51.26 -52.26 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' 1181 ' ' ASN . 89.6 t -44.68 -49.29 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.32 -44.48 91.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' 1192 ' ' PRO . 74.7 mtp -55.72 -41.52 73.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.21 -30.82 69.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.423 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 6.3 mtpm? -77.25 -58.35 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.578 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 24.7 mtt -68.71 -40.86 79.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' 1152 ' ' THR . 35.1 mtt-85 68.74 55.08 0.58 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.6 Cg_endo -69.81 137.31 35.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 0.0 112.334 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . 0.434 HG23 ' HB ' ' A' 1230 ' ' THR . 50.7 p -105.59 -29.3 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 66.0 p -107.92 148.92 28.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.565 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 13.8 p -58.97 -39.7 78.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' 1195 ' ' VAL . 7.4 mm-40 -47.33 -29.54 2.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.514 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 57.6 m-20 -90.94 -39.16 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.772 HG21 ' CE3' ' A' 1216 ' ' TRP . 74.4 t -55.79 -49.02 77.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -56.31 -30.53 62.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.34 -24.22 62.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' 1204 ' ' VAL . 35.3 mm -52.43 146.76 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 8.9 t0 -68.96 138.24 54.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.11 -51.95 1.02 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.645 HG23 ' HE2' ' A' 1208 ' ' LYS . 9.7 p -70.86 144.26 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 5.8 t -100.04 157.85 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -51.4 140.38 17.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 81.51 -55.49 4.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.645 ' HE2' HG23 ' A' 1204 ' ' VAL . 25.3 ttpt -39.61 -56.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.75 -43.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.36 -62.44 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 7.6 ptt? -55.88 -23.42 31.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 96.1 mt -89.85 34.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.654 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.79 -48.64 29.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.1 Cg_exo -48.0 -17.15 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' 1215 ' ' LEU . 6.4 mp -82.22 -66.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.772 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -61.48 -25.44 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.466 ' N ' ' CD1' ' A' 1216 ' ' TRP . 20.3 mt-10 -57.68 -36.5 72.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 99.0 t -68.8 -39.02 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.05 -53.04 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -46.21 -42.58 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -76.74 -45.39 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.418 ' HB2' ' NZ ' ' A' 1159 ' ' LYS . 17.0 t80 -52.99 -39.84 63.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -79.9 -29.0 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -64.69 -38.24 90.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.761 HG23 HD22 ' A' 1226 ' ' ASN . 4.5 t -87.07 -16.58 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.761 HD22 HG23 ' A' 1225 ' ' THR . 18.3 m-80 -119.65 18.48 12.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' 1223 ' ' CYS . 14.8 m 34.23 46.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' 1223 ' ' CYS . 85.4 t -84.83 152.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . 0.492 ' HB3' HD21 ' A' 1232 ' ' LEU . 0.8 OUTLIER -74.12 140.58 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.935 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' 1193 ' ' THR . 21.5 p -129.1 176.57 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 43.52 47.23 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' 1229 ' ' GLN . 26.8 mt -86.83 40.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.578 ' CE2' ' SD ' ' A' 1190 ' ' MET . 14.1 m-85 -75.0 -55.83 5.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 69.2 p -104.19 103.28 13.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 56.5 m -42.42 -45.04 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.869 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 15.2 t -74.34 149.73 40.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.8 142.46 31.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.559 0.695 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 141.75 45.94 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.355 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -73.63 107.81 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 3.1 t -72.38 124.34 24.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -121.63 -160.78 11.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 106.51 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.335 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 44.0 p -174.18 171.91 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 88.9 p -110.75 -43.5 3.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.521 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 58.9 p -129.1 42.5 3.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 2.6 m -93.62 160.41 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -125.21 -135.09 4.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 6.3 t -119.5 80.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.885 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 60.3 p -168.32 154.83 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 150.36 -118.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 48.1 m 58.02 42.57 22.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 1.4 t -127.77 70.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.3 160.63 30.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.511 0.672 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 175.5 8.01 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.676 2.251 . . . . 0.0 112.368 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 99.8 t -42.77 149.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.117 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.57 HD12 ' OE1' ' A' 1150 ' ' GLN . 51.1 mt -91.76 143.36 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 8.3 t -58.58 131.05 49.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -41.06 -44.14 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' 1147 ' ' ALA . 87.2 mt-30 -37.63 -51.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.76 -48.96 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.57 ' OE1' HD12 ' A' 1145 ' ' ILE . 17.5 tp60 -44.36 -51.74 8.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' 1154 ' ' ILE . 4.1 tt0 -52.29 -57.94 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 78.0 m -44.17 -43.49 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -65.73 -37.16 85.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' 1151 ' ' GLU . 85.1 mt -64.93 -43.16 96.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.8 t -70.82 -41.04 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' 1222 ' ' PHE . 21.6 tp -69.33 -55.81 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.602 ' O ' HG23 ' A' 1161 ' ' VAL . 43.2 t80 -37.44 -43.62 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.98 -47.53 88.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 46.3 mttm -56.61 -41.76 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.751 HD21 HD11 ' A' 1219 ' ' ILE . 28.2 mt -63.88 -42.8 97.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' 1157 ' ' TYR . 94.0 t -59.64 -42.15 87.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.35 -39.22 92.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.53 72.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.952 ' HG3' HD23 ' A' 1178 ' ' LEU . 43.3 ttm-85 -79.76 -43.12 23.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.34 -34.96 62.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 12.2 pttp -84.31 -38.34 20.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' 1170 ' ' LYS . 0.6 OUTLIER -63.97 -56.76 12.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -37.27 -53.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.68 -37.8 85.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' 1167 ' ' HIS . 18.4 ttmt -55.95 -51.75 66.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . . . . . . . . . 15.7 mtm -80.07 -1.4 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 68.19 30.09 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.618 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.2 m -119.66 134.53 23.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.99 141.86 16.41 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -47.97 -16.64 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.75 -47.01 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 12.7 mm -51.43 -42.76 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.952 HD23 ' HG3' ' A' 1164 ' ' ARG . 14.4 tp -56.83 -57.34 12.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' 1164 ' ' ARG . . . -160.38 156.07 25.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 26.1 p -94.48 161.12 14.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.113 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' 1185 ' ' VAL . 79.1 m-20 -54.85 -28.64 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 26.7 tptt -62.62 -51.78 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 -40.06 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.855 HD21 ' HE ' ' A' 1164 ' ' ARG . 63.2 mt -60.76 -54.46 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' 1181 ' ' ASN . 79.9 t -49.31 -36.69 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.2 m-20 -60.65 -62.68 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 95.0 mtp -55.51 -20.55 13.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -75.12 -21.68 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 21.4 mttm -102.82 -51.97 3.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.45 ' O ' ' C ' ' A' 1191 ' ' ARG . 0.1 OUTLIER -74.45 -20.91 59.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.633 HH21 HD11 ' A' 1232 ' ' LEU . 13.0 ptt180 33.65 55.05 1.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.7 Cg_endo -69.78 149.48 66.81 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.391 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 61.6 p -127.35 24.11 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 120.97 14.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' 1216 ' ' TRP . 11.3 p -40.31 -39.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . 0.417 ' N ' HG13 ' A' 1195 ' ' VAL . 17.5 mt-10 -56.69 -66.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -48.25 -41.96 29.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.525 HG21 ' CE3' ' A' 1216 ' ' TRP . 94.9 t -50.17 -47.95 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.2 mttp -50.07 -30.92 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -70.98 -29.59 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' 1186 ' ' ASP . 26.0 mm -53.53 101.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' 1201 ' ' ILE . 12.3 t70 -35.3 145.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 96.01 -41.05 2.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' 1201 ' ' ILE . 9.3 p -78.22 138.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 111.068 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 4.0 m -99.98 140.79 33.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -40.22 138.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 83.88 -58.82 5.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' 1209 ' ' ALA . 38.7 tttt -40.38 -55.71 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.638 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -33.93 -39.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.3 -65.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.1 ptt? -49.31 -25.51 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.1 mt -88.94 26.76 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.68 -52.36 26.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.565 0.698 . . . . 0.0 111.05 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -48.01 -16.94 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.678 2.252 . . . . 0.0 112.321 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . 0.565 ' CD2' ' NH2' ' A' 1164 ' ' ARG . 7.3 mp -82.24 -71.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.2 p90 -52.83 -15.8 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.26 -38.86 88.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -66.4 -50.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.751 HD11 HD21 ' A' 1160 ' ' LEU . 82.1 mt -46.49 -40.95 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -55.06 -40.39 70.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -76.84 -42.94 38.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.691 ' CD2' HD13 ' A' 1156 ' ' LEU . 17.9 t80 -53.95 -61.38 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' 1227 ' ' SER . 22.8 p -53.87 -45.67 71.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.874 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -43.4 -68.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.3 m -63.87 -39.45 94.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.454 ' O ' ' C ' ' A' 1227 ' ' SER . 2.6 m-80 -81.22 13.13 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' 1223 ' ' CYS . 72.2 m 33.84 50.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.539 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 84.2 t -97.5 149.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.93 154.77 40.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 20.5 p -145.56 158.77 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 43.4 t0 64.77 42.56 4.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . 0.633 HD11 HH21 ' A' 1191 ' ' ARG . 26.0 mt -83.97 41.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -93.72 136.54 33.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 30.2 t -108.6 95.49 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 47.4 p -143.64 167.2 22.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 28.3 m -103.97 95.77 6.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.445 ' CG ' ' HD2' ' A' 1238 ' ' PRO . 22.2 tttp -145.53 142.54 18.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' 1237 ' ' LYS . 53.5 Cg_endo -69.77 133.12 24.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.652 2.235 . . . . 0.0 112.358 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' 1240 ' ' SER . 51.1 tt0 -44.36 -45.09 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' 1239 ' ' GLN . 99.5 p -37.23 134.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -140.92 -178.99 17.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -176.29 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 39.9 p -56.56 -52.47 64.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.821 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 11.5 m -54.34 117.84 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 12.2 m -123.29 135.06 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 45.5 p -162.03 143.04 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -137.82 112.29 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 83.0 p -69.2 93.79 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 101.71 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' 1140 ' ' SER . . . 134.07 -129.79 5.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' 1139 ' ' GLY . 47.6 p 36.47 47.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 58.3 p -78.67 159.86 27.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.72 146.32 40.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 179.57 3.6 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 84.1 t -41.6 147.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.166 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 47.2 mt -92.65 137.68 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 73.1 m -53.07 132.79 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -45.18 -48.55 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 54.8 mt-30 -34.75 -52.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.57 -53.47 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -42.76 -59.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -42.75 -57.14 2.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . 0.493 HG22 ' HE ' ' A' 1191 ' ' ARG . 90.9 m -46.71 -50.5 17.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -61.14 -40.86 95.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.73 -58.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 73.6 t -54.75 -39.57 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' 1222 ' ' PHE . 12.8 tp -66.32 -57.75 6.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' 1161 ' ' VAL . 75.1 t80 -38.34 -46.69 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -57.12 -46.23 91.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' 1162 ' ' GLU . 21.1 mttm -59.45 -33.22 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 25.2 mt -75.06 -52.67 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' 1157 ' ' TYR . 95.7 t -40.16 -62.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' 1159 ' ' LYS . 4.6 pt-20 -40.47 -56.39 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.68 94.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.673 ' HG3' HD21 ' A' 1184 ' ' LEU . 7.2 tmm_? -59.15 -28.57 66.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' 1168 ' ' ALA . 31.8 tt0 -82.0 -71.6 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 8.9 pttp -43.39 -29.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.525 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.9 t60 -78.02 -37.51 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.773 ' CA ' HD22 ' A' 1178 ' ' LEU . . . -53.66 -61.71 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -55.7 -35.28 65.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 9.9 tttp -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.614 ' HE2' HD11 ' A' 1178 ' ' LEU . 27.3 mtm -76.41 6.27 5.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.36 29.15 18.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.3 m -114.57 139.75 24.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.94 140.23 18.78 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -48.05 -16.68 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.63 -52.34 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 32.9 mm -47.67 -46.7 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.773 HD22 ' CA ' ' A' 1168 ' ' ALA . 16.9 tp -49.46 -65.97 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' 1164 ' ' ARG . . . -148.28 118.46 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.5 t -72.91 139.1 46.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' 1180 ' ' THR . 31.9 m120 -35.77 -46.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.9 tptm -43.34 -58.16 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.39 -59.16 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.673 HD21 ' HG3' ' A' 1164 ' ' ARG . 33.6 mt -47.38 -44.73 24.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 55.4 t -56.5 -55.03 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.486 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -58.89 -42.03 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.2 mtp -58.37 -35.69 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.1 74.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.436 ' CE ' ' HA ' ' A' 1186 ' ' ASP . 49.5 mtmt -76.75 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 13.9 mtt -67.07 -39.27 86.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.493 ' HE ' HG22 ' A' 1152 ' ' THR . 36.1 mtt85 64.31 53.4 1.33 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.639 0.733 . . . . 0.0 110.935 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.71 126.9 13.89 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 34.0 p -96.27 -32.08 12.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.45 ' O ' HG23 ' A' 1198 ' ' VAL . 73.3 p -101.24 147.58 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.572 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -57.52 -36.53 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.158 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -48.38 -52.02 23.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 66.4 m-20 -68.19 -45.96 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' 1194 ' ' THR . 99.5 t -48.4 -52.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . 0.492 ' HD2' HG22 ' A' 1195 ' ' VAL . 4.8 mtpm? -49.53 -33.88 15.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -68.39 -27.97 66.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.795 ' O ' HG12 ' A' 1204 ' ' VAL . 30.7 mm -51.21 139.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 30.4 t0 -65.66 141.05 58.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.85 -48.45 1.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' 1201 ' ' ILE . 9.0 p -65.7 137.44 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 3.0 m -100.0 142.78 31.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -39.06 130.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.96 -63.64 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' 1207 ' ' GLY . 18.1 ttmt -34.36 -48.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.34 -49.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.94 -63.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.2 ptt? -53.0 -22.63 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' 1209 ' ' ALA . 84.1 mt -90.7 32.68 0.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.3 -52.32 12.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 111.132 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -47.99 -17.36 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.44 -67.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.572 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.1 p90 -58.74 -26.98 64.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' 1216 ' ' TRP . 10.1 mt-10 -54.89 -35.81 64.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 74.7 t -71.14 -35.77 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.5 mt -62.6 -46.93 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -47.36 -39.21 14.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.54 ' CD2' ' HG2' ' A' 1224 ' ' GLN . 3.4 t-160 -80.64 -52.78 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.588 ' CG ' HD13 ' A' 1156 ' ' LEU . 47.2 t80 -38.95 -33.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' 1227 ' ' SER . 21.8 p -92.98 -28.64 16.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.54 ' HG2' ' CD2' ' A' 1221 ' ' HIS . 3.5 pt20 -66.52 -46.6 75.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.715 HG23 HD22 ' A' 1226 ' ' ASN . 9.0 t -76.7 -11.98 59.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.715 HD22 HG23 ' A' 1225 ' ' THR . 23.0 m-80 -123.11 15.24 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' 1223 ' ' CYS . 58.7 p 36.2 49.29 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 89.1 t -93.03 142.17 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -69.56 148.0 50.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 72.6 p -137.48 -177.81 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 7.0 m-20 62.65 43.41 7.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . 0.435 HD11 HH12 ' A' 1191 ' ' ARG . 11.9 mt -84.14 41.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' 1190 ' ' MET . 9.6 m-85 -80.53 158.29 25.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 53.9 p -89.53 41.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 3.4 t -154.42 158.25 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 40.4 p -118.76 107.05 13.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -135.97 133.21 19.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.53 0.681 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -178.8 2.52 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 2.23 . . . . 0.0 112.327 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -114.43 134.25 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 4.2 m -156.67 126.62 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -121.64 83.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.62 30.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.273 . . . . 0.0 112.334 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 12.9 t -78.71 92.23 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 89.7 p -66.57 174.4 2.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.821 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 51.9 p -142.05 129.0 20.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.882 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 1.4 t -154.5 130.32 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.829 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -155.51 -144.25 3.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 70.3 m -80.46 44.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 50.6 m -122.87 171.04 9.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' 1140 ' ' SER . . . -163.73 148.27 14.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' 1139 ' ' GLY . 2.1 m -35.8 132.54 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.879 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 29.0 t -81.73 -59.49 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . 0.463 ' CG ' ' HD2' ' A' 1143 ' ' PRO . 40.2 tt0 -169.6 140.19 1.78 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' 1142 ' ' GLN . 54.1 Cg_endo -69.71 162.0 43.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.29 . . . . 0.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' 1143 ' ' PRO . 12.1 p -36.19 143.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.496 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 17.2 mt -81.64 154.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' 1148 ' ' GLN . 25.7 m -98.95 129.95 45.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' 1146 ' ' SER . . . -33.54 -35.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' 1146 ' ' SER . 28.0 mt-30 -46.04 -52.45 11.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . 0.496 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 7.8 pt-20 -99.7 -42.38 6.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.46 HE21 HD11 ' A' 1154 ' ' ILE . 26.4 tt0 -41.89 -57.03 2.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.7 tt0 -46.76 -56.19 6.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 99.0 m -50.21 -49.59 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.34 -33.93 71.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.0 mt -64.58 -56.7 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.4 t -59.37 -43.1 89.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.511 HD13 ' CD2' ' A' 1222 ' ' PHE . 23.1 tp -59.87 -60.41 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' 1156 ' ' LEU . 58.9 t80 -35.96 -47.97 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.06 -46.16 61.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 51.2 mttt -58.22 -42.37 86.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.704 HD21 HD11 ' A' 1219 ' ' ILE . 39.6 mt -62.74 -42.27 99.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.2 t -61.07 -44.11 97.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.94 -46.96 85.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.3 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.088 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.44 -41.62 76.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.46 -61.49 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 17.2 ptpt -52.27 -46.18 65.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.9 OUTLIER -61.23 -46.43 90.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -42.84 -51.79 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -61.9 -44.49 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 61.6 tttt -46.34 -56.99 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.493 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.0 mtm -79.68 0.91 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.94 42.62 19.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 32.6 m -125.14 141.78 39.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.61 0.719 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 135.98 23.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.228 . . . . 0.0 112.349 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.92 -17.45 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.23 -41.2 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 23.8 mm -54.37 -40.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.493 ' CD1' ' HE3' ' A' 1171 ' ' MET . 10.9 tp -60.13 -62.36 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -155.29 150.21 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 71.4 p -87.34 167.61 13.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.39 -38.53 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -50.32 73.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 69.9 mt -51.06 -46.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 61.3 mt -56.25 -50.59 70.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 95.8 t -49.45 -53.61 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.442 ' CB ' HG23 ' A' 1201 ' ' ILE . 9.3 m-20 -54.89 -51.04 67.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 74.9 mtp -53.69 -40.04 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -66.73 -31.44 72.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 31.7 mttm -79.2 -63.17 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 19.4 mtt -61.29 -40.91 95.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.437 ' NH2' HD11 ' A' 1232 ' ' LEU . 39.2 mtm-85 66.08 55.04 0.99 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.588 0.708 . . . . 0.0 110.826 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 141.84 46.34 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.358 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 57.0 p -110.34 -33.34 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.163 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 25.3 p -100.59 144.18 29.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.711 HG23 ' CZ3' ' A' 1216 ' ' TRP . 8.8 p -56.53 -23.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.49 -46.12 84.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -68.75 -37.75 79.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.521 HG21 ' CE3' ' A' 1216 ' ' TRP . 81.7 t -52.87 -45.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 25.3 mttp -52.18 -36.52 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -65.56 -24.37 67.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.698 ' O ' HG12 ' A' 1204 ' ' VAL . 37.6 mm -54.6 148.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.14 134.76 41.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.16 -44.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.506 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' 1201 ' ' ILE . 9.9 p -59.13 131.84 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.093 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1206 ' ' GLU . 48.9 m -99.97 137.89 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' 1205 ' ' SER . 6.4 tp10 -36.41 127.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 92.51 -60.03 2.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' 1207 ' ' GLY . 0.9 OUTLIER -37.64 -49.38 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.77 -47.72 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -40.58 -63.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . 0.466 ' HE3' HD12 ' A' 1178 ' ' LEU . 4.4 ptt? -50.82 -25.05 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' 1215 ' ' LEU . 70.2 mt -88.25 30.9 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.857 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.11 -55.74 19.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 111.096 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.0 Cg_exo -47.96 -18.15 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.338 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' 1212 ' ' LEU . 7.9 mp -79.22 -67.0 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.711 ' CZ3' HG23 ' A' 1195 ' ' VAL . 1.2 p90 -59.19 -26.09 64.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' 1216 ' ' TRP . 14.1 mt-10 -60.08 -37.48 80.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 94.9 t -70.93 -43.6 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.704 HD11 HD21 ' A' 1160 ' ' LEU . 86.4 mt -56.31 -42.55 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.58 -45.8 63.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.481 ' CD2' ' HG2' ' A' 1224 ' ' GLN . 3.0 t-160 -74.91 -56.65 4.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.511 ' CD2' HD13 ' A' 1156 ' ' LEU . 73.3 t80 -34.09 -36.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' 1227 ' ' SER . 78.6 m -90.91 -37.44 13.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' 1225 ' ' THR . 0.2 OUTLIER -55.45 -49.34 72.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.524 ' N ' ' CG ' ' A' 1224 ' ' GLN . 6.7 t -68.36 -37.76 80.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.438 ' ND2' HG23 ' A' 1225 ' ' THR . 25.5 m-80 -86.71 -0.76 56.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' 1223 ' ' CYS . 38.8 t 56.08 36.48 27.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' 1229 ' ' GLN . 94.1 t -92.04 153.56 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . 0.423 ' N ' HG12 ' A' 1228 ' ' VAL . 6.3 tp60 -71.9 146.51 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 24.8 p -137.52 -179.01 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 2.2 p30 44.6 48.82 8.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . 0.437 HD11 ' NH2' ' A' 1191 ' ' ARG . 14.9 mt -77.18 48.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' 1190 ' ' MET . 16.4 m-85 -94.95 173.87 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 89.1 p -94.77 44.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 91.0 p -111.88 147.49 35.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 39.4 p -116.72 39.44 3.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.18 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' 1238 ' ' PRO . 11.8 ttmm -109.85 92.08 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 110.889 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' 1239 ' ' GLN . 54.6 Cg_endo -69.72 -2.38 10.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' 1238 ' ' PRO . 10.6 tt0 -35.77 125.55 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 1.3 t -149.23 156.94 42.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 176.62 -163.86 33.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 173.66 10.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 31.5 p -124.72 170.46 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 51.1 p -104.43 169.98 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.494 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 21.5 m -97.31 144.75 26.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 13.9 t -120.67 -57.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 130.0 166.53 11.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.475 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 19.7 m -121.55 -52.91 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 38.7 m -112.16 90.1 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -129.69 -85.39 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 37.1 p -67.44 -59.9 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.381 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 79.6 p -116.56 108.25 15.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -110.58 88.1 7.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 143.83 51.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.71 2.274 . . . . 0.0 112.349 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 13.6 p -47.28 153.77 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' 1150 ' ' GLN . 67.5 mt -87.85 137.93 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' 1147 ' ' ALA . 20.8 m -65.34 126.84 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -35.89 -52.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.3 pt20 -33.07 -50.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -97.47 -51.53 4.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.426 ' HB2' HG22 ' A' 1145 ' ' ILE . 20.2 tt0 -43.12 -53.93 4.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.02 -60.35 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.0 m -42.46 -46.7 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.132 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.68 -39.33 91.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 80.9 mt -64.32 -52.13 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . 0.67 HG12 ' HZ1' ' A' 1159 ' ' LYS . 92.8 t -61.6 -39.14 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.127 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.937 HD13 ' CD2' ' A' 1222 ' ' PHE . 32.3 tp -69.02 -55.95 9.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' 1161 ' ' VAL . 74.4 t80 -36.62 -46.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -56.79 -50.15 65.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.67 ' HZ1' HG12 ' A' 1155 ' ' VAL . 40.2 mttp -52.82 -44.08 66.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.776 HD21 HD11 ' A' 1219 ' ' ILE . 29.0 mt -61.75 -52.23 65.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.95 HG22 HD13 ' A' 1184 ' ' LEU . 61.7 t -54.04 -42.76 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.69 -47.99 78.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.12 72.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' 1178 ' ' LEU . 10.0 ttp180 -50.25 -39.75 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -64.83 -68.01 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' 1167 ' ' HIS . 15.8 pttp -48.8 -41.44 32.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.473 ' N ' ' HG3' ' A' 1166 ' ' LYS . 2.1 t60 -66.35 -45.86 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -42.79 -62.75 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -50.73 -38.24 46.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -51.21 -56.7 11.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . . . . . . . . . 44.8 mtm -82.13 7.15 14.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 32.8 t70 57.73 36.1 26.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.492 ' O ' ' HB1' ' A' 1168 ' ' ALA . 26.9 m -118.08 138.43 25.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' 1175 ' ' PRO . 64.8 Cg_exo -47.96 136.61 23.08 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1174 ' ' PRO . 66.4 Cg_exo -48.05 -16.85 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.718 2.279 . . . . 0.0 112.288 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.01 -42.87 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.12 -46.78 77.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' 1164 ' ' ARG . 11.4 tp -52.73 -66.04 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -143.61 127.23 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 13.7 t -83.95 165.46 18.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' 1185 ' ' VAL . 2.6 p30 -53.06 -45.0 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -49.49 -48.13 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -56.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.95 HD13 HG22 ' A' 1161 ' ' VAL . 77.5 mt -47.59 -54.34 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' 1181 ' ' ASN . 78.4 t -47.18 -47.69 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.151 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.69 -55.08 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 37.2 mtp -51.65 -16.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -87.15 -51.13 6.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.466 ' HG3' ' CD1' ' A' 1201 ' ' ILE . 0.0 OUTLIER -83.28 -18.13 40.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' 1190 ' ' MET . 15.5 ptt180 33.37 54.95 1.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.671 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.3 Cg_endo -69.79 151.57 68.91 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.69 2.26 . . . . 0.0 112.309 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 44.6 p -130.83 27.62 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.506 ' O ' HG23 ' A' 1198 ' ' VAL . 29.2 p -140.05 125.08 18.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' 1196 ' ' GLU . 11.5 p -42.14 -42.2 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . 0.448 ' N ' HG13 ' A' 1195 ' ' VAL . 16.1 mt-10 -57.75 -60.89 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.28 -40.49 61.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.736 HG21 ' CE3' ' A' 1216 ' ' TRP . 92.8 t -50.36 -38.98 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 21.8 mttm -59.61 -25.73 64.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . 0.561 ' HB2' ' CE2' ' A' 1233 ' ' PHE . 41.5 mtp85 -72.18 -26.49 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' 1192 ' ' PRO . 40.4 mm -51.63 142.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.89 135.13 43.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.05 -50.71 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 3.3 p -67.61 132.23 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 23.8 p -99.74 157.19 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -49.58 149.57 2.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.73 -54.08 4.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' 1209 ' ' ALA . 2.7 ttmp? -53.09 -49.03 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.903 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.04 -46.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -44.79 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 4.4 ptt? -48.64 -23.82 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.02 34.85 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.661 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.54 -49.09 16.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.8 Cg_exo -47.99 -19.22 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' 1215 ' ' LEU . 7.0 mp -79.89 -64.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.736 ' CE3' HG21 ' A' 1198 ' ' VAL . 0.7 OUTLIER -64.83 -25.11 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.424 ' N ' ' CD1' ' A' 1216 ' ' TRP . 11.4 mt-10 -56.71 -43.52 80.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 71.9 t -67.06 -48.61 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.776 HD11 HD21 ' A' 1160 ' ' LEU . 68.8 mt -47.05 -37.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -36.72 75.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.636 ' O ' HG22 ' A' 1225 ' ' THR . 3.1 t-160 -79.82 -43.2 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.937 ' CD2' HD13 ' A' 1156 ' ' LEU . 30.0 t80 -55.68 -40.08 71.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.7 p -83.48 -31.71 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -63.46 -40.68 97.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.732 HG23 HD22 ' A' 1226 ' ' ASN . 5.6 t -80.66 -23.61 39.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.732 HD22 HG23 ' A' 1225 ' ' THR . 10.9 m-80 -108.88 22.05 16.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1226 ' ' ASN . 6.8 t 34.38 42.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' 1226 ' ' ASN . 95.1 t -89.6 144.18 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -70.64 162.49 28.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 76.7 p -151.66 -178.56 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.141 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.5 50.26 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.13 40.88 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.594 ' O ' ' CD1' ' A' 1233 ' ' PHE . 0.1 OUTLIER -174.97 109.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 58.7 m -155.03 147.49 24.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 31.0 t -94.68 83.48 4.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 46.6 m -92.45 136.06 33.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.87 150.52 50.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 126.3 13.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -140.69 148.14 40.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 50.6 m -68.2 118.57 11.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 79.47 70.97 1.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 1.24 4.63 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 5.2 t -100.31 162.64 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 33.6 p -56.26 -57.59 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 87.8 p -106.87 153.41 22.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 11.2 m -160.49 123.05 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -168.19 -58.11 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 31.1 p -108.04 42.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 0.0 110.863 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 47.0 t -113.78 98.85 7.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -92.68 93.83 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.421 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 1.5 t -167.35 145.03 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.342 . . . . 0.0 110.879 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 2.3 t -50.59 126.4 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -114.83 143.84 30.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.609 0.719 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -174.54 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 61.2 t -46.75 140.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.83 129.04 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 44.9 m -50.03 136.19 19.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -44.16 -45.72 8.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' 1147 ' ' ALA . 14.6 mt-30 -35.81 -47.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.01 -48.97 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' 1154 ' ' ILE . 11.8 tt0 -50.53 -61.1 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.585 ' HA ' HD12 ' A' 1154 ' ' ILE . 14.3 tt0 -40.01 -58.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.4 m -48.94 -47.17 43.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.159 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -65.5 -32.64 74.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' 1151 ' ' GLU . 77.0 mt -67.36 -54.62 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 60.9 t -60.96 -40.43 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.78 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.5 tp -65.36 -58.41 5.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 67.7 t80 -38.58 -57.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -47.42 -46.42 22.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 29.7 mttm -59.27 -42.45 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.671 HD21 HD11 ' A' 1219 ' ' ILE . 23.6 mt -62.4 -46.86 86.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.49 HG22 HD13 ' A' 1184 ' ' LEU . 70.2 t -54.23 -40.81 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.27 -50.95 71.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.68 75.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' 1184 ' ' LEU . 17.4 ttp180 -52.74 -38.16 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' 1166 ' ' LYS . 12.6 tm0? -69.04 -70.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' 1166 ' ' LYS . 0.2 OUTLIER -44.37 -39.32 4.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.501 ' CD2' ' HG2' ' A' 1214 ' ' PRO . 1.6 t60 -70.42 -43.73 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -44.68 -62.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -52.94 -34.6 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -50.52 -53.45 30.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.594 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 66.2 mtm -83.15 -6.34 59.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.84 28.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 30.9 m -112.95 141.27 25.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.03 139.02 21.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.98 -17.77 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.23 -43.75 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' 1177 ' ' ILE . 9.4 mm -51.16 -46.1 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.594 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.4 tp -54.85 -69.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -139.5 135.06 33.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' 1181 ' ' ASN . 8.4 t -91.76 139.03 31.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' 1180 ' ' THR . 11.1 m-20 -34.65 -42.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -46.4 -51.23 15.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.1 -48.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' 1164 ' ' ARG . 81.2 mt -51.72 -56.03 16.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 84.7 t -45.54 -51.6 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.93 -44.51 94.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 48.8 mmm -54.73 -42.5 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -67.27 -32.18 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.26 -64.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' 1233 ' ' PHE . 12.2 mtt -68.9 -42.18 77.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.473 ' NH1' HD11 ' A' 1232 ' ' LEU . 34.2 mtt85 70.61 52.7 0.39 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.0 Cg_endo -69.76 136.27 32.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 0.0 112.344 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' 1220 ' ' LYS . 17.9 p -123.7 23.16 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.18 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.408 ' O ' HG23 ' A' 1198 ' ' VAL . 12.0 p -139.77 138.14 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.571 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 6.8 p -54.91 -27.2 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.25 -54.05 14.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 34.9 m-20 -59.11 -49.36 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.793 HG21 ' HE3' ' A' 1216 ' ' TRP . 91.3 t -46.43 -37.76 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -63.68 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . 0.466 ' HB2' ' CE2' ' A' 1233 ' ' PHE . 91.8 mtt180 -67.33 -26.96 66.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.617 ' O ' HG12 ' A' 1204 ' ' VAL . 24.7 mm -56.23 145.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.73 145.57 53.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.59 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.466 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.736 HG23 ' HG2' ' A' 1208 ' ' LYS . 4.4 p -62.27 132.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 31.9 m -100.21 136.7 39.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.08 114.16 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 121.83 -70.6 0.4 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.736 ' HG2' HG23 ' A' 1204 ' ' VAL . 0.0 OUTLIER -32.98 -44.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.73 0.3 . . . . 0.0 110.876 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -30.43 -46.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.063 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.77 -62.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.103 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 15.4 ptt? -63.16 -23.3 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' 1209 ' ' ALA . 81.0 mt -85.77 31.47 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.88 -51.24 2.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.541 0.686 . . . . 0.0 111.122 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.9 Cg_exo -48.02 -21.79 3.03 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.64 -67.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.793 ' HE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.05 -24.63 66.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' 1216 ' ' TRP . 6.4 mt-10 -60.31 -36.95 79.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 53.7 t -73.45 -43.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.671 HD11 HD21 ' A' 1160 ' ' LEU . 56.7 mt -55.1 -34.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' 1193 ' ' THR . 13.7 ttpt -59.2 -48.12 82.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' 1225 ' ' THR . 13.4 t60 -73.75 -41.25 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' 1156 ' ' LEU . 36.3 t80 -53.25 -41.76 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.1 p -82.33 -34.51 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -64.98 -37.17 86.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.785 HG23 HD22 ' A' 1226 ' ' ASN . 10.2 t -83.35 -18.8 37.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.785 HD22 HG23 ' A' 1225 ' ' THR . 12.7 m-80 -116.93 21.2 13.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' 1226 ' ' ASN . 74.4 m 34.32 42.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' 1226 ' ' ASN . 57.6 t -91.02 147.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -73.81 147.55 43.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 38.7 p -143.4 173.8 11.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . 0.406 ' OD1' ' ND2' ' A' 1197 ' ' ASN . 4.2 m-20 60.81 51.6 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . 0.473 HD11 ' NH1' ' A' 1191 ' ' ARG . 11.3 mt -83.32 37.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.594 ' O ' ' CD1' ' A' 1233 ' ' PHE . 0.1 OUTLIER -174.99 119.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . 0.415 ' HA ' ' NH1' ' A' 1200 ' ' ARG . 3.9 t -160.51 110.34 1.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 88.9 p -100.83 121.85 42.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 24.6 m -158.21 120.52 3.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -76.21 138.86 68.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.529 0.681 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 86.57 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.632 2.221 . . . . 0.0 112.354 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -106.46 131.73 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 54.1 m -66.74 -49.04 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -76.41 139.16 23.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -25.72 28.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 9.2 t 52.73 40.4 30.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 10.6 t -95.75 -54.12 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 97.1 p -89.26 135.38 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 110.827 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 5.5 t -95.41 101.68 13.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -172.72 -179.64 43.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 22.5 m -96.51 98.97 10.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 0.0 110.87 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 47.6 p -122.0 137.7 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -143.59 94.4 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 15.9 m -130.94 140.0 50.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.886 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 60.9 m -100.72 136.25 40.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -112.59 150.8 43.24 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 133.46 25.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 0.0 112.345 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 89.6 t -42.54 136.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 48.2 mt -76.66 136.63 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 24.2 p -59.02 135.66 57.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -38.85 -48.12 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' 1147 ' ' ALA . 49.5 mt-30 -35.55 -52.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.27 -51.42 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -43.05 -59.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' 1154 ' ' ILE . 9.4 tt0 -43.68 -61.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.6 m -43.37 -42.57 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -72.04 -36.21 69.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' 1151 ' ' GLU . 82.4 mt -64.56 -49.91 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . 0.709 HG12 ' HE2' ' A' 1159 ' ' LYS . 48.0 t -66.09 -40.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' 1222 ' ' PHE . 22.8 tp -64.01 -57.15 10.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . . . . . . . . . 65.6 t80 -40.51 -49.23 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.72 61.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.522 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' 1155 ' ' VAL . 33.8 mttm -59.19 -41.27 88.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.9 mt -64.96 -52.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 93.7 t -49.39 -34.05 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.05 -51.42 58.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -67.2 -59.1 3.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.656 HH21 ' HB2' ' A' 1168 ' ' ALA . 0.0 OUTLIER -46.94 -44.14 19.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . 0.428 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 44.3 tt0 -63.35 -72.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' 1167 ' ' HIS . 9.3 ptpt -43.09 -28.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.423 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -60.66 -53.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.656 ' HB2' HH21 ' A' 1164 ' ' ARG . . . -37.14 -53.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -58.14 -46.8 85.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 29.6 tttt -47.99 -51.12 25.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.793 ' O ' HG13 ' A' 1173 ' ' VAL . 55.8 mtm -92.52 15.29 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 35.7 t70 43.04 40.79 2.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' 1171 ' ' MET . 32.9 m -117.34 141.42 28.64 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.626 0.727 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -47.9 132.92 22.56 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.356 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . 0.409 ' HA ' ' NH2' ' A' 1164 ' ' ARG . 65.2 Cg_exo -48.0 -17.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.682 2.255 . . . . 0.0 112.325 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.81 -45.37 7.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 16.4 mm -51.2 -43.35 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.6 ' CD1' ' CE ' ' A' 1171 ' ' MET . 8.4 tp -64.69 -69.79 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.629 ' HB3' ' HD2' ' A' 1164 ' ' ARG . . . -150.66 147.38 27.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 70.2 p -94.06 173.79 7.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' 1185 ' ' VAL . 87.7 m-20 -70.03 -33.94 72.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -61.66 -52.44 64.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . 0.586 HG23 HG21 ' A' 1201 ' ' ILE . 92.0 mt -52.59 -51.29 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.0 mt -47.51 -53.98 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' 1181 ' ' ASN . 70.8 t -45.19 -45.84 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -55.23 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 62.2 mmm -47.0 -41.23 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.0 95.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -71.26 -60.6 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.583 ' HB3' ' CE1' ' A' 1233 ' ' PHE . 38.1 mtt -63.9 -49.31 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.498 ' NH1' ' CG1' ' A' 1228 ' ' VAL . 24.6 mtm180 69.39 54.78 0.52 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.568 0.699 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.541 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 53.5 Cg_endo -69.75 133.78 26.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.338 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . 0.414 ' HB ' ' CD ' ' A' 1220 ' ' LYS . 33.1 p -104.16 -22.18 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.3 p -108.1 144.42 35.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 10.5 p -50.52 -35.63 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' 1200 ' ' ARG . 14.8 mt-10 -55.82 -68.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' 1233 ' ' PHE . 84.9 m-20 -41.7 -36.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.485 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.6 t -63.05 -49.07 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.21 -29.58 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' 1196 ' ' GLU . 2.1 mpt_? -67.57 -31.69 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' 1204 ' ' VAL . 23.8 mm -48.91 135.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.39 141.55 57.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.48 -44.27 1.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' 1201 ' ' ILE . 3.4 p -76.88 137.6 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 74.3 m -96.14 172.11 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.58 129.94 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 94.02 -59.66 2.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.448 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.596 ' HE2' HG23 ' A' 1204 ' ' VAL . 30.1 tttt -37.95 -47.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . . . . . . . . . . . -38.13 -44.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.25 -59.82 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 5.5 ptt? -53.11 -24.8 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 33.89 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -68.83 -49.27 27.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.725 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.6 Cg_exo -47.99 -19.14 1.41 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' 1215 ' ' LEU . 7.1 mp -80.64 -68.35 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.576 ' C ' ' CD1' ' A' 1216 ' ' TRP . 0.8 OUTLIER -61.6 -19.19 61.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.06 -35.11 80.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 95.3 t -73.16 -45.48 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' 1216 ' ' TRP . 74.4 mt -52.28 -56.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . 0.414 ' CD ' ' HB ' ' A' 1193 ' ' THR . 16.1 ttpp -43.05 -49.07 6.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.55 -53.52 33.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' 1156 ' ' LEU . 22.1 t80 -47.51 -52.26 17.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' 1230 ' ' THR . 26.4 p -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -61.82 -36.33 80.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.521 HG22 ' O ' ' A' 1222 ' ' PHE . 6.2 t -85.84 -27.58 25.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.448 ' CB ' HG23 ' A' 1228 ' ' VAL . 24.1 m-80 -99.39 6.33 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' 1223 ' ' CYS . 1.4 t 50.5 34.6 9.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.498 ' CG1' ' NH1' ' A' 1191 ' ' ARG . 45.3 t -87.01 143.73 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -68.7 148.36 50.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . 0.454 HG21 ' SG ' ' A' 1223 ' ' CYS . 22.0 p -149.17 175.5 11.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.69 51.94 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.74 38.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' 1197 ' ' ASN . 3.3 m-85 -98.0 -35.61 10.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 36.5 m -110.38 115.39 29.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 39.7 t -110.96 -44.37 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 93.9 m -53.56 -52.13 60.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -75.47 122.63 87.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.573 0.701 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -51.6 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.359 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -92.06 80.67 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 51.1 p -39.64 -57.3 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -169.19 127.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.53 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -0.41 6.86 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.656 2.237 . . . . 0.0 112.353 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 1.9 m -161.9 117.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 94.7 p -44.58 148.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 27.2 p -142.81 139.36 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 15.7 m -106.03 103.73 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 129.04 133.24 3.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 6.0 t -126.85 -57.64 1.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.844 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 3.6 t -98.24 136.27 38.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -166.51 -53.2 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 2.4 t 50.55 42.31 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 2.8 m -162.06 129.62 3.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.828 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -165.82 137.6 3.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.591 0.71 . . . . 0.0 110.898 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.67 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.643 2.229 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.5 m -45.19 170.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 71.6 mt -85.69 132.04 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.167 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' 1147 ' ' ALA . 44.8 t -50.91 132.61 27.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.833 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -37.92 -41.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' 1147 ' ' ALA . 16.1 mt-30 -34.39 -56.19 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.36 -48.28 6.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -40.85 -60.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' 1154 ' ' ILE . 10.0 tt0 -46.04 -60.72 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.2 m -42.16 -46.12 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -66.06 -43.8 86.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' 1151 ' ' GLU . 76.3 mt -57.1 -55.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 91.2 t -60.85 -43.2 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' 1222 ' ' PHE . 28.5 tp -60.66 -60.86 3.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' 1161 ' ' VAL . 64.5 t80 -35.29 -47.42 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -59.55 -51.97 55.88 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -50.12 -42.24 50.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.64 -51.58 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' 1157 ' ' TYR . 95.5 t -45.66 -57.2 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.152 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.96 -57.5 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.38 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.691 ' HD3' HD11 ' A' 1184 ' ' LEU . 16.9 ttp180 -57.57 -45.24 85.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.38 -54.01 50.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' 1167 ' ' HIS . 8.8 pttm -64.11 -38.62 91.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.479 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.2 t-80 -61.71 -51.03 70.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -38.03 -53.49 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.98 -45.58 92.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' 1170 ' ' LYS . 6.6 tmtm? -48.49 -51.18 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.819 ' O ' HG13 ' A' 1173 ' ' VAL . 50.0 mtm -91.53 15.36 12.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 36.9 t70 42.74 37.0 0.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' 1171 ' ' MET . 34.9 m -116.0 136.81 23.02 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.603 0.716 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.97 134.63 23.66 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.02 -16.41 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.372 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.84 -45.06 8.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.057 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 27.0 mm -56.96 -45.05 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.595 ' CD1' ' HE2' ' A' 1171 ' ' MET . 10.9 tp -52.0 -69.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.06 114.85 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 12.6 t -64.89 176.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.631 ' O ' HG23 ' A' 1185 ' ' VAL . 5.3 m120 -61.67 -47.44 85.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -44.67 -55.28 5.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 91.9 mt -51.52 -62.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.691 HD11 ' HD3' ' A' 1164 ' ' ARG . 71.3 mt -45.49 -56.89 4.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' 1181 ' ' ASN . 62.9 t -41.06 -57.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' 1189 ' ' LYS . 4.2 m-20 -56.68 -57.28 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 70.0 mtp -43.94 -23.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' 1186 ' ' ASP . . . -93.12 -32.24 14.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.566 ' HD3' HG12 ' A' 1185 ' ' VAL . 0.2 OUTLIER -74.14 -48.86 26.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -38.76 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' 1192 ' ' PRO . 50.2 mtt85 68.74 54.98 0.58 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.2 Cg_endo -69.73 128.06 15.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 67.6 p -101.94 -24.22 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 70.2 p -102.66 135.74 43.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.546 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.5 p -53.3 -42.34 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' 1195 ' ' VAL . 27.0 mp0 -48.5 -35.35 12.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -84.43 -35.02 23.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.469 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.8 t -62.22 -48.51 88.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' 1196 ' ' GLU . 13.2 ptpt -54.46 -17.15 2.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -82.92 -30.68 28.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' 1204 ' ' VAL . 47.9 mm -43.73 144.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.67 135.33 54.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.3 -45.99 1.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1201 ' ' ILE . 3.5 p -81.38 137.04 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 111.145 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 11.0 t -100.07 156.05 17.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -47.69 151.32 0.87 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 77.93 -62.91 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' 1209 ' ' ALA . 10.5 ttmm -40.6 -50.46 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.765 0.316 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.74 -46.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.09 -64.78 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.1 ptt? -48.46 -31.73 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' 1209 ' ' ALA . 41.5 mt -84.43 30.36 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.86 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.53 -55.17 15.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.566 0.698 . . . . 0.0 111.05 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.8 Cg_exo -47.99 -17.59 0.87 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.697 2.265 . . . . 0.0 112.34 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.95 -65.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.548 ' C ' ' CD1' ' A' 1216 ' ' TRP . 1.2 p90 -60.88 -26.99 67.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.507 ' N ' ' CD1' ' A' 1216 ' ' TRP . 22.8 mt-10 -55.08 -40.17 70.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.1 t -65.79 -42.14 91.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' 1216 ' ' TRP . 70.3 mt -53.71 -49.66 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -51.02 -43.15 60.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 5.7 t60 -69.62 -47.75 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' 1156 ' ' LEU . 31.6 t80 -53.43 -61.23 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' 1227 ' ' SER . 17.9 p -53.15 -44.14 67.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -45.8 -63.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . . . . . . . . . 1.5 m -67.69 -40.52 84.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' 1228 ' ' VAL . 70.0 m-80 -81.76 13.59 3.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' 1223 ' ' CYS . 6.5 t 32.55 49.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1226 ' ' ASN . 71.2 t -99.07 138.37 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -64.81 162.68 15.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 53.3 p -146.69 178.16 8.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 38.7 t0 61.19 42.62 11.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.4 mt -82.91 40.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -85.79 -44.16 12.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 5.5 m -163.02 172.08 15.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 3.8 m -64.83 91.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . 0.462 HG22 ' O ' ' A' 1238 ' ' PRO . 25.0 m -130.02 102.92 6.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' 1238 ' ' PRO . 2.8 mptm? -67.98 -60.36 5.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.893 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' 1237 ' ' LYS . 54.0 Cg_endo -69.79 163.62 37.61 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.342 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -85.7 -49.29 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 36.2 t -92.39 -42.87 9.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 68.71 -157.18 53.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.498 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 128.6 16.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.671 2.247 . . . . 0.0 112.333 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 74.3 m -130.31 154.08 48.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 8.1 t -173.35 157.12 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 80.4 p -81.0 129.62 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 97.0 p -93.86 119.88 33.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 159.97 40.63 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 65.5 m -80.55 125.33 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.866 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 5.4 t 45.26 42.16 6.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.865 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -64.87 96.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.469 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' 1141 ' ' SER . 95.4 p -151.2 166.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' 1140 ' ' SER . 32.6 m -36.72 146.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -109.04 146.36 33.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 0.0 110.95 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 164.19 35.5 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.738 2.292 . . . . 0.0 112.302 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 43.4 t -41.5 131.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.99 136.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 70.5 m -57.73 144.16 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -49.28 -48.19 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 3.3 pt20 -33.38 -49.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -96.62 -52.49 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -43.55 -56.59 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' 1154 ' ' ILE . 8.1 tt0 -52.73 -60.6 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . 0.458 HG22 ' NH1' ' A' 1191 ' ' ARG . 74.0 m -41.4 -46.62 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -61.92 -45.14 95.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' 1151 ' ' GLU . 69.6 mt -55.62 -63.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' 1159 ' ' LYS . 93.7 t -48.63 -54.16 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.557 HD21 HG23 ' A' 1219 ' ' ILE . 9.7 tp -54.04 -63.14 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' 1161 ' ' VAL . 44.2 t80 -38.06 -55.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -50.42 -42.99 43.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.528 ' HD2' HG12 ' A' 1155 ' ' VAL . 3.8 mtpm? -67.5 -43.96 79.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.806 HD21 HG13 ' A' 1219 ' ' ILE . 38.9 mt -60.14 -43.4 95.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.956 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' 1157 ' ' TYR . 98.2 t -57.73 -38.1 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -55.18 -50.52 69.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -68.25 -48.92 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.597 ' HG3' HD21 ' A' 1184 ' ' LEU . 4.7 tmm_? -47.4 -35.13 7.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.6 -69.82 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.477 ' HA ' ' ND2' ' A' 1169 ' ' ASN . 14.8 ptpt -44.96 -34.44 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' 1178 ' ' LEU . 1.3 t-80 -60.65 -37.29 81.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -57.45 -53.7 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' 1170 ' ' LYS . 6.4 p30 -61.08 -49.2 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' 1169 ' ' ASN . 0.1 OUTLIER -48.12 -53.07 17.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 34.6 mtm -78.18 -7.61 57.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.907 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 12.5 t0 68.92 26.65 5.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' 1168 ' ' ALA . 33.8 m -112.66 140.67 24.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.0 139.99 19.46 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . 0.447 ' O ' ' NH1' ' A' 1164 ' ' ARG . 65.9 Cg_exo -48.0 -16.74 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.71 2.273 . . . . 0.0 112.317 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.16 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 29.8 mm -46.54 -39.45 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.518 ' CD1' ' CE ' ' A' 1171 ' ' MET . 13.9 tp -61.04 -72.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -160.17 123.42 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 15.3 t -67.37 162.94 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -52.81 -46.39 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -42.84 -57.81 2.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 94.9 mt -45.48 -64.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' 1164 ' ' ARG . 95.6 mt -44.69 -52.14 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 88.3 t -47.15 -54.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.116 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.22 -46.6 75.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 36.1 mmm -50.86 -37.58 44.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.92 68.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 9.1 mptt -75.69 -60.91 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.533 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 14.6 mtt -70.37 -38.29 74.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' 1192 ' ' PRO . 32.0 mtt-85 66.66 52.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' 1191 ' ' ARG . 54.1 Cg_endo -69.8 137.67 35.9 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.25 . . . . 0.0 112.373 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 64.2 p -127.69 21.69 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 1.2 p -137.53 127.19 25.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' 1210 ' ' ALA . 14.1 p -43.28 -26.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -72.54 -64.59 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -47.65 -43.25 26.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.958 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.2 t -52.43 -42.03 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -58.4 -26.29 63.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -73.83 -33.28 64.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.692 ' O ' HG12 ' A' 1204 ' ' VAL . 43.5 mm -47.5 140.16 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -68.77 142.51 54.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.91 -41.38 2.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.539 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' 1201 ' ' ILE . 8.4 p -78.62 137.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1206 ' ' GLU . 65.1 m -99.5 144.06 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' 1205 ' ' SER . 22.7 tt0 -35.44 130.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 90.88 -59.8 3.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.7 ttmp? -38.41 -52.11 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.84 -52.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' 1195 ' ' VAL . . . -40.5 -66.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.076 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . 0.404 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 3.2 ptt? -47.44 -28.64 2.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . . . . . . . . . 65.8 mt -85.4 30.73 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -63.47 -50.0 75.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 64.5 Cg_exo -47.91 -18.94 1.27 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 0.0 112.329 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.64 -70.77 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.958 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.1 p90 -56.55 -24.47 47.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.451 ' N ' ' CD1' ' A' 1216 ' ' TRP . 30.1 mt-10 -59.5 -35.34 73.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 63.6 t -68.24 -34.76 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.806 HG13 HD21 ' A' 1160 ' ' LEU . 62.5 mt -66.71 -42.92 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.35 -46.52 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.87 ' O ' HG22 ' A' 1225 ' ' THR . 5.2 t-160 -72.61 -41.69 65.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.51 ' CG ' HD13 ' A' 1156 ' ' LEU . 22.0 t80 -54.25 -42.83 70.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 23.7 p -81.36 -34.59 31.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -62.53 -33.68 75.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.87 HG22 ' O ' ' A' 1221 ' ' HIS . 3.1 t -89.72 -15.35 32.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.757 HD22 HG23 ' A' 1225 ' ' THR . 7.6 m-80 -118.65 20.15 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1226 ' ' ASN . 55.1 m 35.55 46.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 41.0 t -93.72 140.43 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.79 153.44 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 47.3 p -146.87 -179.89 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 61.93 45.62 7.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.861 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.64 35.79 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.533 ' CE2' ' SD ' ' A' 1190 ' ' MET . 49.2 m-85 -75.84 158.87 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 2.5 m -82.04 149.33 28.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 32.5 m 58.9 45.14 15.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 8.8 t -100.36 35.12 2.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 17.1 tptm -71.81 133.93 84.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.578 0.704 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 106.01 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.734 2.289 . . . . 0.0 112.292 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.34 139.75 52.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 59.0 p -143.21 119.53 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -148.04 144.48 12.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -43.36 2.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.296 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 45.5 p -51.43 162.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 63.0 m -107.56 -51.19 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.539 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 87.6 p -122.36 -50.12 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 17.0 t -77.4 -57.31 3.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -123.08 123.15 5.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 1.9 t -108.46 177.06 4.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.827 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 36.1 t -63.55 120.41 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -75.74 54.25 2.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 43.1 t -41.88 -61.51 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.827 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 49.0 m -59.17 -54.71 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -156.39 140.21 11.43 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.6 0.714 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 118.76 5.87 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.669 2.246 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . 0.406 HG22 ' N ' ' A' 1145 ' ' ILE . 9.8 p -125.84 155.98 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' 1146 ' ' SER . 35.3 mt -87.45 154.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.422 ' N ' HG22 ' A' 1145 ' ' ILE . 74.4 m -81.98 139.08 34.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.807 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.92 -46.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1147 ' ' ALA . 76.5 mt-30 -35.95 -52.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' 1150 ' ' GLN . 44.1 tt0 -99.89 -47.07 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' 1149 ' ' GLU . 20.3 tt0 -36.81 -50.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -54.54 -56.22 21.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 53.3 m -44.45 -46.74 9.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 2.1 mm-40 -68.25 -35.1 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.38 -53.39 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.123 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . 0.56 HG12 ' NZ ' ' A' 1159 ' ' LYS . 44.7 t -63.57 -39.7 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.492 HD22 ' NE ' ' A' 1191 ' ' ARG . 56.2 tp -66.61 -53.8 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' 1161 ' ' VAL . 74.6 t80 -40.27 -44.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -55.0 -44.93 83.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.56 ' NZ ' HG12 ' A' 1155 ' ' VAL . 44.1 mttp -61.84 -46.16 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.53 HD21 HD11 ' A' 1219 ' ' ILE . 33.6 mt -57.23 -40.73 78.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' 1157 ' ' TYR . 96.3 t -62.59 -44.07 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -64.75 -45.89 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.86 95.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.501 HH11 HD11 ' A' 1184 ' ' LEU . 27.7 ttp180 -59.06 -46.13 89.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -56.58 -61.05 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 26.4 pttt -52.54 -26.89 14.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.22 -47.85 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . . . . . . . . . . . -41.14 -50.99 3.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -65.83 -46.18 79.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 66.1 tttt -45.55 -53.69 8.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 44.6 mtm -84.26 -1.95 56.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.88 30.57 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 33.4 m -113.19 138.74 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.99 136.74 23.21 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.679 2.252 . . . . 0.0 112.37 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.94 -16.79 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.45 -46.39 7.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.3 mm -53.28 -44.81 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.571 ' CD1' ' CE ' ' A' 1171 ' ' MET . 10.8 tp -54.08 -68.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -154.89 129.68 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 3.6 t -75.54 166.1 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.32 -44.44 84.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -48.82 -42.77 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.87 -45.16 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.501 HD11 HH11 ' A' 1164 ' ' ARG . 53.2 mt -60.72 -49.47 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 98.6 t -49.87 -50.95 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.22 -46.8 88.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 38.2 mtp -53.01 -43.39 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.52 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.444 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 26.2 mttm -73.53 -63.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.708 ' SD ' HD13 ' A' 1201 ' ' ILE . 21.5 mtt -59.1 -38.6 79.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.492 ' NE ' HD22 ' A' 1156 ' ' LEU . 31.7 mtp180 62.24 55.02 2.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.584 0.707 . . . . 0.0 110.898 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' A' 1197 ' ' ASN . 53.7 Cg_endo -69.8 135.08 29.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.375 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' 1216 ' ' TRP . 30.3 p -103.66 -36.91 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.409 ' O ' HG23 ' A' 1198 ' ' VAL . 2.8 p -99.99 164.27 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' 1196 ' ' GLU . 14.8 p -62.15 -42.59 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' 1195 ' ' VAL . 27.2 mm-40 -49.01 -50.83 34.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' 1192 ' ' PRO . 0.6 OUTLIER -59.34 -42.7 92.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.675 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.7 t -59.14 -49.21 84.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 64.1 mttt -49.89 -35.87 25.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -71.43 -24.89 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.954 ' O ' HG12 ' A' 1204 ' ' VAL . 23.9 mm -55.45 100.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' 1201 ' ' ILE . 6.7 t70 -34.8 143.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.2 -50.86 1.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.954 HG12 ' O ' ' A' 1201 ' ' ILE . 14.9 p -69.84 137.54 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' 1206 ' ' GLU . 1.2 t -96.82 140.38 31.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' 1205 ' ' SER . 22.4 tt0 -34.21 140.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 79.8 -54.01 4.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.514 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' 1209 ' ' ALA . 43.1 tttm -39.51 -57.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.319 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -35.12 -39.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -42.51 -66.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.99 -22.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.488 HD21 ' HG ' ' A' 1178 ' ' LEU . 73.7 mt -91.84 33.84 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -66.2 -53.32 33.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.723 . . . . 0.0 111.109 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.9 Cg_exo -48.03 -17.65 0.91 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.1 -65.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.675 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -61.02 -21.53 63.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.3 -44.37 95.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 97.6 t -67.21 -38.37 80.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.53 HD11 HD21 ' A' 1160 ' ' LEU . 84.5 mt -59.59 -39.42 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.162 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . 0.401 ' CD ' ' HB ' ' A' 1193 ' ' THR . 23.2 ttpt -64.53 -27.63 69.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' 1224 ' ' GLN . 1.8 t-80 -81.9 -60.64 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.473 ' CD1' ' HE2' ' A' 1159 ' ' LYS . 59.3 t80 -38.36 -37.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' 1227 ' ' SER . 24.8 p -81.99 -33.79 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -66.33 -47.39 73.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.767 HG23 ' ND2' ' A' 1226 ' ' ASN . 9.0 t -71.32 -30.82 66.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.767 ' ND2' HG23 ' A' 1225 ' ' THR . 36.6 m-80 -105.6 14.01 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' 1223 ' ' CYS . 82.4 p 33.9 48.98 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' 1226 ' ' ASN . 60.1 t -98.99 147.63 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -65.22 146.62 54.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . 0.428 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.9 p -145.38 -175.39 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . 0.428 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 47.18 50.14 14.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.73 49.34 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' 1197 ' ' ASN . 33.9 m-85 -86.04 155.52 20.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 3.5 m -44.43 148.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 30.7 t -72.87 80.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 15.3 t -125.99 145.18 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.143 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -58.36 134.68 85.13 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 166.13 28.72 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.342 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -115.61 134.55 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 8.0 t -74.87 169.87 17.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 102.33 62.38 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.523 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' 1243 ' ' SER . 53.9 Cg_endo -69.77 -46.75 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.307 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' 1242 ' ' PRO . 43.6 t 35.19 43.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 97.0 p -109.57 97.26 6.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 22.3 m -141.57 111.27 6.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 72.6 p -129.78 145.24 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -131.28 -157.3 8.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 42.7 p -174.13 148.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 1.9 t -165.93 149.16 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -71.72 -170.29 12.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 3.1 m -126.7 41.89 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 3.2 t -160.79 128.31 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.793 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' A' 1143 ' ' PRO . 21.2 mt-30 -121.3 111.49 33.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' 1142 ' ' GLN . 54.2 Cg_endo -69.77 -173.53 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.37 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.2 m -77.01 146.6 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.88 129.69 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' 1147 ' ' ALA . 11.7 t -56.93 128.65 37.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' 1146 ' ' SER . . . -36.18 -46.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -40.8 -51.92 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -91.33 -49.27 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -41.55 -58.0 2.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -48.71 -61.65 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 88.3 m -42.65 -46.8 5.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' A' 1189 ' ' LYS . 18.4 mt-30 -64.82 -37.16 86.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.84 -57.52 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 95.0 t -56.08 -38.68 54.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.446 HD13 ' CG ' ' A' 1222 ' ' PHE . 33.7 tp -72.08 -61.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.677 ' O ' HG23 ' A' 1161 ' ' VAL . 70.2 t80 -36.79 -40.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.87 -46.2 94.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 54.1 mttm -57.13 -44.64 83.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.69 -52.27 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' 1157 ' ' TYR . 88.5 t -45.76 -45.18 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.64 -46.72 88.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.65 80.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.489 ' HG3' HD23 ' A' 1178 ' ' LEU . 21.9 ttp180 -52.12 -46.45 65.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -57.73 -66.8 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' 1167 ' ' HIS . 10.3 pttp -47.58 -38.29 14.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.465 ' N ' ' HG3' ' A' 1166 ' ' LYS . 0.6 OUTLIER -65.9 -51.93 54.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -38.96 -58.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -57.29 -41.09 79.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.88 -55.23 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.635 ' HE1' ' HG3' ' A' 1211 ' ' MET . 39.6 mtm -80.83 -2.83 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.25 29.31 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.7 m -113.39 138.83 22.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.94 138.31 21.36 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -48.04 -16.93 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.603 2.202 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -95.0 -45.61 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 21.7 mm -51.82 -42.05 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' 1164 ' ' ARG . 10.9 tp -57.54 -67.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.28 129.43 11.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' 1181 ' ' ASN . 9.3 t -83.69 150.62 25.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' 1180 ' ' THR . 5.6 m120 -35.38 -48.7 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -45.1 -56.62 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 81.4 mt -52.28 -52.6 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.546 HD13 HG22 ' A' 1161 ' ' VAL . 71.8 mt -46.36 -57.03 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' 1181 ' ' ASN . 21.6 t -46.55 -50.31 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.728 ' HB3' HG23 ' A' 1201 ' ' ILE . 1.9 m-20 -56.22 -41.6 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 56.4 mtp -68.88 -22.6 64.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -90.27 -29.01 18.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.426 ' HA ' ' NE2' ' A' 1153 ' ' GLN . 9.2 ptmm? -85.39 -44.41 12.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' 1189 ' ' LYS . 15.8 mtm -88.07 -14.79 38.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' 1156 ' ' LEU . 47.9 mtm-85 39.62 54.87 5.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.632 ' HG3' HD11 ' A' 1201 ' ' ILE . 53.7 Cg_endo -69.77 138.79 38.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 80.9 p -131.45 22.33 4.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 13.3 p -138.24 126.27 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . . . . . . . . . 9.6 p -49.08 -27.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -73.78 -30.5 62.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -89.84 -49.88 6.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 91.6 t -45.89 -44.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -58.04 -30.06 65.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -74.5 -14.03 60.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' 1186 ' ' ASP . 23.0 mm -59.58 138.69 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.23 136.99 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.45 1.04 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.761 HG23 ' HD3' ' A' 1208 ' ' LYS . 7.4 p -77.2 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.164 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 38.1 m -100.17 170.9 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -61.49 143.85 55.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 78.32 -57.68 4.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.761 ' HD3' HG23 ' A' 1204 ' ' VAL . 46.5 tttt -39.54 -45.31 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -39.77 -45.19 1.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.08 -65.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . 0.635 ' HG3' ' HE1' ' A' 1171 ' ' MET . 3.1 ptt? -50.15 -25.91 4.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' 1209 ' ' ALA . 53.8 mt -88.99 32.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.33 -51.37 34.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 111.125 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -48.03 -17.18 0.75 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.35 -64.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.566 ' C ' ' CD1' ' A' 1216 ' ' TRP . 0.9 OUTLIER -64.47 -20.7 66.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.27 -37.15 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 76.7 t -68.53 -51.89 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' 1216 ' ' TRP . 59.1 mt -47.15 -48.33 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -48.17 -48.51 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.737 ' O ' HG22 ' A' 1225 ' ' THR . 3.4 t-160 -70.34 -46.61 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' 1222 ' ' PHE . 3.3 t80 -54.01 -38.14 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' 1227 ' ' SER . 28.1 p -85.97 -31.16 22.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -69.0 -35.4 76.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.747 HG23 HD22 ' A' 1226 ' ' ASN . 7.6 t -84.78 -20.36 31.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.747 HD22 HG23 ' A' 1225 ' ' THR . 10.7 m-80 -108.88 -3.69 17.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' 1223 ' ' CYS . 3.5 t 61.06 33.22 19.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 62.9 t -80.81 140.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.173 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -71.43 151.3 44.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 75.9 p -144.88 173.71 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 68.72 47.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.78 43.61 1.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.42 -51.13 7.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 52.3 m -147.76 115.61 6.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 58.8 m -90.48 75.39 6.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' 1237 ' ' LYS . 55.2 p -145.98 167.02 24.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' 1236 ' ' THR . 19.6 tptm -35.01 133.55 0.44 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -2.52 10.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.301 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -91.38 79.06 5.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 57.2 m -136.77 143.54 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -79.22 135.92 16.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.657 2.238 . . . . 0.0 112.387 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 40.7 m -71.07 144.39 50.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 7.4 t -48.32 -45.6 35.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 2.7 t -132.29 104.04 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.876 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 49.3 m -116.61 99.91 7.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -51.81 104.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 19.5 m -54.71 142.04 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 36.9 p -140.91 151.12 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.818 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 171.27 120.66 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 22.3 p -124.83 107.6 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' 1142 ' ' GLN . 7.1 m 57.19 43.82 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.84 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' 1141 ' ' SER . 26.4 mt-30 -35.85 124.52 0.67 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.651 0.739 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -175.86 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 98.1 t -71.24 138.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.106 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 53.3 mt -78.3 144.0 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 19.9 m -78.92 152.54 31.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -43.49 -47.43 7.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' 1147 ' ' ALA . 5.7 pt20 -32.82 -51.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.06 -48.95 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -47.87 -67.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' 1154 ' ' ILE . 6.3 tp10 -40.82 -60.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 98.8 m -43.03 -52.03 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -61.77 -36.61 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.944 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' 1151 ' ' GLU . 96.7 mt -61.58 -58.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 88.4 t -60.15 -40.15 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.939 HD13 ' CD2' ' A' 1222 ' ' PHE . 38.6 tp -62.95 -56.88 13.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' 1161 ' ' VAL . 45.2 t80 -37.23 -42.24 0.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -62.93 -49.27 73.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.432 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 25.3 mttm -53.38 -40.89 65.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.81 -49.36 68.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' 1157 ' ' TYR . 83.1 t -47.55 -41.37 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -62.66 -42.8 99.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.74 96.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' 1184 ' ' LEU . 30.3 ttp180 -62.74 -43.28 99.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.66 -51.27 70.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' 1167 ' ' HIS . 19.0 ptpt -64.89 -44.1 90.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.469 ' N ' ' HG3' ' A' 1166 ' ' LYS . 1.1 t-80 -60.54 -47.98 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -40.13 -53.12 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -61.37 -46.82 88.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' 1170 ' ' LYS . 14.4 tmtt? -43.07 -54.74 4.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.497 ' HE3' ' CD1' ' A' 1178 ' ' LEU . 29.2 mtm -82.86 -4.79 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 18.4 t0 67.27 32.02 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' 1168 ' ' ALA . 35.0 m -115.26 137.79 23.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.606 0.717 . . . . 0.0 111.187 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.93 138.88 20.69 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.96 -16.51 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 0.0 112.394 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -93.78 -47.38 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.93 -41.33 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.497 ' CD1' ' HE3' ' A' 1171 ' ' MET . 11.8 tp -57.55 -63.96 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -153.46 143.97 22.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 59.1 p -93.17 169.57 10.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' 1185 ' ' VAL . 87.4 m-20 -55.32 -37.65 67.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.86 -48.06 82.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.85 -39.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' 1164 ' ' ARG . 77.3 mt -72.71 -48.13 41.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' 1181 ' ' ASN . 93.2 t -52.24 -40.23 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -44.25 72.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 52.5 mtp -59.5 -37.19 77.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -72.4 -27.75 62.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 44.3 mttt -79.33 -63.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.584 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 15.2 mtt -64.92 -39.04 92.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' 1192 ' ' PRO . 29.1 mtm180 66.55 53.71 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.9 Cg_endo -69.77 141.23 44.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.708 2.272 . . . . 0.0 112.344 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 71.7 p -127.58 18.29 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.625 ' O ' HG23 ' A' 1198 ' ' VAL . 31.3 p -137.85 130.8 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.514 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 14.7 p -51.29 -24.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.089 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -71.9 -64.16 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -51.53 -42.92 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.66 HG21 ' CE3' ' A' 1216 ' ' TRP . 88.7 t -47.78 -45.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 27.9 mttp -52.06 -34.13 42.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -64.34 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' 1202 ' ' ASP . 26.3 mm -43.33 153.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' 1201 ' ' ILE . 31.7 t0 -80.69 133.46 35.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.0 -46.03 1.43 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . . . . . . . . . 12.8 p -66.64 134.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 8.6 m -98.91 152.18 20.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -43.47 137.45 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.88 -62.91 4.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.648 ' HE2' HD11 ' A' 1212 ' ' LEU . 40.1 tttt -34.97 -48.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -36.44 -48.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -39.09 -65.62 0.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.075 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . 0.462 ' CE ' ' HG3' ' A' 1208 ' ' LYS . 5.6 ptt? -46.16 -28.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.648 HD11 ' HE2' ' A' 1208 ' ' LYS . 51.2 mt -87.17 32.95 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.845 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -70.42 -54.86 8.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.567 0.699 . . . . 0.0 111.089 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.845 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.95 -17.57 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.91 -64.04 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.66 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.2 p90 -62.42 -21.86 65.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.403 ' N ' ' CD1' ' A' 1216 ' ' TRP . 55.1 mt-10 -60.43 -37.87 82.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.0 t -69.36 -57.9 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.085 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . . . . . . . . . 83.7 mt -38.71 -46.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -46.96 -55.23 8.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.51 ' O ' HG22 ' A' 1225 ' ' THR . 3.1 t-160 -68.04 -46.56 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.939 ' CD2' HD13 ' A' 1156 ' ' LEU . 64.1 t80 -46.65 -47.53 20.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 97.4 m -81.93 -46.87 13.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -46.86 -46.44 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.552 HG23 ' ND2' ' A' 1226 ' ' ASN . 15.4 t -70.96 -37.37 72.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.569 ' O ' HG23 ' A' 1228 ' ' VAL . 15.6 m-80 -90.05 23.8 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 4.7 t 39.37 39.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' 1226 ' ' ASN . 61.1 t -99.35 143.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -71.0 153.1 42.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 25.4 p -145.9 152.39 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.85 54.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 17.2 mt -85.35 25.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.584 ' CE2' ' SD ' ' A' 1190 ' ' MET . 0.7 OUTLIER -151.53 105.56 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 71.2 p -175.03 113.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.859 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 90.4 p -96.01 52.76 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 20.3 m -150.5 144.89 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 54.1 pttt -160.5 139.3 7.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.573 0.701 . . . . 0.0 110.909 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.333 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -61.34 -45.54 93.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 57.4 p -105.86 171.56 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -126.58 176.2 17.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -45.64 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.288 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 58.7 m 41.47 43.59 2.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 69.2 m 41.64 42.19 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.817 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 40.0 t -146.35 148.91 32.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.826 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 59.5 p -42.14 125.08 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -56.16 119.38 14.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 25.8 t -95.23 126.3 40.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 6.5 t -54.43 -49.44 69.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 152.75 172.74 21.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 1.1 t 71.86 40.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 85.7 p -156.43 105.97 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -52.82 111.27 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 147.52 62.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 10.2 p -84.02 148.63 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.52 139.2 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' 1147 ' ' ALA . 89.2 p -54.11 124.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' 1146 ' ' SER . . . -35.12 -48.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -41.67 -49.4 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.52 -52.38 4.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' 1150 ' ' GLN . 2.1 tp60 -42.22 -52.77 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.729 ' HA ' HD12 ' A' 1154 ' ' ILE . 19.7 tt0 -49.22 -60.09 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 70.7 m -41.0 -54.54 2.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -54.06 -40.81 67.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.4 mt -60.13 -53.41 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 58.1 t -61.52 -42.04 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.521 HD13 ' CG ' ' A' 1222 ' ' PHE . 17.6 tp -62.22 -59.13 5.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' 1156 ' ' LEU . 55.8 t80 -35.74 -51.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.47 56.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 17.1 mttm -58.75 -38.82 79.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.455 HD21 HD11 ' A' 1219 ' ' ILE . 38.5 mt -70.07 -42.22 73.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . . . . . . . . . 68.3 t -47.57 -51.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -56.84 -46.2 81.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -61.92 -44.96 95.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.878 ' HD3' ' HB3' ' A' 1179 ' ' ALA . 4.0 tpm_? -60.79 -29.37 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -80.7 -70.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -40.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . 0.58 ' HB3' HD21 ' A' 1178 ' ' LEU . 0.5 OUTLIER -65.26 -54.57 27.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.76 ' HA ' HD22 ' A' 1178 ' ' LEU . . . -37.26 -59.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.42 -35.88 76.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' 1167 ' ' HIS . 43.0 tttp -52.61 -54.31 34.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.429 ' CE ' ' CD1' ' A' 1178 ' ' LEU . 36.7 mtm -81.57 -1.77 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.18 37.37 8.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . . . . . . . . . 25.6 m -119.62 142.39 32.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.98 135.64 23.6 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -47.97 -16.81 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.35 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.93 -45.49 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 35.9 mm -55.41 -38.79 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.76 HD22 ' HA ' ' A' 1168 ' ' ALA . 14.0 tp -59.63 -64.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' 1164 ' ' ARG . . . -168.66 127.41 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 11.0 t -67.82 170.28 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -63.78 -45.8 88.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -42.92 -57.34 2.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 95.6 mt -47.69 -48.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.87 -58.54 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.492 HG12 ' HD2' ' A' 1189 ' ' LYS . 93.1 t -40.87 -53.49 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.7 -56.7 15.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . 0.46 ' HE3' ' HB3' ' A' 1216 ' ' TRP . 42.7 mtp -47.79 -43.5 27.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.0 79.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' 1185 ' ' VAL . 15.3 mtpp -71.36 -63.82 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.537 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 20.2 mtt -63.69 -39.64 94.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' 1192 ' ' PRO . 36.3 mtm-85 65.61 54.67 1.07 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.578 0.704 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.76 143.73 51.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.33 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 6.2 p -124.87 15.5 8.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . 0.567 ' O ' HG23 ' A' 1198 ' ' VAL . 16.9 p -140.03 134.91 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.417 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 11.1 p -57.85 -29.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -67.47 -31.68 71.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -87.37 -37.78 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.728 HG21 ' CE3' ' A' 1216 ' ' TRP . 90.4 t -53.37 -36.48 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.169 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -62.89 -27.36 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -68.21 -33.24 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' 1202 ' ' ASP . 46.9 mm -42.63 160.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . 0.539 ' N ' HG22 ' A' 1201 ' ' ILE . 16.8 t70 -87.36 134.51 33.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 100.06 -38.71 3.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' 1198 ' ' VAL . 7.3 p -68.45 138.82 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 63.8 p -99.82 154.71 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.48 139.18 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 80.7 -56.68 4.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' 1209 ' ' ALA . 14.6 ttmm -36.98 -45.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' 1212 ' ' LEU . . . -35.22 -45.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -41.46 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 9.7 ptt? -52.94 -17.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' 1209 ' ' ALA . 17.0 mt -90.88 31.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.69 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -76.8 -49.87 2.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 0.0 111.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 66.2 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . 0.748 HD11 ' NH2' ' A' 1164 ' ' ARG . 6.8 mp -84.04 -70.94 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.728 ' CE3' HG21 ' A' 1198 ' ' VAL . 1.0 OUTLIER -56.2 -19.18 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -64.02 -35.79 81.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 81.7 t -75.89 -51.79 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.455 HD11 HD21 ' A' 1160 ' ' LEU . 66.3 mt -49.0 -50.57 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -42.08 -45.22 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.4 t-160 -75.59 -56.27 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' 1156 ' ' LEU . 10.0 t80 -41.88 -32.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 83.1 m -90.96 -25.21 19.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' 1221 ' ' HIS . 2.9 pt20 -72.04 -46.95 55.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' 1224 ' ' GLN . 7.4 t -74.11 -24.66 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' 1225 ' ' THR . 36.3 m-80 -102.1 -0.79 32.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 32.1 t 55.37 36.65 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' 1229 ' ' GLN . 74.9 t -83.09 153.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . 0.404 ' N ' HG12 ' A' 1228 ' ' VAL . 1.8 mp0 -70.11 145.95 51.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 23.6 p -143.58 165.62 27.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.13 46.65 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.36 43.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.537 ' CE2' ' SD ' ' A' 1190 ' ' MET . 58.2 m-85 -84.75 41.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' 1233 ' ' PHE . 74.2 m 35.09 43.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 5.0 m -78.0 154.34 31.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.847 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 23.6 p -125.53 -25.07 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.162 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 153.32 55.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.646 0.736 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 143.52 51.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.326 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -63.77 -48.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 41.1 t -68.02 150.13 48.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -119.27 -164.23 12.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -50.14 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.366 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 82.7 p -148.17 151.9 36.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 44.0 p -48.81 160.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 13.0 m -103.77 160.95 14.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.898 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 2.8 m -82.85 -59.03 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.854 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . 118.12 -140.33 15.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 30.2 t -162.42 144.99 11.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 5.2 t -96.37 146.22 24.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . 108.46 158.99 19.66 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 2.5 m -54.72 -46.54 74.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 32.9 m -61.07 160.12 10.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.75 136.52 10.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 155.25 66.63 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.377 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 96.4 t -44.67 135.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . . . . . . . . . 47.4 mt -73.79 138.62 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 19.3 m -58.93 137.19 57.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' 1148 ' ' GLN . . . -39.48 -44.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' 1147 ' ' ALA . 80.8 mt-30 -34.77 -56.91 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' 1153 ' ' GLN . 27.9 tt0 -96.09 -44.56 7.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -44.19 -54.2 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -70.79 -58.82 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 47.5 m -38.05 -53.51 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' 1149 ' ' GLU . 61.6 mt-30 -60.07 -45.64 92.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.99 -51.46 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . . . . . . . . . 94.4 t -61.66 -42.06 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.523 HD22 ' NE ' ' A' 1191 ' ' ARG . 17.0 tp -63.73 -59.82 4.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' 1161 ' ' VAL . 61.4 t80 -36.58 -44.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.49 90.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . . . . . . . . . 28.8 mttm -57.01 -40.44 76.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . 0.474 HD21 HD11 ' A' 1219 ' ' ILE . 42.4 mt -64.59 -46.05 84.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.797 HG13 HH12 ' A' 1164 ' ' ARG . 85.7 t -54.11 -41.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.05 -47.41 83.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . 0.418 ' HA ' ' CG ' ' A' 1166 ' ' LYS . . . -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . 0.797 HH12 HG13 ' A' 1161 ' ' VAL . 14.0 ttp-105 -62.86 -32.42 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -74.83 -55.22 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' 1163 ' ' ALA . 0.0 OUTLIER -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.12 -46.81 48.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -41.38 -52.82 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -59.75 -45.74 91.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 26.2 tttp -48.72 -51.6 27.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.636 ' O ' HG13 ' A' 1173 ' ' VAL . 50.6 mtm -88.01 11.0 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 10.6 m-20 49.83 31.34 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' 1171 ' ' MET . 35.3 m -112.62 136.87 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -48.02 138.79 21.28 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 -17.42 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -94.91 -43.6 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.53 -45.45 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.603 ' CD1' ' CE ' ' A' 1171 ' ' MET . 14.3 tp -51.36 -67.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -152.77 134.12 14.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . 0.459 ' H ' HD12 ' A' 1183 ' ' ILE . 12.1 t -78.86 159.24 27.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.04 -42.93 60.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -47.54 -44.55 26.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' 1180 ' ' THR . 74.7 mt -62.55 -62.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' 1164 ' ' ARG . 94.1 mt -40.01 -54.09 2.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . . . . . . . . . 96.1 t -47.15 -57.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.405 ' CB ' HG23 ' A' 1201 ' ' ILE . 4.2 m-20 -53.73 -57.41 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 65.7 mtp -43.98 -38.19 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.56 73.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -74.02 -58.31 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' 1233 ' ' PHE . 14.3 mtt -69.79 -32.82 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.523 ' NE ' HD22 ' A' 1156 ' ' LEU . 25.9 mtp180 55.7 53.36 8.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.73 135.02 29.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 45.3 p -102.05 -31.85 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 61.4 p -102.62 149.37 24.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.575 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 10.7 p -59.34 -39.15 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -51.93 -25.12 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.417 ' HB3' ' CZ ' ' A' 1233 ' ' PHE . 79.8 m-20 -95.45 -39.31 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' 1216 ' ' TRP . 76.8 t -58.13 -47.58 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -54.64 -29.4 52.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -71.27 -19.93 62.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' 1204 ' ' VAL . 38.0 mm -55.58 149.38 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.62 135.93 50.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.56 -48.82 1.23 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' 1201 ' ' ILE . 10.3 p -73.59 135.99 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 18.2 m -99.47 150.58 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -41.62 141.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' 1208 ' ' LYS . . . 83.19 -65.6 4.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' 1209 ' ' ALA . 32.3 ttpt -34.72 -54.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' 1212 ' ' LEU . . . -33.96 -47.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -37.69 -64.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 6.6 ptt? -48.99 -30.36 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' 1209 ' ' ALA . 43.5 mt -84.86 30.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -64.6 -52.52 51.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 111.11 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 63.8 Cg_exo -47.95 -17.91 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.38 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 8.6 mp -80.91 -65.32 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.575 ' CH2' ' HB ' ' A' 1195 ' ' VAL . 1.0 OUTLIER -61.8 -23.15 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' 1216 ' ' TRP . 21.5 mm-40 -58.66 -38.94 79.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 72.7 t -70.02 -30.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' 1216 ' ' TRP . 68.1 mt -66.12 -44.7 91.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -54.77 -30.06 55.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' 1224 ' ' GLN . 3.3 t-160 -82.92 -56.93 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . . . . . . . . . 49.0 t80 -39.94 -34.4 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' 1227 ' ' SER . 22.2 p -86.89 -30.44 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' 1221 ' ' HIS . 3.2 pt20 -70.53 -46.76 63.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.756 HG23 HD22 ' A' 1226 ' ' ASN . 6.6 t -71.84 -13.49 61.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.756 HD22 HG23 ' A' 1225 ' ' THR . 31.0 m-80 -127.08 14.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' 1223 ' ' CYS . 7.6 t 34.75 48.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 76.4 t -94.65 147.79 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -66.7 144.19 56.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . 0.453 ' C ' ' CG ' ' A' 1231 ' ' ASP . 38.0 p -141.1 -175.29 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . 0.453 ' CG ' ' C ' ' A' 1230 ' ' THR . 0.2 OUTLIER 48.36 53.39 12.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.51 42.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' 1190 ' ' MET . 17.2 m-85 -77.19 145.88 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 27.7 t -62.11 -44.16 97.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 2.7 t -45.08 134.61 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . . . . . . . . . 31.0 m -90.73 138.88 31.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . 0.456 ' N ' ' CD ' ' A' 1238 ' ' PRO . 71.7 mmtt 47.1 53.79 14.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.556 0.693 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' 1237 ' ' LYS . 53.6 Cg_endo -69.71 81.1 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.334 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -141.28 140.46 33.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 22.0 t -161.05 131.58 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . 53.03 85.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 108.9 2.18 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 3.7 t 44.63 39.62 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 49.9 m -125.43 165.21 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.445 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1133 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1134 ' ' SER . . . . . . . . . . . . . 11.9 t -167.12 145.99 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.862 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1135 ' ' SER . . . . . . . . . . . . . 57.1 p -79.79 133.2 36.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1136 ' ' GLY . . . . . . . . . . . . . . . -144.14 146.02 16.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1137 ' ' SER . . . . . . . . . . . . . 37.7 t -150.14 121.4 7.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 110.885 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1138 ' ' SER . . . . . . . . . . . . . 3.8 t -107.14 158.56 16.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1139 ' ' GLY . . . . . . . . . . . . . . . -83.43 79.17 1.94 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.433 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1140 ' ' SER . . . . . . . . . . . . . 73.6 m -116.08 167.43 10.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.856 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1141 ' ' SER . . . . . . . . . . . . . 22.8 t -61.5 -45.15 95.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1142 ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -120.87 127.22 26.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.593 0.711 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1143 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 129.72 18.1 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.66 2.24 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1144 ' ' VAL . . . . . . . . . . . . . 34.0 m -70.82 162.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1145 ' ' ILE . . . . . 0.495 ' CG2' ' HG3' ' A' 1149 ' ' GLU . 35.1 mt -87.95 137.7 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.195 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' 1147 ' ' ALA . 9.1 t -57.67 117.53 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1147 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1146 ' ' SER . . . -34.69 -46.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.054 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1148 ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -37.63 -55.15 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1149 ' ' GLU . . . . . 0.495 ' HG3' ' CG2' ' A' 1145 ' ' ILE . 17.5 pt-20 -89.34 -47.37 8.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1150 ' ' GLN . . . . . 0.577 ' HG2' HD11 ' A' 1154 ' ' ILE . 28.5 tt0 -42.04 -62.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1151 ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' 1154 ' ' ILE . 0.3 OUTLIER -42.81 -59.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1152 ' ' THR . . . . . . . . . . . . . 84.9 m -44.18 -49.96 8.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1153 ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.1 -37.76 88.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1154 ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' 1151 ' ' GLU . 62.8 mt -63.3 -57.2 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1155 ' ' VAL . . . . . 0.437 HG12 ' HZ2' ' A' 1159 ' ' LYS . 45.3 t -58.47 -40.69 79.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1156 ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' 1222 ' ' PHE . 40.1 tp -66.18 -60.98 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1157 ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' 1161 ' ' VAL . 56.8 t80 -37.81 -48.19 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1158 ' ' GLY . . . . . . . . . . . . . . . -52.89 -45.65 61.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1159 ' ' LYS . . . . . 0.437 ' HZ2' HG12 ' A' 1155 ' ' VAL . 29.7 mttp -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1160 ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.18 -47.76 83.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1161 ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' 1157 ' ' TYR . 99.9 t -54.24 -44.65 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1162 ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -63.74 -46.39 85.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1163 ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.18 76.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1164 ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -53.35 -41.59 65.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1165 ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.9 -69.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1166 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -36.93 5.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1167 ' ' HIS . . . . . . . . . . . . . 2.4 t60 -74.64 -43.84 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1168 ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' 1173 ' ' VAL . . . -45.32 -55.71 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1169 ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.03 -36.68 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1170 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -53.89 53.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1171 ' ' MET . . . . . 0.504 ' CE ' HD11 ' A' 1178 ' ' LEU . 15.9 mtm -75.61 -6.44 50.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1172 ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.14 33.63 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1173 ' ' VAL . . . . . 0.429 ' O ' ' HB1' ' A' 1168 ' ' ALA . 27.0 m -121.54 138.97 29.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.133 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1174 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -47.94 136.62 22.97 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1175 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.98 -20.59 2.16 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1176 ' ' ALA . . . . . . . . . . . . . . . -92.52 -38.79 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1177 ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' 1177 ' ' ILE . 19.5 mm -58.91 -46.82 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1178 ' ' LEU . . . . . 0.504 HD11 ' CE ' ' A' 1171 ' ' MET . 13.1 tp -51.31 -61.75 2.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1179 ' ' ALA . . . . . . . . . . . . . . . -151.4 148.83 28.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1180 ' ' THR . . . . . . . . . . . . . 76.6 p -94.91 165.95 12.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1181 ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' 1185 ' ' VAL . 20.2 m-80 -60.05 -37.23 79.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1182 ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -61.56 -48.87 79.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1183 ' ' ILE . . . . . . . . . . . . . 78.0 mt -58.25 -40.74 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1184 ' ' LEU . . . . . 0.447 HD13 HG22 ' A' 1161 ' ' VAL . 83.3 mt -63.55 -54.12 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1185 ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' 1181 ' ' ASN . 94.4 t -55.2 -38.76 48.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1186 ' ' ASP . . . . . 0.553 ' CB ' HG23 ' A' 1201 ' ' ILE . 1.1 m-20 -59.08 -60.98 3.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1187 ' ' MET . . . . . . . . . . . . . 49.2 mtp -53.55 -28.15 30.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1188 ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.99 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1189 ' ' LYS . . . . . . . . . . . . . 22.2 mttt -97.42 -60.47 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1190 ' ' MET . . . . . 0.43 ' SD ' ' O ' ' A' 1186 ' ' ASP . 1.1 mpt? -64.61 -39.76 94.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1191 ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' 1192 ' ' PRO . 49.1 mtm-85 64.17 55.01 1.55 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1192 ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' 1191 ' ' ARG . 53.8 Cg_endo -69.78 119.61 6.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1193 ' ' THR . . . . . . . . . . . . . 52.4 p -92.2 -21.52 20.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1194 ' ' THR . . . . . . . . . . . . . 59.2 p -109.04 144.14 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1195 ' ' VAL . . . . . 0.519 ' HB ' ' CH2' ' A' 1216 ' ' TRP . 8.3 p -56.06 -30.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.126 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1196 ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -58.95 -41.32 87.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . 0.428 ' HB3' ' CE2' ' A' 1233 ' ' PHE . 57.4 m-20 -75.19 -37.09 61.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1198 ' ' VAL . . . . . 0.51 HG21 ' CE3' ' A' 1216 ' ' TRP . 58.6 t -59.11 -49.21 84.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1199 ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -50.91 -28.77 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1200 ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -70.38 -32.15 69.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1201 ' ' ILE . . . . . 0.706 ' O ' HG12 ' A' 1204 ' ' VAL . 21.6 mm -49.57 146.11 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1202 ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.07 142.17 49.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1203 ' ' GLY . . . . . . . . . . . . . . . 99.22 -46.46 1.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1204 ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' 1201 ' ' ILE . 9.6 p -67.51 132.6 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1205 ' ' SER . . . . . . . . . . . . . 58.8 m -96.88 145.66 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1206 ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -40.72 126.8 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1207 ' ' GLY . . . . . . . . . . . . . . . 93.52 -59.7 2.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1208 ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' 1209 ' ' ALA . 1.1 ttmp? -38.69 -48.69 1.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1209 ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' 1208 ' ' LYS . . . -34.67 -46.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.1 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1210 ' ' ALA . . . . . . . . . . . . . . . -43.92 -66.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1211 ' ' MET . . . . . . . . . . . . . 3.8 ptt? -47.12 -26.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1212 ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' 1178 ' ' LEU . 72.5 mt -89.09 32.58 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' 1214 ' ' PRO . . . -67.41 -53.75 21.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 111.102 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1214 ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' 1213 ' ' ALA . 65.2 Cg_exo -47.9 -17.26 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.715 2.276 . . . . 0.0 112.321 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.39 -60.53 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1216 ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' 1213 ' ' ALA . 1.1 p90 -67.29 -28.28 67.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1217 ' ' GLU . . . . . 0.531 ' N ' ' CD1' ' A' 1216 ' ' TRP . 27.8 mt-10 -56.41 -33.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 77.4 t -70.17 -41.21 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1219 ' ' ILE . . . . . 0.45 HG12 HD11 ' A' 1156 ' ' LEU . 83.7 mt -59.82 -53.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1220 ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -45.77 -43.67 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1221 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -76.03 -43.95 41.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1222 ' ' PHE . . . . . 0.689 ' CD2' HD13 ' A' 1156 ' ' LEU . 27.6 t80 -54.18 -38.98 66.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -81.06 -26.47 36.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1224 ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1225 ' ' THR . . . . . 0.644 HG23 ' ND2' ' A' 1226 ' ' ASN . 9.3 t -87.06 -34.93 19.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1226 ' ' ASN . . . . . 0.644 ' ND2' HG23 ' A' 1225 ' ' THR . 14.5 m-80 -91.43 8.19 37.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1227 ' ' SER . . . . . . . . . . . . . 43.1 t 42.04 43.51 2.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1228 ' ' VAL . . . . . . . . . . . . . 70.6 t -89.03 148.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1229 ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -76.09 151.86 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1230 ' ' THR . . . . . . . . . . . . . 71.0 p -145.05 174.64 10.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1231 ' ' ASP . . . . . . . . . . . . . 20.1 t0 66.22 41.79 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1232 ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.41 44.71 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1233 ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' 1197 ' ' ASN . 79.5 m-85 -87.17 148.94 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1234 ' ' SER . . . . . . . . . . . . . 11.7 t -76.57 86.49 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1235 ' ' SER . . . . . . . . . . . . . 46.3 t -156.4 134.76 11.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1236 ' ' THR . . . . . 0.563 HG22 ' O ' ' A' 1236 ' ' THR . 19.2 m -88.03 40.64 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.181 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1237 ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -148.39 106.44 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.721 . . . . 0.0 110.869 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1238 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -40.06 5.68 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 0.0 112.331 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1239 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 40.13 40.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1240 ' ' SER . . . . . . . . . . . . . 99.8 p -50.97 123.23 8.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1241 ' ' GLY . . . . . . . . . . . . . . . -149.15 80.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1242 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.68 13.62 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.703 2.268 . . . . 0.0 112.302 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1243 ' ' SER . . . . . . . . . . . . . 9.4 t -108.01 135.84 48.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1244 ' ' SER . . . . . . . . . . . . . 73.9 p -81.09 -45.45 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1245 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 -179.982 . . . . . . . . 0 0 . 1 stop_ save_